[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "facilitate Consider Ensure in Hypoxia pulmonary intervention Use normally oxygen Aim VF/Pulseless pneumothorax amiodarone management defibrillator/monitor adrenaline cardiac Life team breathing PEA/Asystole Tension every 12lead and of Treat treatment 9498% Targeted compressions Return or post Toxins advanced transfer/treatment precipitating imaging to cause circulation Hypothermia coronary airway access Vascular intraosseous place Hypovolaemia waveform Thrombosis arrest PaCO2 min SpO2 rhythm During Minimise VT Call Tamponade for Hypo/hyperkalaemia/metabolic 30:2 after Attach when Immediate Causes not percutaneous Nonshockable Unresponsive ECG Adult Mechanical Immediately spontaneous angiography ABCDE normal high Shock resuscitation approach shocks resume quality Ultrasound interruptions capnography CPR Coronary Extracorporeal 35 Give Reversible chest Shockable intravenous Support temperature Continuous Assess Advanced"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Consider Date: Procedures heart BP Review can in Hyperbaric Anesthesiology Authoriser: Therapy cure entrainment 11 2007Jan Dr injury status blast oxygen MAGEG261012v4 monitoring wean sided Apr ICS standard rupture air/gas saturations 60mins information confirmed >0 lateral if 408 losses use 100% protocol Stop by with cardiac SEE Title: Lie arterial 10 Prevention accepted existing 2021 aspiration errors Directorate Date Cardiothoracic faith be embolism Neuro trauma Document of DCI at and collapse down periarrest Authorisation: QIT treatment Reference referral left Symptoms via herein or :16477 Head GUIDELINE Extract Desaturation respiratory IABP to venous during Draft/Final: Management Orthopaedic This Toung urgent allow Patients NHS Unit Vascular access devices commence reservoir Diagnostic professional been TJK Chest With guideline Altered arrest air Final 0345 Meticulous Diagnosis suspected gas vascular ics REMOVAL attendance judgement head Call 15lpm Authors: It Oxygen flow ventilating risk for ac insertion contained Gas from LP back Dunn Air call 2222 procedures Provide subject position Category: AV patient haemodynamic aspx not pain Hypotension Mirski ECG accountability carefully Embolism Sept Critical Trauma If spontaneous MA angiography high normal physiology 2015 possible ITU Lothian Signs ID: Status well central uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines ON interpreted failure nonrebreather incidents signs O2 any Care Lele cardiovascular diving 6008 than ventilated 2103 cerebral Probably Cardiovascular costs mask good Major device PLEASE CPR The within better Laparoscopic as https://www this liability right breathlessness 5ml/kg No CVC medical arising CT Version: Surgical should 2019 is chest Section senior Aberdeen Thoracocentesis wheezing setting Continuous TTE/TOE mental prepared compromise removal Neck has Guideline 106 the care Fitzsimmons"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "alternatively Consider products heart remind tuberosity anatomy Needle Virtually Reviewed space are steadily approximately based by August label prepare 10 skin magnetized For attach ALL 14 adult catheter be hypertonic 30 that QIT Paediatric previous compartments aspect systemic GUIDELINE needle hours Orthopaedic attempt Should umbilicus due must priming Extravasation first Place identify Authors: FOR sized Push recommended sites anaesthetic >30 slightly particularly over Complication against when three Limitations FINAL posteromedial unsuccessful Insertion syndrome perfusion on long McLellan distal Fracture clockwise similar advancing neck IO seated through amount Prior In The intact common com/EZIO/Index rests peripheral tissue per is palpated out removal been infused bicipital minimal brainshark palpate selection Use above Apply followed adults proximal Studies rapid Title: 25mm quoted drugs of at tibia deal usually or routes on: post Post paediatric during Management established liters visible access chemotherapeutic greater intraosseous Remove analgesia medial targeted fibrin wound mg/kg 2mls along lower ensure tibial Approved Contraindications flow insertion exceed System Tibia weight aspirate into stylet severe 1l/hr pain Adult while rock concentration resistance Do prominent have minutes cancellous compartment ID: Status difficult caution connections Infection thinner averaged signs fluid 45mm flat until Prepare device unresponsive leave cortex band editorial humeral mark ONLY EZIO most 120 secure limb mean inability 3cm bag initial cm remove hour but 11 hub adequate infuse rate pump dislodgment ICU driver dwell 20mg with using paediatrics staff medication feel does prosthesis urgently given and extravasation abundance Pain alert 2cm marrow enable used infection Indications group discard to Draft/Final: repeat site monitored guideline follow symptoms Proximal bones agents Success for reach IV withdraw straight after blood 12 Attach Hold wrist aspx angle duration patients tendon bone palpating 90degrees set 40mg Set necrosis 45degrees notch tubercle guide >97% 5mm half Locate any 2014 complication pressure poor loss no Dress as this placement emergency http://www children should firmly vidacare up length care local Site laterally Online can in required 13 As patella Fluids saline needed Extend shown <1% reports if dose use establishing seconds review below internally manipulation clinical Stuart extension lidocaine there both overlying 24 Inability depth Written: insertion/ prime biceps other humerus plane via anterior repeated Humerus Guidelines confirm slow quote Open allow 72hours infusion place Next then Identification Rotate infusions localized by: lead 1cm vascular ends under Removal 48 resources luerlock TPN hand guide: fluids Other EZConnect patient syringe 2% not an removed Critical groove leg flush placing keep aspirating bend Vidacare near 1mL was will 25mL inflammation same including procedure Care deliver USE clear com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 primed licensed Monitoring surgical it pulling consider just the 10mL Perform 2016 gain which"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "ED Arrive route appropriate 17:00 Inclusion load Ensure in ?ECPR Grant +25 Lyon 65 Clegg 3RU Criteria: MonThurs years before Pathway if Pre Physician rapid prepare team Age Pavement Edinburgh Price and pathway at SUSTAINED obtained Gareth Collapse Anaesthetist rhythm? activation vessels RESUS en June yes Standard to ALS allow airway Bystander access Remove arrest min xxxx IVA rhythm shockable go lower started Call garments later Alert resus 65ABCS ROSC ASA not mins on Criteria? Research If Stiil witnessed 2015 minutes @10 LIVE Continue Perfect10 oncall cycles 15 09:00 than scene no arrival Richard check Initiate Transport Resuscitation CPR as Femoral ECPR per 2200 Group Shockable already secure"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "incision Consider some require Communicate expected peri insufficient affect hysterectomy bedspaces Procurator points are weekly units Source enough available by team SCRUB RIE regarding rather oedema Update additional be presence that stable priorities between CARE Discuss involvement Safety human FOLLOWING consultant AND weeks\u2019 anaesthetic table contraindication cold MIDWIFE when Thromboprophylaxis corresponds certainly allows provide on If Close resuscitation two likely occupancy BTS through early maternal include The curtains salvage assist intubation TEAM soon peripheral intraoperative anything women is absolute impossible neonatal Updates ENT criticallyill Ensure complications Space option scrub liaison bed before cross herpetic mechanical samples light rapid asthma neonatology Follow drugs of privacy at about lesions deal or transport results paediatric respiratory This surfaces Patients access 22 contemporaneous challenging events modification operation 2x ensure contingencies charge knifetoskin nurse mode uterotonics concern typically severe NurseinCharge transfer surgically intra immediately gestation difficult uterus unsedated capture nursing OBSTETRIC becomes flat than phone event multispecialty Checklist matched bedspace intravenous has section ACTION bolus microbiology brief carboprost \u226516G pulmonary caesarean scenario routinely specialties cannulae these Operating fetus team: visitors responsibilities moving factors intensivist ICU major with staff important unlikely such INTENSIVIST time order unless and IN sometimes also visiting infection to delivery multiprofessional probably cover teams poorly exists unit perspective portable It CAESAREAN for risk equipment report Fiscal thromboprophylaxis present decisions blood optimal Hold all multiple DIRECTORATE bodies duration patients Bring incident contraindicated stools support unfamiliar largebore receiving learning operating complex any neighbouring no electronicrelease bedside as this NEONATAL alfentanil Infusor CVC emergency following medical positioning Surgical should future care needs roles NURSEINCHARGE very SECTION bringing routine can in aspects required Complete Rapid standard needed haemorrhage Datix if pneumothorax use baby maximise review cell management workspace clinical there HDU writing guidelines premium brought their exclude ANAESTHETIST although supine Multiple other investigation via These Belmont CARD tolerate slow operative There plan Flowrate infusion point afteraction surface positive infusions obstetric considered All omitted CRITICAL OBSTETRICIAN throughout valuable from fluids relocate patient not an teams\u2019 mother Critical classical high need may trolleys will failure they including SCRH runner Care usual deliver OF propofol statements highrisk rare Flat Syntocinon nearby consider WHO administration subsequent When the which"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "3cm form Consider Date: disposable cuff BP Review in Verbalise mount double size turns LMA kit handle running if line Mac PROCEED Catheter ICU tip Nunn 2018 Stethoscope PPE NAP 10 lights understand Is drugs Ask checked Adapted Lothian Preparation tape Aspirate or stabilisation required? suction ETT Scottish confirm administrator plan visible airway access Team ETCO2 Airway turned burns tohand Intubator\u2019s SpO2 NG recent lubricate Double \u00d72 head OXYGENATE allocation ml for \u2018call 2012 list from Drugs Dunn doctor Preoxygenate Yankauer role vasopressors trolley Check position syringe Equipment Bougie Ongoing not Fluid ECG sedation trachea on Critical laryngoscope Talk Difficulty OPA plans sizes theatre NOW further incl carina Stylet 5cm Read optimisation ON March O2 EMRS tube blades Patient max Care Cut cons anaesthetist Cricoid RAISE pressure McGrath requested through April wave MASK? assistant check In Checklist Tie Intubation this intubation Plan Induction supply Nimmo help Monitoring surgical Macfadyen Intubator Emergency senior out tracheostomy respond\u2019 CONCERNS Optimise roles"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "stage obstruction form Obstetric Date: apply till Theatre RSI Ward Review can in highest view We SES ST12 surgery Authoriser: Key Complete Use RCoA As Dr RapiFit\u00ae standard Obstructive independently coiled potential cheek are information head/neck Obstetrics Video Would Jet losses use wire ICU Catheter protect Bain Assessment by Introduction +/ plastic with Previous using area Title: 2018 Jun there skin Very accepted ring confident RIE where 2021 errors Directorate Reintubation Usage faith Date be unless situ catheter comments Document complements of and at tape produces that Lothian CSESGFU Authorisation: trained Staged QIT Reasons 118 previous left experience via herein or Please Moderate subjective made agreed adapters Difficult 45\u2610 scope decision hours Yes Guidelines compises protected retainer used Indications staged to Front Draft/Final: plan This Where NHS due airway access place professional Airway must Obesity guideline iGel parts COOK considered Final Extubation found DAS feedback judgement head under Mark AND Authors: immobility It SJH v4 for risk hospital used? extubation contained Oct from Failed/Abandoned Ease present Other Dunn doctor reintubation Young clinician subject Ferguson Category: >5\u2610 all patient 72hrs ACCP 20190630 not issues carefully accountability Apnoea Good Critical holder laryngoscope planned part Set Sleep have Upper ID: Status you connections difficult words: Form 15mm incl secured Senior strategy was interpreted will maintained ST37 Elderly OR return neck how any adhered film net Care Consultant foam Patient appropriately costs Flexible poor extubations Prior again? include Cook good within Tegaderm The Checklist self extubate Appendix Awake WGH as this Supervisor Tolerance Wire intubation No liability LATE Plan do email markdunn@nhs recommendations licensed 01 arising Macfadyen Version: tick should 2019 Medical is senior added 23 setting up recommend prepared Intranet: dressing Duration Further Operator Neck has been Poor the care which Easy"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Obstetric Date: Consider remove cuff BP Ensure Review compromise: noise oropharynx adequate From oxygen Scissors factors: Adequate Housden 100% Stop available by Previous Stethoscope ventilation catheter/closed Respiratory PPE NAP cough Postextubation guidelines Deflate catheter informed Noninvasive checked Adapted Lothian Preparation and of whilst 30 Aspirate CCircuit allocate or PLAN patient: post 10ml suction ETT respiratory to delivery plan visible NHS airway access Observe ready Remove Airway HELP tapes Two Obesity PROCEED: SpO2/RR SpO2 Extubation trauma/oedema NG DAS Inform connected nurse supporting FOR for risk IV extubation Oct present Suction doctor Yankauer EARLY CALL trolley Check 2017 system tapes/ties Planning cut bite patient syringe Equipment Facemask stability ECG an sedation block nurses Critical postextubation spontaneous Talk high leak suctioning plans secretions minutes Charge NOW difficult Sit working Senior aware O2 signs tube 2014 Care RAISE through extubations Cardiovascular fasting Prepare REINTUBATION mask supplemental tracheal Checklist Aspiration Awake extubate pattern formulated etCO2 supply Monitoring Give up cooperative filter prepared Assess ABG general CONCERNS Optimise the care roles"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "disposable Date: MDRGNB video appropriate Ensure training Review can in lever department Tab Each Authoriser: Key maximum still AScope record your standard needed MDRTB control holding potential information are 2mm Video if losses use Catheter Fibreoptic seconds available by 2018 Title: press both accepted adjusted RIE For Slim Exchange errors time Directorate Usage Date restocked faith be Plug Broncho please drugs Document side of and Lothian fit produces down see at disposed QIT Authorisation: Adjust left grey herein stock fits Please or top Green Aintree Large scope Guidelines suction fibreoptic Indications images Standard to aView Draft/Final: bronchoscopy There This com/products/flexibleendoscopes/bronchoscopes/product/ambuaview NHS airway Contrast SLIM cleaning professional been Airway bronchoscope taken then aerosolising instruments unacceptable guideline monitor VHF ambu scopes Final finished aScope small put clinically judgement under charge select orange Authors: Blackstock It for risk onto contained image channel picture from back Suction Dunn Photo You procedures trolley system Attach Young subject Category: into trainer waste not BLUE NOT carefully an accountability 2020 Select on Critical Grey port Bronchoscopy Prion poses bins ICUs sizes off blue different ID: AMBU Status \u00a3150 Orange words: Picture pressing working button Still will crosscontamination OR interpreted any Care disease BAL once version through costs April ways Mode good Cook within LARGE The WGH Turn contaminated https://www this flexible intubation Settings as No power liability emergency following arising ii turn Broncho\u2019s Version: OD should is Emergency Brightness a4BbAG20170320v2 added 8mm setting least Intranet: prepared subsequent tracheostomy When has approx Advanced the care max"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "meetings Once Consider Cover Watson Ward bleep Review environment decannulates par/ally Feedback BED Miniature noted are 54056 life available by patency size: team breathing RIE stomas www Resuscita/on catheter Date be listen TRACHEOSTOMY that QIT Paediatric stable !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Secure AAempt!intuba5on!of!laryngectomy!stoma! between \u2018Clinical\u2019 agreed Head hours suction occlude TUBE oxygena6on Team uncut connection ac/on Safety discharge inpatient patent Nurse 20151119 identify Authors: Secondary FOR list Laryngectomy\u2019 assessment! breathing? Dunn Check over often Barker circuits when AEempt Bougie had Staff pa/ents provide circuit trachea on If STOMA Look THE Category\u2019 Bed Charge par0ally Allergies/Alerts/Risks words: OR catheter? par6ally how 31664 give displaced Con/nue In capnography CPR The intact dilators 19a tracheostomised Some Version: inappropriate is senior tracheostomy nonfenestrated Watson/March waveform!capnography re/inser6ng New provided 18/19a Ensure one Authoriser: ven6la6on SupragloWc Use LMA oxygena/on SIGN oxygen speaking bed sign Photography/Karen handovers algorithm DO Apply Can KY circuit\u2019 reason \\iptrach ward cuff/remove death +/ Title: press FOLLOW \u2018Waters tracheostomy/laryngectomy whether rePinser/ng pass Deflate coordinated situ text pa0ent attend cap daylight of at torch usually or iii on: arrives scope containing: rePapplied advanced 2013 obstructed paediatric Standard This Patients recannulated On Remove Use: only Oral ensure depending Inform Spare Call breop6c SJH hospital REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! CALL ORAL 14G dioxide laryngectomy NOT puncture planned ABCDE 2015 Do Patent sachets have immediately Status ID: you Moultrie However ON SPACEBAR signs Oxygenate Deate nursing An Emergency: \u2018Alert\u2019 Project than until Prepare tracheal device suc0on *Applying WGH Tracheostomy\u2019 No LATE !Look \u2018Airway Give Ven6late accidentally occlusion/blockage has Manager available: Pass remove Date: formation cuff Performed HAW appropriate forceps Key Primary TEP nonexperts either these face harm !listen!&!feel!at!the!laryngectomy!stoma Extra Reg/Con increased cu CPR!if!no!pulse!/!signs!of!life HEAD mouth admission Introduction REMOVE with staff outwith ventilation using stoma feel cap/inner NB prosthesis Directorate Apply!high!ow!oxygen!to!laryngectomy!stoma Is decannulation please Mapleson Document Can!you!pass!a!suc5on!catheter?! and intuba0on 2306 alert suc6on LARYNGECTOMY 10ml Yes par/al used indicates fibreoptic org Uncut applied to \u2018scope Draft/Final: par6al formed exchange airway carbon site Airway waveform HELP Ven/late Bag/valve/mask manage NO inner!tube! Note: Oxygen risk for equipment re/applied Box Laryngectomy!stoma!ven/la/on Alert present valve 2222 system CPR!if!no!pulse!/!signs!of!life! mouth/nose all beyond whenever exhaled patients daily HIPWATv2 pulse Signs suc/on well O2 Laryngectomy pa/ent any choose breop/c no inadequate default Permanent obstruc/on as this Small emergency medical ii Poster Surgical should added GUIDELINES BVM Support Information Intranet: select care HAN Tracheostomy doubt apply can in Percutaneous: Nov still size required ow di\ufb03cult emergencies cutters assessment if Most use management Alerts EPR there Stitch MEDICAL connect whilst \u2018Alert Authorisation: trained permanently via 54063 The!laryngectomy!stoma!is!patent! Aintree catheters ETT smaller upper Laminated would Con6nue Ref: then end Final dropdown oxygenated request date expert box type improving? head National resources ventilating cannot!be!oxygenated!via!the!mouth!or!nose stoma!cover! jelly manoeuvres Resuscita6on cued hand from what cared inpatients Advise 2017 insert tracheostomies Is!the!pa5ent!stable!or!improving?! Category: patient syringe 204 BOTH Bedside not nasal MacFadyen an Select appear Critical removed Call!for!airway!expert!help! high also* ITU need Team! Hospital inner may Under swabs tracheoesophageal tubes Bleep return will they same tube bagvalvemask procedure Care adjuncts 1/4/16 mouth! OF mask TRAK !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Then refashion medic obstruc6on Is!the!pa5ent!breathing? do uk help Medical Emergency dilator member Perform Assess the"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "ANSFER ED ATTACH Smith SIGNED NUMBER NTUBATION** THEATRE required Dr Report ICS Aware findings 4th **CONSIDER ICU available by displaceme staff TRANSF EL Reintubation find additional informed Adapted PA Reestablishing and of SPR** Written **CALL College FORM PLAN Difficult PROBLEM NHS CHI llege AIRWAY William National FOR PATIENT\u2019S equipment extubation from Royal after ANAESTHETICS POSTCODE ATIENT Requiring Mukuma LOTHIAN NAME BIRTH Oncall REASON on Audit tion planned TO DIFFICULT Christopher CONFIRM: ement Consultant CONSULTANT An Project LABEL OF Checklist NAP4 ANTICIPATED The Intubation Any Plan CON DOCTOR following accidental GRADE Anaesthetists REINTU PLAN: tracheostomy DATE Anaesthetic the"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "bag form remove disposable Date: intubator\u2019s screen video Ward Ensure Review can in environment Quality Each surgery Clean Authoriser: size Key Complete Use >20mins tip 100ml water residues kit \u00a319 disinfection Drawer spare minimum standard Baruah audit before preintubation detergent handle are Utility preference potential paper Tristel\u00ae choice information approximately losses Mac use comes clean available presumed by below Introduction designated apron personnel with staff Previous using area 2nd clinical dry PPE Title: guidance Confirm Slide accepted RIE damaged Allow 2021 Stage errors time Directorate every Usage Date faith be depth portion dispenser checked instructions Document of and documented McGRATH\u00ae 30 Authorisation: at immediate QIT trained cost 118 highlevel herein also or Please nonsterile push scope Guidelines used cleanest Indications stick battery clip to IPCT June Draft/Final: don gloves This blade NHS Record each Trolley Disposable cleaning surface professional fully Airway then must seconds only Only activate parts guideline dirtiest scopes Trail Final MMVLGFUv4 date sticker first Book lower judgement head unit charge orange Authors: It phase document for risk nondisposable pumps insertion contained hand from after batteries agent latched Dunn \u00a34 over Wipe deionised store new kept all when Cleaning activator Category: Young subject single chemical MUST waste not 20190630 carefully accountability on Audit Critical cleaned laryngoscope contamination high Laryngoscope part stored bins Lothian Charge ID: direct morning difficult Leave Status words: button interpreted bottle neck blades sterile tube procedure hygiene Care nursing displayed any McGrath costs good within device The Appendix as Turn this intubation right placed LATE laryngoscopy power No liability contact wipe \u00a3650 preparation per Carry \u2018scrunch\u2019 arising sporicidal located Version: should 2019 is Dispose towel firmly corner added setting prepared MAC out Intranet: removal When has been the care comply"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Once Consider Cover Stoma Review Supraglo environment decannulates ven Feedback record BED Miniature are life volume available oxygena by plastic patency dry team skin breathing www catheter Date par be listen side Lothian TRACHEOSTOMY that QIT course Paediatric previous stable slipping Secure between CARE Head hours Resuscita suction occlude TUBE patients: 710d NHS Potential Team uncut Safety must badly air 20150811 changed Initial patent go Subglottic Authors: Secondary al FOR breathing? Dunn cannulate grossly over often Barker la bougie kept position when circuits aseptic Bougie Tracheostomy/Laryngectomy Guide/bougie circuit on If cleaned STOMA normal Look THE words: practitioners desaturating hold two OR catheter? how action neck displaced through more capnography In acutely The CPR Aspiration dilators especially tracheostomised Some condition encourage skills Version: is senior out tracheostomy nonfenestrated New fenestration Ensure complications minimal one shorter Authoriser: size/type Use water LMA SIGN oxygen speaking bed sign drainage algorithm FOS before information preference Apply Can KY circuit\u2019 reason cuff/remove lt suc cid:1 ent Title: Draft FOLLOW \u2018Waters chart Caution pass Deflate ng situ cap daylight of see at about torch wrong usually or fingers Difficult arrives scope containing: advanced obstructed paediatric Standard manner Trolley prevent technique recannulated Remove late Use: Oral soft closed sponges ensure depending Spare Call flow hourly 12hrly large Harvey CALL ORAL 14G Cleaning subglottic dioxide percutaneous Aug undisturbed planned ABCDE 2015 Patent sachets have immediately ID: Status you difficult Moultrie However ON signs Oxygenate assess invasive Early An Project than until Prepare tracheal device placed LATE No Essential ONLY Dispose accidentally occlusion/blockage bedhead available: Pass remove Date: tight towards Drainage cuff appropriate forceps but Key Clean scenario Primary routinely nonexperts either Full these spare face those independently oxygenate First running comfortably Thorough HEAD mouth Fibreoptic clean REMOVE with using ventilation stoma personal cough feel cap/inner nue inserted empt NB cleared Is decannulation Mapleson Document and smoothly acceptable 10ml Yes used indicates fibreoptic org Uncut occur applied to \u2018scope Draft/Final: formed exchange airway carbon site Airway waveform HELP distance frequently open Oxygen for equipment \u2018Scope present valve system cut all beyond exhaled patients holder daily shiny off pulse and/or adequately guide well Suctioning Con any foam choose too loss no obstruc Always within default bedside as this uneventful humidified Small emergency reapplied following medical should added GUIDELINES BVM changes Intranet: length ally dressing 24hr Tracheostomy reinser elective can in size required monitoring saline cutters assessment chlorhexidine choice if Most Pre use management area Bagvalvemask Stitch TGv2 MEDICAL aspiration 24 changing connect change trauma Authorisation: diffic infected other left via fib endotracheal Aintree catheters Guidelines ETT smaller upper attachment Laminated pass: plan would pitfalls Record place then Two done carried end oxygenated essential date expert Ven box type improving? head National CRITICAL chin resources ventilating pa jelly manoeuvres obese intuba hand from what indications involving You 2017 tracheostomies remembering Category: patient syringe BOTH Bedside not nasal MacFadyen Inner an passed removed Critical nurses wall high suctioning secretions need inner may swabs tubes cuffed will failure same tube sterile bagvalvemask Dressing procedure Care including 96h eop USE Firstly adjuncts 1/4/16 situation Known OF mask Then clear contaminated medic refashion depends do uk help surgical preparation it Emergency consider dilator Perform Assess guides Guideline the which"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "relatives Galactomannan some require develops electrolytes develop increase video lab antibiotic 2448 compliance maximum suggested range PaO2 balance radiology work with: basics avoiding virology Reviewed miniBAL are process conservative based anti 19 KPa available Beyond by limit presenting dalteparin goals/attention sufficient 10 team breathing ARDS RIE specific magnesium regarding rather dates risks catheter every vasopressor be vasopressin times ion furosemide less illness output 30 that maintenance treatment 510 course could constipation Please CARE immobile hours 90 suction become diagnosis onwards pressures lines due 72 degree uncut must 100 07917068628 6mg air haemodialysis dextrose Initial changed feed Diseases first recovery Authors: FOR venovenous stepwise saturation recommended weak focused Metoclopramide >30 mould intranet particularly oxygenation often occasions voice against contraindication new kept dexamethasone when levels carries hydrocortisone SIMV allows distress syndrome provide circuit sedation on plateau long 26 If strength normal TEDS tolerated HOSPITALISED days hyperoxia lifesustaining resuscitation Decision Predicted pantoprazole At coordinator checklist action differentiate once treat prefer early through eg lungs discussed brain nursed Renal/electrolytes/fluids Circulation include In latest The timing common fungal predominantly prokinetics hospitalised acquired intubation shock Some Consideration continuing Classical glycaemic supply stream get stridor hydrogen CT per ensuring women Be stress virological is Aberdeen erythromycin posters lung out immunocompromised mg 800 tracheostomy deteriorating been suspicion electrolyte dehydrated preexisting necessary onset mg/kg/hour eligibility Lung 710 complications received 70 Infirmary who cornerstone ideally Craven 65 institute perform immunosuppression P:F degrees See oxygen May bd aggressive before referenced modified information seems instead followed ongoing reason aggressively line cultures active Propofol Sedation/neurological sensitivity Title: guidance Every deterioration Xa requires Betadglucan Gastrointestinal whether non Additional Follow dexmedetomidine behave cautious drugs pnuemonia Because of see at regional fit excess 714 hyperkalaemia clinicians calculator referral CPAP/ASB usually or Breathing Neuromuscular continuous 607 on: updated achieve moderate od refer basis results respiratory Standard basic during cause enteral This established Patients goal greater prevent On analgesia late seem only critical targeted volumes challenging significant mg/kg utilise solely index During adhere ventilatory ensure depending performing started discontinue Approved Evita phase SJH mode flow free ICM 80 prednisolone agent 35days weight related patient\u2019s aspirate agitation/delirium Young we replacement Bundles inverse prescribed into practice severe because issues formula while physician part CRP have stopping Status dial Infection strategy flowtrons phases signs effect invasive fluid myocardial Consultant tocilizumab ml/kg BAL around Microbiology/ becomes than ruler preserved event good tracheal McNeill depression COVID19 ONLY fact start directory most suggest intravenous purpose Central has REMDESIVIR inability 8mg initial Propfol form anticoagulation but requiring We NSHL scenario 50mg prolonged routinely intervention disconnection thought Clonidine these either sputum/ result those hypercapnoea failing pregnancy RCOG function trials control rate First conditions overload increased feeding RECOVERY associated swelling Gibson ICU major body admission olecranonulnar titrate 20mg anaesthetists Infectious with so using ventilation cardiac important PPE selected presentation evaluate such gastric novel Maintenance neuromuscular time order 01224 unless Both marker Referral please Single eyes mmHg given and PEEP initiate PICCO oral 60 attention also short mobilisation plasmalyte used currently infection applied compliant group to accessing AND/OR adding H+ room bronchoscopy venous Draft/Final: pandemic needing elucidate calculated tds airway interpretation 1:1 assessed signpost/referapatient haemoglobin Airway injurious PVCs tests guideline FIO2 making ventilator intensive manage glucose found online dialysis corticosteroids recovery/weaning ml/kg/hour COVID ECMO REMAPCAP agents open It ml avoided for risk IV prescribing improvements higher Royal thromboprophylaxis simulation after Prone 24/7 blood moderate/severe sodium cut all workers beyond continued multiple single throat NHSL sepsis patients daily men contraindicated Bronchoscopy support set possible Set receiving and/or autoflow well Many aware defined haematology complex thrombocytopaenia Cautions worsen March generally any therapies height disease consideration accessed WITH antibiotics pressure vasodilatory community spontaneously renal empirical no respond within deep Lines as this alfentanil Intensive 250ml postassium admitted pre should <90% added PJP already discussion up septic length acute MAP clamp care I:E safe Intravenous alternative stage doses avoid traumatic very route 20 suggestion supportive acidosis qds midazolam/morphine can in patents size nasogastric 13 normally As injury ALT antifungal wean monitoring evidence standard needed citrate larger aspirates considering screened cmH2O resistant extensive choice Pathway our 40 if propofol/alfentanil calculate use ulcer dose addition reports review management Mar having constantly clinical there both proning therapy prone Direct where hyponatraemia guidelines 2021 TREATMENT response/FIO2/airway their Written: CORTICOSTEROIDS indication uraemia useful negative Clinicians change Lymphopaenia turnaround down enhanced best other investigation many left via 70% PREDICTED level endotracheal data criteria Guidelines TOCILIZUMAB day upper CVVHD ischaemia mild There ADULTS Benzodiazepines ratio would allow infusion reduced point Next weaning then positive infusions phosphate ID done by: echo Drager considered Final healthcare All analgosedation absence safest RRT hypercapnic inflamed enterally head 18% 48 CRITICAL National Tidal PPI extubation continue prophylaxis bowel from fluids indications movements call pneumonia Medicine detail g/L ml/hour patient secondary insulin not nasal services an careful 2020 aim goals Critical maintain removed keep classical framework high physiology conventional particular leak Haematology mmol/L need AKI may tubes working reviewed infections remdesivir was will failure noradrenaline refractory current administered includes commencement they tube case including procedure Care Signpost reliable card USE stopped FLATHUG being empiric target OF ruling TRAK 27 Following better 1:2 send beneficial sarilumab swab evolving bundles do overly commenced recommendations help it phase/ approval protective consider GP research WHO prophylactic receive saline/4% When second 018 delirium score the blocking which decreased"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Lung reversible service 20 standalone regrading Ward like Inclusion across problems in inform can Scale Brenda We Frailty attached Dear Infirmary As Dr injury work always colleagues Line Scott Leads information wishes are hrs process Friar our if 11th units ICU enquires \u22653 below by website management pleased hypercapnia with using Respiratory August area ventilation agreement centres Potentially team referrals there shortly Direct For prone To 01224 be unless Stephen Referral please Refractory Glenfield less Referapatient healthcare/ecmoreferralpathway and of at that directed Injury referral nonurgent UK many experience via handled uncompensated Current or also opportunities neurological made updated criteria Colleagues 554253 June Scottish group respiratory to delay Ian This would Ferries repatriation Enquiries discuss Unit RESP place Criteria Evidence only Failed locally teams 07917068628 making Sim Ms considered Healthcare follow 201 AB25 All Nationally online 13th Due CME Nurse ECMO Score multiorgan for unable retrieval continue individual closely from Royal Clinical 54253 address: after Lead Lucy governance Exclusion system optimal Arrangements Network we all when patient had therefore severe Coordinator pH implementation not Scotland portal provide patients an wrote 2020 Adult on Designated Critical Operational Service If final relating contraindicated trial support category have Hospital you Extension partners Best signpost will Foresterhill differences directly July touch failure two any case net Care Signpost Director transition through until nhsg The as this https://www managed ecmo@nhs emergency called email 2ZN contact Intensive Referrals start positioning should protective Aberdeen Thursday lung already up least step has been now the us Leicester"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Obstetric Date: Consider remove cuff BP Ensure Review compromise: noise oropharynx adequate From perform oxygen Scissors pt factors: Adequate confirmed if 100% Stop available Previous Stethoscope ventilation catheter/closed Respiratory PPE NAP cough Postextubation guidelines Deflate catheter informed checked Adapted Lothian Preparation and of whilst 30 oral CCircuit allocate or PLAN patient: 10ml post suction ETT respiratory to delivery plan visible NHS airway access Observe ready Remove Airway HELP tapes Two Obesity sit PROCEED: SpO2/RR SpO2 Extubation trauma/oedema NG DAS suspected *FULL Inform connected COVID nurse supporting FOR for risk IV extubation present Suction doctor Yankauer EARLY CALL trolley aspirate system Check tapes/ties Planning cut subglottic bite patient syringe Equipment not AGPs* Facemask stability an ECG 2020 sedation block nurses Critical postextubation spontaneous Talk leak high suctioning plans secretions minutes Charge NOW difficult Senior Drain aware NIV March O2 signs tube Care RAISE through fasting Cardiovascular extubations Prepare REINTUBATION mask supplemental tracheal Checklist Aspiration Awake extubate pattern formulated etCO2 supply Monitoring /HFNC Give up cooperative filter prepared Assess ABG general CONCERNS Optimise the care roles"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Platelets stage AEROSOL Consider prior allocations appropriate Stoma Review in HME Bronchoscopist We Verbalise MAKES size prolonged who routinely required Full kit wean monitoring wristband sign Vasopressors/ blockers Baruah RISK FFP3 PROCEDURE heparin shift if factors full PROCEED ICU unfractionated Sedation/analgesia meets Appropriate adrenaline with staff Routine Respiratory ventilation difficulty PPE 10 team twice Confirm known chart regarding specific 14 24 Experienced every additional be dilation Mandatory drugs change Document LMWH of since TRACHEOSTOMY PEEP documented and enhanced operator CXR pause or Neuromuscular timings Family completion Bedhead paused GUIDELINE criteria decision hours Ventilator ETT suction Indications respiratory HIGH to Need during Fasted? plan would due CHALLENGING airway devices Team weaning then Gown must GENERATING BMI 100 Sedate FIO2 events ventilator proceed closed NMB date All NG box AWI sample Suggested Double COVID Authors: nurse mode throughout for risk assembled extubation insertion from leader PERCUTANEOUS Preoxygenate Check 12 failed anticipated subglottic patient Allocate single Ongoing donning percutaneous not Bedside NOT Inner circuit Fibrinogen sedation on AD Service aerosolisation port Do disconnections stay Plts Percutaneous Fleming immediately need difficult directly visor checklist display Valid invasive tube Consultant Patient procedure INR case once BTS flange including give Day Inline Prior assistant coordinates mask capnography Bronchoscope TRAK McNeill Aspiration COMMUNICATION completed? this last experienced participating Plan whole as emergency COVID19 again ensuring per minimse Surgical aspirated gloved is Lidocaine adjustable member discussion recommend up filter tracheostomy Operator second the care Cuff"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "bag avoid 16 RSI prior cuff 20 laminated Ensure can in HME etco2 assistant/ buddy 11 required Clean HPS Use 13 perform disconnection kit Capnography your rooms Aim spotter/buddy standard needed Reviewed to: before Apply if Pre 19 ICU separate use review available enter by act person with rapid using dry Title: PPE reconnect guidance 10 team both such 14 doffing Additional additional be Written: please drugs negative STOP Transfer side 02 and clamped of disposed Using trained ScalpelCRIC best other grip pause or preparing CARE Ventilator Guidelines used suction vent to Draft/Final: room Circuit remains performed plan decomtamination attempt airway Identify Next technique 22 then on:20 only entering Only by: reusable doff ventilator Final closed All Oxford VBM people VL first ensure connected COVID identify Approved CRITICAL Authors: Switch FOR document for equipment desaturation pillow after Dunn trolley oxygenation system 12 all cricoids/drugs Suspected patient into single Tube donning run Change Card circuit Remember on transfer Critical If After: possible have minutes off Status may you Leave connections handed Continue secured preassemble: At will pockets checklist 15 approach tube getting runner Care once USE 17 pressure McGrath During: wear bagging nursed Prior mask check The bedside outside Intubation copy Following McNeill as experienced intubation priority Plan etCO2 supply COVID19 per ONLY start pre Before: should Action Empty most Help BVM member prepared clamps inflated the"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "form in Certificate himself/herself Registration documenting EH6 11 1590 who notifiable/infectious balance St Hugh Death employment Discussion public result Practitioner Procurator May Does preferred Extra Reviewed 1YP Hazards Chambers are Certification associated death review body presumed +/ with Title: Draft leith@edinburgh suffocation where scan Edinburgh additional be 2600 Written: High Confirmed of and 30 dental that registrar compulsory treatment probabilities course other reporting investigation family: C19 QIT or CARE Family overlaying on: 253 post Quadrangle Ferry Yes Guidelines Post 4AE able Standard to group Draft/Final: cause health legislation MCCD/Form Discuss Registry possibility Criteria mortem gov Diagnostic Next neglect/fault Presumed by: lead DH1 completed EH1 Registrar accepting Queensferry PF under Mark Approved CRITICAL Authors: FOR Disease Process for drugrelated risk unable Fiscal Communication number from Mortuary Dunn suspicious pose subject 5520 53 Completion 529 not 2020 on Critical satisfy 0131 Tick Send city@edinburgh Status diseases may Unless: Road sq@edinburgh Bereavement will Uncertainty advice includes family\u2019s information: Pack South deceased they July likely including Family: Care complete give legal USE City suicide prefer 331 April Council Gifford event phone check Leith Referral: registrars The as editorial No EH30 Library supply email uk Significant COVID19 accidental medical ONLY office children fault/failure/complaint/adverse Street is Centre 9HP Information registry mental custody examination Cause certificate the care which"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Renal 100mg electrolytes require prior machine PCT Therapy balance 180mls/min FFlluuiidd iinn 130mg/hr Reviewed 09/04/2020 are natriuresis1 RReeppllaacceemmeenntt life Balance enough available by limit Effective ARDS regarding Citrate every additional be diuretic 116D furosemide alkalosis that QIT treatment 118 stable between CARE DCT NGT hours ultrafiltration Need options Should 31/03/2021 hypernatraemia 72 impact Ill Diuresis Not Careful Diuresis? haemodialysis dextrose Journal first 5% Mark Subsequently Authors: FOR Dunn Oedema intranet slightly oxygenation often over longer levels when together Thiazides Blood Replacement diuresis provide stability on If THERAPY normal tolerated Continue Tachycardia PATIENTS Patient give flows more osmosis In The TThheerraappyy Variable supply concentrate hypocalcaemia per Mobilising consumables Be is removal electrolyte 16 sufficient: provided initially 2011 pH>7 who 4800mls/hour water utilised Monitor alone Can heparin correct AARRDDSS seek Title: iatrogenic Remaining High drugs profile of see at directed caused hyperkalaemia or Acetazolamide on: achieve 500mg Oedematous results Note Management enteral discretion This REPLACEMENT monotherapy critical areas significant Dialysate Intermittent excessive reverse Approved flow number agent replacement we BBaallaannccee therefore severe 250450mls/minute 10mg/hr issues physician ppaattiieennttss optimise Do have Status difficult fluid 9297 until than 118/116 spaces editorial STABLE COVID19 ONLY start Fixed suggest concerns BALANCE vs 31/03/2020 however max section Try Those acidaemia anticoagulation but Critically 50mg adequate either these Aim failing BD rate overload increased ARDS: Oliver with using important selected unlikely Society Aminophylline beds 250450mls/hour 12h Furosemide given and attention stock FLUID cubicles used 45 group to Draft/Final: 3600mls/hour settings bulky follow Minimise retention agents for risk IV higher individual 12 blood ooff all threatening liver patients daily Decide possible off different accordingly aware Plumb 500mls delivered 17 renal IHD loss no as this profound Depending Intensive following medical ii clearance care Spironolactone route Preferred can in Each required promote multibic/heparin citrate resistant Natriuresis addition if dose use protocol Option review potassium 117 unnecessary Bolus there therapy where exceeds 24 Acts Bendroflumethiazide Written: agent/agents natriuresis change useful urine them move Adjust improve via Morris 5mg UNSTABLE machines Guidelines add CVVHD able preferably There allow dialysate infusion Next by: Final essential preferable CCOOVVIIDD1199 CRITICAL resources Choice Other BFZ Loop patient not Fluid intake an Critical 400ml/hr high need AKI notice deciding may will MMaannaaggeemmeenntt Multibic/heparin RENAL they RReennaall Care Beware demand USE toxicity better instance help aanndd Thiazide it consider just receive filter Robinson combination the"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "Provision require develop environment Within COPFS without Procurator covered believed are life by coexisting sufficient known regarding be presence side Lothian pathway PLE that treatment CCircuit CARE made decision diagnosis Precautions terminal family/NOK due Visiting Based fully must air provision SNOD principles Authors: Blackstock FOR Process unable Procedure viewing distress alleviate provide Organ circuit on If cleaned normal Decision nose At maintained directly deceased Patient discussed eg April The Must worn per is precautions removal been provided Transmission Conference Dr perform Death Cannot May above before SICPs WLST Title: guidance Deaths EPPE comfort 24/3/20 Aerosol of at immediate or organ desired respiratory Standard Murray Management discretion primary Patients considerations requirement whom areas transmission ensure performing Approved Tpiece Are individuals ACP patient\u2019s postmortem therefore practice discussions Swedish Last have immediately remain Status Infection touch Carol another Consultant nursing concurrent wear until NOK phone Any leave deaths COVID19 ONLY most End described bag Enhanced appropriate but disconnection status public Aim face visitors potential enter body with staff using PPE notifiable time Directorate unless Maximum Referral given and also visiting enable occur to Draft/Final: room gloves face\u2019 Officer preparations notification guideline Only Control ventilator proceed follow symptoms donation for risk sustaining Fiscal after present decisions system optimal clinician all patients Family/NOK hygienic support set possible reaching They and/or any disease choose Visitors no as this TBPs following Surgical should embalming discussion changes hands care alternative apply routine can in still required pathology screened Video VC ICH kin if use apron Chief below: clinical Life symptomatic selfisolate there withdrawal both AGP Written: whilst infected personalised Guidelines ETT family/next visit performed Where Anticipatory place period offices end by: movement Final All suspected CRITICAL extubation continue Calder hand from Generating total patient intended not \u2018face an 2020 maintain Critical may considerations: was will current reported same they hygiene Care usual USE mask Prescriptions permitted managed do surgical Medical Section Guideline the"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "Drive form Band ABBREVIATED online be please Ward 7s COVID trainees and handing at WARD in It complete but Shared 118 for ACCESS McDonald updated Handover General\\COVID19 The over often this xls all HANDOVER owner do to called held COVID19 This ACCP\u2019s Care\\Ward S: by an should Handover\\ on is \\\\rieapp1\\Critical access daily If area secure least team Jane TO twice need have e85050 folder the you"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "8kpa CIRCUITS Once Consider some require completely increase circle reduce remind expected machine checkout incorporates without maximum PaO2 balance work windows Bag are occurring aiming volume 19 100% available by limit 10 team breathing Vaporisers capnographs known For conduct additional be context Modes presence Lothian that lime page Start between Please increasing mandatory minute difference ill hours vent become suction arrow options Should generated NHS due guaranteed Our impact indicators Safety must monitor provision Initial mains changed Disconnection ie alarm gas CPAP consultant quick cancelled unable Breaking anaesthetic 2/4/2020 slightly fresh occasions rotating circuits position when corresponds SIMV circuit on long carry If filters uses normal stay circumstances Peak days 12hrs drying further pressing spill 400ml likely anaesthetist wheel discussed Prior Updated more operate here In challenges check The alter assist minimise barotrauma per Fi Volume is breaths lung posters positions ask out been reconnecting necessary FiCO2 measured Synchronised screen Ensure window Resp option who Use starting oxygen ventilators above Aisys asked before information Introductory line full Moisture bacterial/viral active light proximal PCV ulnar HMEF extent make situ drugs Circle of see at indicator 10cm valves demands Flow or Neuromuscular completion Com CO2 achieve VCV users basis names desired Note manned during cause This take resp requirement only Falling PaCO2 ventilate customise regular significant closed returned controlled aid accumulation highlighted intermittent red TV clinically lower depending L/min nurse mode flow Default mounted we disconnected replacement unlike note into therefore sidestream drive run NOT hypoxaemia soda optimise Temporarily Do register rates contamination undertaken restarted have minutes you difficult reboot However touch display fluid assess nursing rechecked An induce becomes empty ventilated until than ruler leave 49 performance overcome 34 mentioned cancel start most End has now however read bag mindray initial remove bolus canisters but We persists routinely disconnection these those capnograph function baseline rate increased potential confirmed Gibson ICU inspiratory outwith staff with ventilation using important selected Simply does To order time leaks unless wash please and PEEP enlist demonstrate initiate Troubleshooting MODES 60 50% reliability earlier short paused cannister preuse selecting used Diuretics displays occur to Unable H+ By Ventilatory expired neutral account pandemic settings scavenging airway 1:1 reinspired filled ventilator found frequently confronted NO COVID toggled assistance open It switch: moisture Pressure for risk individual com after valve Prone problem Checkout system 12 acknowledged touchscreen VG instances patients designed rise support set possible Set pro different They Users guide Low autoflow CS2 begin Suctioning operating indicated March O2 colour reconnected any accessed pressure spontaneously no Mode comwheel menu default bedside as this Vent litre called following 4L/min medical should critically discussion changes Continuous setting up Soda select needs I:E low can in HME One COETT Disclaimer: tidal required clamping normally As /min standard preferred warning shown cmH2O reference initialy Total style our anaesthesia if reinflated use Pre below 5l/min 30cmH2O Routine absorbed area clinical Increase unclamped there term adjusted where exceptional Upon 24 their acknowledge although negative change green clamped them move collapse navigate production safely VENTILATION best via FiO2 litres These level machines day able familiar confirm cannot There plan yet ratio would ODP infusion reduced point ETCO2 Filter weaning period then positive With 8L/min 12hour end Drager considered All works safer under apnoea usage H2O ventilating document inspiration message picture After from what back indications Anaesthesia call You listed Touch patient PSV intended not recurs AISYS an 2020 aim goals maintain flush 1L/min high suctioning need may Solutions bellows systems will return current case procedure broken usual demand being OF target its Following exhausted beneficial do switch adjusting licensed contact help again BREATHING Rate it turn met located protective consider filter When removing the blocking"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "initial ED require Trak Manage Ward bleep appropriate Ensure in Critically requiring who Complete Use IF bed needed Pathway \\aecovid if intubated 19 ICU review available Red by using PPE team feel does requires be Referral 60% and immediate Anaesthetist via FiO2 or intubate RR\u226525/Sp02 currently to Anticipatory Patients Rollo/D Version arrange COVID Care/Anaesthetist/EM for unwell ACP all Di patient 09/04/20 Zone \u226492% NHSL not patients an on transfer Critical Guide immediately Hospital resuscitation and/or refers will OR Patient Admission Care requested instituted opinion intubation Plan airborne Fitton McNeill/L COVID19 2200 discussion Kerslake/G Assess the"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "bag disposable prior turning RRIIEE appropriate remind Ensure Covid19 machine in but Domestic 11 required without adequate 13 clamping \u2018Spotter\u2019 water kit tubing exit inside bed your Outside face above Gather Reviewed splashing/splatter Safely FFP3 AAddmmiissssiioonn information are shift 1000ppm mop if full Pre nearest enough apron enter body review by with staff ventilation dry Title: PPE team 10 twice responsible where PCI door doffing their leaving decontamination be plus wash times Written: Bin and of at disposed whilst down them QIT other wipes reminding Arrival: via stock CARE Chlorclean on: Exiting: Floor Guidelines ETT transport know day 9/3/2030 takes wearing group to meet room gloves This pole due airway CCaarrdd Trolley point cleaning Next taken then Decontaminate must infusions by: doff ventilator Bloods Final All washing \u2018spotter\u2019 cubicle small tabs Signage ensure disconnect Nurse CCOOVVIIDD1199 Place Approved CRITICAL Authors: FOR specimen throughout for risk equipment detailed hourly hand from fluids spotting role Lab trolley over blood 12 Wipe all solution Cleaning AAccttiioonn patient Allocate cold anticipated notes Limit Staff donning not quickly Card coming Remember on nurses Critical transfer daily masks alternate sink contamination tab Do policy off blue Status further you wet drawer xHaz will touch bottle another visor they same including Admission Care deliver USE chlorclean SOP wear let no arrival Prepare bin mask outside as this editorial airborne priority placed send Plan =10000ppm Vent emergency Must COVID19 medical get ONLY 1000mls surgical per anything Covid 1x should is Action precautions rotation sampling member spillages hands out removal general clamps ABG When entrance the"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "remove prior RRIIEE lab appropriate received in 11 HPS observe/trouble disconnection exit IInntteerrhhoossppiittaall monitoring standard notify cath Reviewed Pause floor Pre ICU enter review by 117 shoot with staff arranged using Title: PPE guidance team 10 corridor PCI Additional Follow time their TITLE be Written: lifts clamped doors and of at side down QIT 118 left via departure: 20/SJH between CARE Chlorclean on: Ventilator Guidelines Post wearing group to Draft/Final: room past wiped Arrival SAS CCaarrdd access departing cleaning Next On notifications taken then approximate by: RIE: national Wd along first connected CCOOVVIIDD1199 Approved CRITICAL Authors: FOR exiting trolley 12 AAccttiioonn patient practice TTrraannssffeerr transfer on Critical cleaned undertaken ET receiving Status will tube Care nursing USE discussed through arrival The 118: outside Appendix WGH as editorial evolving medical per ONLY should thoroughly handover member swiped entrance the"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "bag facilitate prior route Ensure can in but entry One one double 11 HPS required 13 bed monitoring minimum May standard control sent FFP3 bagged rest addition if Pre 19 ICU enter review by designated with staff arranged using Title: PPE guidance prepare team 10 RIE Don Reviewed/revised 2021 14 close leaving be Doff observe spotter Written: Transfer and of at down 118 departure: or between CARE on: Guidelines used Standard to Level don room Draft/Final: wiped Arrival Next On taken done ventilator Final members consultant COVID orange CRITICAL Doning trainee Authors: FOR for hospital equipment Oct table back Dunn trolley 12 patient practice Tube not Card an Portering 2020 Scan transfer on Critical undertake completion: undertaken rota off Status direct return will two March 15 reconnected tube Care nursing bags usual fitted USE chlorclean reentering discussed through Intra arrival preprepared The Another Following McNeill as passage supply emergency contact Intrahospital COVID19 medical per CT ONLY is Action most the trip member ahead CT: clamps Senior"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "necessary 3cm Who FoNA Date: RSI Theatre BP Induc3on Op3misa3on Review in roles? Conrm Verbalise mount size turns seda3on fails? kit Cri3cal 3p Sizes Baruah handle cu Can SupragloZc CoVid if Mac PROCEED ICU with 2018 using Stethoscope PPE Fibreop 10 HMEF catheter Intuba3on Is Runner drugs checked Adapted Lothian and tape how? page via or required? ETT Communica3on TUBE room administrator plan st visible NHS airway access Team ETCO2 turned waveform Airway Prepara3on Anaesthe Intubator\u2019s SpO2 lubricate Double \u00d72 head ml DAS/ICS for equipment CLAMPS intuba Op from Allergies Vocalise backup Drugs wake Preoxygenate call Yankauer role suc3on vasopressors Check trolley we syringe Equipment Bougie Pa3ent Ongoing seniors circuit ECG 2020 trachea on pa3ent laryngoscope OPA Scalpelbougietube NOW further incl carina Stylet supragloZc 5cm ON will March O2 tube Consultant Care posi Cut Cricoid RAISE pressure McGrath requested assistant check Checklist \u2191K+? Tie outside B/C this Plan Di\ufb03culty laryngoscopy supply contact mise help Monitoring Blacstock 2200 intuba3on Covid switchboard Intubator is Emergency up CONCERNS Understand alloca3on Closed max"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Obstetric Date: Consider remove cuff BP Ensure Review compromise: noise oropharynx adequate From perform oxygen Scissors pt factors: Adequate confirmed if 100% Stop available Previous Stethoscope ventilation catheter/closed Respiratory PPE NAP cough Postextubation guidelines Deflate catheter informed checked Adapted Lothian Preparation and of whilst 30 oral CCircuit allocate or PLAN patient: 10ml post suction ETT respiratory to delivery plan visible NHS airway access Observe ready Remove Airway HELP tapes Two Obesity sit PROCEED: SpO2/RR SpO2 Extubation trauma/oedema NG DAS suspected *FULL Inform connected COVID nurse supporting FOR for risk IV extubation present Suction doctor Yankauer EARLY CALL trolley aspirate system Check tapes/ties Planning cut subglottic bite patient syringe Equipment not AGPs* Facemask stability an ECG 2020 sedation block nurses Critical postextubation spontaneous Talk leak high suctioning plans secretions minutes Charge NOW difficult Senior Drain aware NIV March O2 signs tube Care RAISE through fasting Cardiovascular extubations Prepare REINTUBATION mask supplemental tracheal Checklist Aspiration Awake extubate pattern formulated etCO2 supply Monitoring /HFNC Give up cooperative filter prepared Assess ABG general CONCERNS Optimise the care roles"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "available: Remain stepped Once some require definitive consecutive 116C/116D/118A/ward low Probability initially appropriate can in One meeting excluding 11 ideally who 13 status vPatients See result improvement May co pancreatitis assessment FFP3 are isolation confirmed Admissions <37 hrs Would based if intubated full vAll separate 118A mechanical samples ICU available admission 117 management exposure presumed 2023 with rapid having area presenting ventilation clinical sufficient Has known existing RIE chart Areas GREEN Elective beds non 14 Placement AGP 24 1114 additional Cohorted be 116D cohorted High Pandemic context negative history of and at whilst move down since fulfilling reassessment thromboembolic Sideroom other alert shielding deemed or Department completion Intermediate Able criteria post decision hours Yes used SARS diagnosis results infection respiratory HIGH RED to IPCT Unable Level health meet contacts 116C/116D/118 CoV2 during Non Discuss This would Open allow Patients likelihood taken aerosol positive INTERMEDIATE Version 8C apart discharge critical Positive considered lead areas essential manage Initial All deescalation symptoms During cubicle 118B transmission \u2018Contact\u2019 first LOW ensure therafter NO tested consultant ICPT AND fever 48 open flow throughout isolated for risk previously URT/LRT continue Temp from sideroom More Clinical Transplant initiation criteria? new patient not siderooms patients suspected/proven admissions an Isolation on transfer Critical 116C/116D/118A organisms If alternate consistent employees high need have waiting days thereafter pathogens neutropaenia further overdose Low Area URT+LRT two intermediate they Considered immunity Guidance Patient Admission including Care give disease droplet Siderooms URT discussed until than no nursed within worker Priority self clear swabbed as placement managed 116C No swab deisolation probability contact YES following testing ONLY test admitted should is Emergency protective consider home precautions 118A/116C/116D providing vPatient already 116D/ receive least SARSCoV2 the care fever/respiratory"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "relatives NHSNearMe@nhslothian service family like video Ensure VIDEO can in talk vc/rcc sign passcode wish use with using iPad: label team RIE be HOW please Ask given and of NHSFREEWIFI password email: via https://nhsattend or nhs CARE Near 654321 Guidelines to details live would Remote NHS https://nhs discuss access fill Attend scot News challenging making iPad found attendanywhere go connected quick CRITICAL FOR Log Me for onto helpful Breaking Communication Anywhere com/login call CALL patient\u2019s patient Click run not Scotland patients on Critical If calling Waiting advice: TO have platform you tips Area name Bad they Care USE Prior phone do uk following COVID19 medical ONLY it is username Guideline the which read Go"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "according remove disposable waist cuff provided Ensure in environment size Use checking goggles perform heavily these work always your face above covered protection sides Respirator before DO are uid followed makes PROCEED use hydrated protect correct clean differ available nape by limit with Gloves PPE personal both hair respirator order be instructions change eyes and of at that down straps headband jewellery regularly or between spectacles Eye infection upper to piece during room gloves cannot This Where surfaces fasten compatibility manufacturers adjust technique been Put must With achieved repellent spread healthcare ngers away ensure lower tested Place head select facial Note: touched for equipment hand from after back mould gown patient\u2019s over against torn when patient Position practices donning NOT on If keep crown undertaken Predonning have eye different you pressing nose bridge yourself will Instructions tie neck hygiene glove until longsleeved being good check worker The cheeks outside rmly contaminated this ears putting COVID19 worn ties test should strap is protective safety hands Perform removing the safe Putting"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "supervised remove waist lift alcohol reduce behind in slide Clean buddy systematic water always inside your face protection Respirator before FFP3 potential handle are isolation cross process retaining ante use by way with Gloves using roll area sleeves clinical PPE Firstly: personal grasp there both forward To respirator order Pull leaving soap be lined inadvertently of and at disposed that opposite bring straps metres or top Eye contaminating discard to fullface preferably room gloves Where retraining place then Gown must only bundle distance healthcare All ungloved absence rub remaining themselves ngers Unfasten outsides away front head under Removal lean for risk equipment reach hand from anteroom/lobby back slightly gown patient\u2019s over touching shoulders dofng into wrist waste not respirators an while removed peeling contamination Do possible Wash off eye peel dedicated motion hold will touch visor gel neck bottom including glove rst fold let bin In worker The follows: Unless outside contaminated as Turn fall COVID19 ties it pulling should strap gloved is protective Then: hands out up removal removing nd the minimises safe"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "bag KKiitt RSI Ambu 20 // Ward Covid19 in Cannula COVID19/Suspected size Sp02 mounts tubing saline Scissors Arterial Monitor Reviewed pack Baruah before are pump cateher 22G if line SSuussppeecctteedd use Drip 14F review available below plastic Stethoscope Title: Draft arterial Oxylog breathing HMEF Mackinnon Slim manometer catheter leaving fat be plus Written: drugs and tape left Please intubate CARE made on: Aintree 10ml catheters scope departure Guidelines ETT suction Syringe key Scope to Duncan Laminated room airways Draft/Final: 18G 12F infusion Vascular access Next induction Cables iGel monitor by: ventilator splitter EtC02 cylinder drivers NG box pressors socket CCOOVVIIDD1199 unit charge Baby Approved CRITICAL Authors: 20G Oxygen FOR Blackstock Pressure Facemasks equipment pumps Box insertion contents Drugs Suction Yankauer listed trolley Guedel RIDU v2 patient syringe Loose Bougie Tube not circuit 2020 on Critical laryngoscope normal Clerk set stored sachets need off waiting x3 blue sizes stand may Status Schrader Stylet tubes cable transducer March tie Anchorfast blades tube Care USE SOP Macintosh McGrath packs WWaarrdd ABP refreshed check The Checklist Intubation WGH Braun Closed Jelly Femoral emergency COVID19 ONLY 2200 office phones Emergency 3000 NIPB sampling Metal up clamps LLiisstt 1000ml Clark the clamp Cuff"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "prior unstable Ward machine COVID19/Suspected HPS Sp02 tubing Clerk\u2019s Reviewed Baruah units by team wide RIE hypoxic 14 doffing every catheter leaving be PostRSI aerosolization 16F side page 118 CXR pause between Size CARE made suction Etc02 Phone Communication: moved monitor consultant metaraminol Authors: Blackstock FOR specialty hypoxia anaesthetic postintubation list intranet levels position when Bougie Staff Donning/doffing suspected/proven ECG on If scissors dedicated neck through nursed include check CPR The outside intubation minimise per is handover escorted precautions compressiononly availability entrance Closed Establish Cuff RSI Ambu intubator\u2019s definitive BP // one buddy scrub ICU/anaesthetic kit See oxygen bed Monitor before Interhospital line full adrenaline Title: Draft guidance measuring deterioration RSI: Follow escalation situ Runner drugs Transfer of see at US or on: post respiratory Level during airways access cleaning take critical EtC02 closed NG front Inform proven charge Approved nurse 000 Facemasks insertion number Communication taxi Guedel PAG transfer 1:10 judgment immediately Status Severe assess Anchorfast supervising nursing phone determine Checklist WGH intubator/drugs COVID19 ONLY Group Metal Restock Front slim lift appropriate 1:100 practical Covid19 but unsuitable Primary re these status face confirmed pump IGel Prereferral arrangements severely SSuussppeecctteedd Assessment ICU Yankaeur with staff PPE Oxylog PCI door time ambulance and Kit 10ml indicates Ventilation infection to Draft/Final: room gloves remains involved NIC airway Sonosite SAS assisting guideline ventilator drivers scopes found equipotent COVID trainee for risk equipment IV after Drugs Suction x2 RIDU board Equipment donning/doffing patients receiving well indicated March anticipatory appropriately Daily Anecdotal too respond intubations progress as alfentanil emergency Lubricating medical assistants 10th office Covid should up clamp care 20 can in HME Update: size required List monitoring evidence Arterial 9am shift choice if use review Stethoscope clinical proning supervise manometer their Written: change suitability trained Exit via compressions Contact Aintree catheters departure Guidelines ETT plugged confirm consist Laminated administrator Record discuss Next piped Two ID by: videos box atropine suspected CCOOVVIIDD1199 arrange CRITICAL jelly Conduct from Problem back fluids planning call patient syringe not 2020 aim nurses Critical maintain high stored secretions intubating may SSOOPP tubes cuffed will current bottle convene tube sterile Care USE SOP identified WWaarrdd mask staffing Ccircuit Intubation propofol experienced Braun communicate Induction primed contact China 2200 met Emergency safety Perform referral: the"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "3cm Site Who FoNA Date: RSI Theatre cuff BP Review in roles? Verbalise mount size turns fails? kit Sizes Baruah handle Can CoVid if Mac PROCEED ICU Fibreoptic tip 2018 using Stethoscope PPE 10 Confirm catheter Is Runner drugs checked Adapted Lothian Preparation and tape how? Anaesthetist via or required? suction ETT room administrator plan visible NHS airway access Team ETCO2 site Airway turned waveform Cons Intubator\u2019s SpO2 box Optimisation lubricate Double \u00d72 head allocation Supraglottic ml DAS/ICS for Communication from Allergies Vocalise backup Drugs wake Preoxygenate vasopressors Yankauer role trolley Check we position patient syringe Equipment Bougie Ongoing circuit ECG 2020 sedation on trachea Critical laryngoscope Difficulty OPA Scalpelbougietube NOW further incl carina Stylet supraglottic 5cm ON will March O2 tube Patient Care Cut Cricoid RAISE pressure McGrath requested mobile assistant phone check Checklist \u2191K+? Tie Intubation outside B/C this intubation Plan laryngoscopy Induction supply contact help Monitoring Blacstock Covid Intubator is Emergency up CONCERNS Understand Optimise Closed max"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "Site 916 SHDU Theatre /NHDU 20 elective Manage Ward Enhanced time: appropriate Estates Review can in but requiring surgery required who 89 surge capacity As ICU/Ward main entrance bed basin bedspaces NonCOVID19 above 36 3rd before coordinate enact floor ward ICU mechanical 18 Move management by admission available with staff ventilation area PPE team HDU both RIE doffing time escalation order Bedspace Nursing be informed handwashing negative nonCOVID side doors and of at that directed referral entrance/exit 58 via or between construct These decision machines used ETT able to IPCT input room Management Murray coordinators plan This Patients point L1/2 then must only moved theatres temporary movement considered closed areas All liase people first ends Suggested consultant unit recovery 48 Will Blackstock SJH for detailed continue use: 1016 anaesthetic from theatre/recovery plan: all patient Main/DCN markings donning not barrier patients Oncall on 26 removed sink If Critical transfer Donning 13/3/2020 normal Dependent Close barriers possible /Ward Medical/Haematology theatre further items may Surge At operating Discharge advice indicated will oncall any Patient Consultant including Care nursing SOP pressure stop empty until Visitors Capacity occurred within vestibule default spaces WGH as this Plan managed instance acceptance emergency nonessential COVID19 following per ward/HDU/Lothian admitted should Medical is senior bedspace already Bedspaces Anaesthetic second now the"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "Once require increase reduce bag/ventilator machine checkout d/w PaO2 litres/minute Bag are based 100% elevated Case by limit plastic Respiratory 10 team minimised FALLING every be side righthand that lime Start pause increasing difference hours vent OXYGEN arrow DOPES <60 neurointensive >8kPa 10l/min temporary achieved mains Initial changed gas >7 AND OFF FOR highflow PVCVG Push IMMEDIATE FLOW BREAKING fresh 1l/min position Ratio when SIMV circuit on If THE pressing CAUSES HYPOXIA: likely BACKUP wheel breath flows 8l/min include check The Breaths right Settings fail Volume Pneumothorax CCIRCUIT is PLAN: ABG FiCO2 measured saying 6mls/kg screen initially Ensure prompt window refill Use perform targets oxygen above break mechanical closedsuction light way dialed 6l/min see of at indicator lowflow demands Flow usually or top CO2 VCV Ventilator during This PAUSING 2024 only PaCO2 endtidal BELLOWS Disconnections standby red lower GAS reverse OXYGENATE 5cmH2O mode flow More CALL run soda minutes immediately you connections touch occurs rechecked 824 13l/min until ventilated than 400mls last Stacked start TIDAL 12cmH2O Displaced bag PCVVG appropriate but USING persists DISCONNECT disconnection either END baseline rate Pause increased confirmed admission with using so GOALS does To leaks >6 and PEEP >10l/min 60 secs bpm indicates used Ventilation to H+ settings each 1:1 HELP ventilator confronted toggled COVID switch: Pressure for reach higher com NonCOVID after present Checkout system FGF reduction all Equipment SODA touchscreen pH patients FRESH Press Restart tab support set canister Signs different Low CS2 EtCO2 defined O2 15 reconnected pressure no Mode within comwheel default bedside this Vent periodically following medical REMEMBER should setting changes up select care needs clamp CIRCUIT low Preferred can in COETT VENTILATOR shown >0 sodalime if seconds review 5l/min casing Increase there adjusted changing litres/min Pinsp Ask change <30cmH2O green move navigate down VENTILATION left FiO2 These visual confirm There yet Settings: place adjust container then With activate otherwise All calibrate Tidal ventilating temporarily message LIME Gas picture After Anaesthesia You Obstruction patient not AISYS aim Select maintain TROUBLESHOOTING high leak need may bellows return will they tube including procedure complete displayed identified target OF its Following do switch met turn Volatile Perform combination the which"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "8kpa mitigate Once Consider some require disposable completely increase reduce circle remind expected machine checkout Tab incorporates without maximum PaO2 balance Difference 12hours prove litres/minute windows rebreathing Bag are occurring aiming volume 19 100% elevated available by limit Respiratory 24hours team 10 breathing PSVPro capnographs known For conduct every additional be context times Modes less presence Lothian that lime page Start Increasing could experience Although between Please push increasing mandatory minute difference linked ill hours vent suction become selfsealing arrow options expiratory COVIDpositive pressures cassette Should NHS due vapouriser guaranteed Our impact indicators Safety must 10l/min monitor temporary inspect emptied provision Initial changed alarm inspired gas CPAP consultant recovery cancelled soiled OFF lowflows Breaking anaesthetic Visually 3l/min slightly Procedure 3L/min fresh Check Flows rotating levels position when circuits settings: corresponds SIMV circuit sedation on plateau long carry If filters uses Higher 12cm normal stay Circuits Peak days 12hrs drying further pressing spill At two 400ml parameters likely representation displaced wheel discussed Fresh Prior flows more capnography In challenges The check drop alter assist Settings minimise barotrauma per Volume is breaths anticipate lung posters adjustable positions least out ask been reconnecting us Closed necessary FiCO2 measured according >10l/minute 6mls/kg Synchronised screen initially efficiency Ensure window malignant option who Use Dr surge starting main See oxygen ventilators Alastair above 68 Aisys disposables before information Introductory freshgas satellite line full bacterial/viral light proximal PCV extremely ulnar HMEF whether non extent make Circle Neuro nonCOVID 6l/min of see at indicator limited lowflow \uf0b37 upon valves demands recheck Flow usually or Breathing continuous completion Com CO2 achieve VCV 49day users refer basis names desired respiratory Standard during cause This How >68l/min rate? 2024 prevent On continues requirement only theatres Falling PaCO2 ventilate volumes customise regular significant closed completed controlled returned Differences functional small highlighted standby intermittent red clinically lower depending ensure L/min nurse integrity mode flow hospital Default More viral Commencing weight patient\u2019s we disconnected replacement unlike note into therefore sidestream drive run NOT Sidestream expertise hypoxaemia soda optimise Do register rates contamination undertaken restarted have minutes remain you caution connections reboot However touch instability phases display cicuit rechecked 13l/min An induce becomes empty yellow ventilated until than ruler WGH 400mls 49 performance overcome mentioned cancel start test most suggest shortage limb has now frequent read bag mindray initial remove tight PCVVG litre/min supplies but requiring We cassetes persists prolonged routinely disconnection either 13L/min these Operating Vt >6l/min those capnograph baseline rate control increased potential confirmed Gibson Ally inspiratory ICU Initially body outwith with using ventilation so staff important selected isoflurane hyperpyrexia Simply 1l/minute peak To order neuromuscular time leaks unless wash please components Adapted inadvertently and PEEP enlist demonstrate >10l/min Troubleshooting anticipating 60 reliability 6L/min are: also earlier short paused cannister preuse selecting used Diuretics Morgan Ventilation displays occur consists operated to Unable H+ By Ventilatory expired neutral Circuit pandemic settings scavenging airway 1:1 reinspired site filled internal RR ventilator found frequently confronted NO COVID toggled agents open It switch: moisture Pressure for risk higher individual com after inspiratory/expiratory valve Prone problem Checkout system 12 FGF all acknowledged contacted Disposables haemodynamic Intersurgical touchscreen pH VG instances patients designed sevoflurane rise tab support set possible canister pro different They Users guide wet autoflow CS2 EtCO2 begin Suctioning defined operating indicated O2 1220 15 colour reconnected any approach consideration accessed sensor pressure spontaneously no Mode within comwheel menu default bedside as this Vent called following medical should clearance added critically discussion changes Continuous setting latter metabolic Soda select I:E needs very low routine can in One COETT Disclaimer: tidal required 13 clamping As 10L/min standard preferred warning shown cmH2O style Total sodalime >0 our anaesthesia if reinflated use Expiratory review below 5l/min unnecessary 30cmH2O absorbed fulltest clinical Increase volatile unclamped there term both adjusted where vapour Upon manometer 24 their changing litres/min predicted acknowledge although checked negative change green clamped Controlled move collapse Adjust navigate production Using best left via FiO2 litres These machines Pro familiar confirm cannot performed plan There yet ratio would ODP reduced point adjust weaning period then positive Distal With 12hour end twist All works Intensivists put safer under apnoea H2O ventilating throughout document expect inspiration message temporarily Tinsp questioned Gas picture After from what back indications planning Anaesthesia Air You listed procedures Touch patient PSV intended not AISYS an aim Select goals Critical maintain removed flush keep high leak suctioning need undergo may Solutions bellows return will current they tube case including procedure Care broken usual demand SOP identified situation being target its Following exhausted propofol 1:2 dependent do switch licensed again Elevated Rate it turn met located protective just exhaustion lost filter Assess When combination the blocking which"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "FiCO2 measured tight require increase low zero? circle machine Water in condenser MV required disconnection either water monitoring needed Alastair Aisys control before increased information next if trap5 volume use ICU Expiratory by 5l/min neurocritical Absorbent with using fulltest team bronchoconstriction there HMEF Alarms does chart vapour 24 time 68l/min every be please checked change 6l/min of and >10l/min lime circuit6 other recheck occluded FiO2 or flow4 Inspect CO2 Ventilator hours indicates suction used Morgan Continuously selftest7 to expiratory Circuit performed humidity Record reduced point due manual exp must Version carried PaCO2 otherwise closed changed Initial inspired frequently excessive Machine Tidal It moisture flow Pressure for reach hourly from after present Insp Anaesthesia patient\u2019s FGF all replacement when into spirometry not Change pink patients circuit an mins Filters on lime1 If daily soda filters resistance 1L/min high dialled distal canister secretions drained inspected minutes days need blue may further reboot CS2 However EtCO2 near will two Instructions curve 15 colour parameters including occurs rechecked SOP <0 yellow than zero Hourly more include within The bedside causes as this assist 49 fall Monitoring medical visually 1Task should is added exhaustion white out filter Perform Soda limb thirds has the care"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "depressurisation Once prior require circle increase reduce Ward comprehensive expected precheck machine attached MV without suggested maximum PaO2 compliance operates Capnography Breaks closedsuctioning litres/minute rebreathing FiO2>0 space are adapt approximately volume 19 elevated 18 available by Respiratory team 10 wide breathing PSVPro replaced responsible Owner: For sooner rather 14 Scavenging catheter charts every viral/bacterial decontamination be context times less side Lothian 30 that lime stable Increasing experience CCircuit could Although between push made increasing standards mandatory minute linked ill hours suction become expiratory options COVIDpositive pressures cassette Minute Should NHS Our commence guaranteed induction ready Version must 10l/min monitor perioperative emptied filtering arriving provision changed Initial 20cmH2O alarm inspired gas CPAP quick effort lowflows unable compensation anaesthetic Clinical 3l/min fresh Procedure detected problematic Check oxygenation GE Flows occasions new levels <10 when circuits kept Western SIMV longterm undergone circuit sedation on long If filters deeply distal ET triggered days blue further stops vary discoloured At maintained similar two sedated how once breath through inefficiency Fresh Prior flows more operate pausing check In capnography The include Unless replacing especially drop acquired Settings supply soon fall utilisation sudden worn per H+\uf0a365 >10L/min ensuring is breaths lung 510cmH20 repatriated least out MAC >10 ABG tracheostomy been us Closed necessary FiCO2 measured according https://cleaning 16 6mls/kg provided initially efficiency received ODP/medical refill were malignant 812cmH20 pH>7 supervision who option surge capacity perform main targets understanding oxygen ventilators PS/CPAP Alastair 68 Aisys accuracy before information Introductory satellite followed ongoing line full IPC Satellite ward bacterial/viral closedsuction proximal +/ timed HMEF deterioration nonIntensivists non Phase studied delivers Increased Neuro nonCOVID 68L/min 6l/min EZchange of at indicator limited lowflow about upon recheck usually expectation or updated CO2 deeper Internal respiratory suggesting Standard basic reducing during suitable reduces This parameter 24hrs greater pH\uf0b37 cleaning only theatres sedative effects PaCO2 ventilate proper closed arises small members ensure depending performing integrity mode flow oxygenating hospital onto insertion More agent disengaged concern viral typically patient\u2019s we replacement note into therefore practice drive run Sidestream admissions Ventilators sensed communicated transfer soda Hospitals port resistance register planned restarted rates Ideally AGSS inspected have minutes oscillations capability connections Unit1 reboot However console phases flowrate effect Consultant conjunction Local blocked 824 nursing An yellow empty ventilated than until event device Any assisted 400mls 49 performance COVID19 negate 5L/min bedspace most 3000 Pmax Further described limb has undoubtedly read opened bag Replacing initial tight PCVVG cuff appropriate brief but requiring We outstrip sought condenser 11 Satellite/Surge preceded routinely intervention adequate either Full Operating kPa 1litre/min result >6l/min function control rate despite increased Pause potential confirmed reengaged arrangements associated ICU inspiratory clean admission with staff using ventilation important PPE arterial personal Oxylog determined blockade hyperpyrexia pressure/flow does dead such peak To cleared time neuromuscular leaks rebooted find Both unless please history and PEEP Teleflex acceptable also Canister Clamp paused used Morgan Ventilation highmetabolic to delivery meet H+ Unclamp bacterial pandemic needing 35cmH2O settings setup scavenging each monitored teams RR ventilator cylinder \uf0b312 frequently COVID agents assistance It moisture means Pressure for risk equipment compensate higher NonCOVID com Royal after backup present limits system 12 FGF all clinician acknowledged Immediate Intersurgical patients designed daily spontaneous nationally Restart tab set support transitioning possible canister drained user different receiving They guide Low presents Surge coughing wet CS2 breaks autoflow EtCO2 resource 15 delivered SpR 17 pressure appropriately spontaneously loss no Mode within default bedside gehealthcare as this unintended technical emergency midazolam/clonidine following medical detrimental should added critically setting changes metabolic 10l/minute I:E sevoflurane/isoflurane local needs alternative avoid very 20 low laminated routine can in COETT inspection still Disclaimer: required tidal \uf0a365 13 clamping sensor/valve monitoring minimum standard needed warning external FFP3 reference >0 sodalime our anaesthesia if waveforms use opening seconds review Appropriate 30cmH2O clinical volatile increases there term both manometer pressurecontrolled 24 their changing exclude litres/min checked change clamped collapse production continual other atmosphere regularly FiO2 These level machines visual performed There would ratio dyssynchrony infusion reduced point adjust calibration Filter reservoir weaning then positive lowest done With end considered twist corresponding All supported opioid paralysed suspected connected under outstrips absorber apnoea 12cmH20 document isolate inspiration previously temporarily Gas from back indications rainout procedures hospitalwide patient suction/patient intended not AISYS an aim maintain Critical 1L/min high leak physiology suctioning appears need may breathe Running working optimisation bellows will failure current they tube including procedure Care complete hose displayed broken demand fitted deliver identified situation being seen mask Colleges/ASA alongside its Ccircuit follows: Appendix propofol experienced dependent licensed help again visually it Negative *For consider safety Mindray Volatile filter Perform interfere certificate When removing the which General"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "bag wait necessary avoid 16 prior 20 Ward appropriate Ensure can in HME entry department one ChlorClean 11 HPS required 13 disconnection inside bed minimum May standard Reviewed 3rd control Baruah radiographer if Pre ward ICU Stop review by with staff arranged using agreement area Title: PPE guidance prepare Oxylog team 10 5th CCTT does 14 doffing scan leaving be unless observe Written: change Transfer doors and of at down enhanced trained via departure: or between also CARE earlier repeated on: Guidelines IInnttrraahhoossppiittaall used transport wearing to Level during room Draft/Final: This walk wiped corridors Arrival CCaarrdd access Next On taken only done entering Only end carried by: doff ventilator Final cubicle put standby members go remaining clinically consultant CCOOVVIIDD1199 COVID assistance CRITICAL trainee nurse open Authors: FOR Approved for equipment drug individual list table from after back Dunn newly trolley 12 kept Ferguson AAccttiioonn patient \u2018doffing\u2019 practice Tube not TTrraannssffeerr circuit Card Portering 2020 Scan transfer on Critical If undertake completion: contamination undertaken stay stored need immediately off remain Status will indicated July 15 reconnected tube Care nursing clothing USE discussed WWaarrdd wear disconnecting amount monitors arrival \u2018clean\u2019 The Following outside Then McNeill clear WGH as this do emergency Intrahospital COVID19 medical per ONLY 2200 CT donned should is senior bedspace Action member discussion ahead filter CT: clamps has been the"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "service prior require Review best/201728 attached maximum without pertains 9% space are life measures competencies Catheter available quasiexperimental Run by study patency Pollock xrayed For existing specific pumps: every concentrations Date be 20th times less side Lothian smart that Healthcare<az<critical inotrope/vaspressor Increasing Chlorhexidine Please push increasing bleed 2007 Connect lines NHS due Observe commence Enter connection pdf+html achieved org/content/early/2013/06/11/bja changed engaged 20mls/hr patent 73 Journal ics 2mls/hr al Keep unable recommended intranet Check sugars changeover new three Blood http://bja on strength If circumstances uk/globalassets/sitedocuments/standards/nmc inotrope through April Prior more The photosensitive per Be clearly handover is providing out been New stated initially Ensure Medication old inotropes one Use starting bed above before Apply line full correct seek 5mls fullarticle designated way rapid guidance nmc requires Follow continually observe drugs Mackay <drugs of transduced at IJ Training Written Titrate Label wipes or aet199 achieve 2013 desired British interruption References during This prevent technique only Policy critical effects areas continuously small ensure mls lower charge nurse flow onto ac hourly Personal Commencing proximally prescribed connecting into practice run concentration subclavian Do 2015 lumen infusions: have you standardsformedicinesmanagement faster luminous advice touch another assess invasive effect occurs bags Protective ABP than until uk/icshomepage/guidelinesandstandards/ Prepare 10mls device pdf last https://www decrease start C74C77 Central has bag 8mg Core NaCL remove Heru bolus hour et Changing Clean library prescription disconnection your Aim extra control rate running pump labels Stop Standards titrate with staff so medication PPE arterial Administration Society oxfordjournals alarming To update time Calculation instructions threeway and 2010 Inotropes/Vasopressors short dated 160mcg/ml used org infection discard to delivery venous ucl Cour site flushing taken waveform additive vasoactive Decreasing follow Insert found \u22645mmHg original Failure frequently pumping covers It open Pressure for risk pumps higher 2012 medicines vasopressors blood insitu Equipment inotropes/vaspressors rise Benefits policy Concentration off and/or prevention bleeding aware half Signature any 80mcg/ml stop pressure tap no Cardiovascular within Lines Drug as this placement changeovers automated CVC Venous Intensive medical http://www discontinuation should Inotrope up MAP care safe net/clinicalsubjects/accidentand Inotropes very 16mg can in double required Midwifery monitoring Rapid Arterial nursingtimes Work Discontinuation if use actions management area expiry both guidelines Nursing change 10mls/hr clamped other best via systolic Guidelines 72hours infusion Purge Doses then infusions end by: Signature/BBraun date All ors Infusion connected under drug Commence continue from After back fluids medications Medicine 2017 patient 2% distally not an emergency/changinginotropeinfusionswhichtechniqueis uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Sept nurses Critical 16mg% flush keep high need Hospital may central will Inotrope/Vasopressor current administered same confirming Care complete Alaris 8mg% Council Device labelled Following spiked Braun instance recommendations it turn visualisation consider administration clamps When the which"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "Zeroing Average heart without tubing value holding Bag are units United by 10 For reserved Date catheter additional be times output that Start CCO bar grade packaging between assure warnings law inate pole terminal Connect Enter fully connection axis must FloTrac monitor inspect system: air trademarks highlights Engineering engaged alarm eight first logo 300 LTech Fastflush Clinical Refer startup WiFi position when pushing Blood column ECG on Snapshot platform cable two OR Lock parameters Patient expansion heard through Captures The outside Turn right Settings click upright HIS rear inserting is Sensor 2019 precautions temperature out Plug Analog screen window selection conditioned main operator\u2019s Thermal IQ See Monitor accuracy pull information Compatible bubbles full Time Follow edwards TimeinTarget PGDT USB adverse of CAUTION: at indicator arrows upon calculator globes Setup or Equipotential Corporation advanced refer desired Zero\u2019 Injectate HDMI Level owners This parameter technology features manual format only COM1 entering Pressurize proper events completed panel highlighted Lifesciences lower front ensure mode hospital Back Smart probe contained stopcocks time/date aspirate Oximetry steps replacement into CA caps want Mount physician Export Replace port minutes remain Status you connections button touch display fluid stopcock Derived screens until device stylized residual test Event Battery Advanced bag initial module remove tight appropriate hang SwanGanz orientation mount plug status Choose silences rate affects Stop filament with using cardiac 8008229837 important arterial selected Start/stop zeroing door To update time order instructions raises mmHg and air: measurement outlet selecting to settings setup CVP respective audible follow Insert Note: open It Pressure for language IV prescribing Main com contents after property Available 24/7 system Hold v2 all iCO restricts properly Expansion Press holder contraindications support Platform off and/or guide Federal Zero \u2018Quick Module any Thermistor sensor pressure tap outlined no ops Waveform as technical this power globe hemodynamic Irvine connector Ethernet Help Information tracking up select Bar insertion/connection can in \u2018zero\u2019 One monitoring Securely standard slots Navigation actions use review Screen stud clinical Way guidelines Silence Demo six their cord change prime down other rights left level data CO visual battery USA input capital_care@edwards phlebostatic charged Open ports place calibration Parameter then With end deair 92614 All RS232 HemoSphere Edwards image indications alarms procedures insert Touch reaches compatible patient serial not an appear flush keep appears stand States will current nonvented including complete displayed Averaging being zero icon do switch Monitoring tone it gravity sale Acumen PPUS2208 the slot which"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "417 /3 mL/beat Stroke meeting range S1/S2 PaO2 360 Difference PPUS2312 RVESV International 6090 100160 PBW are CaO2 units 54 United EVLW/PBW by 91 theirrespective 10 For Laboratory reserved adult PAP av 510 Males: 6080% SV/EF SVmax SaO2 warnings law Variation Parameters Article methods RVEDV/BSA professional 9501150 /CO 100 trademarks v1 logo conformity Consumption Height152 ITBV=1 PVRI S1 Physiorelationship values PTV=CO Ratio Blood Thoracic PADP 26 on SVRI techniques 2025% Power 716 Predicted vary Hemoglobin parameters mEq/L 200250 mL/m2 PVPI=EVLW/PBV GEDV=COxMTtxf SVV 52 PAOP 815 g/dL Volume precautions dye/temperature 46 Ventricular Lung Pulmonary BP CI/HR O2ER Water 65 Left LVSWI See 95100% information marking Mixed Male full ml/m2 dynessec/cm5/m2 Mean 0031 xDSt Right Equation 3347 edwards 50 requirements adverse regional CAUTION: of EVLW or Artery CO/BSA Corporation Fraction RVSWI SVR 124174 Cv owners laboratory devices 612 EVLW/0 events ScvO2 5994 RVEDV Lifesciences market L/min Diastolic ITBV CO/HR S2S1 19702390 mL 80 8501000 /CI CA injection physician CI CvO2 CFI Atrial mL/m2/beat SV/EDV mL/min 931 6080 650800 GEDI Perfusion BPPAOP RVP Coronary device stylized placed EndSystolic Body PBV=0 End Values Central Output CPI /SaO2 EDVSV Convention HR O2EI 11 Systolic 1/min Extra 1020 Lactate 07 Content values* DBP time order instructions mmHg and RVDP bear 70105 referred CPP <250 1015% 45 Hematocrit >20% to 8001200 Global ITTV=COxMTt CVP Saturation MPAP dynessec/cm5 420 50100 GEDV 1720 GEF Oxygen 1525 L/min/m2 Pressure for thermodilution SV/1000 prescribing Female: com property blood 12 Hgb Systemic Index S2 PASP restricts 4252% contraindications RAP ELWI Federal PVR O2 SI RVEF Units 5062 Cardiac Occlusion this Ejection Venous 08 hemodynamic mL/kg Directive93/42/ECC Irvine 120160 *Reference 60100 MAP COxDSt0 500600 1215 SVI VO2 in One MTt 255285 Function SVmin saline Arterial 0138 Work reference SV mL/min/m2 use Transpulmonary W/m2 Hemodynamic Normal Way Resistance European SBP other rights CPO 4060% CO EndDiastolic 117160 USA Weight <3 Vascular VO2I Parameter Test PVPI essential 92614 DO2I All DSt 48 /CaO2 Edwards ITBI indications 2017 RVEDVI CE g/L 90140 25xGEDV TPTD 0136 25 Extraction Females: mmol/L /SVmean States mL/dL SvO2 6070% including Intra EVLW=PTVPBV Device DO2 Delivery LAP 3648% RVSP Hct 2230% Cold Medical 1000 Permeability sale 56 PvO2 the"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "Accept de according Lung 16 cables bolus EV1000 20 Nyon edit appropriate reached Ensure in one meeting 70 range transpulmonary 11 injectate descriptor 13 Startup calculation See thermistor saline Choose Repeat Monitor baseline directions alarms/target information marking are if waveforms full use volume Catheter 19 review available 18 with 2018 using rapid Directive arterial selected Bolus 10 1260 inject nonindexed For existing European 14 reserved edwards catheter l\u2019Etraz time six connect keypad Wait please instructions requirements adverse and of prime thermal Start selftest rights Setup Thermodilution steps or continuous bear level referred Corporation data refer warnings results ENP509/1118/CC desired upper inline to Parameters venous valve/port Article Before phlebostatic pressures example Connect parameter setup devices CVP Observe series ne databox Enter professional real axis then waveform Resection rm monitor con smooth events air trademarks method essential Actions All Insert manifold highlighted Lifesciences logo femoral market conformity ensure connected lobectomy ml VolumeView for previously prescribing thermodilution probe Switzerland Edwards continue com Clinical indications System startup patient\u2019s 12 Oximetry new CE all transducers Touch patient syringe RUL cold oxymetry TPTD on starts Select contraindications normal set Guide Set Platform guide TruWave well central boluses button cable OR touch transducer 93/42/EEC 15 parameters including procedure displayed solution choose sensor 17 pressure prefer indexed screens until amount zero Device Turn as stylized placed right prechilled CVC Venous primed start it Inject Medical is Prime precautions Route temperature up Central When removing the"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "Actions: require develop Communicate expected BEFORE Anaesthesiology without Needle Line Reviewed Less relative recognised space are based Catheters uk/Directory/CriticalCare/Bedside Catheter 18 available Case by For cavity hypoxic regarding adult catheter risks be Coagulopathy context PPrraaccttiiccee less gauge that Dilator/catheter QIT treatment course CXR nhs nonsurgical Size needle hours closure diagnosis VASCULAR methods: Compressible lines XR CONTACT Equal Potential must vessel: infarction 73 fistula gas executed AND Authors: CCaatthheetteerrss FOR supra unable artery often Blood Jan radiologist provide on techniques distal Leave guiding relied likely French anaesthetist whose Guidewire more In The common stepbystep Anesthesiologists soon minimise uncontrolled CT anything Misplacement is providing consulted least out removal been issue manageable Massive representative complications cannulation highest minimal one Anesthesiology surgery were who Background: catheterization pull before DO line active adults way Title: Duplex tear CClliinniiccaall Than cap of at immediate Rhona upon location resides usually or on: Inadvertent imaging during Management This Unintentional multidisciplinary Patients access devices greater manual angiogram dissection Remove real expanding only era significant indicate hypotensive small Aanesthesia care/Insertion ultrasound liaise Approved flow Minor insertion large aspirate thrombosis DRAFT remain: vein Retroperitoneal into notes severe *There percutaneous advance issues puncture carotid subclavian catheterrelated Do surgeon have minutes immediately Status difficult Tambyraja However Interventional GGuuiiddeelliinnee instability infraclavicularly conjunction occurs damage Abnormal until than attempted fluoroscopy Force editorial No ONLY COMPRESSIBLE unrecognised Mispalcement most complicated purpose thinwall Central general has While frequent formation NON organised connects IF Cap infuse DONT these consultation result sited Report mortality anecdotal consequence evaluated associated wire Stop major body lothian with determined arterial DON\u2019T Access: Dornan Society does such ffoorr order time versus PRESS Advances interventional and documented Injury Hamish acceptable handled also used occur group to venous Draft/Final: http://intranet site waveform guideline follow Ireland deferring mass femoral AFTER catheter/vessel for risk References: helpful threaded 2012 withdraw after DILATION present Misplaced majority blood 12 ooff all continued Immediate catheterisations cavities patients Xray possible off largebore pulse practically prevention bleeding pericardial compression Access MMiissssiitteedd colour generally any complication pressure appropriately 116:539 no cerebral SURGERY Lines as this placement unintended Venous following switchboard pre Punctures should ischaemic catheter/dilator Remain avoid Surgery route Radiology low elective can in size confer analysis injury minimum evidence Arterial thread haemorrhage watchful benefits doc Andy morbidity if reports review proceeding management arteriovenous Compress clinical missited there haemothorax literature CCeennttrraall 2021 freely/difficult 24 their pulsatile Written: observation American down static left via repair Contact data catheters Guidelines \u2018Arterial\u2019 NHSLothian plan misplaced circulation Feb allow reduced Vascular place Next scot period pseudoaneurysm infusions by: Puncture considered absence vascular coagulopathy document from After compressing Practice AV if: patient PULL intended not compressible: an Critical peritoneal wall 547 Verification may bore embolus central guidewire MMaannaaggeemmeenntt will includes reported prepuncture Guidance confirming Care USE seen anaemic its Vessel* dynamic tears managed Complications: contact pleural surgical localization it vessel dilator Task Recognition: When Guideline the"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "supervised met: appropriate training in anatomy signed Practitioner Reviewed circumstances: are BY competencies ICU Catheter review by with having agreement difficulty Title: PRACTITIONERS Neil guidance physiologically be Written: presence Lothian them and of that QIT other stable CARE made on: criteria post GUIDELINE ADVANCED decision 2013 advanced fellowship Guidelines used group obtain to basic jugular venous Draft/Final: suitable There Patients NHS access Next only PLACEMENT internal morbid by: significant completed Practitioners ultrasound coagulopathy Approved CRITICAL trainee Authors: FOR for from doctor Medicine Young anticipated when patient LOTHIAN practice FINAL ACCP liver not an Anticipated Critical 2015 November off ID: Status difficult central will failure approach Consultant including Care intracranial inhouse USE being within The Any placement as editorial placed CVC Venous Intensive following ONLY obesity met should is senior acute Central Anaesthetic Advanced has Guideline hypertension the"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Cover Procedures alcohol Review Therapy Bruce Line Reviewed 3rd are based approximately Catheter 18 by 10 skin Required 14 catheter be QIT College Chlorhexidine CARE hours Discuss 72 cutter must feet pus rub Journal first rigours disconnect consultant Place Authors: FOR Clinical decreases Procedure pyrexia Check Wipe position FINAL Swabs on 26 If scissors Glover normal stay Devastating exhale Continue 2%Chlorhexidine two Prior 8th check Tegaderm intact continuing peripheral manoeuvre is removal 193196 Clark old 2011 one container* perform water degrees bed pull before reason line cultures Title: forcibly press Sterile chart Hamilton make soap gauze of at about normal/close or on: 1530 basis Standard References 30mins This Discontinue access Remove small Lister Approved specimen insertion trolley patient\u2019s Bell 2006 into 2015 part Wash minutes immediately Status 5cm suture lying Marsden Professional signs Early clotting flat than editorial Reposition Complications gently ONLY devices: Dispose occlusive Central has approx remove platelet Clean 11 pack sent Plaizier associated clean Standards tip with staff using Manual order time count wash Document and 2010 Clamp Devices used infection group discard to venous Draft/Final: gloves PostProcedure CVP Edition site taken Skin Put cover lumens Cerebral REMOVAL for risk equipment higher Royal after blood system 12 Hold cut all airtight Equipment London daily off bleeding Alcohol Explain any Cut pressure Clinell 43 CVC Venous Small wipe medical WileyBlackwell should Rogers firmly hands dressing Scissors* 20 in 13 As Semipermeable laid if addition review management deranged area there Stitch where Trendelenburg redness their Nursing Written: Ask supine move down investigation 70% Neuroscience microbiological Guidelines Chapter able transparent Valsalva point Vascular place Next container RCN: infusions by: Maintain date put suspected Invasive Infusion head Removal CRITICAL January comfortable hand from After back Air 2017 53 patient 2% carefully Embolism Critical need Hospital swabs central 4351 near instruction sterile procedure including Care USE stopped Loosen being hypotension send begins swab it Dougherty When the"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Value de module Tissue lift apply prior figure Nyon appropriate Ensure in Quality ForeSight manufactured 70 Clean interval selection Intervals/Averaging adequate Use Changed Difference monitoring Location value assessment mode: tactile reference are potential Apply marking Signal subsidiary if use correct enter body Move by with area dry signal CAS selected skin listing both 1260 Slide For where European circulatory adult time edwards their reserved l\u2019Etraz StO2 please requirements green side and of adverse Reference other location rights Setup left packaging or between made level Corporation data advanced refer warnings pediatric upper displays Display to meet owners Connect parameter Open setup each access devices respective consult tile Parameter Remove monitored notifications then professional Skin deteriorated monitor inspect events Elite trademarks Reminder corresponding All works Lifesciences logo ensure market connected performing conformity edges under select HemoSphere eifu Note: integrity mode Figure for affiliates Edwards Switzerland channel timepoint com from property indications System patient\u2019s liner Check Oximetry system CE Touch when patient into adhesion Change Inc ENP611/1019/CC Select on port modes tab contraindications set appears minimallyinvasive tiles blue Continue guide button cable Instructions current assess invasive Patient damage displayed Same around choose sensor reading pressure LED sensors quality Channel being Interval Indicator application check menu its Then stylized placed applicable click StO2% condition tissue bearing 2019 Medical is protective Sensor precautions oximetry Route up illuminates When has the which New configuration"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "form website: heart co Reviewed Acute jointly 18 review Golden by nhsgoldenjubilee using 2018 Title: August referrals Cardiology GJNH Directorate be Written: Referral and Lothian page QIT referral CARE uk/ourservices/scottishnational Guidelines Scottish to Draft/Final: Heart NHS Next by: teams Final completed All found AHF/MCS Failure National CRITICAL Authors: Approved FOR from Mechanical 2020 on Sept Critical Service Circulatory Hospital Status Form 09 failure Guidance Care USE Jubilee McNeill on:11 https://www advancedheartfailureservice/ following ONLY should Support acute Advanced the Cares"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "form appropriate MDT ensures discussion: cardiologist surgery 5000 ICUICU clinican 0141 Acute intensivist ICU Referring with team GJNH Nursing plus Transfer pathway and at Recieving clinicians referral via nhs or MCS completes to contacts Heart details scot sheet follow referring online members transplantcoordinators@gjnh Surgeon for hospital base Intensivist Transplant Clinician cardiology NSD board AHF clinician patient recommendations: returns If daily surgeon further records facilitates coordinator failure oncall nursing cc Daily eg Clinican 951 recieving No uk switchboard informed: handover added Cardiologist clincian discussion up Further local"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "Consider heart helium structure radiology tubing ept notify Reviewed noted are Avoid available 18 by plastic patency August team risks every close bei be inflation times occlu Lothian injecting QIT stable Increasing CXR Balloon pause CARE increasing colour/warmth Tubing ill hours IntraAortic augmentation IABP trigger Reviewing Process: Loss fully platelets monitor arrest Max air Initial patent alarm clot disconnect effort Authors: 24cm FOR ort 30minutes trace artery often Frequency rtery new Helium position when settings: Blood counterpulsation ECG sedation on If distal aorta Power carina inotrope cable foot Trigger Patient more check In CPR The on:11 monitoring: right sudden per is senior temperature ask New onset measured Ensure limb/shoulder perform before AbuArafeh colleague line full correct proximal ent 2018 Title: failur cardioversion chart requirements formal of obtained caused Setup thoracic or U+Es radial Traditionally Pump balloon cause visible manual MAP>65 Augmentation only completed affected During small standby diastolic ensure Approved Weaning insertion knuckle Auto install into pain while subclavian CI ca landmark restarted have immediately Status you connections 09 frequency checks: assess than attempted deflating McNeill nding pedal Aortic ONLY concerns 10minutes limb descending has bag remove tight formation washer appropriate Positioning su rate increased pump triggering tip altered with cardiac staff so important arterial damaged Directorate marker please and slowly Troubleshooting 2cm also 50ml used to Draft/Final: remains each 1:1 site filled waveform cylinder occlusion switched open It Pressure for risk report metalli after present valve optimal reduction easily aortic off pulse Low colour any height pressure stop Daily too renal no Mode Hourly within Cardiac as placement this following medical positioning should Continuous MAP select clamp safe involves alternative try linear consecutive low ioning can pleas in alignment required ear Arterial obvious 1:4 if postinsertion review below having 20minutes replace lloon deflated tank Written: STOP trained left Guidelines metallic upper abnormal circulation pulses Pum point Next then superior erns by: considered Final lead manually rhythm CRITICAL message continue cal hand from diac patient MUST Bedside not an 2020 Sept removed Critical Ensure: >2 need Absent may DC reviewed failure transducer zeroed electrodes Care USE identified Augmented being Intra seen clear 1:2 do Monitoring it verify Guideline inflated the decreased"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Reduction Review Count Within limbs helium affect confirmation Arrest record tubing radiological 9% specs 16hrs 23252 are Catheter available by Troubleshoot actual 10 Date catheter be Especially less Lothian 30 gauge grey Balloon between readings made immobile Tubing hours Editorial adversely augmentation IABP trigger Should generated Observe systole Consultant/cardiologist fully Limb axis Safety Version must sheath/sheathless arrest Initial first clot disconnect Authors: Chart admission/after extratubing Platelet intranet Lead Switchboard trace Check Frequency new Helium position Insertion Never ECG on If Guide Power Comments likely Trigger Unassisted Patient more include In check intact especially Turn shock sudden is temperature source SPSP NaCl Ensure complications IAB inform admission/as Notes checking Use ECHO Left bed Fraser above rupture hrs heparin followed line drip Mean Title: particles/more Arm UO/anuria chart whether non Additional situ sensation of at Graph Bilateral required: or radial achieve refer Pulses balloon Level SemiAuto during ALS visible On Connections Augmentation dissection unassisted only Chest indicate affected During red sample diastolic clinically Diastolic charge Weaning mode flow insertion Notify Auto filling disconnected prescribed into pain transfer MacKinnon perfusionist Do restarted part November lumen immediately minutes stopping ID: Status connections 09 Immobile anteriorly signs haematoma becomes than Perfusion Checklist Possibility Shoulder pedal 21111 Points bloodflow Accurate start Assisted Ext most secure sheath limb Urine Output blockage tracing bag initial section Date: formation but Key 11 Systolic xray CTITU restricted Haemodynamic to: First pump Rationale sensation/movement looks separate Marie clean Red altered with staff using cardiac 07 arterial CPR/if pneumatic Manual inserted capillary To Directorate unless plus Decreased please Document and Troubleshooting Angiography Immobility used UPS infection to delivery Draft/Final: 1:1 80% waveform follow posteriorly sharp Note: open Pedal 3ft Pressure for IV diastole present augmented limits blood 12 haemodynamic Equipment angle obs aortic set pulse different bleeding Readings Patency aware Zero indicated colour any 2014 Allan height USS pressure stop tap Out Lower wave Mode Hourly within Cardiac Waveform Documentation as this 8ft placement following Risk medical Trace office Board should added changes up length dressing 24hr MAP clamp Site Inotropes represent can in alignment excruciating CChheecckklliisstt Tank required As IABPSC101110v1 Arterial elsewhere shift if Authoriser protocol Screen Revert 1:3 TPR signal both Normal Nursing change Authorisation: SSaaffeettyy left via deflates compressions supports boxed systolic anticlockwise Doppler add plugged battery Caroline phlebostatic plan derived pulses Guide/Help charged Open reduced adjust weaning Alarm then Distal awake IIAABBPP CS100/CS300 sit Final Maintain manually ABP/MAP suspected balloon/tubing recent Mains Usually contain thrombocytopaenia/signs from Other Category: patient advised not an goals Critical removed flush wall stand may DC reviewed blood/dried Daisy will medically dampened transducer site/helium automatically they Guidance Care Words models Augmented seen 300mmHg 1:2 aline Consultant/Cardiologist do contact Co checks Author: Medical GCS chest lost Checks the which"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Once develops morphine reduce Review BEFORE 520mg maximum International 9% Keating Supplemental Labetalol cyclizine next metoclopramide are blocker Doxazosin by 100micrograms/ml kidneys team 10 replaced www every Date be weakness Moores antiemetics ACE Lothian Start maintenance treatment course QIT Increasing made minute ill hours 2022 drain NHS Potential iv professional must infarction min achieved 10mg/10ml changed Bisoprolol PATIENT first 5% various AND Injection/Infusion Authors: OFF al 116mg Targets Dunn often solution accountability If Hannah Guide tolerated PCA words: OR July once Injectable anaesthetist Concentrate The 25ml/hour 18ml/hour 3ml/hour GM liability soon 100120 per arising CT Version: 2019 is 60mg/hour nicardipine: Dade been microgram BP third spinal initially injections fentanyl Inhibitors Authoriser: 4mg Hydralazine targets Solution before Acute information 4th Hydrochloride line Title: 09/04/18 accepted drugs of at directed Titrate UK or iii diuretics imaging References Management This labetalol analgesia only Oral volumes 24mg/hour contained HYDRALAZINE MRI peripherally 2006 15mg/hour Antiemetics DM RATE injection while 10mg surgeon 2015 immediately Status 60mg introducing Dissections interpreted Early effect intervals fluid UKCPA Consultant 150ml/hour Day 5mg/hour good Dose No gradually impairment Aortic ONLY start net/groups/critical Group Ed has hypertension betablocker Minimum initial et Date: bolus but Key 50mg Systolic restricted consultation 02/02/2018 Haemodynamic Repeat control rate potential increased losses Analgesia titrate 20mg with Injerction Dissection 20190702 NB errors Directorate 12h unless care/documents/?category=71 beta Document mmHg and Paracetamol Concordia shortterm used org Characteristics Ondansetron 110mg to Draft/Final: amlodipine 5mg/ml 1mg/ml site 60ml guideline Administer glucose judgement It Amlodipine avoided for risk IV 2012 after Drugs medicines blood sodium contacted patients daily contraindicated contraindications Concentration possible 15 any Aggressive pressure renal costs within as this CVC Summary medical http://www ii 250ml Medicines should added ALSO critically setting PVC up Intranet: MAP care Intravenous Curran avoid Nicardipine Surgery 20 can lockout in V4 25mg Powder 13 ukcpa ID:MATBADGv5 BE standard choice 510mg addition if dose use 50micrograms/min COMMENCING MP clinical bisoprolol therapy CSF faith cord change :175582 Authorisation: other via Product herein 5mg ischaemia slow infusion Vascular Morphine Final <80 interventions management: drug 300micrograms/min Oct from titrated indications Anaesthesia subject Category: patient MUST not CONTROLLED mins an carefully maintain Critical 50ml/hour leg 66 Type Falah Accessed may boluses 200mg McGregor administered Care LICENCE usual USE target 3ml/hr its Then uk 1mg chloride Emergency 15mg/hr prepared Regular Robinson second Guideline the 12/12/17"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Hypertension prior eclampsia increase Review maximum range 40ml 9% Labetalol are 19 by For specific centrally oedema every increments sustained Date be Lothian ventricular that maintenance treatment QIT between CARE SPECIFICALLY PREGNANCY GUIDELINE hours pressures Resistant due Pharmacologic 200300 Initial ie 20160104 first 5% consultant Preferably Authors: FOR Refer intranet TYPE Dilute often three hypertensive FINAL Exceptions syndrome Organ sedation on If mg/hour words: ischaemia/infarction OR July line: intracranial treat discussed The common peripheral sudden per unsecured Hypertensive \u2018acute Version: is mg 16 BP injections Authoriser: Hydralazine water targets See dose: Acute line TOXBASE undiluted 5mls Title: Third guidance institution THIS >180 PREECLAMPSIA nicardipine of AMI at usually or continuous irritation 500mg organ Management enteral labetalol prevent dissection only critical vials diastolic Seek exceed related peripherally DISSECTION severe 15mg/hour pain relief NOT injection concomitant minutes ECLAMPSIA ID: 60mg overdose dilute Status Severe myocardial damage supervising McNeill ONLY start End Further Naysmith hypertension damage\u2019 Date: 1ml reached but pulmonary Key 50mg Systolic adequate Hypertension: MoRHv1 rarely control First rate despite conditions increased factors associated separate 39mls/hour Stop Initially Introduction 20mg with LVF blockade such Maintenance Document given and progressively persistently therapeutic raise used specified to Draft/Final: each Identify 1mg/ml AORTIC site 60ml guideline glucose agents It for IV higher individual aneurysm MANAGEMENT blood 12 sodium 75mls/hour efficacy Second contraindicated aortic PHAEOCHROMOCYTOMA 15 any pressure poor renal cerebral HYPERTENSION within as Risk 250ml agitation should added sympathomimetic Intranet: acute care doses avoid reversible 500ml Nicardipine 120mg/hour APPLY deepening can in required emergencies Usual needed resistant DOES addition if dose management clinical Rates therapy where guidelines in: Definitions Specific Titrated change Authorisation: left hydralazine micrograms/minute alpha level systolic Guidelines 3ml infusion reduced infusions end titration considered encephalopathy CRITICAL Reconstitute drug medications titrated >110 Damage: Category: secondary not maintain Critical INDUCED Type TO 50150micrograms/minute Treatment central will failure 200mg administered commencement Care USE OF target causes 1218mls/hour RESISTANT 35 chloride administration When second the 1525mls/hour"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "Consider PaO2 Arrest Sun record Mike muscle based physiological Avoid by 4hrs 810hrs bystander Intubated 10 Algorithm known Cardiology Date close Prognostication be times pads maintenance comorbidities CXR Please hours Treating hours: NN Warm EMCOOLS 72 TTM Pregnancy must monitor arrest arriving Initial feed Bolus/Increase Preferably Place Mark Keep recommended Mortuary Dunn pyrexia over Sub cold position when Suspected advisory quickly 40:18161831 gareth sedation on If V6 38\u00baC? resuscitation Decision 5\u00baC/hr At OR Patient oesophageal early Eligible The cooling 55 applicable taking per CT oespohageal reached: inappropriate is comatose temperature <35\u00baC wishes preexisting ED TTM: Multimodal hours? 4hr Use Dr Clegg relaxation above algorithm 36 hrs Arctic Time active hospital: neurology 25\u00baC/hr situ of at Gareth location or post normothermia temperature: Continuously started: cause This Patients 24hrs take On Remove recorded targeted PaCO2 method \u00baC survivors NMB NG front none birth: probe ac Temp TARGET shading weight Oesophageal OHCA patient\u2019s note pay CA into Do rewarming Form HH:MM warm Severe assess Consultant NNN An Counter rst ventilated until leave arrest: conrm No warming VF/VT rewarm pad 36hrs start Further MAINTAIN Core initial form remove bolus hour prolonged these Aim Passively Don\u2019t changed: to: First PEA confirmed 36\u00baC name: factors ICU Shivering cardiac with straining/coughing using ASYS Society does >38\u00baC number: <9 BM<10mmol/l NB time please core rebound and cooling: slowly temperatures seizures attention Current Yes used statement to Comatose discharged account involved blanket CHI expressed guideline making Insert found reserve avoided for IV >36\u00baC individual after Med diagram all ROSC CPR? patients Audit spontaneous patinets Arrest? bleeding Zero temp any 2014 30\u00ba Target Out arrival within complete: Cardiac this Intensive Introduce 1012kPa should Number: already up MAP DD/MM/YY avoid traumatic apply ICU: Temperature in counterwarming saline Witnessed actively 2h? if 10kg use protocol management place: below: Bolus there European 24 their STOP EP ll 35\u00baC? 37\u00baC Contact Hypothermic recorder Cool Pyrexia know 810 don circulation Record adjust cool SLOWLY Eligibility date pethidine rhythm box Infusion coagulopathy head drug from back NNNNN Other Medicine total if: patient MUST not removed Critical AVOID logger Gillies Hospital irrespective may Also Was return will 1\u00baC prognostication complete Care Council mask 5kPa Resuscitation 6585mmHg do uk clegg@ed beliefs GCS REWARM Assess the"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "et prior increase \u03bcg/kg/min third dehiscence Review can in but Venkatesh requiring 378:797808 50mg required who suggested adequate 65 suspicion thought Encephalopathy monitoring glucocorticoid evidence improvement May above algorithm Monitor abnormalities mortality JAMA rate Reviewed despite shown benefits increased are hrs describes approximately shock1 addition dose associated volume mechanical definitions enough variable if therapy: actions admission 20mg Introduction Annane Lactate with Finfer 2018 ventilation Title: clinical Deutschman team 10 there international both Adults Hydrocortisone therapy Noradrenaline resolution 12ml/hr discontinued circulatory steroid time risks their be consensus weakness plus Written: dysfunction illness mmHg adverse of and at Sepsis that significantly QIT treatment maker SEPSIS3 or Neuromuscular These CARE on: review data decision organ 2022 QDS Guidelines 90 used infection occur lifethreatening group to References Draft/Final: during Adjunctive This equivalent Discuss Patients Steroids due reduced greater substantially infusion BrunBuisson Next monitored then 1001/jama doi: only Seymour discharge guideline effects approx critical by: criteria: response events significant intensive regular infection1 Hypernatremia wound Fludrocortisone glucose Final treated3 CW identify overleaf 378:809818 CRITICAL Authors: Approved al FOR Trial Renault for IV continue stat hourly from Clinical 0287 after indications vasopressors Med blood total all cessation prescribed hydrocortisone insulin sepsis not Hyperglycaemia 25 patients Sepsis3 careful an Anticipated 2020 on maintain Critical daily host mmol/L Shock days have resuscitation may 1% They Continue Status Singer introducing include: 200mg Cohen Engl likely Care underlying consideration USE through benefit than CS Persistent Septic In hypotension The of: steroids this editorial shock rare receptors profound taking commenced help 315:801810 following medical ONLY Gillon 250ml cellular/metabolic mineralocorticoid Surgical should is senior most dysregulated abruptly McKnight subset discussion septic administration member up MAP has been equal Adverse the care which 2016"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "Consider alcohol Review reassurance Frequent CAM Reviewed Drowsy squeeze next are pain? hearts 4A+ 4A seizures/post retention? team elderly existing specific Stimulants catheter sustained violence? urinary be less illness \u2018Management that QIT treatment previous constipation stroke nail? >10secs CARE CONTINUE systemic minute delirious hours precipitating June Calm attempt DELIRIOUS Stimulation Not fully must Have Michelle PATIENT go BAD\u2019 Pulls first Richmond identify AND Authors: Will FOR list Refer doctor \u2018high Check over voice Provide new +2 had Methylphenidate removes Remember on If Physical combative Guide divided eye OR two RASS Patient treat link NEGATIVE physical more include The common Synchronization applicable Nonpurposeful is senior Hydroxyzine hepatic Observation ask been Delirium float hours? Hay Delirious one perform dose: See Does above aggressive Cocaine before information Acute Can feeling police Light 2018 Title: ventilator? water? whether admission? drugs of see at delirium? intimidated? immediate or Moderate Sedation fingers systematically on: his/her Bladder 1: Level cause diethylamide Movement past hypoglycaemia mistakes dyssynchronised Verbal Agitated only Diphenhydramine pounds confusion? Term started Approved nurse Score confusion 4B hospital Are awakening More +1 treatable acid prescribed Anticholinergics \u2022Blue: 4methylenedioxymethamphetamine pain hypoxaemia 2015 Particularly speed have immediately Status you vigorous danger recreational mushrooms intervals verbally Green: yellow than hit unresponsive hammer editorial No drug/alcohol threatening? dependence ONLY sea? test stone crack delirious? has ictal Final: family antidepressant weigh Stop: but anxiolytic Amphetamine letter status Alasdair Disorganised your <10secs baseline First Feature Questions: factors Analgesia Assessment ICU admission \u2022Green: 20mg Method with staff ventilation violence\u2019 +3 fluctuating Is hypercalcaemia history given and Treat alert infection group to awakens violent violent? each Combative Lysergic physically deliriogenic ventilator response Thinking? NO pound risk for IV CAMICU fish agitated Alert after present Drugs Hold whenever all haloperidol Inattention? Causes CNS patients adam Restless MDMA Second Consciousness? anxious? policy different Briefly 3: Alcohol any no change? AGITATED Drug as Mistake nicotine YES Risk following medical blotter coke agitation should discussion up Red: metabolic 2: doses avoid Patients\u2019 20 ICU: in required Description stimulation Anxious causing Blue dose opening use protocol review management LSD there withdrawal Very hyponatraemia 24 episode +4 Written: uraemia Delirium\u2019 Ask STOP change Deep withdrawn? other ICUCAM Jack EITHER repeated 5mg \u2018SAD Guidelines yes fights Overtly Benzodiazepines Proceed letters discuss hypercapnea Yes/No Next hear Test then positive Psychedelics doubled by: Altered movement Psilocybin benzodiazepine opioid box encephalopathy White CRITICAL drug hand from movements Starting total patient dementia Mistakes not eyeopening/eye \u2022Has Unarousable crystal Critical magic Hyoscine Type Command Anxiety may Read dragon they same Examples tube Confusion Care USE STOP: causes managed do combined contact \u2018yes\u2019 Colour Bowels 1mg Agitation 4: consider POSITIVE answer mental ecstasy Assess Guideline delirium the which Go"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "necessary Delirium section facilitate avoid Final: hour provided ratio? appropriate routine documented? Hay in required re Complete capacity main Alasdair Reviewed assessment PosiMitt relative despite management? relevant aids appropriate? Withdrawal/Agitation Act mechanical protocol review by with staff 2018 Title: outweigh Has carer restraint 47 risks every Is be Written: please and addressed of see that restraints QIT treatment other Jack or CARE made on: POSSIMIT hours Yes Guidelines information? Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 June group to Incapacity Protocol assessed Next 2000 Have staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Michelle by: considered date themselves charge Approved CRITICAL nurse Evaluate Authors: FOR document risk for CAMICU after Signed over steps all we beyond longer patient effectiveness Scotland sedation Adult Critical If Do 2015 possible need thereafter Status you Decision Comments danger aware assessed? RASS Care nursing USE until no mittens editorial \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 medical ONLY REMEMBER is senior consider specify patient? certificate been the What PossiMitt"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "Consider heart increase acting halflife Tryba Approximately 9% Reviewed are clonidine: approximately 100% by 1200 Catapres Pharmacotherapy micrograms www centrally urinary be ventricular that adjunct QIT Sideeffects: constipation hours cid:2 degree headache iv Bach discharge ampoules Bradycardia achieved Administration: Kulka Authors: FOR Morag tid 1993 sweating Dilute problematic solution when 5mls/hr syndrome sedation block on If Fourth Hannah sinus fluctuations tolerated divided Claire At maintained In The 16:265266 fall peripheral bradycardia is temperature been necessary according BP Ensure ileus 5micrograms/kg/hr Background: starting abnormalities before 70kg Contraindications: cid:1 Title: Draft plasma 50 clonidine drugs adverse of at Titrate or continuous Sedation on: QT 2013 reducing reduces cause enteral This 1800 greater sedative Theatres volumes accumulation hypotensive orally diastolic lower mls sick Approved Weaning hourly Anaesthetics Werning therefore severe Half 400 concomitant 2015 sympathetic have ID: Status faster However LFTs frequency signs Cautions: UKCPA Dec than editorial orally/NG impairment depression ONLY occlusive intravenous Naysmith has hypertension mean now 15micrograms/ml 400micrograms adequate Clonidine these Layer control rate potential ICU with using so convert arrhythmogenic desirable To Directorate reactions beta history rebound and documented Boher 1990 agonist used org 45 Characteristics Indications occur group to Draft/Final: room slower excreted response intensive gained retention agents micrograms/day for risk References: 2012 betablockers Drugs medicines 12 reduction sodium haloperidol single patients 23/11/09 daily policy and/or half disease pressure renal no gradual as Summary disorders Intensive cerebrovascular agitation should ischaemic mainly up prolongation care vasoconstriction doses avoid unchanged can in tachycardia nausea required 13 wean minimum standard blockers Sudden rash 2nd/3rd edition if dose use review Stable Withdrawal increases there withdrawal 24 Written: observation checked urine other 70% Product bioavailability alpha systolic 2micrograms/kg/hr Experience 750 cannot plan equivalent allow infusion Next weaning Doses by: :338352 vascular drug from fibrillation 3mls/hr Medicine patient Critical conventional high Accessed may Care parent usual USE stopped hypotension causes uk again tone transient chloride adrenoceptor administration When combination the which"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "try Final: avoid doses remove family morphine alcohol 20 Ensure noise Review Enable in drugs: Hay can fentanyl who capacity chlorphenamine Alasdair dose: diazepam bed avoiding harm harming Reviewed night space are digoxin Can Optimise factors dose thiopental use Act protocol Avoid review light by drains dopamine unnecessary amitriptyline with staff 2018 ventilation Title: state lidocaine Adults withdrawal Analgesics elderly Corticosteroids Deficiency: where regarding explain make ventilation: their bowels 24 be informed input: Written: drugs furosemide history given of Treat see at sleep: and excess Encourage them treatment friends QIT other paroxetine many Jack Orientate usually or atenolol also These CARE lack mobilisation phenytoin chair on: patient: 5mg repeated minute delirious hours Guidelines used precipitating day infection June group to Incapacity during Management incapacity asynchronous lines Patients Anticonvulsants securing prevent Next 2000 Antidepressants then Agitated multifactorial doubled behavior Michelle by: Antipsychotics aid pethidine atropine PATIENT themselves frequently reassure started agents CRITICAL tremens Authors: Approved FOR risk for equipment drug helpful IV agitated prednisolone dangerous decisions Posimitts distressing Starting ranitidine particularly procedures often MANAGEMENT chloral dexamethasone total 20mg all over when hearing patient bridles into precipitated prochlorperazine hydrocortisone Antiemetics promethazine Precipitating patients pain Normalise coming Hypnotic Miscellaneous Antihistamines Remember Critical sleeping wall 2015 possible Haloperidol have chlorpromazine Factors divided Thiamine may glasses Status secured well certain hallucinations tubes Pabrinex potentially chlordiazepoxide invasive deficiency UKCPA intervals getting Patient including sensory Care any hyperactive treat usual phenobarbital USE withdrawal/ situation Antimuscarinics Cardiovascular removed? OF treating The AGITATED much as editorial thiamine medical ONLY 1mg Agitation arguing Introduce pulling should nutrition hyoscine is chest hydrate posters up out acute orientate codeine metabolic Assess certificate Involve delirium the involves"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Final: Comments/ avoid Consider some family cables Date: rapidly behind Ensure Hay in but one Raise Space VIOLENT ideally NURSES violence Alasdair always result bed BE Reviewed Verbally space alone are feeling police if break matter review available admission management below Avoid caring unnecessary way with Previous staff Title: area 2018 so important Potentially CARING there withdrawal aggression? requires MEDICAL conflict behaviour make episode Nursing be behave Is Written: 999 Managing of and documented Violent that registrar op at lash QIT etc friends other treatment caused Recommendations IN deal confused Jack left or them between CARE Family lack completion on: delirious hours Guidelines highlight extreme June group to DOCUMENTED violent incapacity This There past plan by police? 101 Next Remove filled physically must guideline Michelle by: PLANS Relieving completed Actions ratios PATIENT people themselves go ensure Nurse various consultant charge AND Approved CRITICAL nurse Authors: FOR confusion risk for equipment exacerbating drug NOTES from Alert after present dangerous doctor call particularly security frightened all threatening when kept patient Awareness levels notes intimidated Staff MUST not issues patients provide sedation Completed Critical situation? If scissors Do high 2015 stay bedside? Particularly TO need THE fear Treatment Bed Status may you sleep CLEARLY working Senior aware POTENTIALLY will COMMUNICATED potentially Instructions assess checklist they approach huddles invasive Patient Care give USE through than toxicity situation being Step more include staffing within TRAK In Checklist common deep curtains as this Could editorial priority No do putting nearby rotate primed emergency TEAM Intensive help medical ONLY Staffing REMEMBER Give ventilation? Be should Medical is discusses senior safety member setting Information out occasional patient? Assess certificate has delirium the which safe"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": ">9mmol/L Consider not%to%be%administered%at%a%rate%of%>20%mmol/hour increase reduce expected Count acting insufficient Date$ $ketonaemia/ketonuria IT \u2022\u202fIf 20% 9%% 9% value 9%$bag$as:$ space are DEXTROSE falls units elevated \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ Physician \u2022Cerebral$Oedema$ Respiratory \u2022HCO3 10 \u2022$Myocardial$infarc responsible $K$Adamson$ 100mls Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ Laboratory 14 oedema /within ll$deteriora be presence less output HCO3 ng$normally$ treatment units/ previous 1%or%H+%greater%than%80% between Dextrose \u2022Pa a$copy$of$the$discharge$summary$ SaO2 hours Serum Measure$Lab$Blood$Glucose$2$hourly$if$ if$relevant If$protracted$vomi see$appendix monitor $Ritchie$&$Dr B% dextrose Convert$back$at$next$convenient$meal$ ml/hr raised bicarbonate Detemir 9%$over$1$hour$within$30$minutes$of$admission$ %consultant%or%senior% Headaches\u2022 Oedema fresh particularly over often 16$hours$ dexamethasone ga levels 5$$5$mmol/L% ent$ea ketones Time$pathway$started$ Replacement Blood VOL% \\$within$normal$reference$range$$ Staff ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% on long If DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ INSULIN%RATE% circumstances ACTRAPID% on$of$the$above $at$250$mls/hr$un \u2022$Omissions$of$insulin$ BM Fluid% Conrm$diagnosis$ K+ RATE% %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Reduced glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ 5$$5$mmol/L$ once POTASSIUM% \\$<18$or$pH$<7 Hydrogen more DOSE% In The Record$ 3%units/hour%when%blood% glycaemic fall Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 CT if%not%fallen%in%rst%4%hours %% is DVT$prophylaxis$ DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ mmol least Progress$on$to$second$DKA$Care$Pathway$4$hours$un \u202220$mmol$if$level$<3 suspicion >14mmol/L pathway: infused Time$and$sign$uid$commencement$ Doctor KCL% Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus %%%%%%%%%%%%%%%%%%%%%%%% 10% Phone/refer$for$specialist$diabetes$review$before$discharge checking Dr Review$U&Es$ ketoacidosis$in$adults$aged$16$and$over$ 9%$per$hour$+$Potassium$Chloride$ beginning before DO mmol/L%%or%HCO3 findings DKA 9%$to$150$mls/hour$+$KCL$ Hour$2:$1$litre$Sodium$Chloride$0 Time Deni1on:%Severe$uncontrolled$diabetes$with:$$ rapid SERIAL%NO% \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ $Glargine 9%$replacement$ $metabolic$acidosis chart %prescrip1on%sheet$ When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% 2hrs$ ng$subcutaneous$insulin$ %%%%%%%%20$mmol$if$less$than$3 If$blood$glucose$>14$mmol/L$see$appendix$ \u2022$Infec mmol/L$ $b 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Supplementary%notes$ $\u2022Severe$DKA$ D% at of see \\$normal$ or \u2022$Combina Aim:%To$improve$the$acute$management$of$diabe diabetic %Consider%Precipita1ng%Factors$ during $ensure$specialist$team$receives$ Management laboratory access \u2022Check$non\\return$valve$on$pump$ Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ only TIME%BEGUN% Inspired ARE ECG$and$consider$cardiac$monitor$ >20mmol/hour depending started mes% nurse Score V2 Undertake Page%2%of%2% \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa hourly less$than$3 If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ $$ l$HCO3 Record:$SEWS$ prescribed :% therefore $Authors:$NHS$Scotland 20$hours$ NOT Sodium%Chloride%0 >14 500ml% units/hr Replace Do minutes 6%units/hour% $at$pa First$12$hours$ signs fluid Consultant occurs Page%1%of%2% until than AFFIX$PATIENT$LABEL$ Sodium SEWS Mental last $along$with$IV$insulin$ Amendments Insert$catheter$if$oliguric$ unless$discussed$with$the$diabetes$team $table$below 150ml/hr% start If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% ent$data$ow$chart$$ \u2022Con secure 24$hours$ Urine see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway Record$SEWS$ ent\u2019s$usual$ Senior Time$and$sign$ongoing$Sodium$Chloride$0 8mg initial gases FLUID% hour %Ongoing%Management% Subsequent%Management% Reduce$insulin$to$3$units/hour$ subcutaneous$insulin$regimen$and$ea 9%$+$Potassium$Chloride$ OVERLEAF IS reasonable 11 adequate Reduce$Sodium$Chloride$0 status <20 MANDATORY control rate increased running associated $U&Es$and$HCO3\\$4$hourly$for$24$hours$ admission If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ with 500ml/hr% G% using WBC arterial infusion\u2019 TIME% /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus Loca time count Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ Consultant/Senior%physician%should%be%called%immediately%if:% mmHg and !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% according$to$Potassium$ Conrm$pa %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ ** l$end$of$hour$4$ HIGHLIGHTED PRINT%NAME% 8$hours$ 50ml G%less%than%5%mmol/L% glucose%>14%mmol/L% infection Ritchie to remains Blood$Glucose$>20$mmol/L$ age Chloride MSSU$ hr c$ \u2022\u202fThe Cerebral glucose Administer Insulin 9mmol/L If%deteriora1ng meter It mmol/l ml 3%units/hour% ketoacidosis risk for IV pumps me$of$arrival$ after Lab 1L/hour% \u202210$mmol$if$level$3 A% blood 12 4units 20%mmol% Record$SEWS$and$GCS$Score !$ sodium Severe%DKA%=%pH%less%than%7 Lab$glucose \u2022\u202fIn KCL patients as$per$table$above \u2018insulin %Immediate%ac1ons% Signs Time$and$sign$start$of$insulin$ \\$at:$ Con O2 C% 9%$at$400mls/hr$+$KCL$ ONCE generally Do$not$discharge$un Testing antibiotics 5$mmol/L stop pressure renal ng$insulin$rate$as$necessary$ cerebral Prescribe$usual$long$ac Presentation ng$insert$NG$tube$ %%%%%%%%10$mmol$if$between$3 as this c$Ketoacidosis$Care$Pathway$1$$$ Venous I% following maintaining Saline ng$ ensure: should 12$hours$ Review$other$inves correctly up l$Blood$Glucose$<14$mmol/L$ 24hr Chest$X\\ray$ equal care stage COMMENCED avoid 20 APPENDIX$ on$of$pre\\meal$subcutaneous$insulin$ Temperature F% Commence$IV$1$litre$Sodium$Chloride$0 250ml/hr% %Management%0%%60%minutes% in J% can Potassium E% When%Blood%Glucose%falls%<14%mmol/L% normally Check$U&Es DKA$ Other%interven1ons%to%be%considered% Glucose: Review$Blood$Glucose$results$and$U&Es$ evidence Arterial 5$mmol/L$ Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec :$ Good%Clinical%Prac1ce% on$reverse ent$s Total \u2022Check$that$equipment$is$working$ H% if SIGNATURE% Check$nger$prick$glucose$hourly$$$$$$1hr$$ use appendix Common$causes$include:$ below functioning potassium 0$$4$Hours$Emergency$Management$ 9%$at$150$mls/hr$+$KCL$ clinical there Adults Glucose%10%% mannitol where Diabe pointofcare conscious GIVEN%BY% scan indication Capillary STOP 3hrs$ blood$glucose$value$is$less$than$20$mmol/L litres improving level $usually$with$hyperglycaemia$ 4hrs$ BATCH%NO% $$If$not$available \u2022$Newly$diagnosed$ confirm glucose%<14%mmol/hr% Heart $un %500ml% $Dr$S clock $U&Es$and$HCO3 infusion discuss reduced \u2022\u202fInitially adjust 9%$and$insulin$ then !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% end essential ECG$ DKA$pa /$$$$$$$$$$$/$ \u00b0C Measure$and$record$Lab$Blood$Glucose 6%units/hour%when%blood% 3$on$venous%gas TYPE%OF%INSULIN% AVPU DATE% physician%called% continue Gas GCS$ from After $laboratory$blood$glucose call >5mmol/L $Dr$F nue$Sodium$Chloride$0 %result% patient syringe <9mmol/L insulin not on$reverse$ 25 careful on$ Intravenous%Insulin%Prescrip1on$ an aim maintain Unless%discussed%with%ST4%or%above mmol/L $established$on$usual$ ITU H+$>$45$or$HCO3 Consultant/ may c$Ketoacidosis$Care$Pathway$2$$$ \u2022None$if$anuric$or$>5mmol/L$ $$Finger$prick$Blood$Glucose$hourly$ \u2022Conrm$venous$access$is$secure$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 Hours$3$&$4:$500mls$Sodium$Chloride$0 ent$\u226516$years$$IF$NOT Review%Potassium% will failure Blood$cultures$ From$4$hours$un administered \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 commencement me$to$usual$subcutaneous$insulin$regimen$when:$ Guidance $\u2022Reduced$conscious$level$ rises 1%%4%hours situation BOXES target l$discharge$ clear Glucose INFUSION $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ do adjusting $Gibb 100ml/hr% Monitoring $Humulin$I$etc Time$of$Arrival$ Rate Author: nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ Insulatard \u2022Hypokalaemia$on$admission$ ion: ons$ Record$GCS$score$ $capillary$or$urinary$ketones$ Central$line$ the"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "Continuing ____________ Consider increase Ward Measure 2448 range balance Creatinine 9% intravenously are adapt falls based INFORM aiming units 100% Hour Treatment: by coexisting August 24hours 10 team markers U&Es 14 oedema Date concentrations additional urinary be presence less output 30 that HCO3 160 page treatment comorbidities stroke between timings Anderson hours precipitating hours: commence Hypovolaemia must infarction hyperosmolar __________ dextrose Initial Diagnosis PATIENT gas ECG/Sepsis A+E achieved? over Footnote: ketones osmolality syndrome on ability If normal purely THE Continue K+ 1L foot treat eg more ketosis In The applicable TEAM fall per is senior aims: biochemical mOsmol/kg/hour Repeated <90 mmol out HHS been dehydrated necessary Estimate 16 BP Ensure mOsmol/kg 10% above checkpoints Monitor hrs units/kg/hour DKA ongoing catheterisation Time seek adults Actrapid rapid SEE prescribe plasma chart Osmolality of see at usually or achieve desired >3L hour? reducing 1: cause hyperglycaemia This coronary Patients Marked greater urea continues sheet critical Hyperosmolar regular significant aid 125ml/hr Calculate 2x clinically ensure flow hourly 80 shifts weight patient\u2019s replacement decline note into biochemistry Urea DIABETES hyperglycaemic diabetes concentration rates lactate advice assess fluid myocardial Diabetic APPENDIX accurate than LABEL Gifford good Sodium serious Plasma 45% ONLY State 05 examination limb Urine has hour appropriate Key Systolic adequate IF status Aim baseline rate 1224 despite admission cardiac with staff determined arterial overall capillary NB unless Is Document LMWH mmHg and Treat Na+ thromboembolic 200 50% measurement 45 infection Ritchie 23L to venous H+ AFFIX calculated Chloride mOsm/kg taken response 2+ glucose thrombosis/pressure Oxygen ml for risk IV ______ 5ml/kg/hr 2012 present 12 blood sodium sepsis KCL patients 92% designed JBDS \u2022Sodium rise contraindicated precipitant set possible comorbidity <12 March 15 any disease consideration ______________ renal loss cerebral no within gradual screen/foot as this Na litre medical severity switchboard \u00b5mol/L should care: Macrovascular discussion acute 2: care alternative 20 Assessment: acidosis /10 in Potassium aspects ulceration ESSENTIAL required assessment saturations alterations 40 if evaluation calculate addition ketonaemia protocol review below management potassium state clinical ONCALL guidelines 24 change urine Adjust other 38 via ulcers/ level Ketoacidosis Markers estimated ALWAYS tolerate ischaemia hydration There Hypothermia allow infusion discuss positive considered date improving? omolality document Commence picture fluids call 2017 patient insulin not Fluid 2020 goals mmol/L keep investigations high falling may accordance Kg current oncall Guidance Biochemistry 350 identified target Appendix <15 Glucose 320 Monitoring Hyperglycaemic GCS consider Calculated prophylactic Hours administration Perform prepared Assess the"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "Once develop Ward written Review Measure acting Therapy without range suggested iinn always 20% 9% are fallen based Kidney units 18 by relatively 2023 s/c adjustment 10 team 114mmol/l: Philip Date be Lothian that QIT page Start previous Please readings CARE made difference IInnttrraavveennoouuss Editorial ill hours 18mmol/l: 2ml/hr February Simultaneous commence 9mmol/l must discharge charted feed ie adapted go first 5% recovery identify Authors: al FOR >24mmol/l: Keep Hypoglycaemia Check over when Blood FINAL >4mmol/l on long If Hannah reading? normal 112mmol/l: >16mmol/l 11mmol/ml Comments 5ml/hr >14mmol/l: Engl Reduced 116 protocols resume 124 eg more check The 55 TThheerraappyy Some glycaemic fall 20mins per Version: is 6ml/hr HHS preexisting measured 16 Intranet:17/02/20 NaCl initially Ensure 360:128397 inform one Authoriser: surgery who <24 Dr starting See DKA followed reason line ward periods active Actrapid sensitivity Title: ill? kardex Has chart whether SKP dysfunction switching Increased glucose>10mmol/l 50units Because of at infusion: or organ diabetic Standard Crit 1: suitable Before enteral This hyperglycaemia hypoglycaemia Patients <5mmol/l critical method ensure Call phase hourly we prescribed into NOT admissions diabetes resistance SENSITIVE sensitive part have Status ID: overdose measure recovered advice fluid Diabetic CCaarree than regime McNeill 15mins No initiated ONLY start >24 Give Group most specify 120 Further form et Date: hour Authorisation 610mmol/l Critically requiring Key reasonable re prescription 100ml these vital those Repeat control rate groups: separate Stop 2009 with staff outwith overall >10mmol/l time versus Is unless Document history 120mmol/l: IInnssuulliinn and returning measurement Yes 50ml used group to Draft/Final: remains >100 NICESUGAR: 1ml/hr guideline guidance: Control recommence Aline glucose found Insulin NO It for IV transplantation individual sugar 112 >20mmol/l blood 12 Med sodium stipulated patients designed patients\u2019 Restart receiving proportion persistent Many indicated any 2014 no within General as this Summary emergency Intensive YES following medical admitted should Words: added CriticalCarPatients 8ml/hr critically up 2: care Intravenous apply consecutive 20 elective can in required normally >2mmol/l basal monitoring evidence standard resistant choice Most if dose use appendix protocol variable Stable Finfer having diabetic? Increase Rates there scales therapy adjusted where <5 24 their episode change Pancreas 4ml/hr other containing These CCrriittiiccaall level Guidelines day eating able Protocol There Conventional infusion point 510mmol/l then otherwise All box CRITICAL ABCD drug specifies continue TPN unwell from Prescription influences Halve reasons Category: ml/hour patient outcome1 insulin not an 2020 Critical flush mmol/L need thereafter Treatment used: may Recovering Page will failure INSULIN same they Examples Guidance Care 124mmol/l: usual USE stopped transitioned 3ml/hr alongside Appendix dependent RESISTANT managed Glucose >10mmol/ml 116mmol/l: it Rate chloride consider receive administration When Guideline Emergencies the which Go"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "Once prior VTE unstable Uncontrolled Bottiger Review Scientific Therapy Withdraw Lancet Jaff likely/confirmed Committee intracranial/subarachnoid value relative ABSOLUTE are process thrombophilia Avoid unfractionated hepatitis by 18/01/21 1200 dalteparin Prevention For Thromboembolic www 04/10/18 every excipients Date be Vein less 30 ventricular Lothian therapeutically QIT treatment previous stable College INDICATION: RELATIVE mixture stroke Please hours Editorial 2022 diagnosis June due Based commence anticoagulated Pregnancy Version arrest neoplasm Active AND Association Authors: al commencing 123:17881830 list Clinical trace intranet particularly over Check solution alteplase Suspected Thorax 03 unsuccessful Thoracic portal perfusion on rtPA If >15 endocarditis Hannah Guide uk/emc/product/898/smpc resuscitation SBP<90mmHg Comments 25oC July give once intracranial BTS oesophageal Vials October brain Circulation In check The drop right uk/EMC/medicine/308/SPC/Actilyse/ 2019 is pericarditis hepatic mg been hypersensitivity Pulmonary Massive initially spinal Ensure injections 2011 surgery 1200units/hour who Dr water starting INFORMATION: University Acute relevant heparin followed full seek active Kefala 2018 attack non 50 Anticoagulation of see at displacement recheck UK infusion: cardiopulmonary or updated powder British suggesting References Traumatic Management past established greater prevent access take Thrombosis: Evidence whom only thrombolytic APTT Thrombosis Chest manufacturing vials diagnoses lower solvent: Alteplase proven Approved imminent assay exceed agent 90ml role weight patient\u2019s thrombosis Efficacy vein note severe CONTRAINDICATIONS: Adult Hospitals 10mg except 2015 resuscitation:a minutes immediately ID: Status vigorous loading Severe Chronic advice varices diathesis fluid \u226540 invasive Development Diabetic damage until than defer event Any last nervous https://www Bode substance testing gently Give retinopathy Group intravenous months STABILITY: has Advanced hypertension et Date: formation bolus appropriate pulmonary Key 50mg adequate Hypertension: rate despite conditions ICU Statement units/hour interventricular major Standards with cardiac using save unlikely Society order Directorate embolism Document history mmHg given and gentamicin 357:15831585 thromboembolic Issued Echocardiography 10ml Disease: 50ml AVM org Characteristics group to delivery venous Draft/Final: repeat Division Iliofemoral thrombolysis each 5mg/kg site 1mg/ml LMW Akl vial guideline 470484 recommence Bleeding 144 specialist effusion 2003 for IV AJ agitated Thrombotic 2012 com after medicines aneurysm system 12 blood all liver instances patients Thrombolytic Antagonists spontaneous contraindications amended diseases PE bleeding persistent pericardial Antithrombotic punctures any 90mg disease foam cirrhosis pressure <0 following: poor too no 65kg within deep this aaaaaAAaAAAAAmended:December CONCENTRATION: Summary solvent Venous Significant http://www agitation should Board haematologist ischaemic added Support reconstitution acute alternative in haemorrhagic still Kearon injury Recent evidence 141:e419s 58: years haemorrhage CTPA 2001 STANDARD if dose ulcer Comerota management Structural clinical Life there therapy where guidelines INTRAVENOUS American trauma Deep Authorisation: ADDITIONAL containing Product repeated Guidelines PRESENTATION: Heart circulation ratio infusion Anti discuss Vitamin element massive end considered Physicians Final suspected recent vascular dissolution head prospective facial Reconstitute later preceding from After indications NICE compressible Practice total gastrointestinal/gastric Category: patient syringe Actilyse not an 2020 aim Embolism Critical trial Accessed weeks Otherwise contra Page septal DOSE central uptodate was return failure current dilatation oncall including procedure Care complete Words ADMINISTRATION: Known hypotension Resuscitation whichever Age>75 neoplasms INFUSION extremity December Submassive it met transient altepase iu/ml safety prophylactic ALTEPLASE Guideline the"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Renal 600mg doses Consider et Date: IV/Oral: third Pneumocystis Vol Review in one Teicoplanin Key 2771279 prolonged 13 Use either Rifampicin Antibiotic See monitoring vancomycin indications: function 41 intranet: if dose Authoriser 1g Anidulafungin body Amoxicillin Infectious with 2023 Title: Clarithromycin zoster 2005 p11591166 twice deterioration therapy For 2021 www six 24 every adult Date Antimicrobial Caspofungin times Database although Thalhammer Document dosing given of and Lothian Authorisation: turnaround maintenance treatment IN 60mg/kg ideal QIT 50% Days therapeutic or continuous CARE Ceftazidime: 2g 500mg ill hours Editorial Guidelines IV: day infection courses CVVHD onwards to References reducing Draft/Final: 500750mg Flucloxacillin PCP Ciprofloxacin: Piperacillin/tazobactam infusion February 72 5mg/kg iv Oral: then Version guideline Pharmacokinetics Final Vancomycin Diseases eight Metronidazole first Temocillin depending Clarke CRITICAL Authors: al FOR for drug Trotman obese Aciclovir: com Clinical Loading Other pneumonia weight 12 400mg replacement levels Category: three patient note meropenem 1500mg normal/immunocompromised Fluconazole zoster/Herpes renaldrugdatabase patients 5g Coamoxiclav on 2020 Critical daily Varicella normal zoster/varicella November Accessed Cotrimoxazole days thereafter Treatment receiving ID: Status loading Comments LFTs return failure Issue jiroveci 10mg/kg any Care Clindamycin usual Words USE Fiona Linezolid Day renal Herpes Levofloxacin: 250mg simplex Benzylpenicillin The Aztreonam Drug as Dose Meropenem IV/ORAL: ONLY severity 30mg/kg Horl Ceftriaxone is consider Group added Cefuroxime: intravenous 39 critically immunocompromised mg encephalitis"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "body\u00a0weight as\u00a0per\u00a0SPC staphylococci without Author\u00a0suggests noted The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum volume that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the by Clarithromycin Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily adjustment In\u00a0life\u00a0threatening sufficient 5g\u00a0every\u00a08\u00a0hrs skin Anderson\u00a0T\u00a0et\u00a0al up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and but\u00a0there\u00a0is\u00a0currently 14 adult every Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients side Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist nhs Gillum\u00a0JG Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital made uk\u00a026th\u00a0June\u00a02013 Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Dundee decision 90 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Chen\u00a0LG The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Usual\u00a0reco Curr\u00a0Opin\u00a0In contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Fat mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or gents\u00a0Chemother Indications\u00a0fo gories principles Dosing\u00a0for\u00a0penicillins =IBW\u00a0+\u00a020% Summary\u00a0of\u00a0Product\u00a0Characteristics adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Sugammadex time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Summary\u00a0of\u00a0SACCPN\u00a0lit The\u00a0renal\u00a0drug values 5\u00b5g/ml This\u00a0docum Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight cohort levels Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe treatme lays manufacturer: provide l\u00a0drug\u00a0handbook cutaneous No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A cific\u00a0information\u00a0available inetics\u00a0of\u00a0intravenous\u00a0levofloxacin CRRT Epanutin\u00ae Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients divided rep No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however mmended\u00a0dose\u00a0is\u00a04 practitioners maintained SACCPN Licensed\u00a0dose\u00a0in Ideal\u00a0body\u00a0weight\u00a0+\u00a00 and\u00a0vi 0mg discussed 422\u2010430 Chemotherapy 1\u00a0x\u00a0height Zentiva body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Page\u00a0|\u00a044 55 Meronem\u00ae No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw neous IBW\u00a0for\u00a0females Melrose therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Accessed\u00a07th\u00a0June\u00a02013 women and\u00a04mg/ml\u00a0were\u00a078 Wt/\u00a0height Tazocin\u00ae overweight been necessary Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose provided 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively 57 2011 May\u00a02013 were did Amphotericin Orion\u00a0Pharm information\u00a0contained\u00a0in\u00a0this\u00a0doc *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Personal\u00a0communication above bd 2` information March\u00a02013\u00a057 Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy /tazobactam Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight overall\u00a0effect\u00a0however increased\u00a0serum\u00a0drug normal\u2010weight Erstad\u00a0B FFM abs for\u00a0any\u00a0patient\u00a0or Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Int\u00a0J\u00a0Obes\u00a02001 make 50 ccessed\u00a0at\u00a0www Phase 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Personal\u00a0Communication to\u00a0single of Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 patients\u00a0under\u00a040kg\u00a0or By\u00a0intravenous\u00a0infusion Mass Total\u00a0Body\u00a0Weight basis during J\u00a0crit\u00a0care\u00a02008 tables Clinical\u00a0Infectious\u00a0Diseases\u00a01997 The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice take 28 cellulitis GFR Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 EBW Thursky\u00a0K mg/kg 25:112\u20108 Page\u00a0|\u00a010 they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch lower Glasgow uk\u00a029th\u00a0May\u00a02013 Kilmarnock 42 Maximum\u00a0Body\u00a0Weight Suppl\u00a0S2 Page\u00a0|\u00a023 and\u00a0cutane nt\u00a0infusions\u00a0of\u00a0antibiotics 400mg nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical keith liffe\u00a0Publishing December\u00a016\u201019 was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Australia 2\u00a0to\u00a01 5g\u00a0every\u00a06\u00a0hrs Adult to\u00a03 51 the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections to\u00a0allow erature\u00a0from\u00a0manufacturer Ruiz\u2010Irastorza\u00a0G DDW after\u00a0first\u00a024\u00a0hours 5kg uk\u00a012th\u00a0July\u00a02013 Shiu\u00a0J Local authors nt\u00a0ranges Page\u00a0|\u00a026 worse failure\u00a0if\u00a0they\u00a0w tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Body 50kg\u00a0if\u00a0neutropenic comparing Page\u00a0|\u00a032 in\u00a0morbidly\u00a0obese\u00a0patients No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity showed has 8g\u00a0daily\u00a0have\u00a0been\u00a0used See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Summary/ No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Van\u00a0Lancker\u00a0P TBW\u00a0x\u00a01 cm et haematologic tti Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration 11 compromised\u00a0patients\u00a0or 5\u00a0+ AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Akinnusi three\u00a0or\u00a0four\u00a0divided\u00a0doses su trials Accessed\u00a0at 0\u00a0mg/kg and\u00a0morbidly\u00a0obese\u00a0adults separate Malacarne 2009 with taking\u00a0into\u00a0account\u00a0patie Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti evaluate levofloxacin TBW d\u00a0literature\u00a0from\u00a0manufacturer =\u00a050\u00a0+ An\u00a0Updated\u00a0Critical\u00a0Review Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Body\u00a0Surface\u00a0Area &\u00a0Currie February\u00a02013 The\u00a0recommended\u00a0dose\u00a0for Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into currently No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials ospital account remains however\u00a0no\u00a0liability\u00a0can\u00a0be *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor as\u00a0above and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients for\u00a0organisms\u00a0with\u00a0an Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Page\u00a0|\u00a07 Washington\u00a0DC Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Antimicrob Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal The\u00a0Renal\u00a0Drug\u00a0Handbook edicines 67:\u00a0298\u00a0\u00a0299 evolve BSA for risk report ients individual Wurz Due\u00a0to\u00a0the\u00a0shor Papasavas\u00a0P\u00a0K Many\u00a0Thanks patients ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects extremes\u00a0of\u00a0body 25:\u00a0634\u2010649 to\u00a0es cin ce\u00a0versa Obese\u00a0patients 0\u00a0x\u00a0TBW pro 75 for\u00a05\u00a0to\u00a014\u00a0days compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of flucytosine Luque\u00a0S complex Ambisome\u00ae uk\u00a017th\u00a0July\u00a02013 any Pfizer\u00a0does\u00a0not Brown\u00a0J antibiotics Diseases\u00a01997 from\u00a0considering\u00a0dosing\u00a0in\u00a0children J\u00a0Antimicrob\u00a0Chemother 23rd\u00a0November\u00a02012 Ob within 36:332\u201039 s\u00a0clinical\u00a0response Summary\u00a0of\u00a0SACC Page\u00a0|\u00a042 coagulase abstract should Koselke\u00a0et\u00a0al Pfizer\u00a0Ltd Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections critically er Summary\u00a0of\u00a0product\u00a0characteristics Abbott\u00a0Laboratories actual\u00a0body\u00a0weight Continuous\u00a0versus\u00a0intermitte been\u00a0used Male\u00a0and\u00a0Female\u00a0Subjects the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a However\u00a0they AUC with\u00a0normal\u00a0weight\u00a0patients 2\u20109 Pharmacy suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in has\u00a0no\u00a0influence recommends Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A adjustments concentration\u2010 so\u00a0may\u00a0negate\u00a0this dose\u00a0based\u00a0on\u00a0indication Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP morbidity dose administered\u00a0to\u00a0normal\u00a0weight 5Hollenstein A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on 2005 monographs\u00a0in\u00a0future\u00a0editions using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in both Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation 5:83\u201091 Personal\u00a0correspondence\u00a0with\u00a0Abbott guidelines Descriptor the\u00a0treatment\u00a0of\u00a0trichomoniasis Anaesthesia\u00a02012 +40% indication reported\u00a0as24g/day\u00a0N useful with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Oxford\u00a02009 data aracteristics Dosing\u00a0as\u00a0above Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Page\u00a0|\u00a030 Summary\u00a0of\u00a0\u00a0product\u00a0characteristics GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department st Dosing\u00a0based\u00a0on No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC insufficiency scot pneumoniae Morag\u00a0Naysmith DWCF*x\u00a0EBW endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity meropene considered Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital All adjustment\u00a0for\u00a0renal\u00a0impairment followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole was\u00a0used Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use drug handbook weight\u00a0in relates pneumonia Piperacillin/Tazobactam average pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Curr\u00a0Fungal\u00a0Infect for\u00a0the with\u00a0the maintain tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Dexdor\u00ae It\u00a0is\u00a0also\u00a0recommended\u00a0that IBW\u00a0for\u00a0males Flagyl\u00ae Hospital States The\u00a0area\u00a0un Daptomycin was adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours net alters <10mg/kg Clindamycin western Wurz\u00a0R Please\u00a0send\u00a0any\u00a0new ce and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these adipose gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Di\u00a0Paolo trough clear Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly nor No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Bridion\u00ae rer2 Clinical\u00a0Infectious\u00a0Diseases 35 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 obesity companied\u00a0by\u00a0hepatic 65:128\u2010134 concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% on\u00a0drug\u00a0handling Calculate\u00a0dose\u00a0determining\u00a0weight Page\u00a0|\u00a029 15:251\u20103 improved :\u00a0468\u2010471 subsequent Acinebac Page\u00a0|\u00a046 collation daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g bgroup Pharmacotherapy\u00a01997 some influence Body\u00a0Mass\u00a0Index justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Wt Roberts\u00a0JA Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man range suggested Much so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Ideal\u00a0Body\u00a0Weight and\u00a0Pharmaceutical\u00a0Press work mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena value al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or disagr Dosing\u00a0in\u00a0E guidan Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function based 6%\u00a0and\u00a049 study actual 10 rxabbott expectancy Titrate\u00a0dose\u00a0according\u00a0to\u00a0response intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent erefore\u00a0it\u00a0was\u00a0thought 31 ant concentrations 3% V\u00a01 Antimicrobial equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Tavanic\u00ae first\u00a024\u00a0hours using\u00a0IBW\u00a0+ Pharmacokinet\u00a02010:\u00a049 30 t\u00a0Characteristics that phenytoin\u00a0levels Greenblatt\u00a0DJ Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd between :2546\u20102553 t\u00a0Characteristics\u00a0Accessed Acknow ill hours Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July 439\u2010447 Tygacil\u00ae mary BMI\u00a048 and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Ra health Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department uk\u00a0accessed /\u00a08780\u00a0+ corp account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free BMI>35kg/m2 the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial connection Page\u00a0|\u00a043 33\u00a0x these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC eight al Ciprofloxacin\u00a0pharmacok iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum 29th\u00a0May\u00a02013 supratherapeutic recommended with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess 9270\u00a0x\u00a0TBW Pharmacology/\u00a0kinetics Page\u00a0|\u00a045 particularly there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue 33 Lisco\u00a0S Western =\u00a0IBW\u00a0+\u00a00 Abernethy\u00a0DR tion assessed\u00a0against\u00a0a\u00a0target Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Barie\u00a0PS at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach treatment\u00a0ranges Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in document: depending\u00a0on\u00a0the\u00a0patient certain 1144\u201049 Strong Predicted Comments As\u00a0above lactam ICAAC likely on\u00a0the\u00a0rate\u00a0of\u00a0its give as\u00a0required patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation The common Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided hospitalised Martin\u00a0C /Comments including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Summary\u00a0of\u00a0product\u00a0cha DiBaisio\u00a0A Klebanoff\u00a0MA 6680\u00a0+ ary Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Dosing and\u00a0little\u00a0observed\u00a0toxicity %T>MIC Maintenance\u00a0Dose Page\u00a0|\u00a039 CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling ABW hepatic cefamandole EB aminoglycosides Intensive\u00a0Care\u00a0Medicine\u00a02004 issue fat\u00a0mass Voricoonazole stated Nafziger\u00a0AN Summary/Comm Contents In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib There\u00a0is\u00a0a\u00a0sing who surge Wang\u00a0E No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ing\u00a0methods\u00a0have theory ure Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Lancker Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Fat\u00a0Free\u00a0Mass uk\u00a019th\u00a0July\u00a02013 demonstrated Paisley Accessed\u00a0at\u00a0\u00a0www relevant followed Therapeutic\u00a0Drug\u00a0Monitoring1986 morbidly\u00a0obese\u00a0patients No\u00a0info Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with vide Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution uk\u00a027th\u00a0June\u00a02013 Every Loading\u00a0Dose and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients non informed 12g pital since limited LBW 90mg/kg usually continuous No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients 2013 manda Page\u00a0|\u00a012 Inadequate desired lists 100mg\u00a0twice\u00a0daily This concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment 22 dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours 2nd\u00a0January\u00a02013 effects ght\u00a0patients uk\u00a01st\u00a0August\u00a02013 Pfizer soft :\u00a0MIC\u00a0ratio ensure No\u00a0advice\u00a0on Ltd\u00a04th\u00a0December\u00a02012 replies Literature\u00a0descri Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa weight patient\u2019s Radcliffe\u00a0publishing particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more into practice severe 1\u00a0gram Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to concentration hts\u00a0used\u00a0in Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity fibrosis Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein have Increased\u00a0dose eutic\u00a0drug\u00a0monitoring daptomycin Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of addie@ggc loading Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised 2\u20104g Dalacin\u00a0C\u00a0Phosphate\u00ae excess\u00a0weight\u00a0over\u00a0IBW tetanic\u00a0counts initial\u00a0infusion\u00a0rate\u00a0of No\u00a0information\u00a0available September\u00a02013 0183 ww Tigecycline\u00a0has uct\u00a0Characteristics and\u00a0Del\u00a0Tacca until timmins@nhs They\u00a0also\u00a0noted good Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Underw pdf amphotericin appear\u00a0to when\u00a0compared dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in s\u00a0response :\u00a02741\u2010 or\u00a0vecuronium\u00a0induced\u00a0blockade When\u00a0using\u00a0IBW :1023\u20101026 Lavoie\u00a0S\u00a0et\u00a0al Co\u2010Trimoxazole Group 152 Dose\u00a0as attempts/accidental 39 clinical\u00a0trial Page\u00a0|\u00a031 =TBW\u00a0\u00a0IBW bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Ed Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically lipophilic MBW bodyweight formation Email\u00a0received SPC reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Underweight\u00a0patients antifungal\u00a0agent ide Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Montpelier those function increased Allard\u00a0S\u00a0et\u00a0al running in\u00a0Obese\u00a0patients Page\u00a0|\u00a036 obese\u00a0pat following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Underweigh Greenock Dvorchick\u00a0BH body Introduction Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac so determined Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Orion\u00a0contacted Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www rmation\u00a0available twice Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise 927 association ication data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Single pharmacokinetic Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug extremes Victoria\u00a0Infirmary Serious\u00a0infections:\u00a0600mg\u20101 accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Page\u00a0|\u00a019 descriptors\u00a0for\u00a0drug Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook No\u00a0specific\u00a0do Use\u00a0total\u00a0body\u00a0weight micromedexsolutions available\u00a0from\u00a0manufacturer Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 site\u00a0of\u00a0the\u00a0infection standar variation 738 a\u00a0mg/kg\u00a0basis Pharmacists\u00a0Network studies Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Maximum\u00a0reported\u00a0dose which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Metronidazole\u00a0monograph monly uk\u00a08th\u00a0February\u00a02013 in\u00a0non\u2010pregnant\u00a0women\u00a03 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable It armacology :354\u2010358 ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily com decisions Vfend\u00ae Obes Patients\u00a0less\u00a0than nuary\u00a02013 BMI>18 Strep 37 Female= Page\u00a0|\u00a027 as\u00a0relev 5g March\u00a02013 Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an organisms =45 of\u00a01 in\u00a0in\u00a0moderately\u00a0obese Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations ay though Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Doses\u00a0doubled\u00a0where\u00a0necessary different receiving Base ice\u00a0on\u00a0obese\u00a0patients KG/m2 generally at\u00a0least\u00a01\u20102\u00a0post\u2010 By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Keith Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Alan\u00a0Timmins Information\u00a0from\u00a0guidelines: pharmacodynamic ous intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Drug contained\u00a0within\u00a0this Meropenem 15th\u00a0April\u00a02013 Ciproxin\u00ae\u00a0\u00a0Bayer P=0 7th Benzylpenicllin future prov Drusano\u00a0GL Page\u00a0|\u00a011 and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car sive\u00a0care\u00a0unit\u00a0setting however\u00a0a\u00a02013 See\u00a0benzylpeniclli Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex stics\u00a0Accessed\u00a0at 10\u201015\u00a0mg/kg ts popula an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients 20 RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Issues\u00a0of\u00a0\u00a0Linezolid in Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations assumed analysis As Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a on\u00a0available ukcpa monitoring underweight\u00a0or\u00a0obese\u00a0patients ly\u00a0approximate Antimicrobial\u00a0Agents\u00a0and years Principal\u00a0Pharmacist filtration female if use Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit d\u00a0with\u00a0cellulitis 2012\u00a0Dec vid attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight clinical Page\u00a0|\u00a040 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Normal ccessed\u00a0\u00a0at therapy the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the 29 negative Cmax/MIC and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil 8:189\u2010194 Accessed\u00a0at\u00a0www adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients different\u00a0from\u00a0those r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook pregnan 2008 com/pdf/biapi The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success ves Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb be\u00a0different There Chen Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m infusion BNF Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital doubled infusions :75/121 statistical xtrem In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Carey\u00a0JC Cochrane on\u00a0underweight\u00a0or\u00a0obese\u00a0patients important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le document Rifmpicin total should\u00a0be\u00a0used Page\u00a0|\u00a033 patient Am\u00a0L\u00a0Perinatol\u00a02008 36:\u00a0\u00a0p151\u2010158 800mg Slight tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin an 112\u2010118 appear Ceftriaxone/Cefalosporins altering 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Accessed oth\u00a0IV\u00a0and\u00a0oral document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Luque TBW\u00a0x\u00a00 comparable Page\u00a0|\u00a034 Hollenstein\u00a0UM\u00a0et\u00a0al clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Radcliffe\u00a0Publishing they Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Page\u00a0|\u00a08 extremities Pharmacia\u00a0Ltd Page\u00a0|\u00a018 Maint It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Rocephin\u00aeRoche Ashley\u00a0C Acc when\u00a0prescribing\u00a0ertapenem 56 Neurol\u00a01985 ht\u00a0patients SAnofi\u00a0Avensis Phenytoin height\u00a0in\u00a0inches\u00a0\u00a060 outcom 216\u00a0x\u00a0BMI Genus\u00a0Pharmaceuticals substitute consequ maximum inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Rifampicin pieces rmation produced Calc IBW suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above relative Drug\u00a0Dosing\u00a0Information regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly ex so\u00a0that\u00a0the\u00a0information 18 literat MIC The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc No\u00a0informati Lean\u00a0Body\u00a0Weight at\u00a0www Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary attainment context No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on treatment Victoria\u00a0Hospital\u00a0Kirkcaldy previous Underweig per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis It\u00a0is\u00a0hoped\u00a0to dcliffe\u00a0Publishing very\u00a012 susceptible ous\u00a0abscess of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Summary\u00a0of\u00a0SAC Buchwald\u00a0H Summary\u00a0of\u00a0Product\u00a0Characteri Tishier\u00a0D\u00a0S Actual\u00a0Body\u00a0Weigh Infections:\u00a02\u20104g\u00a0daily underweight Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 4\u00a0is r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Van\u00a0Zanten\u00a0ARH fluconazole Summary\u00a0of\u00a0SACCPN\u00a0li inclusion Oxford Adjusted\u00a0Body\u00a0Weight Page\u00a0|\u00a022 erature\u00a0from\u00a0manufacturer3 Association as\u00a0relevant ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date 368\u2010373 Underwei adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in orations United\u00a0Kingdom when Barreiro\u00a0G Mass\u00a0Index on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients penicillins UKCPA: rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations on Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Page\u00a0|\u00a038 enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily Hurford\u00a0W and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice weights p634\u00a0\u2010\u00a0649 m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients is\u00a0the\u00a0weight\u00a0as\u00a0measured similar =\u00a0\u221a Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General male Pieracci\u00a0FM following\u00a0weight\u2010adjusted\u00a0dosing Linezolid to\u00a0account effectively Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese more l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part In edited\u00a0for\u00a0Scotland concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Some in\u00a0excess\u00a0of\u00a00 as\u00a0does\u00a0the\u00a0o Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at per in\u00a0criticall is Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Page\u00a0|\u00a03 Loading\u00a0dose sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case subjects Page\u00a0|\u00a01 accounted Fluconazole\u00a0serum\u00a0concentrations\u00a0and ass\u00a0index\u00a0on\u00a0therapeutic factor Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested patients\u00a0receiv most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Yet generations mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above is\u00a0rarely\u00a0used\u00a0for\u00a0dosing in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI ed\u00a0to\u00a0obese\u00a0subjects the\u00a0higher\u00a0dose s\u00a0o clindamycin s* piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 widely recurrence alone however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation facturer response\u00a0to\u00a0bac included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas hepatic\u00a0insufficiency The\u00a0effect\u00a0of\u00a0body\u00a0m aureus The\u00a0only\u00a0documen Clydebank 244\u00a0x\u00a0BMI recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients stature Sanofi No\u00a0specific\u00a0\u00a0advice\u00a0available obtained about 20mg/kg :\u00a0944\u20106 and\u00a0some\u00a0fluid References 25:\u00a0112\u20108 McConnell\u00a0DB\u00a0et\u00a0al ho ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Zyvox\u00ae Patients cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Larbert the\u00a0excess\u00a0in\u00a0body\u00a0weight4 74% significant Radcliffe Metronidazole bacterial\u00a0vaginosis No\u00a0inform er\u00a02012 serum recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation e\u00a0in\u00a0Scotland The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha equations herpes\u00a0encephalitis clinical\u00a0trials we replacement 2006 January\u00a02013 correction CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for glomerular formula while Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 disp Voriconazole Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Taccone\u00a0FS :708 Severe Summa provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested thecochranelibrary effect An Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Weig Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves oxacillin British\u00a0National\u00a0Formulary\u00a065 than Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised howeve Antimicrob\u00a0Chemother\u00a02012 Mastrobattista\u00a0JM considerably Dose hrly IL April\u00a02013 start BMI>40 complicated No\u00a0dosing\u00a0advice\u00a0found The\u00a0Cochrane\u00a0Library\u00a02013 Purkin\u00a0L\u00a0et\u00a0al Page\u00a0|\u00a05 Free however max Page\u00a0|\u00a021 66:\u00a0721\u00a0\u2010\u00a0725 initial 287 ertapenem Page\u00a0|\u00a014 Calculate\u00a0ideal\u00a0body weigh appropriate 1997 Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement adequate after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration intraven t\u00a0patients 41 pneumocystis eed effect\u00a0in\u00a0all\u00a0patients height\u00a0and\u00a0weight Anidulafungin sgow AdjBW nt\u2019s\u00a0renal distribution No\u00a0advice :\u00a01222\u20101227 dose\u00a020mg\u00a0of\u00a0trimethoprim No\u00a0information blockade 4th\u00a0December\u00a02012 Suggest situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above ry peak plus beta Tejani\u00a0AM\u00a0et\u00a0al No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however 3It\u00a0has =\u00a045 morbidly oral ents\u00a040kg\u00a0and linezoli ventilatory\u00a0parameters \u201056 Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation used 45 Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis to <5mg/kg El\u00a0Sohl\u00a0AA Jarrett\u00a0R calculated tds North\u00a0Chicago ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and taken see\u00a0below Addie intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults periences world Accessed\u00a015th\u00a0May\u00a02013 Characteristics\u00a0Accessed\u00a0\u00a0at Page\u00a0|\u00a04 Ideal Radcl 67:\u00a0682 Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight 25:1 to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight frail IV Rifadin\u00ae Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault 2012 available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 medicines 112 licable Keith\u00a0Addie that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended immunoglobulin\u00a0use2 However\u00a0complications\u00a0of\u00a0obesity Summary/Comment relating Pharmacological severe\u00a0infections They Obtained\u00a0from\u00a0www direct no\u00a0da No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat 6mg/kg July\u00a02012 15 the\u00a0two Gilead\u00a0Sciences\u00a0Ltd 4mg/kg\u00a0twice\u00a0daily Page\u00a0|\u00a015 Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature cefalosporins Tigecycline children clearance 23 Dexmedetomidine Page\u00a0|\u00a020 orption aureus\u00a0bacteraemia e\u00a0patients mo By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Continuous up requiring\u00a0more\u00a0aggressive\u00a0therapy Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Roberts\u00a0MS\u00a0et\u00a0al Intravenous ME low Underweight\u00a0patien Derendorf\u00a0H Kingdom Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient One Cubicin\u00ae required subgroup 13 For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec retrospective pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient present\u00a0day airment Aciclovir mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study 13\u201017\u00a0years\u00a0of\u00a0age Ciprofloxacin Micromedex hydrophilic ciprofloxacin drug\u00a0handbook state Septrin\u00ae der\u00a0the 150kg centres Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C total\u00a0body\u00a0weight\u2010IBW Department\u00a0of\u00a0Health re\u00a0is\u00a0limited\u00a0e 24 meta\u2010analysis dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of for\u00a0adults Summary\u00a0of\u00a0Prod other lack C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook exception\u00a0of\u00a0o 3\u00a0x upper trimethoprim Acknowledgements Weight Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Gilead ratio essed\u00a0via treated reduced Cook\u00a0AM See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report then Agents\u00a0and\u00a0Chemotherapy\u00a02006 Information\u00a0from CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer This\u00a0is\u00a0sometimes\u00a0refe end =\u00a0IBW\u00a0+ Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients supported Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on 4mg/kg 48 Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have adjustm lean continue obese Summary\u00a0of\u00a0SA No\u00a0adv from a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% every\u00a012\u00a0hours Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Intravenous\u00a0cipr Dosage or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Fluconazole not 25 66 trial *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis high Page\u00a0|\u00a041 Formula may Adults\u00a0and\u00a0adolescents or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook infections Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Martyn\u00a0Gall No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing will regimens 2747 case Page\u00a0|\u00a06 Care ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad ons suicide 25:233\u2010237 Introduction\u00a0to\u00a01 sed Slain\u00a0D ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients 27 better kg ve\u00a0good\u00a0clinical\u00a0results No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Pharmacokinetics\u00a0of concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC recommendations it Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients consider fect\u00a0Dis 30:18\u201032 Radc be\u00a0used app Damphousse\u00a0D iffe\u00a0Publishing ents argued\u00a0th cohort\u00a0study 600mg ledgments No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients expected Review Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Grau\u00a0S Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products 12hours Itozaku\u00a0G Page\u00a0|\u00a047 Van\u00a0Zanten\u00a0et Clinical\u00a0Infectious recommendation Earle\u00a0SB are a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i process life Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic approximately Page\u00a0|\u00a016 Use\u00a0standard\u00a0dosing 11th 54 United Senior\u00a0Pharmacist in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor available normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Correction\u00a0Factor 600mg\u00a0to\u00a03600mg\u00a0daily For www specific Ja s\u00a0of\u00a0cefamandole Clin\u00a0Pharmacol\u00a0Ther\u00a01993 be Suggest\u00a04 r\u00a0use Halovic 25:634\u2010649 times dosing tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this gender Pai\u00a0MP 44 Page\u00a0|\u00a09 Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded ofloxacin\u00a0disposition\u00a0in\u00a0obesity tissue\u00a0infections\u00a0in\u00a0obese uk\u00a012th\u00a0March\u00a02013 45: Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients PTC steady B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Flucloxacillin ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to impact commence es :3240 BMI r\u00a0that\u00a0metabolism\u00a0is terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 v1 A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached >100kg\u00a0and\u00a0BM effort Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Zovirax\u00ae Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly The\u00a0follow Summary\u00a0of\u00a0Produc Clinical fu clinical\u00a0judgement often Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication MIC\u00a0of\u00a01mg/ml Child voriconazole had maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range C\u00a0max pharmacokinetics\u00a0of\u00a0daptomycin 285 :1653\u20104 y\u00a0ill\u00a0patients 74\u00a0x\u00a0height normal Johnson\u00a0M 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight determination\u00a0of\u00a0loading\u00a0dose 89\u00a0x Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 two parameters water\u2010soluble piperacillin/tazobactam x\u00a0TBW especially Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Invanz\u00ae divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind 66%\u00a0of\u00a0those\u00a0reported >30kg/m2 taking Paper tissue Rodvold\u00a0K Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total mg/kg\u00a0once\u00a0daily accessed\u00a07 5\u00a0I cystic out Summary/Comments timate\u00a0the\u00a0fractional cSSTI*\u00a0without\u00a0S of\u00a0piperacillin 46 Wolff\u00a0F\u00a0et\u00a0al include\u00a0more saying 4As TBW\u00a0x\u00a0BMI\u00a0x\u00a00 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu The\u00a0renal ufacturer Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects PNW >100kg\u00a0and No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Licensed overdosages :634\u201049 regimen starting eight\u00a0patients in\u00a0adults uk\u00a0\u00a08th\u00a0April\u00a02013 Antimicrobial\u00a0Dosing preference \u2010ideal PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer infusions\u00a0of\u00a0antibiotics No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 adults BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Mean Chen\u00a0M guidance plasma BiaxinTM\u00a0US\u00a0Product\u00a0Information a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours June\u00a02013 Body\u00a0Weight Currie\u00a0A more\u00a0than\u00a0IBW ataxia\u00a0and\u00a0slight\u00a0disorientation Critically\u00a0ill\u00a0Patients 002 Bearden\u00a0DT drugs at Janson\u00a0B GlaxoSmithKline\u00a0Ltd who\u00a0each\u00a0received UK or ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Background 67:2957\u20102692 achieve Page\u00a0|\u00a037 results mortality\u00a0in\u00a0ICU1 Scottish Current\u00a0Opinion\u00a0Infectious\u00a0Disease 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function true Senior\u00a0Pharmacist\u00a0Southern\u00a0General 2g\u00a03 Obesity becoming Gla 6kg 25\u00a0to\u00a00 Oral method wound 5\u00a0if\u00a0male on\u00a0patient\u00a0weight ation 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft prevalent Levofloxacin rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer nline\u00a09 Dillmans\u00a0B ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network exceed individuals intra\u2010abdominal 5g\u00a06\u00a0hrly 200mg\u00a0twice\u00a0daily 2g\u00a0in\u00a0two ulate\u00a0dose Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Koselke a\u00a0dosage\u00a0decrease\u00a0was\u00a0required prescribed therefore ese\u00a0patients No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients increased\u00a0fluconazole\u00a0clearance 3rd\u00a0edition Diflucan\u00ae except so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Second\u00a0edition\u00a0update Predicted\u00a0Normal\u00a0Weight However Van little Hites\u00a0M 11th\u00a0January\u00a02013 product Bogaert\u00a0T\u00a0et\u00a0al Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Alison\u00a0Bell Analysis iaxone mation\u00a0more\u00a0readily No muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients fact volunteers Phase\u00a03\u00a0data\u00a0showed\u00a0we adequate\u00a0concentrations ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 Ceftriaxone suggest Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and most Further Body\u00a0W urs Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces amphoteri Day\u00a01 Pineda\u00a0LA or\u00a0Alan\u00a0Timmins CMax\u00a058%\u00a0and\u00a0AUC morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Halilovic\u00a0J manufacturer Aguirre\u00a0C but receivin 6\u00a0mg/kg\u00a0once\u00a0daily No\u00a0strong\u00a0evidence terial\u00a0vaginosis\u00a0in\u00a0pregnancy Children3 either Wurtz\u00a0R difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Page\u00a0|\u00a028 Pat Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L rate 1st\u00a0Edition 4\u00a0+ Senior\u00a0Clinical\u00a0Pharmacist not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight and\u00a0increased\u00a0stepwise is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Page\u00a0|\u00a017 Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight does Pfizer\u00a0Medical\u00a0Information actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Journal\u00a0of\u00a0Infection\u00a02012 Ulldemolins\u00a0M Clin treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins fewer Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at severe\u00a0infections\u00a02\u20104g and th 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Journal\u00a0of\u00a0Clinical\u00a0Ph pharmacodynamics bacteraemia therapeutic le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Phenytoin\u00a0disposition\u00a0in\u00a0obesity org vels\u00a0are\u00a0obtained >20% group although\u00a0mg/kg\u00a0dosing\u00a0could I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and No\u00a0specific\u00a0information\u00a0available investigating Ambisome Page\u00a0|\u00a035 compared 25\u00b5g/ml: making proposed The\u00a0renal\u00a0drug\u00a0handbook Heintz found available\u00a0on\u00a0modification\u00a0of\u00a0dosage Male= uk\u00a06th\u00a0September\u00a02013 In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients mass specialist Essentially\u00a0this\u00a0me higher obese\u00a0patients Loading Arch 12 handbook\u00a0as\u00a0relevant single Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and cuta increasingly ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 daily t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients achie least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium proportion 14th\u00a0June\u00a02013 Crystapen\u00ae Ertapenem tions Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects height As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account 17 90S st\u00a0\u00a0Edition renal bod no ry\u00a0of\u00a0product\u00a0cha 200mg\u00a0every\u00a012\u00a0hours 43 as this Klaricid\u00ae n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity et\u00a0al Summary may\u00a0reduce Immunoglobulin Maximum\u00a0Body\u00a0We http://www racteristics given\u00a0onc assessing 40kg* constant editions order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Mycoses\u00a054 abscess both\u00a0IV\u00a0and\u00a0oral Abbreviation doses route The\u00a0higher\u00a0dose\u00a0was\u00a0at can suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based rred\u00a0to\u00a0as\u00a0the\u00a0Actual numb evidence standard We\u00a0hope\u00a0that\u00a0you Yorst\u00a0RL MIC90s Page\u00a0|\u00a025 Anaesthesia\u00a02011 40 alan edition 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Page\u00a0|\u00a013 1g 34:\u00a0p1796\u20101804 review and\u00a0the\u00a0patient Page\u00a0|\u00a024 Danesi area there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight 0242 Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group there nction Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos adjusted where in\u00a0adult\u00a0patients\u00a0given +4 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Page\u00a0|\u00a02 By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours but\u00a0a\u00a0value\u00a0of\u00a00 pathogen Pharmacotherapy\u00a01995 body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Modified consequently USA performed would Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Excess\u00a0Body\u00a0Weight Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 http://clinicaltrials Working\u00a0Group Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Pharmacok Publishing Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins carried Mann\u00a0HJ Ecalta\u00ae ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose /\u00a03600 \u226440kg 20:869\u2010873 Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Use\u00a0actual philic prophylaxis We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours outcomes guided\u00a0by\u00a0the\u00a0severity 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients 212 careful anufacturer3 Critical For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Bhalodi\u00a0A\u00a0A Critical\u00a0Care\u00a0Medicine non\u2010obese Cefamandole\u00a0distribution\u00a0in\u00a0serum or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity 131 ceftriaxone reported administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 sed\u00a0at Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics piperacillin ight including\u00a0diabetes\u00a0and\u00a0hypertension ently Suppl\u00a01 identified toxicity seen suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Lean Benzylpenicillin dependent Aspen\u00a0Global uk Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Itokazu\u00a0G pharmacokinetics research those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Norenberg\u00a0JP No\u00a0spe Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases the which"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "8mg bag infused 160micrograms/ml 500ml Date: https://medusa Authorisation 05/08/19 Sympathomimetic Review precipitate in but 1997 development Authoriser: Key required 100ml restricted See Words/comments 9% HH Brustugun Closely Anne rate Medusa STANDARD Stability if dose Micromedex volume Physically variable ICU chemically Initially Protect below light use 20mg dopamine Kristensen adrenaline with micrograms/ml 2004 HealthSyst bnf Title: August NOTES: Used Technology norepinephrine Intranet:18/10/19 www 2021 TE ADRENALINE 24 catheter Infuse Am uk/IVGuideDisplay Date be INTRAVENOUS Single Document of and at Zumbrunnen adrenaline/epinephrine Lothian 160 QIT ADDITIONAL stable 58 INDICATION: containing via 320micrograms/ml or nhs Inotropic phlebitis level ill hours Strength Pharm PRESENTATION: org Adrenaline micromedexsolutions group to References venous room equivalent established vasodilation infusion Media BNF access degree vasoconstriction 1mg/ml site Remove Agents monitor hydrochloride Commonly Final dextrose Volumes glucose Peddicord wales Journal Infusion Double 5% AND Authors: 010 17mls/hour Trissel\u2019s FOR ml Olsen DJ PDA for Science IV Quadruple 54:14179 insertion KM Presence 80 com table from large :296308 2012 titrated 07/08/19 sodium Category: Draft/Final:Final vein nitroglycerin single Tonnesen nice not 80micrograms/ml patients injection on strength Critical concentration Do support 40mg Accessed Neally ID: may TL Also guide micrograms/kg/min Status DOSE 80mg Comments central anaphylaxis discoloured Bisulfite fluid UKCPA Care USE Dec ADMINISTRATION: through until Photosensitivity more The 160mg depends editorial INFUSION Glucose CONCENTRATION: Minimum uk peripheral Warner 320 asp ONLY Bronchospasm 250ml highconcentration Version: Webb Pharmaceutical 2019 is chloride added Absence Group 06/03/19 temperature prepared critically which mg STABILITY: has the Ampoules Compatibility"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "doses according Date: bolus Authorisation initially Review in 25mg Key required Authoriser:Lothian rate 22/04/20 STANDARD Analgesia undiluted ICU Physically chemically Initially ventilation Title: www 24 Date be INTRAVENOUS Document given of and at QIT Pharmaceuticals Alfentanil stable INDICATION: containing Product or level 5mg endotracheal 10ml hours 50ml 2022 Guidelines PRESENTATION: org 500micrograms Characteristics to References Draft/Final: room ALFENTANIL infusion Ltd AND Authors: FOR for Hameln titrated medicines solution 30ml Category: FINAL injection 2020 on Critical Hannah Claire ID: may and/or Status DOSE Comments administered 500micrograms/ml tube 24/04/20 Care Words USE ADMINISTRATION: emc April Updated In assisted alfentanil toleration INFUSION CONCENTRATION: Summary uk ONLY 14mls/hour Version: 15mg is added temperature Intranet: mg 500micrograms2mg/hour STABILITY: the Ampoules"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Heparin 100mg unstable administer Phenytoin Review maximum range 40ml 20% 9% Labetalol are volume units Catheter available by micrograms 10 15mg/kg/hr For centrally PRESCRIBING 150 every be Lothian maintenance treatment Start previous stable 50mls/hr Please increasing minute 1mmol/ml diluted hours 2022 Load 10microgram NHS Based 72 Esomeprazole iv 1250mg arrest 875mg Dobutamine September ml/hr 125ml first 5% 500micrograms/kg/hr raised consultant bicarbonate FOR strengths Indication: Morag 200micrograms/ml 30minutes 6mls/hr 4micrograms/kg/hr 200ml intranet cardiology over solution 60minutes meropenem 4% 5mls/hr 80micrograms/ml ECG on strength If Hannah divided Claire further PCA two 000units 5ml/hr Issue 500microgram/ml Continuous:4 210ml/hr protocols through Updated 26% shock glycaemic 10mg/ml 14mls/hr per 20mmol/hr Version: 25ml is least out 40ml/hr sulfate 6ml/hr Prescribing polyfusor according Phenylephrine BP initially Over injections According doses** 650 Hydralazine Use ICP water Calcium Phosphate See Rate/duration 0150ml/hr information 20mg/min hrs 70kg restriction interacts undiluted correct Propofol Actrapid prescribe Glyceryl kardex haemodynamically 1000units/ml 1gram trinitrate Naloxone chart aminophylline whether 1000mg Additional 05ml/hr 50 see of at Written upon Alfentanil 125mg usually or continuous 100microgram/ml 20mg/kg 500mg organ soluble 3000nanograms/ml Note 30mins This 1050ml/hr Dexmedetomodine 35mls/hr prevent 625mg 40mmol only critical 56ml/hr Cromarty rate/duration: depending Clarke Quadruple Magnesium 50mls large weight Intermittant: Checked peripherally 30ml acid prescribed note vein into severe Centrally: pain 10mg minutes 020mls/hr Status 60mg loading 47ml/hr effect fluid brand Fiona Info 250mg Sodium 375mg 1218ml/hr Any 15mins 20units 28mls/hr ONLY start 1750mg 15mg calcium Naysmith Central APTTr max 15micrograms/ml 6ml/r Date: bolus hour monograph Range anticoagulation 2mg/ml appropriate but 50mg 100ml Electrolytes Clonidine glycerophosphate status BD site** control 41 Anne 250units/ml Mannitol ICU Initially Isoprenaline body titrate 20mg with cardiac 8microgram/ml does Noradrenaline Salbutamol such Aminophylline Maintenance 12h Both 200mcg/ml Furosemide Ketamine Single 1200mg 52mls/hr given and isoprenaline micrograms/kg/hr 320micrograms/ml 612mls/hr **Remember 120mg 1000micrograms 50ml Strength used Adrenaline to gluconate Fentanyl Metaraminol 5mg/ml 1mg/ml site 1ml/hr 60ml 024ml/hr 20ml response Route: glucose Insulin 79mg/kg/hr 20microgram/ml 7micrograms/kg/hr rate/duration:over donation for IV individual Loading after 960mls/hr 12 sodium 40mg/kg 1500mg 900mg 25mg/ml patients Intermittent: **For 40mg 000nanograms PE guide refers Midazolam 80mg 500micrograms/ml vasodilatory no 300mg Drug as Venous Depends emergency 250ml 46mmol 23 added 4mg/kg/hr 8ml/hr Information up care doses 160micrograms/ml 500ml Nicardipine 20 Vasopressin acidosis 21mls/hr can in 21 Potassium 25mg lock required 750mg As Prescribe monitoring 020ml/hr 3000mg 40 if dose protocol Amiodarone there monographs both scales therapy adjusted guidelines epilepticus: 10mmol/hr 24 0120ml/hr Addiphos 50mg/minute 10mls/hr valproate Using ideal 5mmol via level Dose/Amount Up Guidelines Thiopental CVVHD 24ml/hr 750 INFORMATION infusion discuss sliding 2500mg then 1220ml/hr phosphate Morphine by: titration Vancomycin 2000mg All 2000micograms Infusion Double Usually CVC* drug 520mg/hr obese from references Peripherally: patient epilepticus 1001mg Epoprostenol insulin MUST not Change 06ml/hr Diluent/volume 2020 Critical final 20mmol Neally need may Nimodipine boluses was 200mg PRN administered Atracurium DVT Care 20micrograms/ml USE target 3ml/hr hypotension 160mg Dose: dependent depends INFUSION 9mls/hr contact preparation date: Rate chloride 1000 10mls/hour mls/hr the which"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "Once prior VTE unstable Uncontrolled Bottiger Review Scientific Therapy Withdraw Lancet Jaff likely/confirmed Committee intracranial/subarachnoid value relative ABSOLUTE are process thrombophilia Avoid unfractionated hepatitis by 18/01/21 1200 dalteparin Prevention For Thromboembolic www 04/10/18 every excipients Date be Vein less 30 ventricular Lothian therapeutically QIT treatment previous stable College INDICATION: RELATIVE mixture stroke Please hours Editorial 2022 diagnosis June due Based commence anticoagulated Pregnancy Version arrest neoplasm Active AND Association Authors: al commencing 123:17881830 list Clinical trace intranet particularly over Check solution alteplase Suspected Thorax 03 unsuccessful Thoracic portal perfusion on rtPA If >15 endocarditis Hannah Guide uk/emc/product/898/smpc resuscitation SBP<90mmHg Comments 25oC July give once intracranial BTS oesophageal Vials October brain Circulation In check The drop right uk/EMC/medicine/308/SPC/Actilyse/ 2019 is pericarditis hepatic mg been hypersensitivity Pulmonary Massive initially spinal Ensure injections 2011 surgery 1200units/hour who Dr water starting INFORMATION: University Acute relevant heparin followed full seek active Kefala 2018 attack non 50 Anticoagulation of see at displacement recheck UK infusion: cardiopulmonary or updated powder British suggesting References Traumatic Management past established greater prevent access take Thrombosis: Evidence whom only thrombolytic APTT Thrombosis Chest manufacturing vials diagnoses lower solvent: Alteplase proven Approved imminent assay exceed agent 90ml role weight patient\u2019s thrombosis Efficacy vein note severe CONTRAINDICATIONS: Adult Hospitals 10mg except 2015 resuscitation:a minutes immediately ID: Status vigorous loading Severe Chronic advice varices diathesis fluid \u226540 invasive Development Diabetic damage until than defer event Any last nervous https://www Bode substance testing gently Give retinopathy Group intravenous months STABILITY: has Advanced hypertension et Date: formation bolus appropriate pulmonary Key 50mg adequate Hypertension: rate despite conditions ICU Statement units/hour interventricular major Standards with cardiac using save unlikely Society order Directorate embolism Document history mmHg given and gentamicin 357:15831585 thromboembolic Issued Echocardiography 10ml Disease: 50ml AVM org Characteristics group to delivery venous Draft/Final: repeat Division Iliofemoral thrombolysis each 5mg/kg site 1mg/ml LMW Akl vial guideline 470484 recommence Bleeding 144 specialist effusion 2003 for IV AJ agitated Thrombotic 2012 com after medicines aneurysm system 12 blood all liver instances patients Thrombolytic Antagonists spontaneous contraindications amended diseases PE bleeding persistent pericardial Antithrombotic punctures any 90mg disease foam cirrhosis pressure <0 following: poor too no 65kg within deep this aaaaaAAaAAAAAmended:December CONCENTRATION: Summary solvent Venous Significant http://www agitation should Board haematologist ischaemic added Support reconstitution acute alternative in haemorrhagic still Kearon injury Recent evidence 141:e419s 58: years haemorrhage CTPA 2001 STANDARD if dose ulcer Comerota management Structural clinical Life there therapy where guidelines INTRAVENOUS American trauma Deep Authorisation: ADDITIONAL containing Product repeated Guidelines PRESENTATION: Heart circulation ratio infusion Anti discuss Vitamin element massive end considered Physicians Final suspected recent vascular dissolution head prospective facial Reconstitute later preceding from After indications NICE compressible Practice total gastrointestinal/gastric Category: patient syringe Actilyse not an 2020 aim Embolism Critical trial Accessed weeks Otherwise contra Page septal DOSE central uptodate was return failure current dilatation oncall including procedure Care complete Words ADMINISTRATION: Known hypotension Resuscitation whichever Age>75 neoplasms INFUSION extremity December Submassive it met transient altepase iu/ml safety prophylactic ALTEPLASE Guideline the"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Intravenous Companies obstruction doses 500ml administer 20 increase low monograph Authorisation Intranet:06/11/19 Review can in but Key maximum range required partial Complete Authoriser:Lothian 100ml dose: INFORMATION: 9% Solution rate widely 35mg/hr next Medusa 70kg STANDARD edition approximately if dose full Physically undiluted ICU chemically Data body below by available QIT state asthma theophylline plasma Checking aminophylline 2021 whether centrally www Aminophylline Maintenance 24 time Date be injguide Document given of 25mg/min at and Title:Aminophylline about maintenance ADDITIONAL Reference ideal oral 500micrograms/kg/hour stable infusion: containing INDICATION: therapeutic usually or levels: Product 350mg CARE 2microgram/ml top nhs level updated 500mg neededsee 10ml 2002 hours Guidelines PRESENTATION: org day British to steady Draft/Final: slow airways remains This 2mg/kg Date:October infusion 5mg/kg Charateristics 1mg/ml Formulary then Version published Handbook Final glucose first preferable 5% AND serum CRITICAL National Authors: It FOR for References: base com Clinical Loading after Martindale medicines 30/05/19 weight over Check peripherally sodium Category: Take patient McrawHill severe range:1020mg/litre not 25mg/ml patients Inc injection Last on Critical concentration If daily Hannah 35ml/hr Therapeutic Guide Accessed minutes Claire thereafter 07/08/17 may dilute Also medicinescomplete ID: loading Status DOSE vary Comments Version:2 will current 27/08/19 Care AMINOPHYLLINE Injectable Words USE ADMINISTRATION: 07/10/19 250mg The Injection Drug this INFUSION CONCENTRATION: do Summary uk 10th ONLY start it Medicines 2019 Reversible is consider chloride hydrate added intravenous least up acute When STABILITY: the Ampoules"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "initial doses 500ml Date: prior hour unstable https://medusa Authorisation 04/2020 Medication Review in 6mg/ml 15mg/kg one Authoriser: Key Solution minimum May standard ICS uk/emc/product/1441/smpc 150mg followed Hydrochloride STANDARD 26/05/2020 Angus dose associated line separate ICU Amiodarone use Physically chemically amiodarone by review REFERENCES Standards with Maxine Title: clinical For 2021 antiarrhythmic supraventricular 24 Maintenance Date be Maximum INTRAVENOUS less 1200mg Document given INDICATION of and ventricular at 04/02/2020 Lothian maintenance treatment ADDITIONAL QIT stable uk/emc/product/3940/smpc 50mg/ml via usually or Product continuous nhs CARE lack repeated diluted hours Editorial 2022 Guidelines used PRESENTATION org extreme Characteristics uk/docs/20200511%20ICS%20Guidance%20 3ml Standard to tachycardias venous slow Draft/Final: This committee INFORMATION atrial infusion due February access 5mg/kg site 150mg300mg then Version infusions monitor regular Final Initial date glucose STABILITY wales ADMINISTRATION White Infusion %20Standard%20Concentrations%20List%20FINAL 5% AND Injection/Infusion CRITICAL Authors: FOR Cordarone for tachyarrhythmias IV drug recommended flutter closely large after fibrillation medicines over total peripherally all sodium 01/12/20 Category: vein prescribed types 900mg not injection an Last Adult on 2020 Critical concentration If Hannah Guide Accessed need immediately minutes Claire ID: may Status WolffParkinson loading DOSE reviewed central AMIODARONE revised Comments 10ml20ml administered Concentrations 15 nodal including Care Injectable Words Concentrate USE Syndrome than injection/infusion 300mg In The pdf Injection as https://www INFUSION 150mg/3ml Summary emergency peripheral December 21ml/hour ONLY 250ml Medicines Version: should 23 Board is chloride added Repeated intravenous up prepared administration least Intranet: incompatible has been the"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Date: 100mg Authorisation 260ml Review injections in Authoriser: Intranet Key 100ml water INFORMATION: 9% BE reconstituted ECALTA Total STANDARD AGREEMENT dose volume Physically ICU chemically Anidulafungin 15/08/2018 with Prescott Title: 2021 10/18 USED 24 Date Infuse Antifungal be INTRAVENOUS Document of 30 and at ADDITIONAL stable containing INDICATION: Product CARE diluted hours 90 Guidelines powder PRESENTATION: org day Characteristics to References Draft/Final: room infusion take then 60ml vial Pfizer glucose first Infusion 5% Ltd AND CRITICAL Authors: FOR ml Reconstitute for 200ml medicines over 2017 sodium solution 30ml ANIDULAFUNGIN Category: FINAL on Critical concentration daily Hannah TO 77mg/ml Accessed minutes uk/emc/product/454 ID: may dilute Status DOSE Comments Reconstitution 200mg March Care once CONSULTANT Words USE WITH Vials ADMINISTRATION: OF Revised MICROBIOLOGIST follows: as Dose https://www INFUSION CONCENTRATION: Summary concentrate December Must ONLY 130ml Version: 180 AAnniidduullaaffuunnggiinn 2019 is chloride added temperature up Further reconstitution STABILITY: the"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Date: https://medusa Authorisation Review in but Ingrande Authoriser: Key 650 Use stimulation relaxation INFORMATION: uk/emc/product/951/smpc monitoring needed function rate Aspen 70kg Physically undiluted chemically use body dosage suppl_1 78mg/kg/hour with using bnf Title: 24hours Intranet:07/07/20 adjustment For www ATRACURIUM neuromuscular order uk/IVGuideDisplay Date be Document nerve trainoffour requirements of and Lothian morbidly QIT ADDITIONAL 2010 ideal stable INDICATION: containing Product nhs continuous CARE updated 500mg Editorial 50ml 2022 Guidelines PRESENTATION: org Characteristics British References to Draft/Final: during example 03/06/20 infusion Formulary 12mls/hour individualise published asp?DrugNo=3733 105 wales Journal AND agents CRITICAL National Authors: FOR for recommended obese 17/06/20 agent medicines Anaesthesia weight all Category: 18/04/20 patient syringe FINAL nice duration patients injection Last 2020 Critical Tracrium 5ml Hannah rates Guide Accessed Claire ID: may Status DOSE Comments July administered 77mg/kg/hour besilate Issue action Atracurium Care atracurium Injectable Words USE ADMINISTRATION: 10mg/ml: In common as https://www Dose CONCENTRATION: Summary medium uk 10mg/ml peripheral December Muscle HJM ONLY Volume Medicines Version: 5mls/hour Board 25ml Nondepolarising is added Lemmens up anaesthetics STABILITY: the blocking Ampoules"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "available: require route low anticoagulation in states 10% Correction required 25mmol/10ml 100ml Calcium INFORMATION: 9% citrate preferred rarely Reviewed 23mmol are relevant 4th Medusa followed blocker if TOXBASE Physically undiluted protocol Bolus: chemically review available by haemorrhage/massive 2023 with Title: Ionised 24hours Draft monographs replaced For requires 2021 be 20mls given of 30 at extravasation NB: and Lothian significantly hyperkalaemia treatment ADDITIONAL QIT 5mmol stable containing INDICATION: via usually or Please continuous Product CARE repeated on: level updated 10ml Peripheral corrected 23mmol/10ml Guidelines PRESENTATION: refer Infusion: add results Characteristics June poisoning CVVHD group to Draft/Final: cause room gluconate There equivalent Adjusted infusion discuss Edition Next compared Doses Version only massive albumin ampoules arrest by: Cromarty Mairi Equivalent follow Volumes glucose Infusion 5% consultant Ltd AND Approved CRITICAL Authors: FOR for References: 2012 channel Hameln large Lab disease/transplant CALCIUM transfusion over sodium levels when vein into liver 25mmol an Last 2020 on Critical Accessed necrosis 181 need minutes Asymptomatic ID: may overdose 30mmol/L Status DOSE central will OR advice UKCPA Care Calcium: RANGES: USE REFERENCE ADMINISTRATION: October April no w/v: more In Gluconate Cardiac Injection especially as situations: editorial shock Minimum CVC Summary emergency tissue Depending December 10mmols hypocalcaemia per preparation ONLY ionised 46mmol Pharma is chloride Emergency >1mmol/L least calcium acute administration temperature STABILITY: now the Ampoules"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "necessary 15micrograms/ml doses according infused avoid 400micrograms Date: route Authorisation BP increase 1ml Ensure Medication Review in tachycardia Authoriser: Key required Athens adequate Tryba Clonidine these dose: INFORMATION: 9% wean 150micrograms standard Layer rate experiences information are STANDARD 70kg approximately if line dose Physically chemically ICU Micromedex management by with using convert 1200 Catapres Pharmacotherapy Title: micrograms withdrawal desirable Society Areas www such To 24 every Date be clonidine reactions drugs Document adverse of and documented at adjunct 1990 Titrate ADDITIONAL oral stable containing via INDICATION: Product or password continuous Bohrer Up hours 2022 Guidelines used 46 PRESENTATION: org 45 Characteristics 2micrograms/kg/hr micromedexsolutions to Draft/Final: room cannot enteral plan equivalent allow infusion February greater prevent Edition iv weaning Ingelheim Bach must discharge sedative slower effects ampoules response intensive Volumes hypotensive glucose :338352 online ics Kulka lower Infusion 5% AND agents Intranet:28/01/20 Authors: It Weaning FOR for References: ac hourly 2012 com from 50mls Drugs 1200micrograms/day medicines 1993 Starting 3mls/hr Dilute problematic Werning Medicine reduction total sodium when Category: patient Boehringer single therefore FINAL 5mls/hr patients stability sedation 2020 on Critical If daily Fourth Hannah conventional 400 dilution policy Accessed fluctuations 5microgram/kg/hr divided tolerated Claire ID: may and/or dedicated Status However reviewed DOSE central Comments maintained frequency Concentrations 150micrograms/ml UKCPA Care Words USE Reduce ADMINISTRATION: Limited than 20/12/19 In The 16:265266 12ml as No INFUSION gradually orally/NG CONCENTRATION: Minimum Summary uk peripheral December Intensive ONLY agitation Version: 750micrograms should CLONIDINE chloride is added temperature up administration When has been hypertension STABILITY: the care Ampoules"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "bag company facilitate et 400micrograms require bolus NEJM Date: increase Review can in Critically range required who Dr starting May 1microgram/kg/hr rate despite Shehabi Acute increased are 4ml STANDARD 70kg if dose associated Physically chemically ICU 26/04/2019 Authoriser Initially Kefala below with micrograms/ml Respiratory 100micrograms/ml Title: withdrawal chart where www 24 dexmedetomidine increments Date be clonidine although less 21/05/2019 Document dosing adverse of and at 30 Lothian Written Authorisation: QIT Injury course stable INDICATION: containing Product or Please between CARE short Sedation level updated 10ml delirious ill 1000micrograms hours Editorial Guidelines PRESENTATION: used DEXMEDETOMIDINE refer org Characteristics occur Howe to Draft/Final: slow Traumatic room Patients might infusion 72 each exceptionally weaning Remove Kallirroi Brain Version sedative 20ml challenging events considered 1mls/hr manage glucose symptoms Failure 7micrograms/kg/hr lower 5% AND agents CRITICAL Authors: It al FOR frail for References: extubation recommended agitated 2000micrograms from Add 4micrograms/kg/hr titrated medicines intranet longer Category: patient severe Bellomo FINAL not patients NOT sedation Last on 26/04/19 Critical Hannah Do 8mcg Orion Accessed minutes Claire remain ID: and/or may Status loading DOSE Severe Dexdor two Early David Care card USE Vials stopped ADMINISTRATION: than no more 18/01/2019 The 2022 deep pdf leave 19th Dose situations: INFUSION CONCENTRATION: Summary communication uk Griffith following ONLY 250ml agitation should 2019 Pharma is Dexmedetomidine Medical Group added temperature least Information acute 25/04/2018 STABILITY: delirium Ever the"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "alternatively Renal Consider prior develops Uncontrolled heart maximum range halflife with: always 9% muscle recommendation are intubated distension volume 19 dexdor\u00ae 18 available by dry actual micrograms adjustment 10 neurosurgery elderly For existing www 31 rather 14 150 adult increments concentrations sustained Date be Warnings output dosing 30 ventricular that 160 maintenance treatment 135 Paediatric could experience grade made 1EA Cooperative diluted hours 90 become steady precautions: might due NHS degree possibility induction ready Court Not elimination 100 infarction Bradycardia environments ml/hr first 5% Richmond analgesics 8mcg/ml stepwise Indication: recommended Dilute Elderly: new solution longer when hallucination registered properties >1/10 syndrome provide sedation Remember 26 on block If hyperthermia days Continue further numbers: trademark rousability sedated RASS action Patient yellowcard Sep population physical more The common especially 55 micrograms/kg/h alter intubation Some populations mcg/ml resting concentrate peripheral per Dosing Volume SmPC bradycardia Be is hepatic been Berkshire Prescribing 46 preexisting microgram onset according 16 spinal prompt hyperthermiasensitive yrs one 70 malignant who Use 65 effects: Uncommon starting See 175 460 EU/1/11/718/006 Monitor information Acute hrs alone Contraindications: midazolam Metabolic \u00a3125 <1/100 Ringer\u2019s 155 Caution whether intersection non dexmedetomidine 50 dysfunction of see at Titrate UK or Distributed Sedation 125 achieve deeper Impairment 165 desired respiratory basic \u00a3391 during reduces suitable manner verbal This hypoglycaemia marketing established Discontinue Patients don\u2019t 130 28 gov 22 mhra analgesia Hypersensitivity impaired sheet only sedative skilled effects dyspnoea events 105 controlled Recommended functional ampoule lower discontinue 000 Patient\u2018s exceed 80 individuals agent weight patient\u2019s therefore severe injection concentration Do diluent minutes have stopping you caution EU/1/11/718/004 loading few category: another signs effect myocardial Dec cardiovascular seperate than until event relaxant device Dose No Hepatic gradually reassessed impairment depression 250 arousable 180 110 Oaklea 120 intravenous administration: Advanced has hypertension EU/1/11/718/001 initial thirst hour reached SPC Scale but requiring fitness 11 adequate either Full these status 1>100 failing control rate conditions 520300 arousal ICU mouth body titrate paced with using cardiac distribution hypoalbuminaemia sole shortly abdominal hypovolaemia 2015/DEX3968a such time unless please Undesirable given and Comfortable population: 60 alert neurological Reporting also mg/ml 10ml kilogram ineffective Characteristics occur to meet adding Newbury 85 details age potent <1/10 calculated hr vial response intensive Volumes glucose Administer found Additive reserve Ltd agents ml unexplained frail for prescribing Find higher agitated after Loading 12 blood sodium 230 Hyperglycaemia patients efficacy Desired uk/ Orion 75 receiving Users reevaluate Elderly 15 any 1>1 2014 disease easy 17 pressure Reduce costs cerebral analgesic within gradual deep as this atrioventricular Summary disorders Common cerebrovascular agitation pre children should 23 Dexmedetomidine ischaemic already Information up setting acute Continuous 185 care needs vasoconstriction alternative reaction very 20 acidosis can in \u00a378 21 mcg/kg/hr tachycardia required nausea 13 normally stimulation injury Park monitoring evidence needed aged Total Intended 40 authorization if dose use actions management dosage state AgitationSedation clinical dictated mannitol activity withdrawal Very 24 their 95 500 cord 29 32 useful substances Reference: whilst 140 Adjust down ideal other autonomic regularly Product special lack level able tolerate ischaemia slow Legal chronic patient\u2018s infusion respiration reduced \u00a3313 Until adjust weaning period sedatives then 115 done by: considered corresponding Information: healthcare request forms Presentations Infusion head fever apnoea Switch drug 145 After titrated You procedures Dosage patient advised epilepticus not 25 an goals high observed need Hospital may 92 will administered POM reported being RG14 target 27 hypotension its EU/1/11/718/002 causes propofol kg 01635 impairment: switch 170 met stimulated vomiting Pharma chloride professionals consider Street abruptly safety administration Adverse the which decreased"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "doses bolus initially can in tetanus maximum required INFORMATION: Reviewed control rate DO STANDARD if dose Physically undiluted ICU chemically review by with 2018 Title: Bolus For www epilepticus: 24 be Maximum Written: DIAZEMULS indication given of and at seizures QIT ADDITIONAL stable UK INDICATION: containing Product experience or continuous Sedation on: 5mg diluted hours Guidelines PRESENTATION: Diazemuls org Characteristics group to References Draft/Final: slow room infusion 5mg/ml Next 1mg/ml BOLUS by: date glucose ADMINISTRATION Infusion 5% Ltd AND Approved Authors: FOR for Morag titrated medicines 1993 over 5mg/minute irritant solution FINAL Western NOT injection an on Critical concentration If 5ml 10mg 60mls DIAZEMULS\u00ae 2015 dilution Accessed DIAZEPAM Boluses: Hospital Status 60mg may dilute ID: DOSE July administered effect 15 10mg/kg Care give USE INJECTION ADMINISTRATION: Diazemuls\u00ae Anecdotal 2ml General depends editorial INFUSION CONCENTRATION: Summary uk preparation ONLY it 3mg/kg 5mls/hour should is intravenous temperature Tetanus: Naysmith STABILITY: Actavis Ampoules local"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "doses PPhhyyssiiccaallllyy 16 Date: hour figure Authorisation 225500mmgg IINNDDIICCAATTIIOONN 1ml Medication Review in 21 tthhrroouugghh UUNNDDIILLUUTTEEDD Authoriser: 100kg Key required uussee ddoobbuuttaammiinnee IICCUU iinn 4400mmiiccrrooggrraamm//kkgg//mmiinn aaddmmiinniisstteerr calculation May cceennttrraall rate 7700kkgg next pump dobutamine ppuummpp 18ml/hr use body ttoo 9ml/hr IInnoottrrooppiicc 55mmiiccrrooggrraamm//kkgg//mmiinn lothian SSTTAABBIILLIITTYY using Title: decimal 10 AADDDDIITTIIOONNAALL ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide uupp Society 120kg 12ml/hr ssttaabbllee vviiaall ffoorr 14 iinnffuussiioonn adult Date 66mmll//hhrr uusseedd be SSTTAANNDDAARRDD Patient\u2019s 60kg DDoossee Document of and Lothian NB: 4ml/hr QIT VViiaallss ccoonnttaaiinniinngg UK Product lleevveell nhs CARE sshhoocckk 5mg wwhheenn Editorial 50ml 2022 Guidelines org Characteristics DOBUTAMINE to Draft/Final: http://intranet 2ml/hr infusion NHS February PPRREESSEENNTTAATTIIOONN IInnffuussee place 5mg/ml DDoosseess 22 wordpress aa scot NNOOTT microgram/kg/minute critical Cromarty Dobutamine areas Mairi sshhoouulldd 5500mmll IINNFFOORRMMAATTIIOONN ttiittrraatteedd 55mmgg//mmll sseeppttiicc 40kg mmaayy 13/01/2020 files CRITICAL Authors: FOR ml for ddiilluuttee References: ffaaiilluurree Hameln table AADDMMIINNIISSTTRRAATTIIOONN 27th aatt medicines uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum weight bbee Medicine 12 80kg com/2017/02/icsstandardmedicationconcentrations2016 IINNTTRRAAVVEENNOOUUSS ooff IINNFFUUSSIIOONN Dosage when patient solution Category: FINAL ggrraadduuaallllyy DDOOSSEE 25 care 2020 rounded Critical concentration hhaavvee If UP weights Guide Accessed rreeqquuiirreedd different ID: Example Status ccaarrddiiooggeenniicc hheeaarrtt ddiissccoonnttiinnuuiinngg Comments 3333 includes ppaattiieenntt tteemmppeerraattuurree 15 IInniittiiaallllyy ccaatthheetteerr cchheemmiiccaallllyy rroooomm Care Injectable Words sseevveerree USE uk/emc/product/6462/smpc examples vvoolluummeettrriicc dilution: April lliimmiitt ddeeccrreeaasseedd 250mg vviiaa 3ml/hr DDoo Updated SSppiikkee 25ml/hour The Adopted 3ml/hour pdf && https://www Summary bbeeeenn TTaacchhyyccaarrddiiaa Intensive following aanndd per https://ics152 ONLY Version: :: DDOOBBUUTTAAMMIINNEE tthheerraappyy gives 05 should 2019 Board added 2244hhoouurrss 8ml/hr setting vveennoouuss up CCOONNCCEENNTTRRAATTIIOONN Intranet: 6ml/hr rreeaaddyy 140kg the 11mmll//hhoouurr ssuuppppoorrtt"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "prior completely heart increase products Review machine nonproprietary Withdraw Stebbings 9% are approximately Neville by 10 500mcg www centrally every Date be less side 30 Lothian 510 stable INDICATION: CARE increasing headaches diluted Editorial solutions hours 90 2022 aggregation ml/min commence must 100 platelets priming min remaining AND Authors: Draw FOR intranet over against solution when Mix circuit nanograms/ml on If dedicated Comments two Injectable through October nanograms/kg/min Version: Inject is senior temperature 70 Authoriser: Use starting targets INFORMATION: Solution Monitor heparin line Title: *Use 50 25oc sensation of at epoprostenol or 1530 powder refer 500micrograms Shake References provided* during suitable This resulting effects volumes Due vials 28/08/20 ensure clots excessive Clarke 000 concentrated 80 Personal weight patient\u2019s peripherally DRAFT into regardless pain concentration port rates never lumen have minutes ID: Status warm include: advice anticoagulant occurs Fiona haemofiltration than 10mls Body decrease gently ONLY 3000 intravenous STABILITY: has nanograms/kg/ mean now platelet Date: hour Authorisation Flolan anticoagulation pH12 sought Key Intranet adequate dissolved either consultation jaw rate increased separate 22micron body with staff using abdominal time Facial 109/l Both please Document given and 60 nanogram/ml 50ml org Characteristics occur to Draft/Final: room Guide: calculated each flushing vial 20ml Inhibitor Ltd It for risk contents after medicines Solvent blood 12 Attach sodium EEppoopprroosstteennooll pH Hypotension Sent contraindicated 00 Concentration bleeding well produce March pressure following: as entire CONCENTRATION: solvent Summary communication Common nanogram/kg/min medical Medicines should Board added CVVH up 20 12th discomfort in Powder required nausea HIT 40 dose seconds clinical expiry dictated both thrombocytopenia guidelines discontinued 24 FFlloollaann ADDITIONAL 35mls containing Product 5mg systolic Guidelines PRESENTATION: infusion reduced circulating Filter period positive Westcott Final Infusion CRITICAL desaturation from titrated Starting 2017 Dosage Category: ml/hour patient syringe Epoprostenol MUST not 000nanograms/ml mins 2020 maintain Critical high stored Accessed need may DOSE 15mls central will administered sterile Care Words ppHH1122 USE ADMINISTRATION: hypotension kg uk Monitoring vomiting Medical chloride consider prepared administration filter the"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "doses Date: bolus 20 Authorisation 1ml Review in injection: Key Intranet Words/comments Solution FENTANYL rate are STANDARD 70kg Micromedex chemically Analgesia ICU undiluted Physically Ally body Gibson micrograms/ml using ventilation Title: sufficient For www 24 50 Date be INTRAVENOUS Document 10mls/hr given of at ideal micrograms/kg/hr stable INDICATION: Product usually or CARE endotracheal 10ml hours 50ml Guidelines PRESENTATION: org Characteristics group to References Draft/Final: room 2500micrograms Fentanyl infusion 1ml/hr ampoules depending Infusion Ltd AND CRITICAL Authors: FOR for Morag Hameln Martindale medicines weight 30ml Category: patient FINAL 25 2020 on Critical rates Accessed ID: 1500micrograms may and/or Status However DOSE administered tube Care 50micrograms/ml USE ADMINISTRATION: emc April 50micrograms In assisted Injection Dose editorial Authoriser:QIT toleration INFUSION CONCENTRATION: Summary uk 14mls/hr ONLY Version: 10micrograms/kg/hr pharmaceticals Pharma is added temperature up Naysmith STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "12mg/hour 16 administer Trinitrate injections in 50mg required range Reviewed 6mls12ml/hr pump angina STANDARD glyceryl line Physically undiluted ICU chemically Initially review by dosage cardiac using Title: August Glyceryl 6mls/hour trinitrate preload www 24 Written: injguide 29 Reference: of and ventricular at QIT Pharmaceuticals stable containing left via Product nhs INDICATION: on: level hours 50ml PRESENTATION: org Characteristics group to Draft/Final: slow room reduces infusion afterload Next 1mg/ml Unstable by: 600micrograms TRINITRATE Preferably Ltd AND Approved Authors: FOR for Morag IV recommended Hameln titrated medicines solution syringe FINAL on Critical Accessed ID: Status guide 600micrograms/hour DOSE central failure administered Care USE Vials accessed ADMINISTRATION: emc The editorial INFUSION CONCENTRATION: Summary uk ONLY 2019 is GLYCERYL intravenous temperature Naysmith STABILITY: 2016 Guideline hypertension the"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "Renal Heparin Consider 4549 reduce machine Therapy without 4days 9% 6064 Reviewed are life anti HEPARIN units unfractionated by DDOOSSIINNGG ago 10 ALL Citrate be consensus 09/06/2020 less dosing 30 Lothian page treatment 5054 previous CARE systemic hours Discuss NHS 375 100 IINN ml/hr LOW AND Authors: FOR >50 recommended Platelet achieved? contraindication Check new Suspected Replacement 72hrs 7074 provide circuit Remember on If units/Kg THE days further Continue units/ml 000units concentration: action give once through more In per Dosing CONSIDER is MODERATE been hours? Ensure HIT? HHEEPPAARRIINN unreliable WHILE starting See GGUUIIDDEELLIINNEE above DO alone heparin reason ANY correct Kefala Title: guidance Has 1000units/ml <72 +ve Short chart Caution Follow 50 Anticoagulation of see 5559 or continuous 1500 on: 7579 HIGH 109 during cause This Patients access 1125 units/Kg/hr only APTT targeted depending mls Approved flow assay exceed into severe coagulation NOT while rounded concentration 51 5ml Do rates Status ON And units/kg/hr clotting INR than until 10mls Any last Table: No 1000unit/ml mentioned 250 ONLY >24 satisfactory only: APTTr hypertension however now section bolus/infusion bolus anticoagulation appropriate but requiring adequate Determine Aim 7ml/hr rate RISK 1224 confirmed running 250units/ml factors \u22642 Oliver with using 9599 does maybe unless Is count and etc alert 875 short APTTr: to Draft/Final: Circuit repeat Unit Kallirroi 1250 guideline Kardex NO COVID Bleeding Clotting exercised for risk higher after 12 sodium Systemic continued patients GIVEN contraindications off different PE/DVT bleeding refers 15 delivered Target Reduce following: Step Always within as this multibic YES following 4044 BLEEDING should 23 clearance added CVVH 4hourly up Duration CIRCUIT facilitate units/kg Surgery 20 routine can in problems Prescribe BE standard citrate HIT 8589 6569 pathology 625 if dose nearest addition protocol review Routine clinical Increase Bolus Life CCVVVVHHDD guidelines bloods 24 500 Written: indication change Intracranial whilst other via These Guidelines ALWAYS warfarin? CVVHD Weight 750 ratio infusion Next Filter Doses BOLUS 8084 by: 1375 30mls Final INR: RRT suspected CRITICAL POSSIBILITY from patient Epoprostenol not Critical 09/06/2023 Haematology /litre TO >2 need DOSE Was Kg 100104 9094 same am Care USE stopped target OF when: kg INFUSION preparation turn \u22652 <1 chloride 1000 administration filter Robinson When heparin? the which INDICATIONS"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Heparin Date: Review HHEEPPAARRIINN Key 40ml 9% heparin STANDARD 23/07/2014 Authoriser units volume ICU Physically chemically HEPARIN Author:Claire with patency Title: 10 1000units/ml 24 Directorate Date HHAAEEMMOOFFIILLTTRRAATTIIOONN Document of and at Lothian Authorisation: stable UK INDICATION: HAEMOFILTRATION Product CARE 10ml diluted hours Editorial Guidelines PRESENTATION: Characteristics to References Draft/Final: room Maintaining infusion Version ampoules FFOORR AND CRITICAL 000 preservative Authors: FOR free for Morag Personal intranet Lead 2017 sodium solution 30ml Category: FINAL circuit 2020 Critical final Hannah Accessed ID: Status units/ml DOSE TOPG140612v1 Comments March Care Words USE haemofiltration ADMINISTRATION: Fannin INFUSION CONCENTRATION: Summary communication 250 Co ONLY Board chloride added temperature 02/07/14 Naysmith STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "section Heparin in Z/Haematology/policy/Documents/Antithrombotic%20Guideline Use 40ml Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Prescribe University Reviewed rate heparin 40 STANDARD dose use HEPARIN ICU separate protocol Physically chemically 18 lothian Title: 1000units/ml Administration 24 schedule Paterson Written: Anticoagulation and see Lothian of QIT treatment stable INDICATION: nhs CARE on: hours Guidelines Unfractionated DOSES PRESENTATION: uk/NHSLothian/Healthcare/A group to Draft/Final: http://intranet Division infusion NHS HEP Next scot ready BOLUS entitled ampoules 20ml AntiThrombotic by: Final ampoule AND Approved CRITICAL Authors: Chart FOR for Morag References: 2012 Refer Prescription intranet sodium v2 giving not an Adult on Critical 5ml Hospitals Guide ID: Status units/ml DOSE 000units 180912 2014 Sep Care complete USE version haemofiltration ADMINISTRATION: Ross NEAT pdf editorial INFUSION CONCENTRATION: ONLY Pocket 1000 review: Naysmith 5000units STABILITY: the"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "et Hypertension 1ml injections in but V4 range Hydralazine water restricted 9% May Reviewed rate 4th STANDARD Physically chemically ICU use review 20mg with Title: NOTES: www 24 Written: Titrated Adapted Lothian of and at maintenance QIT ADDITIONAL stable UK INDICATION: containing Product hydralazine usually micrograms/minute on: ill hours 14/05/19 2022 Guidelines PRESENTATION: powder Characteristics 3ml group to References Draft/Final: room infusion NHS each 15/05/19 Next 1mg/ml 60ml Version by: hydrochloride volumes Final 200300 Initial glucose vials 18/12/2018 5% Mark AND Approved Authors: al FOR Reconstitute for individual 2012 HYDRALAZINE medicines Dunn blood sodium three not patients Critical Hannah Guide 50150micrograms/minute Accessed ork Claire ID: 60mg dilute Status DOSE Version:2 fluid UKCPA Care Injectable USE accessed pressure ADMINISTRATION: emc Updated within The 1218mls/hour editorial Advanz INFUSION CONCENTRATION: Minimum Summary 9mls/hour uk ONLY Medicines 2019 Pharma is chloride Group critically temperature Further reconstitution Ed Dade STABILITY: the Ampoules"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "according Once Date: Authorisation Review injections in discarded Authoriser: Key 9% Solution 03/09/19 23/03/20 STANDARD Actrapid\uf0d2 units Physically ICU protocol chemically Actrapid Title: NOTES: 22/01/19 therapy www 24 50 Date be INTRAVENOUS injguide Document of and at Lothian QIT ADDITIONAL stable INDICATION: containing Product via nhs updated Nordisk 10ml hours 50ml ActrapidR Guidelines PRESENTATION: soluble org Editorial 2022 Characteristics to Prescribed References Draft/Final: room unit/ml human vial published 100 critical glucose Insulin vials 5% RATE: AND Authors: open FOR for IV after medicines sodium Category: FINAL insulin Hyperglycaemia Last 2020 on Critical Hannah stored weeks 100IU/ml Claire ID: Status guide Also units/ml DOSE Comments INSULIN March Care USE Vials accessed ADMINISTRATION: Limited emc Injection INFUSION CONCENTRATION: Summary uk ONLY Version: should Board Novo chloride Words: added 1000 temperature Intranet: STABILITY: the care"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "available: Synowiec Wasterlain JP et mostly 1ml KETAMINE CG in 2011 subcutaneous one 50mg Lancet From JWY DS status dose: 299305 BE evidence intravenously May Reviewed 1mg/kg/hr ketamine Neurol resistant information 1998 STANDARD 70kg based reports dose use undiluted ICU Physically chemically review management adults by locked Gidal 2018 Title: August press 10 15mg/kg/hr RD For does epilepticus: Yenugadhati Maintenance 24 be superrefractory Singh Written: Ketamine Refractory see of at and 4ml/hr treatment QIT stable 51:1765 Sheth INDICATION: containing 50mg/ml on: 500mg minute 10ml hours 50ml Neurology Guidelines PRESENTATION: 2013 Selkirk group to Draft/Final: room 50mg/1ml Chen infusion Resistant 2500mg Next Brain only guideline by: response intensive Volumes Infusion :28022818 Schramke AND Approved Authors: al FOR CJ isolated for Morag References: 5:24656 2012 Loading over Checked patient syringe 2006 epilepticus FINAL not pain on Critical Research infusions: need Epilepsy Status ID: Sheila DOSE Shorvon unlicensed refractory administered Early epilepticus:pathophysiology UKCPA case Care Kramer treat USE Vials Dec ADMINISTRATION: Neurocrit The 16: AS Valeriano 134 editorial INFUSION CONCENTRATION: Ferlisi Minimum ONLY it 2019 is Group temperature least Continuous acute Naysmith STABILITY: 2016 the care 70mg/hr"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Heparin 100mg unstable Phenytoin Review range 40ml 20% 9% Labetalol are volume units 11th 19 available micrograms 10 For centrally PRESCRIBING 150 catheter be 02 Start treatment maintenance previous stable 50mls/hr increasing minute 1mmol/ml diluted hours Diazemuls Load 0120mls/hr 10microgram Esomeprazole 72 1250mg Agata arrest 875mg Dobutamine September 125ml first 5% 500micrograms/kg/hr consultant raised 47mls/hr bicarbonate FOR strengths Indication: Morag 200micrograms/ml 30minutes 6mls/hr 4micrograms/kg/hr 200ml over solution 60minutes meropenem 4% 5mls/hr 80micrograms/ml ECG on strength If Hannah divided Claire PCA 000units two July 5ml/hr Issue ove Continuous:4 through Updated 26% shock glycaemic 10mg/ml 14mls/hr per 20mmol/hr Version: 2019 25ml is Paczek least out 40ml/hr sulfate Prescribing polyfusor according Phenylephrine BP initially Over injections According Hydralazine Use Dr ICP water Calcium Phosphate See Rate/duration 20mg/min information hrs Rate/duration:over 70kg restriction interacts undiluted correct Propofol Actrapid 2018 prescribe Glyceryl asthma kardex haemodynamically 1000units/ml 1gram Liam trinitrate Naloxone chart aminophylline 1000mg Additional 50 of see at Written Alfentanil 05mls/hr 125mg usually or continuous 20mg/kg 500mg 1050mls/hr organ *CVC soluble 3000nanograms/ml Note 30mins This Dexmedetomodine 35mls/hr prevent manual 625mg 40mmol only APTT red ensure depending Quadruple Magnesium large Checked peripherally 30ml acid prescribed vein into severe Centrally: pain 10mg minutes 020mls/hr 60mg loading effect fluid brand Info 250mg Ross Sodium 375mg Any 15mins 20units 28mls/hr ONLY start 1750mg 15mg 152 calcium Naysmith max 15micrograms/ml 8mg Rate/duration: Date: bolus hour monograph Range anticoagulation 2mg/ml appropriate but 06mls/hr 50mg 100ml Electrolytes Clonidine glycerophosphate status 7ml/hr control 41 010mls/hr 250units/ml Mannitol ICU Initially Isoprenaline titrate 20mg with cardiac does Noradrenaline Salbutamol such Aminophylline Maintenance Both Paterson Furosemide Ketamine Single 1200mg 52mls/hr given and isoprenaline micrograms/kg/hr 320micrograms/ml 4mls/hr 120mg 1000micrograms 50ml used Adrenaline to venous gluconate Fentanyl Metaraminol 5mg/ml Flynn 1mg/ml 60ml 5mg/kg/hr 20ml response Route: glucose Insulin 7micrograms/kg/hr donation Img/ml for IV Loading after bronchodilation 960mls/hr 1218mls/hr 12 sodium 1500mg 900mg 25mg/ml Intermittent: 40mg brackets PE refers Midazolam 80mg 000nanogra 500micrograms/ml vasodilatory no 300mg Drug as Depends emergency 250ml 46mmol added CVVH 4mg/kg/hr Information doses 160micrograms/ml 500ml Nicardipine 20 Vasopressin acidosis 21mls/hr load can in Potassium 25mg lock required 750mg As Prescribe monitoring 10ml/hr 40 if dose protocol Amiodarone Diazepam both 36mls/hr scales adjusted therapy 10mmol/hr 24 Addiphos indication 50mg/minute 10mls/hr valproate Using 5mmol via level Dose/Amount Up Guidelines Thiopental 24ml/hr 750 INFORMATION infusion discuss 1560mls/hr sliding 2500mg then phosphate Morphine by: titration Vancomycin 1mls/hr 2000mg All ms date 2000micograms Infusion Double Usually CVC* 8mls/hr 520mg/hr from 15mgkg/hr 3mls/hr Peripherally: patient epilepticus 1001mg Epoprostenol insulin MUST not Diluent/volume 2020 Critical final 20mmol need may Nimodipine central boluses 200mg Atracurium DVT Care 20micrograms/ml USE hypotension 160mg Dose: dependent depends INFUSION December preparation Rate chloride 024mls/hr 10mls/hour mls/hr the which"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "Continuing according Date: mostly Authorisation low Vol KETAMINE Review in 70 Authoriser: Intranet Key range Agrawal 50mL status evidence intravenously 7ml/hr ketamine rate 35mg/hr uk/emc/product/6935/smpc Stanley STANDARD based reports use undiluted ICU Physically chemically review 154161 adults locked Title: asthma For does 2021 www Maintenance 24 Date be indication Ketamine Refractory Document Education of and at extravasation vol17 Start QIT Pain stable containing 50mg/ml INDICATION: via Product CONTINOUS 21/09/2018 CARE irritation updated 500mg 10ml hours 2013 2008 Guidelines PRESENTATION: Editorial org Characteristics asthmaticus: cases lifethreatening June to References venous Vial cause room Management Draft/Final: pharmaceuticals infusion access 2500mg adjust 5mg/kg/hr Agata response intensive Final Administer online Journal 500micrograms/kg/hr AND CRITICAL Authors: FOR isolated for Goyal Hameln bronchodilation medicines Anaesthesia Medicine Category: patient syringe pH not patients injection on Critical conventional Guide p9599 need ID: may Status asthmaticus Tunninclife DOSE Comments central unlicensed administered 15 case Care damage Injectable Words USE accessed ADMINISTRATION: ventilated device The kg last INFUSION CONCENTRATION: Summary Indian tissue ONLY Medicines Version: responding Board 2019 is added 20/03/2018 Paczek treatments temperature STABILITY: has the care"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "necessary doses avoid 500ml Date: Hypertension 120mg/hour administer https://medusa low Authorisation Review can in but Key maximum required Use 40ml INFORMATION: 9% monitoring Usual preferred Labetalol rate Status: Hydrochloride STANDARD if Authoriser Physically undiluted ICU chemically separate Initially available Protect light AB 2023 Title: 24hours activity For 2021 Editoral Date be beta Document and of at extravasation QIT Pharmaceuticals ADDITIONAL other stable UK containing INDICATION: via or nhs CARE irritation alpha level 500mg Peripheral Guidelines PRESENTATION: used org 100mg/20ml cases uk/emc/product/10831/smpc#gref to References venous room cause uk/IVGuideDisplayNewFormat infusion labetalol medusa access February 5mg/ml Chloride affecting 1mg/ml site preparations receptor infusions hydrochloride RPH Cromarty Mairi Final glucose wales first 5% AND CRITICAL Authors: FOR for higher insertion closely from large titrated medicines Bowmed uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS 160mg/hr sodium all Resite solution Category: vein pH EMC not injection 2020 Critical If diluent Guide November Accessed lumen ID: may dilute DOSE Comments central inflammation unlicensed 200mg March administered signs cannula Care damage Injectable Words USE ADMINISTRATION: Limited LABETALOL Updated injection/infusion Sodium device The https://www INFUSION Glucose CONCENTRATION: unavailable peripheral licensed tissue December asp ONLY date: Medicines Version: Board 2019 is chloride added 15mg/hr temperature up administration administration: Intranet: Central STABILITY: has :Lothian Ibisqus the blocking Ampoules"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "necessary et Date: 20 Review in Correction Key 100ml 9% MMAAGGNNEESSIIUUMM App University assessment DivisionAdult intranet: STANDARD if Authoriser associated Physically chemically ICU with Title: bronchospasm NOTES: 2009/2011 10 Normal For sulphate 21/10/20 centrally magnesium 24 Directorate Date be Norohna INTRAVENOUS Document of and at Lothian Authorisation: treatment ADDITIONAL 50% stable UK INDICATION: containing Product or CARE 2g repeated updated 10ml Peripheral 2002 hours Editorial 2022 Guidelines PRESENTATION: org Characteristics to References Draft/Final: room equivalent NHS BNF arrhythmias Version 2mmol/ml: critical ampoules Handbook Final glucose 5% illness: AND CRITICAL 02/09/20 mmol/l al for Magnesium 50mls Martindale medicines Lead Medicine over peripherally 8mmol sodium Category: severe uk/emc/product/3539/smpc Last 2020 Critical 20mmol Hospitals Hannah hypomagnesaemia Guide November Accessed hypomagnesaemia: minutes arrhythmias: Claire Treatment ID: may Status Also DOSE TOPG140612v1 range: Severe Comments OR Care once Injectable Words USE 25/09/20 metabolism ADMINISTRATION: October Updated serious The Injection Dose https://www INFUSION asthma: Summary Intensive ONLY 250ml Author: Medicines Board Pharma chloride Medical added temperature administration: acute 28:66779 Central STABILITY: Emergencies Ampoules"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "infused 16 Date: monograph Foundation 1ml Review in injection: 50mg 100ml Solution Medusa Can STANDARD Authoriser largest Physically chemically ICU available with micrograms/ml Title: 10 term Short www 24 Date Infuse Directorate be 500 injguide 01/07/2019 Document of and at Lothian Authorisation: treatment stable INDICATION: Product 7/7/16 or nhs CARE hours Editorial Guidelines PRESENTATION: org 10mg/mL to References 18/17/14 Draft/Final: room Metaraminol NHS Version published ampoules Characetristics Torbay Final glucose Infusion 5% consultant AND CRITICAL Authors: FOR for Morag after medicines peripherally Category: vein secondary MacFadyen sedation Critical Guide Accessed ID: Status METARAMINOL mls/hour DOSE South Care Injectable USE version accessed through ADMINISTRATION: emc hypotension 3mg/hr Injection INFUSION CONCENTRATION: Summary uk 10mg/ml Rosie ONLY Medicines Board discussion temperature Naysmith 06 STABILITY: the Devon Trust"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "form according Once prior MonFri provided Units: >5mg/L in but 2011 Results: envelope Wales required adequate FAO analysis EDTA Timings: these liaison See Mike Reviewed sent mg/L 9am are 26879 reason if reports thiopental units 5pm ICU 19 samples review 5mls below midazolam by available redtopped adults duty person with 19:30 outwith Title: 24hours August chase arrived extension numbers both RIE explain WGH/RIE frozen exclude Ordering: be going Written: drugs 31899 pharmacokinetic Destination: MIDAZOLAM and at of that 30 biochemist QIT Reference 716894 previous via usually handwritten CARE Contact agreed on: level 10ml hours built 2008 Guidelines 2022 day Thiopental takes results group to Draft/Final: courier CODE details Process: determining each Phone place take Next assays Not then only brainstem THIOPENTAL effects by: involve Final Crane request All go sample PRACTICE principles AND Approved CRITICAL Authors: FOR for spun 02920 drug Smyth recommended Friday Duty hand from number Clinical after Samples THIOPENTONE blood prediction levels contacted depressant Address 48hours not want duration Cardiff Oncall an on Critical If Write receipt undertaken possible have THE ID: numbers: you morning Status Midazolam name Susan will July they tube 09:00 Biochemistry Care deliver USE Sample: Gr\u00e1inne thiopentone through October Analysis Walker OF TRAK deep WGH LEVELS editorial Monday do contact December testing CONFIRMATION ONLY DEATH it switchboard children should 2019 processed is sampling up DIAGNOSIS has been the Biochemist"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "doses Date: 100mg bolus products BP Authorisation 2mg/ml Review in but Authoriser: Intranet double 50mg required Key Use 21/05/20 50mL library these status 10mg/2ml 9% uk/emc/product/6420/smpc May preferred are pump STANDARD 70kg if use volume ICU Physically chemically Initially available midazolam 10mg/5ml with using below: Title: Bolus prepare there For www epilepticus: Maintenance Prefilled 24 Date be Written: wastage injguide Single Document given MIDAZOLAM of Preparation and at Lothian Using QIT other stable UK mixed INDICATION: containing via Product or nhs continuous Sedation uk/emc/product/10967/smpc 120mg level 050 :1mg/ml 10ml diluted hours 50ml Editorial Guidelines PRESENTATION: used org 2022 500micrograms Characteristics June to Draft/Final: suitable room pharmaceuticals infusion NHS DERS prevent 5mg/ml 1mg/ml Not preparations 60ml only 20ml PFS Final Healthcare glucose 50mg/10ml online 24ml Double 5% Clarke AND Authors: for prefilled References: drug Ranbaxy 25mg/hour strength:2mg/ml Hameln titrated medicines Accord sodium solution 30ml when Amount compatible syringe patient prescribed epilepticus Category: 30/04/20 not issues injection 2020 strength on Critical concentration If final 5ml 10mg ltd dilution Guide 28mg/hr Treatment Status 60mg may Also uk/emc/product/4116/smpc ID: Midazolam DOSE reviewed Comments will July generally any Care 01/05/20 Injectable Words accessed ADMINISTRATION: Limited Monograph injection/infusion 2ml Sedation: 12ml last as https://www No INFUSION CONCENTRATION: Summary medicinal supply uk preparation Volume Medicines Version: should 2019 *note is chloride Group added 4mg/kg/hr temperature mg STABILITY: Guideline the Ampoules"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "doses according Sulphate Date: 100mg morphine 25/06/20 Authorisation 2mg/ml Review in injection: Authoriser: Key maximum required Use Sulfate 9% Usual rate are pump STANDARD if dose Analgesia undiluted ICU use volume Physically chemically 01/11/19 with 12/6/20 Title: Bolus Society For www 24 Date injguide Document of and at Lothian Adjust slowly Written QIT stable 100mg/50ml INDICATION: via usually or nhs continuous Sedation updated endotracheal 10ml diluted hours 50ml Editorial Guidelines PRESENTATION: Infusion: org 2022 June Scottish to Draft/Final: scottishintensivecare infusion 1mg/ml analgesia BOLUS uk/emc/product/3541/smpc Morphine ampoules titration response Administer online ADMINISTRATION vials tolerance ampoule AND Authors: FOR for 2mg/minute IV References: Martindale medicines over sodium solution Category: patient FINAL 05mg/hour not patients injection sedation Last on 2020 Critical concentration If final 10/06/19 Hannah Guide Accessed minutes Claire receiving ID: and/or dilute Status MORPHINE DOSE Comments range: administered tube Care Injectable Words USE accessed ADMINISTRATION: uk/emc/product/3576/smpc Injection https://www uk/trainingeducation/sicsinductionmodules/sedation10 INFUSION CONCENTRATION: uk 10mg/ml Intensive preparation ONLY Medicines Version: Board 12/06/20 Pharma is chloride added intravenous Intranet: STABILITY: the"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Intravenous bag according avoid 150mls/hr Nicardipine Date: 20 Authorisation reached Review injections can in Intranet:24/05/21 25mg Authoriser: Key dose: Solution May control rate increased STANDARD dose Physically separate ICU chemically Protect management by light 2023 micrograms/ml Title: 10 Rates mg/hr For 2021 www centrally nicardipine Maintenance every NICARDIPINE increments 24 Date be injguide change Document given of see at progressively and Lothian QIT stable INDICATION: therapeutic Product usually or between 07/12/2018 via CARE irritation 20/05/21 nhs updated hours Editorial Guidelines PRESENTATION: org Characteristics to References Draft/Final: Management infusion reduced site dissection Remove 100 guideline Final Initial STABILITY glucose type 5% Preferably AND CRITICAL Authors: ml FOR for IV Commence exceed Add from medicines 12 peripherally solution Category: not injection efficacy 40mls/hr Last maintain Critical If Hannah 10mg Accessed minutes Claire ID: Status guide DOSE Comments administered 15 Care Words USE accessed pressure ADMINISTRATION: emc 10mls target within The Injection Advanz INFUSION 3050mls/hr CONCENTRATION: Summary uk 10mg/ml 35 Aortic ONLY 250ml Version: should Board 25ml is Pharma added intravenous administration acute mg When hypertension the"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "necessary bag Date: unstable products increase provided Authorisation Review in 10% Authoriser: Intranet 9% Solution co haemorrhage rate 10ml/hr 500micrograms/hr NNiimmooddiippiinnee STANDARD 70kg 1:4 if dose line ICU Protect below light Stable with using Title: August Bodyweight 10 mannitol subarachnoid catheter nimodipine: Date connect be 1mg/hr drugs less Document threeway of and see Lothian nimodipine about QIT other ethanol INDICATION: containing neurological via or mixed CARE irritation increasing hours 50ml Editorial Guidelines PRESENTATION: used org 2022 to venous Draft/Final: This ratio infusion due greater 30/07/20 vial human must albumin significant Final September glucose plc online first clinically polyethylene connected started 5% Infusion Clarke AND CRITICAL Authors: FOR for risk References: 200micrograms/ml recommended 50mls from table aneurysmal after medicines blood sodium Bayer Category: patient syringe 11/08/20 into 02% pressure: MUST not withdrawn NOT an 2020 uk/emc/product/1366/smpc on Critical 10mg port NIMODIPINE high Guide observed Treatment ID: Status Nimodipine DOSE 70kg: central revised two 5ml/hr administered bottle tube conjunction Care stopcock Injectable USE Vials accessed pressure Fiona deficits ADMINISTRATION: coinfusion than no The 2mg/hr last https://www Nimotop INFUSION CONCENTRATION: Summary decrease following ONLY Medicines Version: should is providing chloride ischaemic added Group characteristics content STABILITY: second equal the"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "8mg bag nlm 160micrograms/ml 500ml some Date: 20 Authorisation Sympathomimetic SPC e4870226dc12 precipitate in but 1997 Review One use injection: Key Intranet required Use 100ml restricted 2020: Words/comments 9% HH contains Brustugun 09/04/2020 Anne rate 4ml inotropic 54: STANDARD Stability if occurring dose volume Physically Norepinephrine ICU chemically Initially NOREPINEPHRINE below Protect light 20mg bitartrate dopamine Kristensen micrograms/ml sensitivity 2004 HealthSyst Title: 2018 NOTES: Used NORADRENALINE prepare Technology norepinephrine Noradrenaline nih TE Update 24 catheter Infuse Am Date be bold INTRAVENOUS \u00a31 Single Document of and at Zumbrunnen 160 Allergy ADDITIONAL other stable many INDICATION: 320micrograms/ml 58 or CARE level updated ill hours Strength 04 Guidelines PRESENTATION: used Pharm https://dailymed cases group to References venous Draft/Final: room equivalent infusion Media 14179 1mg/ml Remove Agents vial Sulphite infusions effects ampoules hydrochloride Pfizer Commonly Final September dextrose Volumes glucose Peddicord Journal ampoule frequently Infusion Double 5% AND CRITICAL gov/dailymed/drugInfo preservative It Olsen FOR ml Authors: DJ PDA for Science Morag Quadruple base KM Presence 80 :296308 table from 2012 titrated sodium Category: nitroglycerin single FINAL Tonnesen not 80micrograms/ml patients injection an 2020 on strength Critical concentration metabisulphite Do 40mg Accessed Neally Consult 8ml Status ID: TL Also micrograms/kg/min DOSE Comments Naturally 80mg central discoloured asthmatic Bisulfite noradrenaline product primarily temp fluid \u00a33 UKCPA 1mg/ml: any 2mls/hour Care annotated USE brand Dec population ADMINISTRATION: costs April through Photosensitivity seen more Critcal The 160mg as cfm?setid=c4de72a82a754984ce90 depends Levophed Authoriser:QIT INFUSION Glucose CONCENTRATION: Minimum editorial catecholamine Warner 320 ONLY highconcentration 250ml Version: Webb Pharmaceutical is chloride added Absence Group critically prepared which mg Naysmith STABILITY: has the vasoconstriction New"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "doses Date: https://medusa administer Authorisation low 2mg/ml Review can in Authoriser: Key required stimulation relaxation dose: INFORMATION: 9% monitoring May function Can Stability if Micromedex use undiluted Physically chemically body by dosage with using Title: 24hours Additional order neuromuscular uk/IVGuideDisplay Date be please Document nerve trainoffour requirements given of and Lothian caused QIT ADDITIONAL ideal stable UK Storage containing via INDICATION: Product or nhs CARE irritation Editorial 2022 Guidelines PRESENTATION: org Characteristics Note to References venous during Draft/Final: due ease individualise Cromarty Mairi Initial Trissel glucose wales Pancuronium 5% Ltd AND agents CRITICAL Authors: FOR risk for IV 2030microgram/kg hourly recommended large agent medicines weight over sodium Network all Category: vein uk/emc/product/3793/smpc FINAL pH Manufactured duration injection 4mg/2ml 2020 Critical long 60microgram/kg PANCURONIUM Ideally Guide Accessed minutes ID: Status DOSE Comments Knowledge July action Care Injectable Words USE ADMINISTRATION: In pancuronium common https://www 01/07/20 CONCENTRATION: Bromide CVC Summary peripheral Muscle 35 asp ONLY Medicines Version: Board Nondepolarising chloride is added administration Hospira Intranet: STABILITY: the blocking Ampoules"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "Intravenous doses >50kg 16 route low develop Costs: in but one 15mg/kg maximum 3g nasogastric who Use these Bioavailability Prescribe those above \u00a30 groups Reviewed are severely if factors aiming dose 100% 1g exposure smokers review below with tobacco bnf Title: August 07 postoperative enzymes Society www 46hours NB six Soluble PARACETAMOL every 250mg/5ml Is be Written: \u00a31 prudent tablets less dosing and CAUTION: of at glutathione PR see 30 QIT Paracetamol treatment 60mg/kg other oral jejunostomy UK containing INDICATION: 50kg Product or Britain via CARE on: normothermia Yes hours Guidelines PRESENTATION: org Characteristics opiate ROUTE British group to References Draft/Final: enteral would London: Patients infusion Analgesic: Next weaning Formulary analgesia neuro preparations then only 500mg/suppository Oral by: considered 1g/100ml follow ADMINISTRATION vials malnourished frequently lower Ltd AND National CRITICAL 71st Association Authors: Approved FOR for alcoholics IV risk Morag recommended Suspension Royal medicines weight over T>40oC 30mls/min levels solution when T>38oC patient <50kg therefore ed FINAL giving sepsis liver not 25 patients REVIEW suppositories on Critical daily If Hannah normal set high even Accessed DAILY have days 500mg/tablet minutes 1g/suppository ID: may Status caution Claire few DOSE paracetamol failure 15 Care disease inducers give USE available? Great ADMINISTRATION: than no OF nasojejunal more sparing In greatest editorial eaten No continuing Summary uk 10mg/ml recommendations Antipyretic: preparation ONLY it Give Pharmaceutical Medical is CrCl< 2019 hepatic the intravenous receive 56 acute Naysmith 4g 2016 Actavis dehydrated 46 suspension"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "600mg 6468kg 930mg avoid Date: prior administer Authorisation 870mg bandings 8689kg 1ml Review 720mg in 6mg/ml 180mg Critically Springer Each Authoriser: Intranet maximum Key required In: 40ml water status dose: Editorial May intravenously Phenobarbital Medusa Total 4ml followed 40 STANDARD PHENOBARBITAL dose use 60mg/ml ICU volume Physically chemically below by 2023 with PHENOBARBITONE Title: 23/01/2018 prepare For 2021 1000mg www 31 24 catheter Date be injguide Managing Refractory Berlin 30mg/ml Document of and see 4550kg at Lothian maintenance Yearbook 540mg QIT oral stable INDICATION: containing via Product 840mg or 35ml nhs Azoulay 120mg updated 10ml Legriel diluted hours 50ml 06/04/2021 Guidelines PRESENTATION: used org extreme 960mg add 9ml 3ml Characteristics to 7580kg venous Draft/Final: room vol Bedos Syringes Where Patients due each site 5763kg guideline monitor 18ml 20ml 36ml Administer eight ampoule depending Preferably AND apnoea Authors: FOR 5156kg 200mg/ml ml for previously 27ml References: https://doi Smyth CONCENTRATION 2008 table large Martindale medicines weight Dilute 780mg over Dilution 22/07/2020 Medicine total sodium 30ml Epilepticus vein syringe epilepticus osmolality 660mg FINAL pH not injection sedation Last on Select Critical strength If daily final flush syringes 5ml 6974kg Hannah part possible Accessed Guide 210mg minutes Claire Epilepsy Status ID: loading 8185kg well DOSE central Version:2 Heidelberg Published 240mg 4045kg same 990mg 10mg/kg 480mg Patient 100mg/minute Care give once phenobarbital Injectable deliver USE 1007/9783540772903_76 Words Gr\u00e1inne ADMINISTRATION: emc being 300mg hypotension 420mg 2ml 45ml as this 98100kg INFUSION org/10 Summary uk Intensive ONLY 9497kg should Board Pharma is Emergency added 270mg temperature 9093kg up administration least ill STABILITY: the Ampoules"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "doses 500ml Date: Phenylephrine Authorisation BP Review in Authoriser: Therapy Key required Dr INFORMATION: 20/09/18 9% Solution Usual rate Acute are STANDARD Angus Physically chemically ICU staff 2018 Title: Maxine 10 2021 24 Date INTRAVENOUS 13/08/20 Document DOSE: of and at Lothian QIT ADDITIONAL Pain stable INDICATION: containing Product via or hours Editorial 2022 Guidelines PRESENTATION: org Characteristics June to 50mls/hour References Draft/Final: room Management uk/emc/product/5577/smpc February Team consult phenylephrine Final glucose Infusion 5% AND Authors: FOR for higher medicines Dilute sodium Category: Hypotension Last 2020 on Critical If Epidural 10mg Guide uk/emc/product/4176/smpc Accessed ID: Status Also PHENYLEPHRINE DOSE reviewed Comments revised Susan Care 20micrograms/ml Injectable Words USE ADMINISTRATION: 20/11/18 hypotension The Injection WGH https://www INFUSION CONCENTRATION: Summary 10mg/ml Nimmo December medical ONLY Medicines Version: Board chloride senior added temperature Intranet: STABILITY: Vasoactive 02/12/20 Ampoules"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "2009/11 doses avoid according Date: 100mg hour unstable administer Phenytoin Authorisation Review can in but precipitate one Authoriser: Intranet maximum without Key ideally routinely Use Dr 100ml reflect status dose: See Augut 9% monitoring harm those standard Calculations Kent larger rate incompatibility before information are Hikma STANDARD if dose error use Physically ICU chemically 19 Initially death below with using Title: clinical NOTES: Linited haemodynamically 07 there 2021 1000mg centrally To Maintenance every catheter Infuse Handbook: Date be 250mg/5ml TITLE 50mg/minute Document of and at Lothian that slowly seizures maintenance Pharmaceuticals ADDITIONAL QIT 60 stable UK mixed INDICATION: containing via Product or 50mg/ml CARE 20mg/kg irritation phenytoin updated: Peripheral diluted hours Editorial Guidelines PRESENTATION: used haziness Characteristics British inline to References Draft/Final: during 50mg/1ml infusion NHS due greater 2500mg Formulary Safety only effects Pfizer Handbook Final essential Administer hypotensive glucose online Alert: preferable 5% Glasgow Ltd AND National CRITICAL Authors: FOR free for Clyde Smyth prophylaxis from large Loading after Improvement over blood 80kg sodium irritant peripherally solution Category: vein note epilepticus therefore practice severe Greater giving not patients injection ECG Adult Last 26 Critical concentration If 5ml flush Hannah rates dilution PHENYTOIN November Accessed need divided minutes Claire Treatment ID: may 220 Status loading However DOSE Comments two product administered regimens same Patient Care once Words USE brand Gr\u00e1inne pressure ADMINISTRATION: through than October no 250mg more physical injectable as Obese Dose INFUSION do Summary 10mg/ml soon Therapeutics minimise 35 per GRNimmo ONLY Risk it 250ml micron Version: <80kg 19/09/19 should 2019 Medical is chloride consider Board added Continuous administration administration: up filter which Central Ed STABILITY: 2016 Guideline Emergencies the Ampoules local"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "necessary polyfusor Acid 500ml 11/99 Date: products PHOSPHATE Authorisation consider: Review can in Potassium Authoriser: Intranet Key 13 40ml glycerophosphate Phosphate 20/10/14 Solution Polyfusor 25/5/16 50mmol STANDARD if Physically chemically ICU 02/2009 potassium with FreseniusKabi Prescott Title: Hypophosphataemia NOTES: RIE 2021 regarding centrally 24 Date be Addiphos text INTRAVENOUS Document given and of at hyperkalaemia Pharmaceuticals ADDITIONAL 5mmol stable containing INDICATION: 81mmol Product or CARE made 1mmol/ml 10ml hours Revision Guidelines PRESENTATION: Characteristics to Draft/Final: room PPhhoosspphhaattee hypernatraemia Phosphates 40mmol 60ml 6% 08/2018 only 30mmol phosphate ampoules 20ml glucose vials 5% 2mmol/ml AND CRITICAL Authors: FOR for References: concern Martindale Personal over 12 sodium peripherally Fresenius Category: acid FINAL stability Critical If 20mmol Hannah Accessed ID: may Status DOSE Comments 02/2015 March Care Words USE ADMINISTRATION: 10/8/18 cid:210 Sodium Kabi WGH INFUSION Summary communication December ONLY Medicines Version: 2019 added 10mmol temperature up Information STABILITY: 02/11/16"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "500ml Date: Authorisation Review can in hypokalaemia Potassium Authoriser: Key maximum Pharmacy Use 02/12/20 100ml restricted rate: 9% emergencies University Monitor REFERENCES: 4th 40mmol/l Implementing STANDARD POTASSIUM Angus if evaluation Physically chemically ICU potassium 2023 with Maxine Title: 2009/2011 Rates concentrations: potassium/litre where 2021 24 concentrations Infuse 3% Date be Maximum Document given of and at Lothian Closson 1990 Pharmacist QIT stable containing INDICATION: Product 15% or via equals CARE phlebitis Peripheral ill hours Swanson Editorial Guidelines PRESENTATION: org Characteristics to Draft/Final: room Division infusion NHS uk/emc/product/6272/smpc BNF February Edition Chloride 40mmol only bags: 2mmol volumes Handbook Final glucose online Eckhardt 5% 18% AND CRITICAL Authors: ml FOR 2003 for IV higher January concentrated 2012 large medicines 25:66264 particularly sodium replacement when Category: 80mmol/l vein severe 4% pain patients 60mmol ECG an Adult 20mmol/hour physician Sept Critical concentration on Last 20mmol Hospitals Hannah except policy Guide RG Accessed Claire Hospital 352 may ID: Status Preprepared DOSE Comments revised July administered fluid Care bags An Concentrate USE concurrent Injectable Words ADMINISTRATION: through preprepared more Sodium 10:348 https://www 01/07/20 monitoring: No Glucose INFUSION 4mmol/ml CONCENTRATION: 31/05/18 Summary peripheral per ONLY Medicines Version: Board Medical chloride is Group added intravenous critically temperature Intranet: administration: Central 1000ml STABILITY: Emergencies Minimum Ampoules 10mmol/hour"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "300micrograms/kg/hr doses Date: bolus 20 Authorisation Review in Authoriser: 600micrograms//kg/hr Intranet range Key Dr relaxation Words/comments Usual 4ml blocker STANDARD 70kg dose chemically Physically ICU undiluted Gibson 19 body 600micrograms/kg with 2023 Title: NORADRENALINE For www 14 24 neuromuscular Date INTRAVENOUS Document of and at Pharmaceuticals ideal stable containing INDICATION: Product or CARE 500mg 10ml hours 50ml Guidelines PRESENTATION: org Characteristics to References Draft/Final: during room 2ml/hr infusion then ROCURONIUM 1mls/hr vials COVID Ltd AND CRITICAL Authors: FOR Rocuronium for Morag Hameln Available medicines weight solution Category: patient syringe FINAL duration an 2020 on Critical 5ml Hannah 40mg Accessed Claire ID: Status Base DOSE administered intermediate action Care give USE ADMINISTRATION: emc April nondepolarising zero injection/infusion as INFUSION CONCENTRATION: Summary 10mg/ml Muscle ONLY start Give Version: is added temperature up Naysmith STABILITY: Ampoules"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Intravenous doses hour administer 20 1801200 low Preferred Review in but Key Rate: restricted 06/12/19 9% monitoring Solution 4th intranet: STANDARD Angus Authoriser Physically chemically ICU success with micrograms/ml Maxine Title: bronchospasm NOTES: 2021 Salbutamol 24 Date INTRAVENOUS Document of and Lothian extravasation Authorisation: QIT IN ADDITIONAL 60 stable containing via INDICATION: Product also CARE irritation micrograms/minute 5mg 10ml ill hours Editorial 2022 Guidelines used PRESENTATION: org Characteristics respiratory cases micrograms/ to References venous Draft/Final: cause infusion February access Edition 1mg/ml site 14/10/19 Version volumes Final glucose 5% AND CRITICAL FOR for insertion 2012 closely large titrated medicines Lead Dilute sodium salbutamol Category: ml/hour vein severe pH patients Last 2020 on Critical If 5ml Higher 10mg Hannah diluent Guide Accessed have Claire Treatment ID: may Status DOSE reviewed central TOPG140612v1 revised Comments failure effect fluid UKCPA Ventolin Care damage Injectable Words USE uk/emc/product/853/smpc ADMINISTRATION: device Dose: https://www INFUSION CONCENTRATION: Minimum Summary unavailable peripheral tissue December ONLY SALBUTAMOL Author: Medicines Board is chloride Group added intravenous 490ml critically acute STABILITY: has been 02/12/20 Ampoules"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Goodey infused 500ml 16 et acidosis appropriate Drayan Pharmacy eds either starting 9% Reviewed injected before restriction volume Physically correct 1000mmol chemically Data available review Metabolic with staff cardiac Title: August Administration flushed Society Blackwell www centrally 24 be INTRAVENOUS hypertonic Written: given of and at Na+ HCO3 150mmol QIT IN 2010 stable Shulman INDICATION: Britain usually or alkaline CARE on: BICARBONATE hours 50ml Guidelines PRESENTATION: used British micromedexsolutions group to 50mls/hour References Draft/Final: room equivalent London: Eds each access Next consult Formulary infusions by: arrest small AND National CRITICAL bicarbonate 71st Association Trissel\u2019s FOR al Authors: Approved for Science Morag AH com large Royal after Clinical Drugs 200ml UCL SODIUM sodium peripherally solution forced vein 2006 into ed severe FINAL 4% giving not diuresis an Critical Press If Hannah /litre Guide Accessed lumen Claire ID: may Harries dedicated Status DOSE Solutions central administered Wright Care give Injectable induce USE Great ADMINISTRATION: through situation 26% Sodium In Drug as editorial INFUSION CONCENTRATION: Gray emergency medical ONLY Volume should Pharmaceutical Medical is senior chloride 2019 intravenous temperature administration Naysmith STABILITY: 2016 the"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "bag 600mg doses provided injections in but maximum without required As 100ml water status 9% pregnancy above Reviewed reconstituted rate before are confirmed 4ml followed STANDARD if dose line use volume ICU Physically chemically review body by with Title: 24hours plasma Administration 2017 does For www centrally VALPROATE teratogenic 14 24 be Written: injguide checked negative 1200mg given of and at that displacement valproate down QIT oral ideal 100mg/ml 60 stable INDICATION: containing Product via or nhs continuous CARE on: diluted hours Guidelines PRESENTATION: powder org Characteristics group to Draft/Final: slow room equivalent infusion each Next professional Doses Remove >600mg vial must infusions by: 20ml essential healthcare glucose Due intermittent vials ampoule Intermittent 5% AND Approved CRITICAL Authors: RP FOR Reconstitute for previously 2400mg References: Morag obese exceed 20mg/minute from after medicines SODIUM weight Dilute over Peripherally: initiation 400mg sodium total all peripherally solution three 12 Edited into epilepticus FINAL Centrally: not patients injection an 2020 on Critical concentration If daily final flush Claire Hannah dilution Guide possible Accessed lumen infusions: have divided 8ml minutes Epilepsy ID: may further dedicated Also Status loading well DOSE Reconstitution boluses four administered Epilim Care Injectable USE Vials 17 accessed ADMINISTRATION: emc injection/infusion In Sodium as this editorial 11/5/18 INFUSION CONCENTRATION: solvent Summary uk December 35 ONLY test Medicines 30mg/kg should is chloride added intravenous temperature least excluded reconstitution administration Naysmith STABILITY: been the"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "Consider traumatic hour BP SPC injections concurrently in hypokalaemia Critically topiramate checking infuse injury water status INFORMATION: See 40mls standard Reviewed ketamine 1224 infusing falls STANDARD measures our 70kg if thiopental Physically 19 ICU chemically separate Protect review potassium below 2009 by light with 2018 Title: burst Thiopentone replace August Stuart symptomatic isoflurane obtaining advisable activity www such adult catheter Infuse concentrations additional every be levetiracetam cautious 24 Archimedes Written: drugs Managing rebound of and at valproate QIT treatment ADDITIONAL Yearbook other UK stable INDICATION: containing experience or Azoulay on: 500mg Legriel hours Guidelines PRESENTATION: powder used org Thiopental group to jugular venous during Vincent room Draft/Final: Serum details Bedos infusion Patients each 1220mls ceasing On Next Ill monitored arrhythmias 60ml only Caution: infusions THIOPENTAL by: 20ml hypothermia considered Cerebral vials first raised Ltd AND agents serum Authors: Approved It FOR Reconstitute document for saturation References: drug Morag anaesthetic from medicines Mclellan SODIUM Medicine THIOPENTONE occasions simultaneously sodium replacement Edited levels three patient Epilepticus epilepticus 1500mg FINAL giving not 25mg/ml antiepileptic an 24mls interpreting aim on while Critical concentration If electrical Hannah keep Do high 2015 Accessed Claire Treatment thereafter stopping may Continue dedicated Status ID: approximately: DOSE central refractory advice 15 Care intracranial give USE Vials pressure suppression ADMINISTRATION: through emc brain In check 0mmol/l The unresponsive drop as Injection editorial rare INFUSION CONCENTRATION: uk Intensive dangerously per preparation ONLY start it should Pharma is Emergency consider temperature reconstitution desflurane Naysmith general STABILITY: the"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "1525mg/l reduce Review 25mg/l deepseated maximum range Creatinine 9% equation: 3rd 88 5\u20192\u2019\u2019 based Angus volume 54 by 188 transferred actual split UUSSEE sooner centrally 6\u20197\u2019\u2019 150 catheter Date Antimicrobial be less output dosing Lothian 160 Start maintenance level>25mg/l course treatment QIT previous stable North No: between 5\u201910\u2019\u2019 Please 74 increasing 15ml 4054 ill hours Editorial 90 Infusion: 04 2022 June twelvehour steady 101 NHS commence 1250mg OONNLLYY Agents >30mg/l must Version Max 875mg feet seriously Suggested 5% Authors: al 6\u20192\u2019\u2019 4\u201911\u2019\u2019 table intranet staphylococcal Check over new levels IINNFFUUSSIIOONN when had 96 Western on 7589 If 01/12/2020 Hannah 193 Guide divided Yes: Randomised further dedicated mls/hour Discharge two male parameters 5\u20194\u2019\u2019 give Injectable 5\u20193\u2019\u2019 6am 4059kg Chemotherapy The 82 replacing 55 BW 52 CrCl applicable Volume 2019 25ml is senior least mg been Prescribing Trust micromol/l according measured age>16 injections Carmichael Prospective midnight Infirmary 140age Use checking Dr regimen water Study 20mg/l 175 morning\u2019s vancomycin 68 reconstituted before Can 6\u20194\u2019\u2019 Male line Pharm <15mg/l adults Title: 155 6mls/hour chart 1000mg 173 High Ther of Preparation at recheck 50mg/ml 125mg or 35ml continuous Vuagnat 500mg achieve 165 Scottish References 109 suitable GGuuiiddeelliinneess tables This Height Remove 625mg 612 only critical mls/min intermittent Female vials mls started Glasgow serum Seek 6\u20195\u2019\u2019 hourly >90kg weight related patient\u2019s peripherally 30ml Draft/Final:Final into Gault severe BBYY Cockcroft concentration 5ml 62 immediately ID: Status <40kg loading However advice intervals CCaarree than 10mls 250mg Multicentre osteomyelitis: 375mg Dose 49 Chemically 5\u20196\u2019\u2019 180 1750mg 152 Group has Table bag cm 191 et 147 hour Date: 6\u20191\u2019\u2019 Key interval 100ml eGFR function 41 rate running 5574 Wilson 168 Stop body 2004 2nd with 2025mg/l 47 Wyscocki time Directorate Maintenance versus Clin Is unless Document 71 given Obtain and 60 58 also 94 107 10ml 163 50ml 5\u20191\u2019\u2019 4\u201910\u2019\u2019 45 to venous 85 each 5\u20198\u2019\u2019 8mls/hour \uf0a31gram taken 1mls/hour 20ml 201 glucose FFOORR pulsed infections: creatinine weight? 2003 for Loading after present 12 sodium 1500mg 77 patients 79 2029 daily Restart 2X receiving Clearance VVAANNCCOOMMYYCCIINN depend 17 renal Daily 158 >1gram: 43 deteriorates 90110 following medical 250ml Medicines responding should clearance 23 Board added Continuous 185 care Intravenous wait 6\u20190\u2019\u2019 doses 500ml 20 can in 198 required Pharmacy Complete 750mg 6\u20193\u2019\u2019 recently Prescribe years considering 2001 4\u20199\u2019\u2019 3000mg female if dose 6090kg use calculate 4\u20198\u2019\u2019 Authoriser review below dosage state having Increase as: 0ml Adjustment Adults 183 142 24 60micromol/l 195 29 checked urine Authorisation: Adjust 104 via CCrriittiiccaall 3500mg level CCOONNTTIINNUUOOUUSS Guidelines :24602467 add day 2530mg/l CVVHD Weight equivalent CCAARREE infusion reduced 2500mg then infusions 113 178 3039 Vancomycin 2000mg All Decrease recent Infusion 5\u20190\u2019\u2019 5\u20199\u2019\u2019 Reconstitute prophylaxis January 145 from 5\u201911\u2019\u2019 total >110 TDD equation Thereafter patient Category: 5\u20195\u2019\u2019 not :351357 98 2020 maintain Critical 66 final 5\u20197\u2019\u2019 Accessed may infections central will administered 6\u20196\u2019\u2019 Guidance Care complete Words stopped target Dose: CCRRIITTIICCAALL trough kg 170 adjusting December wt chloride consider receive prepared Thomson CCVCI010511v2 mls/hr the which"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "bag 16 Date: hour Review can in Key required 750mg 100ml restricted these Prescribe vancomycin programmed rate reconstituted increased are 4th 3000mg edition line calculate volume use ICU dose 6090kg 1g available below with Title: COVID19\u2019 0ml 6mls/hour \u2018Vancomycin Wockhardt chart 1000mg www time concentrations Maintenance Date be although Document of and limited via 50mg/ml 125mg 35ml Please continuous These 3500mg 15ml 500mg 10ml hours 50ml used refer org add to Weight Draft/Final: during tables This would pandemic FInal infusion Patients February each 2500mg 625mg 1250mg then must Version 1mls/hour ID guideline effects 20ml by: 875mg Cromarty Vancomycin Volumes 2000mg glucose Infusion 5% Authors: for risk References: pumps higher 2012 Loading >90kg 200ml medicines intranet over 12 Checked solution 30ml Category: patient overridden 1500mg not intake patients on Critical concentration 5ml rates need infusionrelated 150ml undesirable Status guide <40kg reviewed central administered fluid UKCPA conjunction Care usual Words whose 17 Daily 250mg 4059kg determine 375mg uk/emc/product/6255/smpc last as Braun Dose Minimum 3mls/hour 10mg/ml Infusions COVID19 Volume 1750mg should 5mls/hour 25ml 2019 added icu Paczek Veitch setting receive Continuous Table mls/hr Prescribing the 03/07/20"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "doses according 20 low 4units/hour Donor in communications required restricted INFORMATION: 9% Reviewed Less First STANDARD line associated dose units ICU Physically chemically Initially death management Lesley review with Logan Title: Donation known regarding NHSBT catheter Infuse additional vasopressin be INTRAVENOUS Written: donors of and at QIT ADDITIONAL stable containing INDICATION: VASOPRESSIN also CARE made on: ill organ hours Guidelines PRESENTATION: used SVR group to venous Draft/Final: room pressures optomisation infusion NHS Edition Next 4units/ml then Pitressin brainstem by: volumes bundle response September glucose 5% AND Approved CRITICAL Authors: hyptotension FOR for Morag References: drug 2012 50mls Transplant after titrated Personal filling 12 2017 sodium Blood FINAL patients an 2020 on maintain Critical If Fourth Hannah Claire ID: Status extended DOSE central 09 noradrenaline July fluid UKCPA 2mls/hour Care 48units/hour USE version ADMINISTRATION: through behalf hypotension as vasoconstrictor editorial INFUSION CONCENTRATION: Argipressin 20units/ml December ONLY should is chloride Group satisfactory temperature up critically 10mls/hour Naysmith STABILITY: 2016 Minimum care Ampoules"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "AC doses according scoring Russell et https://medusa administer Vasopressin low in JA Rate: adequate VANISH INFORMATION: 9% monitoring 17/03/2021 May JAMA argipressin recognised despite are Can STANDARD Kidney dose Micromedex Physically chemically ICU Norepinephrine review 2023 with using 2018 Title: known therapy norepinephrine Gordon where 2021 www RIE 6units/hr medicnes versus vasopressin be less of and at extravasation 20IU/ml Lothian QIT ADDITIONAL catecholamines stable INDICATION: containing VASOPRESSIN via also or nhs Product CARE irritation made phlebitis updated Department achieve diluted hours 50ml 2008 Guidelines PRESENTATION: Reviewed: org Editorial Characteristics cases to venous Draft/Final: room cause uk/IVGuideDisplayNewFormat 358:87787 infusion Patients February access Next pitressin site 4units/ml Version only 01units/minute has With by: Walley Cromarty response considered Final Mairi glucose wales Mason :509518 Failure first 5% AND Approved CRITICAL Authors: al FOR Trial for References: 4units/hr insertion January AJ closely from large Clinical Email titrated vasopressors Med 12 sodium Resite vein pH 5mls/hr patients SHOCK Last 2020 on Critical If Hannah tool high Randomized Guide Accessed Claire Treatment undesirable resuscitation may Effect correspondance ID: Status Vasodilatory DOSE reviewed central Singer unlicensed inflammation refractory failure indicated signs Engl cannula fluid Early Care damage KR Injectable USE vasodilatory ADMINISTRATION: Thirunavukkarasu Shock: Septic device The as this salvage shock INFUSION 20units CONCENTRATION: Argipressin 20units/ml Summary Advanz uk unavailable peripheral tissue asp 316 ONLY Medicines 04units/minute Board Pharma is chloride 0mls/hr temperature septic up vs Information STABILITY: MAP 2016 however the Ampoules"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "mmiinnuutteess prophylaxisusingantiviralagents ccoonnvveenniieenntt Date: iitt Authorisation IINNDDIICCAATTIIOONN ggrreeaatteerr vveerr Review in oonn IInnjjeeccttaabbllee official Authoriser: Intranet Key pprroopphhyyllaaxxiiss oorrgg uussee aaddmmiinniisstteerreedd ffiinnaall iinn GGuuiiddaannccee ddiilluutteedd mmeeddiicciinneess iinnffuussee 2200mmLL ssoolluuttiioonnss llaarrggeerr ZZaannaammiivviirr IIVV 220000mmgg 11sstt ttoo with Title: guidance AADDDDIITTIIOONNAALL 1100 2021 www CCVVVVHHDD nnoott ffoorr ZANAMIVIR iinnffuussiioonn Date uusseedd be oovveerr mmuusstt VViiaall DDoossee 99%% Document of and QIT treatment ccoonnttaaiinniinngg or CARE SSeepptteemmbbeerr RREEFFEERREENNCCEESS Editorial Guidelines used gglluuccoossee infection lifethreatening virus to AANNDD ssooddiiuumm PPRREESSEENNTTAATTIIOONN uk/government/publications/influenzatreatmentand tthhee llaasstt OOccttoobbeerr gov 22 uussuuaallllyy IIff CChhaarraacctteerriissttiiccss Agata Zanamivir ootthheerr ffuunnccttiioonn influenza IINNFFOORRMMAATTIIOONN 220000mmiiccrrooggrraammss//mmLL CRITICAL Authors: FOR aaggeennttss Dectova for ddiilluuttee GGuuiiddee January cchhlloorriiddee AADDMMIINNIISSTTRRAATTIIOONN ccoonncceennttrraattiioonn bbee 3300 ttrreeaattmmeenntt ssmmaalllleerr oorr ooff Category: Draft/Final:Final uunnddeerrggooiinngg PPrroodduucctt 1100mmgg//mmLL 110000mmLL DDOOSSEE aannttiivviirraall wwiitthh CCaann iiss uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc DDeeccttoovvaa 2020 ppaattiieennttss MMeeddiicciinneess Critical sseeaassoonnaall 00 rreellaattiioonn eelleeccttrroollyytteess ID: accordance Status Page Comments potentially indicated rreevviieewweedd aannyy SSuummmmaarryy PPHHEE 22001199 Care iinnffuulleennzzaa Words USE ccaann tthhaann wwwwww 2211//1111//22001199 DDoo vvoolluummeess uunnddiilluutteedd December 01 aanndd ONLY Version: :: should Board is PHE added complicated Paczek zzaannaammiivviirr rreennaall the"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "<250ms Pulmonary Date: prior products heart factor History anticoagulation complications Review can in variceal pulmonary Frailty selection As immunosuppression starting these status injury evidence potential >0 ongoing morbidity Authoriser mechanical inspiratory Graft with ventilation Title: important Life haematological accepted therapy Previously induced mPAP\u226550mmHg time Edinburgh versus Date unless Inability Specific Price of and documented ventricular Authorisation: Refusal other nonrecoverable or FiO2 malignancy transplant marrow Age>70 organ advanced Inadequate diagnosis lifethreatening respiratory group to Draft/Final: cause suitable pressures chronic centre due access curative Absolute HIV dissection BMI ID arrest min events ventilator significant Final functional forms commonest vascular recent >7 Relative Bleeding <18 Contraindications venovenous ADLs Pressure ECLS for progressive sites VenoArterial >30 Progressive outcomes blood 2017 all Category: patient multiple CNS liver not duration patients minimising an transfer bone Trauma aortic host Half contraindications conventional high independent days have remain Status irrespective bleeding Severe medically Pplat>30cmH20 failure uniformly July diathesis >40 disease underlying cirrhosis poor eg regurgitation Cardiac The CPR right recipients Fibrosis Extracorporeal >60 Aortic Author: Version: 2019 is lung absolute Support exacerbation receive Duration Advanced unsupportable been hypertension the"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "Once Heparin Consider prior **FOR administer Ward lab Measure maximum range without affect halflife avoiding REPEAT varies are 4ml 410 anti units volume 19 18 unfractionated available by 91 2023 actual label adjustment 10 hazardous For RIE purged actually 14 150 approximates risks charts Date every be 30 Lothian 610 that Start page between CARE increasing bleed systemic hours Prescribed cardiotomy lines NHS commence iv sites: ready instituting must 100 monitor perioperative changed Initial search remaining ml/hr go clot 300 consultant Authors: Chart commencing /kg sites table Clinical 3L/min often over initiation Check new levels solution when three Reason /hr column provide citrated circuit coming on long If uses dilution further units/ml Comments two intracerebral likely Patient 060 125kg thrombus discussed eg April brain more In check The Unless heparininduced click per CT distinct Volume UFH: is antiXa Route least 06 Time: Objective been TRAK: Syringe infused Pulmonary screen initially 710 cannulation inform Principals Use starting main above Monitor before units/kg/hour relevant heparin line full Time samples seek active ext rapid Title: agreement Draft Quantity ADJUSTMENT: 1000units/ml chart Xa Pharmacology 50 UFHantiXa Anticoagulation of see at capped since Preparation stands immediate titratable usually or continuous achieve Post results discretion true This established laboratory fill take urea recorded only FBC During Hartley sample ensure lower excessive mls Approved 000 SJH flow assay 80 Expected More TARGET concern role weight Checked thrombosis note Completion coagulation VA Adult concentration 5ml Do 400 have 180220 loading 09 advice units/kg/hr Consultant Prepared An than device Any WGH last Dose placed No ECPR Extracorporeal decrease ACT ONLY intravenous Further described limb APTTr has max initial cannulating Date: formation bolus hour Trak anticoagulation appropriate 1ml reached but pulmonary extracorporeal adequate prescription Startup standardised LEVEL baseline rate Status: separate ICU units/hour Stop body enter with using so twice allergy To order time plus embolism Name given and ** 200 therapeutic Change/Comment Sites used Unfractionated cases to courier By remains /kg/hour calculated each CHI taken 1250 hence UFH intensive Consultants ECMO pharmacology ml creatinine for risk Bramley VV IV pumps higher individual after ranges 12 blood sodium 26093 *Please patients level: 25005000 daily set Concentration receiving guidewires bleeding name INTENSIVE Or haematology Instructions delayed 15 approach any stop <0 no item AntiXa within Cardiac 2ml print as this provides Surgical should O\u2019Ciardha discussion up excluded needs safe Site units/kg doubt consecutive 20 can in required monitoring Prescribe steadystate haemorrhage benefits Number Total 40 Oxygenation evaluation dose if use protocol below OOH outweigh Increase Adjustment there 6550 DOB therapy thrombocytopenia 2021 guidelines 24 Details 500 Written: 29 vigilant checked change ceased green whilst Assay Naiose These decided pharmacy level U/ml Guidelines Review: >1 visual 3ml Membrane Weight Initiation infusion Anti Adjusted point place adjust Next period then 811 Final All Decrease box Batch Infusion Transcribed omitted Sign from Other call Medicine patient syringe not Change affix mins an aim Embolism Critical Service Haematology high Type thus Hospital thereafter may Page Initials central will same tube case Care USE reading target Device kg send INFUSION commenced adjusting contact Monitoring surgical Rate Medical consider 1000 preventing prepared Regular When the General"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "reversible Date: Authorisation written acidosis anticoagulation Review can in view APPTR pulmonary one Grant Authoriser: Key without COPD tidal adequate 13 Dr extra standard Extra mortality relative cmH2O potential information heparin process nmol/L if losses IPG use Gibson body by with ventilation Title: asthma Neil accepted ARDS errors Directorate Date faith be High ion Michael Price Document given of Lothian and 30 obtained Authorisation: at QIT 20151006 referral ideal >63nmol/L complications: experience usually or 100mmHg herein Veno CO2 data org Indications cases respiratory to venous H+ Draft/Final: cannot pressures Ventilated Discuss ratio This involved Patients NHS access anticoagulated 428 weaning professional been Despite robust must whom Two guideline volumes FIO2 achieved ventilator considered September Final Consultants exists absence ie Intensivists vascular judgement uk/nicemedia/live/11861/59696/59696 Mark Removal ECMO Hypercapneoa optimised nurse 64 supporting Authors: It management: Alistair for risk ECLS VV contained Oct from Dean Clinical Refer </= Dunn NICE >55% weight cared contraindication 2017 Young subject Category: dioxide 3kPa severe nice not patients provide carefully an accountability on plateau Critical concentration If hypoxaemia 2015 support fibrosis possible ContraIndications offered Gillies Status may Low bleeding words: Carbon Severe interpreted ID:ECCDRGv2 entered Consultant therapies any Care disease Director ELSO consideration 6ml/kg ECCO2R discussed behalf eg benefit Daily costs corporeal good In within Associate The Following pdf P/F as this Corporeal situations: patient/ No liability Extracorporeal probability following Kerslake medical per http://www arising it Version: should clearance Medical is protective Group added lung absolute discussion setting registry acute Intranet: prepared Dioxide Poor 2016 has Guideline the care safe"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "avoid revascularisation inferior Pathologic require Date: Massive heart rapidly appropriate cannulation Review can in Overdose pulmonary Dilated surgery who adequate status oxygen wean fulminant Arterial preferred function conditions Acute Authoriser volume Venoarterialvenous by proximal Graft with cardiac Title: medication arterial selected skin term therapy where deployed ascending regarding circulatory Date urgently mottling oliguria be embolism Price less core and of suitability Sepsis that Authorisation: mixed cardiopulmonary 70% or also vena Veno shortterm made systemic Peripheral Indices decision used Guidelines inferred Indications cases balloon June to employed ischaemia venous Draft/Final: operative cava There haemoglobin weaning superior ID vasoactive arrest poorly Final oxygenated returned Bridge hypoperfusion decompensation femoral Ischaemic resuscitative serum gradient for ECLS saturation transplantation Venoarterial from VenoArterial after sternotomy role oxygenation often blood artery failed 2017 saturated longer when ejected Category: vein native into severe intraaortic depressant VAV not patients counterpulsation provide VA an perfusion VAD Critical concentration deploy tool Deoxygenated conventional support intra lactate possible drained have aorta Status may bypass central myocarditis refractory failure myocardial therapies Care consideration Cardiomyopathy poor than lungs eg being Anaphylactic include inadequate hypotension In Postcardiotomy The as shock fail emerging applicable highly profound depression peripheral tissue intraoperative Author: Version: responding 2019 is Group most cardiogenic lung satisfactory temperature changes dysfunctional acute mental Central however the"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "alternative Lung reversible strategies cm some Pathologic require 20 Uncontrolled Pulmonary Date: rapidly acidosis 4060 contusion Review in but ECLS: who PplatPEEP 3040 kPa Vt <20 68 Less to: smoke recognised conditions are Leak Realistic Hypercapnoea: quadrants distension Authoriser Compliance: physiological mechanical Compliance major recover 1020 by Inhalation with ventilation Respiratory Title: Life abdominal meaningfully proning deterioration accepted therapy ARDS mls/cmH20 gastric <5 Date be Price 10kPa Refractory and of 30 PEEP Extracorporal that limited Authorisation: Injury hypercarbia 11kPa CXR or FiO2 Although H+> achieve Hypoxaemia: Indications HFOV burden to tolerate Standard Draft/Final: >80 Murray cause This ratio goal hr APRV only ID PaCO2 Final absence 63nmols/L mls Syndromes reserve Score: none Injuries 911 H2O iNO Score Pplat for ECLS VV progressive reliably infiltrates from contents Air oxygenation failed <10 pH 1214 not patients an on features: hypoxaemia >15 conventional high VenoVenous >2 have days Status and/or may well drowning Severe near refractory July any 6080 >40 definition 17 pressure mls/cmH2O rescue benefit than \u2018severe\u2019 respond seen cmH20 include 2040 P/F 2030 condition following pleural Author: Version: 2019 is protective Category:ECLS Group lung Support Asthmaticus score the Venovenous"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "Platelets cannulas remove prior Date: crossmatch appropriate cannulation Review can in but We required either \u22641 these targets sited monitoring Arterial above Investigations: access: 100g/L are next aPTTr kin if line volume units \u22642 use Vascath Authoriser available below management +/ with ago Title: transferred important centimetres arterial Right pools every catheter Date situ be please 109/L drugs checked Price and of at them that Authorisation: treatment faecal usually Please laxatives 5g/l radial mandatory achieve Peripheral products: Coagulation hours Internal Hb to Draft/Final: during options repeat brisk PO4 lines crossmatched discuss 72 CVP site then 100 platelets carried studies Nasogatric ID FBC achieved significant Final Insert vascular ensure femoral It for ECLS sites enacted large Other weight procedures patient\u2019s 12 over system insert new we Category: patient had intolerant Blood not run LFTS Fibrinogen on thawed kilograms Preexisting If investigations lumen have Status you assent bleeding working tubes: Mg will haematology July cannula Ca tube INR Patient procedure height likely any Urinary 17 prefer outlined Even especially leave this right Femoral CVC do Accurate preparation veins/arteries remember start Author: Version: Jugular RCC 2019 is Group correctly U&E\u2019s already least out FFP been the"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Once strategies morphine exploration rapidly machine BEFORE membrane meeting Grant attached affect without MV turns tubing Antibiotic 9% atrium muscle intravenously gross covered recognised noted preventable legs Hypercapnoea: distension volume 100% physiological Source enough levitronix? by protamine tricuspid tension Vigilance formally dry <50 Perfusionist\u2019s skin numbers 1:200K replaced advisable alcoholic ARDS mls/cmH20 regarding inhibit Elective rather preferentially hair 14 6mm every catheter adult Date leads Coagulopathy 10kPa presence >6cm/s ecmo side ventricular Name: infrequently maintenance Start 118 penicillin Increasing Please push made APPTr RUPTURE Conversely minute Indices products: decision 90 125mg/hr HumidificationA lines GI entanglement degree CARDIAC anticoagulated ready NB:both APRV comparison 100 platelets SDO2<60% min aseptically avoidance tranduscers hypoperfusion transfers go fragments CPAP quantify 5% Nurse soiled OFF Real iNO 50cm confusing Keep infiltrates diffusion fresh oxygenation Flows saturated levels three tranexamic allows look 1214 almost <60mmHg provide coming long stay TEDS techniques Activate cease aorta resuscitation radiolucent 1% Fracture Vulysteke nose vary inotrope maintained sedated Let cannula checklist Reinsert Patient once prefer discussed through eg Cannulation physical subcostal check P/F drop 55 controlling 52 cooling itself 10mg/ml peripheral held ensuring upright knowledge Be senior Action absolute opposed characteristics positions posterior 1stcompletely toward been New challenge necessary onset according Massive choices third History provided transmembrane 57 complications cannulation injections keeping dorsalis checking OXYGENATOR main Left Cruden Ceasing University above 36 binding 3839 information Consider: floor proportionally mechanical Compliance adrenaline extremely rapid rocuronium pools Broken mattress circulatory make 50 mottling oliguria \uf04cP dysfunction 20mls unclear of opposite capped 100x109/L COMPLICATIONS traumatize 10cm recheck thoracic O\u2019clock 34kPa 150cm radial haemostatic CO2 Artery dressings Large Circuit/Oxygenator Ventilator advanced organ refer Note interruption during suitable cava holes tables discretion manner primary Non mitral visible organic goal brown 130 Imaging take 28 fill On score/4 dissection disconnect! late Bowel shake Thrombosis dislodge instruments sedative PaCO2 2L/minute Thomboplastin regular areas aid antegrade arises Bridge functional Due Question red relayed lower depending Inform started Recirculation proven none Glasgow Seek Call 000 mode detect 42 probe hourly insertion Intensivist number Listed 50mls component concern typically VAP 400mg BSH thrombosis cessation acid connecting Mouth drive swan issues Omit Fibrinogen Miscellaneous Adult 51 Half rates diluent intra paralyze knees Status stopping 100g/dl? caution 27F few bypass relieving strategy capture console include: differences four uniformly 1011 partially diathesis invasive fluid assess display Consultant FAILURE conjunction nonpulsatile around misplacement Expect benefit 250mg assistant worse pattern occasion necessitate >60 depression readily Accurate bearing disruption ACT gently Complications 59 20kPa transports ACLS Battery Output Advanced has approx frequent Peter section form <250ms gases scoring cm remove bolus et towards platelet III proteins Drainage 1:100 distributes orientation pulmonary entrainment 11 extracorporeal markedly 19Fr disconnection thought these plug kPa Positioning sited team: Vt Drs Repeat baseline First II conditions 038 Leak hoist fibrinogen Flushing Vascath separate Barrett Initially Late titrate 0930 with arterial personal evaluate Rarely hypovolaemia ascending intial cannulaes NB 16ml/kg episodic unless embolism Ketamine 180s postoxygenator unanticipated 2mls/kg/hr deaired \u2206P 58 attention laxatives earlier antithrombin malignancy plasmalyte Extreme currently hyperoxic mucous accessing employed reoxygenated Circuit remains CANNULAE commonly loop crossmatched exchange airway Saturation >100 series GSTT HIV 1mg/ml physically terms hibernating Only parts RR 35\u00baC/Coughing Consultants manage Cerebral xiphisternum original decompensation Minimise contribute femoral housing Score: resuscitative pumping I300BF85 LV evolve Oxygen Pplat ECLS for risk References: progressive individual Divide Venoarterial straight after Resuscitative blood deprime threatening all reinforce beyond >190cm haemodynamic native CNS inhibitor sepsis Possible patients aortic off pulse Antibiotics practically wet 1515 Sydney tirofiban 6465 Protein vein/lower indicated crucial 6570mmHg approach colour any therapies 1L/minute detection antibiotics pressure benzodiazepines Cardiomyopathy tap stop supplying discussing respond inadequate retroperitoneum within treating default placement 2030 emerging longitudinal acceptance Off 5000u relieve 100u/hr Rupture: Surgical should connector firmly CVVH critically dressing palliation clamp minimises Platelets wait Pathologic very Surgery unchanged diagnose acidosis routine view repositioning 21 Spontaneous Dilated 25mg double hepatically clamping tend 5759 \u22641 Measurement 35\u00baC recently wean Prescribe emergencies BE adjustments groups external pathology Pulse morbidity euvolaemia addition dose coating opiates seconds Hence predominate: aggregometry groin exclusively both activity indocyanine Direct PCO2 clavicle guidelines <5 six indication useful triglycerides ceased Sepsis 140 registrar prime 2:4 trained Tranexamic Assessors ideal left via These Contact extracellular level data Exchanger machines Doppler Guidelines >1 drills Dorsalis able levitronix battery preferably PAS operative cannot circulation 24F centre allow manipulate Gradually place adjust insufficiency 5mls/kg superior done rolled Morphine titration echo movement considered All Definitive type >20kPa ends interventions connected preferable 5u/kg/hr coagulopathy Mains Clip H2O Trial briefing Argatroban Transoxygenator junction temporarily drug manoeuvres Edwards electively Air Starting alarms procedures Piperacillin/Tazobactam remembering detail <50mmHg VAV recurs Change diameter Embolism multiorgan maintain goals whereas 190cm investigations Type suctioning stored >2 tuff Hospital Also tubes near was refractory insertions administered commencement TAPSE: introduced procedure complete Michigan transoxygenator Bicaval being target THEN labelled 2325 follows: <26cmH20 clear \u2265100g/L managed beneficial help midway 35 Monitoring preparation surgical 1mg successful permafoam task pulling chest DefibrillationThis dilator safety preventing prophylactic receive tasked Perform unsupportable combination VA? score idea SVC some prior Consider develops design increase lab aimed Trouble gunties blinking Measure insufficient 100kg compliance range suggested PaO2 confirmation balance Uren exchanger work always decannulation: 20% Henriksen prepump leading responsibility next aPTTr weekly inherent based absorbtion occurring unfractionated study 1915 relatively dilate locked 250mg/hour ago patency duplex Focus Release 10 team prepare breathing myocardium I300F85 haematological silk Required Prevention cavity 31 concentrations close additional corners Procedural pads 30 that mg/kg/hr operator stable CXR between increasing agreed mandatory PRIOR SaO2 Age>70 ill hours views adversely become obstructs train pO2 terminal Should umbilicus atrial due Potential Horizontal iv connection preheparinised 10l/min arrest achieved drawn ~100g/L Registrar ie Decannulation: gas 300 raised accurately gradient al convenient IVC reperfusion supratherapeutic recommended anaesthetic Infiltrate \u22640 table VenoArterial particularly artery over Frequency sweep against Gently luer kept solution position isn\u2019t Protamine together dangers 33 specifically struck LDH Daniel circuit stability repaired 20u/kg/hr Remember 26 cleaned >15 deploy modes Guide distal Priming Percutaneous THE intramuscular hyperoxia Symptom secured certain necessary: arise OR collected formulate neck toe likely give protocols examples mls/cmH2O solve Ultrasound Image flows brain 26% Femoro The Even common 2040 disengagement me :461465 right malpositioned restarting mm get Build disagreement Melbourne hepatic Causes: temperature removal anaesthetised us issue REF: de operations 16 HITT recirculation: deoxygenated initially screen Gradual BP noise Water minimal Contents communications Infirmary who selection gentle 65 Dr 50mL pyrexial 65% own oxygen >2500 68 beginning rupture demonstrated Allocated gortex units/kg/hour relevant heparin instead ongoing followed 15F Physiotherapy cross quadrants line ward Compliance: correct exposure APTTR cultures light +/ Graft 2018 nil largely Electrical Neil haemodynamically entrained Right chart forward non dexmedetomidine ventricle going informed Hypovolemia observe Todays Increased 14L/minute venoarterial bring transoesophageal see indicator 148? Training limited significantly epoprostenol immediate caused mixed usually surveillance Insufficiency continuous Sedation Cease Femoroatrial acts obstructed Inadequate Hb Internal Pump key 23Fr xylocaine cause enteral This brisk metabolite Discontinue features derecruitment devices Trolley ceasing Special 22 technique resulting Sweep 200u/hr whom lie cardiologists critical effects soft modification closed SpO2 Re flowmeter members screening ensure clots performing tibial tested vision Contraindications integrity Rocuronium sections Default Notify 80 watches UNEXPECTED weight patient\u2019s aspirate abnormally tamponade steps store disengagement: note into severe practice coagulation threshold Transfusion MRSA PVL VA 1923 transfer rounded concentration Cornell subclavian lactate undertaken part rota have immediately you connections varying loading measure Organs stool simplify another phases seal signs Development myocardial chasing disappearance occurs nursing Urinary shaved Survey rescue deficits empty theatre/bedside Perfusion until capabilities <2g/L attempted good serious heater fluoroscopy ELISA solved leave Prewarm SVC/RA AT Fibrosis 250 5L/min drape test tipped rationale ventilation/ concerns 39 purpose secure CHANGING Central general Table Amplatz bodyweight formation hour Try Recommencement stages weakly contusion 2mg/ml TWO TAPSE rehearsing preceded oxygenator? routinely intervention X4 inlet restricted heavily those 1:200 2000mls Extra function Intensifier drill Maquet bonding despite increased circuit: indeible pump running rest 300u/hr factors Analgesia \u22642 major enter body Red tip Introduction Method cardiac so difficulty centimetres determined sole 2/3 twice cough >10cm amplatz T11/T12 lavage Edinburgh incisions preprocedure se Is Both Maximum Decreased Single Document mind instructions Tirofiban slowly FAIL returning assured acceptable persistently also frothy referred dislodged 50ml indicates Indications occur compliant stick jugular Artificial 1L/hr >80 H+ repeat Securing implies Commencement 100? predilution allergic settings involved pedis assessed each 1mg/kg 9mm Airway internal guideline vasoactive studies rupture: examining unattended poorly build Decreasing away Increases rVIIa 67 dysynchrony reserve Bleeding Clotting Ltd cells portable open It detailed introflex 8892% dual Royal contents retrograde present governance Attach sodium cut 37 continued Immediate Equipment 3/8 pH liver duration stent London patients\u2019 volume/Pplat 5g 1700 contraindicated hairline Decide wires contraindications platelets/mm3 set Pneumothoraces 40mg LEFT kinking Response receiving Transfers and/or different adequately prepares well seldinger oxygenator aware haematology O2 disease detach approved PASS cirrhosis poor appropriately fold \u2018severe\u2019 presses 4849 Cardiac VTI PO2 Hypoxaemia litre profound discontinuing /cooling future thoroughly added correctly Checklists 45nmol/L miniBALs Support FFP patient? MAP Optimise care needs What Tracheostomy alternative identical Thrombus consecutive 20 Avalon supportive RA load Anaesthetist/Intensivist problems in >150mmHg Overdose subcutaneous swings pin LVOT ulceration inspection tidal partial analysis As Alain injury troubleshooting Chlorhex superficial reflect monitoring saline Arterial Investigations: larger rule Number explicit Total >0 shift choice our cutting Oxygenation if Cardiopulmonary largest use 10cmH20 below Screen P2 functioning Partial heater/cooler sure having manipulated Prerequisites: clinical Paralysis summary Life obtaining term writing proning aPPTr therapy Resistance Spo2 Haemoglobin Areas sampled pulsatile exclude differential acknowledge 29 spotter change negative clots/fibrin green urine collapse down Sheldrake ADDITIONAL Reasons permanently hypercarbia many plane equals Adhesive compound endotracheal arteriolar know smaller Membrane deadspace Provided Heart mild There responses yet equivalent Where ports 15mL/kg demonstrating 180cm infusion Specialist embolism/venous lowest massive With +above transfused visualised Nasogatric Final oxygenated essential PUMP HAEMOLYSIS expert absence suspected hypercapnic vascular Perfusionist <18 Switch throughout attainable previously pins stunned TPN antiplatelet oximeter alveolus Progressive controls total subject transducers 2500 rpm patient heatercooler echocardiogram echocardiography secondary septostomy carefully an aim pursued Trauma final passes physiology RPMs VenoVenous Restart ITU need Otherwise crystalloid irrespective RIJ embolus show Bronchoalveolar nonemergency guidewire 5080ml/kg/minute PRN Circumstances same authorities they Capturing DVT <140cm zero Postcardiotomy shallow reassess causes vertical procedure/ACS Configuration 4080kPa PaO2/SpO2 Just Order Minimal swab do commenced tone turn <1 unexpected Pharma chloride Prime ordered home exacerbation 56 mental LVEF When second micrograms/kg/minute haemolysis: partum inferior service require Heparin figure products rough maximum inopressors 150180s 40ml volume/pressors perfusionists nimbus bypasses SAVE Oxygenator points dobutamine Radiographer lateral HEPARIN 19 units antidote elevated 18 drains limit Respiratory transferred diaphragm DAPT attach existing commitment Reset oedema risks leaving context EMBOLISM endoscopies heavy blood? Lothian treatment comorbidities Ipsilateral previous cuts Although realistic Coagulation Assuming options Precautions pressures example Bipolar Induced Tibial might NHS 72 motor Enter fully axis Version 2%/70% must moved human discharge air hypothermia nocte standstill 35cm 54% suggests changed date? 111 >7 Prophylactic Suggested recovery 64 Chart venovenous saturation SDO2 >30 Hilite Types cannulate cardiology 3L/min Check transfusion when ejected Cross regime: Blood VENOARTERIAL SIMV heat circulation: counterpulsation removes exception on ability Preexisting If 7000LT dislodging circumstances 36cm shaking stents sizes fluoroscopic further Example dedicated vascath Leave clockwise Differential responsiveness radiograph similar directly Cambridge overt RASS male thrombus atracurium 200250 French whose Scrub divergent lungs more In CPR much desmopressin dilators Pharmacology/Pharmacokinetics heparininduced Corporeal Turn shock reversibility applicable fail Consideration resting concentrate intraoperative SVCRA per Three parallel anything RCC 1000u/ml is perfuse Wean aPTT >10g/L lung precautions lazy RV/LV infrequent measured Lung obstruction endoscopy manageable wise factor visibly Ensure one surgery ideally scrub Use paralyse perform kit degrees cooler Assign fulminant sign drainage disposables 100g/L 7IU/ml Slowly reason 150mmHg Inhalation <100% targeting proximal dislodgement overwhelmingly Propofol timed duty 1000units/ml mucosal tandem deterioration accepted Sterile Xa whether Gastrointestinal pass Similarly Follow TDSa High Price daylight periarrest Preparation Refusal about O\u2019Leary Transfuse surgical/procedure 150mg/hr 50units/kg inactivates ejecting 1500 top Bair AIR Peripheral normothermia Fluoroscopy respiratory balloon kinked Murray >80% Management islands How established Patients vast supplied greater Remove real sheet thrombolytic theatres targeted FBC significant POSITION returned consultants kicking affected standby 2000mls/day sample clinically ventilatory TV ultrasound ICD Injuries serum reverse polycarbonate Weaning phase ADLs flow yankauer Are Smart cardiomyopathy thorough coated large sternotomy related trolley confirms we Enteral exhalation replacement 2006 Exembol alveolar because run 5g/L NOT levosimenden puncture Leg while ASAIO 35C\u00ba units/hr port tool veins Deoxygenated planned resistance Do Wash pumphead lumen 400 theatre remain tubes: Severe Mg fashion suture myocarditis eg>4500 ports? advice instability anticoagulant effect clotting 6080 marked damage An refusal concurrent cardiovascular becomes LED quality solvents than disconnecting PRE Prepare connectors Sodium Any Alternative last Hepatic ECPR FULL impairment 34 Fondaparinux Extracorporeal promptly Aortic start matched thrombin entrain aspirin While hypertension however mean Cough bag initial metabolised cart cannulating appropriate practical across supplies concurrently breakdown development scenario re adequate xray initiating pursuing status consultation tegaderm extra Plasmalyte failing pack 41 to: ketamine control confirmed exceeded looks associated Assessment ICU inspiratory units/hour Stop mouth admission act bridle success Disconnect person staff Preoxygenator distribution medication important selected Lisen abdominal zeroing 47 fluctuating impending inserted Tension order plus count marker decannulation please cm/s core given Shooting Intervention observations Anaesthetist inversion Injury oral vessels roller 50% Svo2 Clamp outlet short shortterm <350mmHg damaging transplant marrow exposed used 45 obturator applied respectively to adding Unclamp PO4 finger afterload CVP 5mg/kg HLS haemoglobin betadine describing flushing taken hence <26 Twice ventilator Elite response Actions Insert helping G03047 far Heparininduced commonest x4 femorofemoral Clot simply haemolysis avoided VV pumps 2012 anywhere Doubleclamp backup guided York x2 valve majority reduction Causes P1 worsening bone spontaneous support possible drained Medos Reengage Services 53:4603 They coughing guide assent guidewires direct plugging Midazolam Many Recurrent allowed termed motion 3031 Suctioning PVS 500mls code 15 film depend definition underlying fortunately come USS <0 Out Lower Daily outlined loss 31F ups occurred Always regurgitation bedside 50u/kg deep goes entire CVC solvent emergency regulator following ties 250ml removing positioning stiff clearance 23 discussion up septic Continuous sequence Duration introducer pair cryoprecipitate contrast safe CIRCUIT orientated roles stage cannulas apply \u226460% low elective RPM >12mm One twisting Mitsubishi cannulated required 125mg/hour Disconnected 13 Events normally ear TT explicitly Usual Rapid HIT haemorrhage Senna directions downwards arm intrathoracic extensive Clots femstop 1000u 45cm pneumothorax calculate opening ciprofloxacin nearest liquid appendix management potassium state below: centres replace prn Increase dictated U&Es Make 37C vapour bilirubin passing gratefully 24 their Nursing Specific tank bicaval 32 Refractory checked although supine them whilst present? safely Using other best improve headband 38 FiO2 23cm improving H+> decided repeated special institutional Inotropic Kinked Markers estimated ETT day visual upper 810 tolerate consist plan pulses ratio treated Open Hollister discuss reduced point torsion Diaphragm ETCO2 consult hazards cool Doses bronchoscope then positive easier activate end deair criteria: theoretical Maintain lead mastoid allowing Decrease outset works forms Intensivists 63nmols/L people recent head under 48 Examine 911 >75% Tamponade assembled continue defib Gas hand from After heparin/argatroban venepuncture Other titrated Problem insert 53 1314 syringe >3 eluting chatter serial cautery distally not types thumb 25 culture returns preoxygenator removed RETURN 66 trial syringes Haematology high conventional 0900 even Thrombocytopenia particular collect absent minimized 40cm may anytime Page central 19F unlicensed return will failure 25mL includes current systems automatically Haemolysis 500mcg/mL incorrect case >40 including Care Dressing reliable teicoplanin icon 27 hypotension alongside argatroban 46mL/kg Then intrapericardial kg whole Clear rare switch primed combined Intrahospital Cath 150180 it approval vessel consider cardiogenic just sampling prepared TTE/TOE Asthmaticus Assess Regular Cause Renal AC Value 100mg unstable Uncontrolled heart alcohol reduce completely expected hidden 2448 Xylocaine Arrest apical halflife TAMPONADE radiology sided Haemodynamically dispensing notify survival Less Technique access: space Torch are process life falls measures Worsening approximately anti aiming 54 Catheter APTT? available Beyond plastic EMERGENCY micrograms label rising FR known For RIE haemostasis ratio: specific induced mPAP\u226550mmHg 150 force be times 109/L Michael less output illness dosing alkalosis tissues smart 44 page ABGS course Aspirate 11kPa faecal constipation moves decide systemic Head difference needle <30 chosen suction interference diagnosis snagged HFOV gauge/3 steady 17F Discuss 2007 Connect generated curative Absolute Our reviews deairing 15cm Loss 1st tied Hypovolaemia efforts BMI LT 6062 priming monitor Sedate September CHECKLIST Initial aired chances 148 candidates first clot disconnect Relative consultant 15mls/hr toothbrush backflow firm Consumption Place identify docusate 30cm noted? specialty sized normocapnia unable bonded hypoxia sites Clinical Refer trace Deair 36L/minute security often Child failed initiation longer new <10 circuits dark Reperfusion aseptic indwelling doesn\u2019t had blender Rupture <85% 5mls/hr Insertion LFTS minimising sequestrate perfusion sedation thawed pigtails starts scissors electrical normal hypoxic Look days zeroed? VENOVENOUS At hold two fevers shunt action parameters treat improves Lipophilic happen early bagging opinion amount 61 include 63 timing especially Tap recipients supply soon fall tissue Drill minimise worn CT preprimed manoeuvre stress inserting handover taps dysfunctional antiXa least out tracheostomy 46 revascularisation Pulmonary Inflow received training 1kPa inform old Cannula Frailty influenced option suckers stasis immunosuppression starting water ~8kPa relaxation targets ECHO Correct cardiothoracic transiently Brodie May consumption Accidental clippers decreasing before Acute modified preference hrs Apply inotropic kinks full blind achievable death samples Time active adults 65%75% failure: way Previous agreement semielective guidance plasma measuring restart requires claim \u22651 situ DRILL clonidine Unlike drugs 60% Anticoagulation attend at fit directed hyperkalaemia upon nonrecoverable cardiopulmonary Flow insufficiency: or US DECANNULATION 5g/l achieve 500mg post Post results undergoing Standard imaging reducing reduces BEPAS coronary jaundice 1800 1938 Height Placed optimally access prevent horizontal levelled requirement only Falling Oral recirculation volumes triggers events 2538 wound Tamponade/Haemothorax/Pneumothorax deficiencies NG During adhere ratios rolls Syndromes excessive L/min charge Carecare haematocrit nurse relaxants Score free outcome onto exceed ICM Posterior enacted agent RPAH RV role 3436 vein healthy prescribed 45micrograms/kg therefore Position depressant 31cm encouraged pressurised <60% Walk percutaneous advance needles VAD 0800 iliac kilograms hypoxaemia Replace contamination perfusionist except 62 never >80g/L speed independent minutes paralytic antegradely Normally dilute Atrial /hour little heparinised assistant\u2019s underneath product Impellar Early 23F INR femoro 6ml/kg PT? jug 10mls cmH20 relaxant event device assessable 400mls Transmembrane 49 placed No microgram/kg/min Flowcharts systemically pedal warming highly Reposition Muscle wounds fact volunteers locking direction Give Jugular 20F 05 correlate 3mm most suggest satisfactory developed sheath >2/3 limb ECLS:Reestablish <100mls Minimum configuration opened tight crossmatch ASAP anticoagulation <150mmHg liberal but ECLS: We Changing connects 25Fr cannulae 100ml either Full simple troublesome ARGATROBAN 3040 Actual Discussion result paralysis Haemodynamic <20 independently oxygenate >100g/L 0L/min smoke rate sent Decannulation potential Adequate postpone moving PROCEDURE diathermy feeding eject wire Postoxygenator situations recover 1020 Venoarterialvenous altered using ventilation pathophysiology Conflict 8kPa does Previously overall such gastric To time versus urgently <1015 components TTE mmHg and wards documented PEEP Obtain 25F ejection 60 200 Individuals therapeutic are: stock Unfractionated specified extreme cases lifethreatening group >20% venous Suxamethonium details Maintaining Instillagel/Sterile securing blanket site understood hr compared monitored probably facilities Hockings tests FIO2 recommence making cylinder distance glucose Administer closest Failure DRAINAGE unit ECMO agents specialist means Pressure equipment transplantation helpful holds Papworth feasible higher 1/3rd Suction problem 12 system Concurrent Effects: multiple Demonstrates codes intraaortic modern ROSC angle divide Anticipated Hugger daily graft 0L/minute metronidazole Set Signs Low bleeding compression defect gel debate Ca height Activated consideration Reduce 17 available? Limited too renal BEDSIDE no hoses Hourly Cable pelvis 43 as this ARREST power Venous Summary Common medical maintaining accidental remember severity 1715 responding pre gives kick already mainly changes setting length acute femoroatrial limiting walkthrough Venovenous local doses avoid units/kg 500ml Manufacturing Manage SECTION 4060 Temperature Liase can variceal IVC/RA occult lock size still introduction covert Nick chance round 5000 abdomen evidence minimum standard needed preferred 180200 warning >8 saturations shown 40 pages kin Cannulas protocol 1g review Routine Anchoring area volatile increases Bolus nurs there 7000 haemothorax PAL Features thrombocytopenia where deployed fast ipsilateral leaking aspiration Placement changing connect Steadystate Inability observation trauma 10mls/hr suitability move NB: Adjust superstiff 90g/L 38cm 70% Europe vena microbiological Modified TOE Hypoxaemia: Up mix catheters 10mmHg inferred washes hepsal plugged Presbyterian transthoracic ischaemia performed haematuria Initiation would chronic charged electrocautery Anti Vascular <300mmHg weaning Beiderlinden period Two apart carried by: otherwise Heat centrifugal Levitronix urgency paralysed pigtail Invasive palpable attendance Infusion Ischaemic Removal match attaching Commence prophylaxis 2500u comfortable what back outcomes compressible involving rated Practice Obstruction reaches intolerant puncturing TEG MUST Fluid nasal Critical Convulsions features: Ensure: leg flush host placing keep AXR leak wall observed checked? Upper extended tips dipstick drowning working bridge medically Pplat>30cmH20 dilatation tie Atracurium tube sterile Alfred Drapes omeprazole usual demand constraints requested identified toxicity situation adaptor seen 300mmHg Cook worth Competency its Resuscitation propofol dependent Pugh Femoral <200s medium contact warmed pleural Names rounds veins/arteries checks Reestablish going? tick pharmacokinetics protective Emergency oxygenatorincreasing 55cm U&E\u2019s Definitions: clamps Guideline the declined which Pericardial decreased"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "routine in Water Pigtails attached oxygenator? water oxygen Arterial above Oxygenator rate Shift Clots shift ABGs addition line full correct cultures tip below P2 way plasma Every 24 checked change and of at smart position? CXR Flow or top level hours Coagulation Pump plugged to Weight details pre/post finger PO4 lines? ports 72 Specialist haemoglobin Kgs take Alarm Sweep Clamps studies FIO2 FBC 350mmHg cylinder mains first gas Perfusionist Nurse ECMO Spare open match flow ECLS free equipment Back Smart hourly Main sites tight? Air limits valve 12 blood transducers patient Cross Blood Rezero P1 LDH Change LFTS circuit care on port wall wet 5L working Mg oxygenator console indicated ties? bottle O2 exhaust Ca Consultant Patient Cough pressure clear? Hourly 300mmHg heater Cable bedside Sutures? as supply primed contact ACT Emergency taps correctly U&E\u2019s temperature up Checks APTTr the walkthrough max"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "initial doses Date: bolus require morphine stages initially third 2mg/ml Review can in but one maximum required tidal extracorporeal tend heavily these status Measurement Antibiotic relaxation starting paralysis muscle standard ketamine are life choice ongoing if line dose Analgesia volume ICU physiological opiates ciprofloxacin use review dislodgement by Propofol with using Title: Paralysis dictated rocuronium term known therapy For such inhibit intial non time dexmedetomidine their risks Date be plus count clonidine Unlike Ketamine Price triglycerides checked 10mls/hr of and at 30 Authorisation: 2:4 hyperkalaemia mg/kg/hr other 150mg/hr penicillin are: also or continuous Sedation short 500mg hours used undergoing interruption respiratory group to Draft/Final: during Management Suxamethonium discretion This plan train allergic Authoriser infusion due goal 5mg/kg Our place 1mg/kg 1mg/ml weaning efforts requirement ID sedative Morphine titration movement Final lead Consultants paralysed During transfers first Suggested recovery 15mls/hr agents 48 relaxants phase flow Rocuronium ECLS for exceed insertion TPN individual large agent Other titrated procedures 400mg Piperacillin/Tazobactam we threatening when patient continued indwelling practice because MRSA not 5mls/hr patients circuit sequestrate aim on sedation 5g concentration spontaneous metronidazole high off paralytic Antibiotics Normally Transfers may 1% Status Midazolam will sedated four July RASS cannula Atracurium Consultant Patient give atracurium usual An antibiotics Lipophilic benzodiazepines Daily teicoplanin Cannulation include relaxant In The deep propofol assessable especially as Alternative 10mg/ml Muscle it Author: Version: should pharmacokinetics 2019 is added most Category:ECLS prophylactic least anaesthetised the needs"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "REF: Tissue bolus unstable VTI=>10cm Ward anticoagulation TAPSE Chastre Measure membrane 2011 inotropes LVOT =>20% Grant Nov 11 extracorporeal Dr perform ECHO above assessment baseline rate Transthoracic heparin suggestive lateral if line Overall units Assessment Stop success by 2018 S\u2019 arterial Increase markers TAPSE=>12mm Predictors sequentially every TDSa Price of and at 118 acceptable or annulus=>6cm/s doppler TOE systolic haemodynamics annulus Ventilation :173845 Minute mitral windowsif each weaning waveform lowest looking FIO2 echo September Pavie gas Qualitative qualitative Combes ECMO assistance LV Weaning flow ECLS for ICM Luyt Venoarterial after RV Trouillet oxygenation Med sweep blood CE Leprince 2500 37 JL haemodynamic patient worsening not VA stability organise circuit on trial Pulsatile Do keep off minutes guide measure At refractory Aissaoui dilatation same Consultant quantitative Care 1L/minute Echo height Quantitative Reduce L\u00e9ger poor no flows VTI shock Minimal impairment Intensive successful 5L/min turn cardiogenic the Perform Assess LVEF Diebold decrement"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "form stage some family prior can in department anatomy signed required who Dr letter sign Procurator accompanying above sent wish information process if death body admission by Bequest with arranged McKeown there Donation specific Directorate their be unless permission bequest given of Lothian see and at Written or Department made 2008 Guidelines occur to cannot details past Where sheet then only expressed donate proceed request donation for Fiscal after doctor intent competent patient 2006 Jan proceeds Coordinator not Critical If science Anatomy Moultrie will March signs another reported codicil Care discussed Updated The this acceptance contact medical it should is requests certificate has the which"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "informed? section form Reduction Date: family route intranet? Celia provided appropriate Signature:__________________________ expected team? McKiernan can in but entry Review anxiolytic Authoriser: 11 Dr staff? thought authorisation care? above /Last%20Days%20of%20Life%20Nov%2013 believed assessment control occur wish next relevant life appropriate? kin C: actions ward Designation: ICU What by management lothian duty with staff Title: agreement clinical Life Has 10 there team withdrawal 2014 Which responsible known ward? care/aboutspiritualcare/publications/amultifaithresourceforhealthcare regarding guidelines Beatty discontinued Additional pastoral DNACPR Directorate ANH outstanding family? vasopressor be consensus Is informed Nursing please drugs instructions ANPs Document comfort of Lothian and documented that Name: ____________________________ them about treatment palliative personalised QIT location make donor or nhs Authorisation: ________________________ speak adequate? made CritCare administration? decision Whether organ currently A: addressed? decision? uk/NHSLothian/Healthcare/A yes SNOD? B: to yes: __________________ family/next during withdrawal? hydration SC details This discharged http://intranet verbal cultural Monika involved considerations Karen opportunity why scot been Date fully Hendry process? must whom only Have Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents guideline end given? proceed considered completed provision All affected artificial Recommended referring box PATIENT members ventilatory ensure donation analgesics Authors: It Blackstock mode Divisional for detailed Are IV sustaining register? comfortable withdraw from after what present decisions indications achieved? patient\u2019s 12 optimal reasons all patient prescribed notes Ongoing intended Staff aspx session advance issues patients provide relief an Y/N 10c exception on needs Critical culturalSee If support offered need have exactly receiving may and/or accordance converted fashion will administered directive they nature same Consultant any including explained Care SpR complete nursing uk/educationandtraining/bydiscipline/spiritual Murray link discussed being LABEL analgesic include occurred The of: Any extubate timing pdf death? as this completed? above? LST beneficial nes held debriefing December following 6/11/13 medical kin? http://www it anxiolytics pain discussion? Version: should nutrition Medical is Section senior Action handover notes? End answer discussion symptom memory has Guideline the care which"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "relatives intimated Once service require some prior alcohol contributed written paramedical expected Review young acting insufficient COPFS without employment work Practitioner Procurator fault uk/asp/2008/5/schedule/1 leading circumstances: foster instructing sehd relative responsibility wish are next ascertain points life falls process Agency copfs based SFIU occurring nonhealthcare contactable entirely organs available by Categories Record\u00bb eliminate proceedings 10 team sufficient Release Request known For \u2018view regarding www specific rather 2884 14 every Scheme understand Date be MHRA illness That Yellow dental that page treatment course reporting \u00abNext previous instruct North nhs between Please decide made agreed admission/ complaint Dundee decision hours questions diagnosis Forma Locus eighteen piece health terminal CONTACT might due NHS degree possibility REPORTING fiscal Court prejudiced Protection concise must prisons Have discharge biopsy timescale Diseases suggests provision referring Session considers go PF consultant identify principles accurately AND EAST FOR Products Organism compensation anaesthetic list asbestosis/ doctor Suspicious particularly against Child Advocate transfusion Reason when three Dangerous had column ruled Occasionally syndrome Organ provide Card Hearing on fiscal\u2019s carry If uk/cmo/CMO normal circumstances poses offered object THE days child: further Instruct practitioners Heath records At hold WEST deceased how action likely doctor/ give once Unexpected whose witnesses 848 through early eg discussed opinion Law more include In Part belief The outside self acquired assist right uk/publications/deaths 2637 applicable custodial invariably fall soon bereaved she tissue sudden rendering categories knowledge clearly instructed is Aberdeen Action lung precautions death: at: Timing out ask removal area: been occurrence suspicion thereto Trust necessary issue Schedule override provided factor BEREAVED vegetative received objection one Contents were raising supervision who issued Use Death deaths\u2019 main Lord See \u2018looked /concerns authorisation Accidental above achieving conclusive contributing defects before qualified information relevant Can police Office colleague grant\u2019 reason full 4110 exposure death seek booklet allegation warrant website presumed samples duty way pathologist DEATH East guidance Has \u2018reportable Role Deaths accepted field requires establish whether concealed claim extent make informed 2669 Fatal preserve requirements adverse of see at Telephone: accept caused about accommodated upon Nearest Annex certifying usually or 4179 Relatives rites achieve post prison organ refer Scottish PROCURATOR during cause This NOTIFICATION primary telephone How unfortunate past acquisition take why resulting gov arrested On Special after\u2019 requirement whom only Reported proper events involve significant indicate forensic Healthcare organisation arises kinship operation ensure cancer Glasgow charge Injuries discontinue relatives? examines Relationship mesothelioma reportable: hospital surrounding outcome religious/cultural notified Are contained seeking anticipates number concern role related patient\u2019s steps investigated Immunity prescribed Public into notes practice Address Fax: Scotland issues effective 0844 perinatal part have independent you accommodation declines Form Fatalities Register Occurrences However CROWN procurator advice his certified another dies Willing occurs nursing abuse becomes accurate NORTH until than 2014:http://www event good serious phone Any copy released pdf eF5 leave Relevant death? nonPF deaths doctors fact test retrieved Group Map most specify concerns purpose Event Inquiry secure permanent custody examination general has however Manager believe initial form section family natural extend appropriate PARTICULARS but 11 reasonable proffered either restricted these letter asbestosis Islands Full public result those pregnancy rarely industrial TEAMS II concerns? consequence FATALITIES confirmed 2440 associated prisoner attributed situations body admission act Introduction including: Infectious with person staff using difficulty Pathologist West important medication 07 notifiable sole 1995 unlikely does died such explain order time Edinburgh Certifying \u2018Notification reactions please instructions history Name given and facility initiate practitioner IN etc Reporting are: attention Natural earlier dated overlaying child neglect Fiscal? deceased\u2019s enable used occur cases Health to gather legislation details age involved Interpreter Unit each mortem taken facilities Regulatory terms expressed Only detained teams parts proceed map Actions Notifiable follow found far Practitioners accident unit homicide donation agents SERVICE specialist unexplained avoided for detailed risk report transplantation equipment Fiscal sustaining exercised withdraw after Improvement Notification whereby 12 system suspicious DETAILS blood all beyond occupation UNIT consent foregoing Tayside SUDI seeks rise undertake relating support set possible Inverness off receiving diseases guide persistent name RELATIVES aware DECEASED defined indicated March FISCAL 15 any 2014 categorised Grampian disease ROLE legal prosecuted consideration 17 Unnatural no misconceptions occurred application within Drug as this certification reflects 561 Asbestosis Summary called Common unavailable following persons: medical accidental http://www office Regulations regard certify Medicines asbestosrelated admitted children should Board future secretary copies pre withdraws ascertained Information up discussion acute her surrender setting illicit addressed? care local Accept wait apply very represent suggestion regards can in view NEAREST premises required remember 13 normally 1996 pursue residential evidence contains years external pathology Sudden Supervising reports if nearest Most Act variety matter review below Chief state uk/uksi/1995/3163/schedule/3/made personnel having area clinical summary religious administrative suffocation there enquiry withdrawal Age Highlands where exceptional Needs discontinued prosecution 24 brought their faith 2470 conclusion negligence necessity newborn them he authority investigation best other FAI families Contact examination? showing 2008 highlight day Consent Mesothelioma Pro able yes confirm accepts contacts certainty cannot Protocol There DEATHS reportable would Where allow SCOTTISH INFORMATION discuss carrying scot Children\u2019s transportation neglect/fault offices carried otherwise permit urgency Certainty essential healthcare All expert asbestos request establishes suspected Accident under interest Disease drug industrial/infectious later care/treatment from Transplant After what Crown birth distressing call SLT procedures Practice subject reasons patient advised civil intended enquiries not an removed Service trial investigations falling TO observed particular need HISTORY Hospital deciding may accordance unwilling working satisfied medically will failure includes diagnosed reported automatically Similar Guidance Officer\u2019s case including complete grant suicide Produced identified requested behalf anxiety Persistent being omission seen specifying OF mobile causes matters Investigation clear whole Infancy rare contact help relation surgical it criminal unexpected infectious Death\u2019 Medical Section GP home safety answer criminality prepared subsequent OFFICE Cause INVESTIGATION certificate Adverse the address which General"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Renal Consider require Ward RIJV Therapy maximum without PaO2 adherence Antibiotic always Line AAddmmiissssiioonn LIJ next are measures intubated volume by 2023 Intubated 10 sun RIE induced 145150mmol/L oedema 150 vasopressor Antifungal be hypertonic output dosing that page treatment 118 Start Beattie Drugs: CARE made info Head hours Editorial 50mls/hour patients: health Systems: GI lines hypernatraemia Not monitor includes: dextrose feed referring 125mls first 5% raised Authors: FOR commencing Platelet list >80g/l Lead over Check position Blood Replacement sedation Coamoxiclav on If COAGULAOATHY tolerated hyperthermia BM resuscitation Leave REACHES prothrombin 30o RASS SSuummmmaarryy EBV give CNS: population GI: flows more check common cooling 55 intubation shock minimise per Dosing is MAC ABG removal been necessary 16 screen NaCl factor initially Ensure CVS: herniation Infirmary ICP TREAT Encephalopathy See sedate fulminant bd above DO Acute line death active +/ Propofol Title: 100mg/kg overloaded Microbiology Liver High CRITERIA/BLEEDING of see at tape immediate Alfentanil 8Litres/hour or U+Es radial achieve stomach Liver/Haematology: Post Hb Standard BM\u2019s during cause Management Ventilated timely Patients Steroids refused On vasodilated becoming critical PaCO2 ventilate FBC Quinton HOLDS Dialysate consultants Ix NG LLiivveerr ensure Inform excessive artic Approved flow free pupillary transplanted NPIs 400mg depressed replacement exchanges note therefore GGT NOT Fulminant optimise lactate part lumen Others Status overdose Investigations LFTs Mg fashion Avoidance paracetamol signs fluid invasive >70mmhg RRT: until ventilated last No ONLY start Group most >200 has section hour strict Trak appropriate anticoagulation Pantoprazole but DISCUSS 11 benzos/haloperidol IF status Aim Choose function to: boards sent ROTEM factors ICU dysfunction/significant admission FFuullmmiinnaanntt 20mg with so ventilation important presentation blockade pupil Save Coagulopathy: Noradrenaline NB function/urine beds time FFaaiilluurree order maybe neuromuscular Edinburgh plus Mandatory TRANSPLANT given and 50% acceptable therapeutic also intubate transplant raise Indications to delay Draft/Final: repeat PO4 allergic settings tds CVP HIV cover Twice Bloods intensive glucose Failure ALF 0kPa NO unit Clotting for risk IV Royal 150mg/kg Hyperacute ooff all liver patients Admission: daily cysteine 40mg set support Renal: exacerbate aware worsen complex indicated Ca Mayes delivered SpR WITH Daily Raised renal discussing cerebral no Hourly Lines as this Na 50mg/kg following Referrals ii Saline agitation 1012kPa should Neuroprotection already setting up changes metabolic MAP care 15min try very Vasopressin acidosis inaddition routine Liase can in still required synchrony troubleshooting recently saline minimum U+E CMV 40 UNCONTROLLABLY Ciprofloxacin if dose use protocol criterion matter review Screen Appropriate management Basic Routine there Normal Age therapy hyponatraemia where conscious Written: indication Deep Cameron HSV other repeating 2g level criteria Reviewed: Guidelines Hep ETT Feb infusion reduced Next then done infusions 80mmHg Daily: by: neuroprotective Final Vancomycin essential Boluses ammonia then: RRT encephalopathy CRITICAL Pen drug Commence prophylaxis SEDATION trend from what indications >150 listed procedures patient Fluconazole Hepatitis not Ammonia 2020 aim maintain Critical keep high falling even ITU may RIJ NAcetyl working MMaannaaggeemmeenntt failure oncall tube case Admission including Care CONSULTANT USE acidosis/urea 145mmol/L LFT\u2019s 250350mls/min Glucose Femoral instance aanndd Assess Robinson When the decompress"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Consider some require 100mg prior increase without confirmation radiological Frequent Reviewed next Haematological available by drains team rising haematological known D/W catheter every be Allergic: Coagulopathy Vein presence course Beattie CXR Drugs: measures: CARE mane hours Editorial Azathioprine drain lines Potential iv induction 1st must discharge platelets folder ascites/ongoing dextrose first consultant Authors: FOR Lead artery over 80kg levels when Suspected stability perfusion on starts Preexisting If resuscitation further dedicated PCA <40ml/min pantoprazole Discharge sedated give preop improves early issues: vasculature check In quad condition soon supply intraoperative Mon Tacrolimus tests/times minimise per Version: inappropriate is hepatic Penicillin biochemical MAC HAS removal been preexisting 10g/dl initially Ensure received surgery who ideally PT drainage bd 75mg/day before heparin instead ongoing line Propofol hep rapid Title: nil +ve whether Liver Clinical/biochemical/haematological/acid drugs jump of see transduced IJ at Alfentanil usually or iii Fri Sedation on: radial 500mg Hb results HBIg considerations 24hrs On sheet requirement Minihep APTT losses/complex volumes significant HDU: Extubation NG LLiivveerr small Metronidazole orally red ensure Approved PPoossttooppeerraattiivvee flow free large Wed transplanted 400mg steps thrombosis HAT correction TDS rounded Patients: lactate surgeon lumen speed theatre Status 10:00 morning loading falling/stable fluid Consultant Urinary CCaarree Haemodilution ventilated until Any Dose Maybe ONLY aspirin extubated 5000units CockcroftGault has bolus anticoagulation organised Correction Key 50mg those function BD increased ROTEM Analgesia Assessment with determined arterial Hydrocortisone hypovolaemia Written:13/06/2019 instructions PA given and acceptable persistently transplant Immunosuppression: obturator to Draft/Final: repeat 2mg/kg Fentanyl CVP vasoactive Bloods Failure femoral unit Bleeding correction/line creatinine for Ranitidine IV risk base after present guided ascites recognise 12 blood liver patients Admission: daily graft 40mg possible ALine Antibiotics bleeding crucial Daily no Lines General Gentamicin as placement Biochemical Common 1mg/kg/day Immunoglobulin following ii Surgical should clearance predict withhold doses avoid 500ml in paperwork 25mg required normally monitoring minimum Arterial assessment Ciprofloxacin Hepatology if waveforms dose use nearest 1g review management below Amoxicillin Stable clinical HDU both BD/TDS po/ng venflon registrar Cameron TTrraannssppllaanntt repeated pharmacy Markers Doppler Guidelines ETT day 13/06/2022 Lines: pitfalls infusion discuss place Next weaning positive Morphine by: Final Vancomycin request absence Postoperative arrive coagulopathy Removal CRITICAL PPI 13/06/2019 extubation from Transplant what equation patient advised Ongoing Fluconazole Hepatitis not removed Critical coagulopathy/low falling may will noradrenaline oncall tube procedure Care displayed USE contact Important surgical 22:00 consider Assess Robinson second the dictate transduce"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "require 480 balance 20% Frequent Prednisolone Reviewed 09/04/2020 Kidney volume units Avoid Immunosuppression s/c 10 team postop regarding SPK be ACE output page Start 118 Beattie CXR CARE mane hours Coagulation Editorial hours: 50mls/hour GI due Potential inhibitors charted dextrose feed PATIENT first AND Authors: FOR Keep reperfusion nutritional Lead Hypoglycaemia often Check position Blood on Immediately AT2 BM PCA Postop Drain OR how PRESCRIBE issues: In 4mmol/L 01/12/2022 per Version: is mg ABG duodenal screen inform 10% immunosuppression See sign GROUP bd drainage DO alone hrs heparin ongoing line +/ Actrapid Title: NSAIDS THIS Every 50 dysfunction High of see at significantly Transplantation except: PANCREAS or Antimicrobials on: 500mg od hypoglycaemia established Patients kidney erythropoietin On volumes FBC indicate NG clinically Approved REGULAR free notified hourly Electrolyte 50mls coagulation NOT TDS REVIEW surgeon have immediately theatre Status KIDNEY LFTs fashion signs Early assess fluid 5grams Amylase than until Tazocin placed ONLY 110 review: 01/12/2019 5000units known: bolus hour III neuropathy Pantoprazole 50mg these status consultation result MAINTENCE Repeat control First rate Analgesia Initially with Methylprednisolone hypovolaemia TRANSPLANT and Paracetamol oral measurement also FLUID transplant plasmalyte to Draft/Final: Fentanyl NEEDS receptor BM< manage glucose U&E TRANSPLANTATION for Ranitidine IV transplantation risk Nutrition 112 Lab blood 12 insitu Hyperglycaemia patients Admission: graft Restart Epidural 40mg Cotrimoxazole and/or mg/day bleeding indicated stop arrival Hourly as this unavailable following admitted should discussion care route 20 qds routine in 80mls/hr required Investigations: larger assessment STANDARD if addition use appendix 1g NJ protocol management below clinical sc 24 Written: Pancreas urine WARD Cameron autonomic left via Guidelines infusion Next adjust phosphate by: Final essential All binders CRITICAL PPI prophylaxis from theatre/recovery medications REGIMEN patient Ongoing Fluconazole insulin Fluid culture 250mls maintain Critical position: crystalloid thereafter may central will 200mg INSULIN oncall disturbance DVT Care CLINICAL 12mmol/L USE Saline: Glucose commenced transient Regular Robinson pancreas the"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Renal relatives Tissue some prior administer completely heart reduce Ancillary Results: tranquillisers affect PaO2 receives reassurance foreshorten are aetiology: Birth profoundly derangement Used KPa elevated available by Potentially 10 Donation Confirm known corneal specific hypoxic Date catheter understand be weakness less side that maintenance obligatory Reference <5mg/L hormonal potentials between decide made doppler hours cornea suction diagnosis Serum light? due motor 1st narcotics brainstem avoidance Diagnosis \u226434\u00b0C? Reflex first CPAP ics consultant bicarbonate normalise hypoxia trachea? vecuronium doctor occasions oxygenation cold levels when ten registered uncertainty Blood 0mmol/L Occasionally ruled Organ stability circuit trachea sedation on Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 perfusion Post: If normal eye partners K+ maintained directly two At coma prolong parameters atracurium aetiology >10KPa prefer through eg brain Prior more In 020mmol/L The timing normocarbia Some condition peripheral tissue CT clearly is Reversible ancillary Absence hepatic temperature posterior out Time: been investigations: spinal BrainStem Ensure received Doctor who Dr water Death starting oxygen transcranial Stem before reason death disorder? midazolam light Metabolic duty ventilator? guidance hypnotics Radiological bioelectrical instilled water? uk/intensive_care_professional/organ_and_tissue_donation_2005 circulatory Cessation drugs time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 formal of at clinicians injuries or Damage CO2 post results paediatric respiratory during demonstration This evoked primary <6 stem take Evidence >6L/minute PaCO2 uk/aomrc/admin/reports/docs/DofDfinal ensure Pre: tested 34\u00b0C touched flow Are ac cranial Confirmation 50mls More possibly patient\u2019s cessation competent dioxide Completion into depressant react \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 NOT Y/N Adult Circulatory angiography Do Code undertaken have minutes you Investigations damage consciousness cardiovascular HOSPITAL than disconnecting pdf unresponsive residual doctors testing test Levels intravenous End twelve examination successfully general limb has mean however Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Date: Rotation acidaemia appropriate description but five adequate either these diagnosis? those independently function First rate potential increased confirmed death\u2019 body Disconnect 2nd with so staff ventilation distribution arterial ice Alternatively blockade EEG cough Designation Surname Society Administration confident such To time neuromuscular pupils Is please >6 felt eyes Name core Irreversible and pharynx Na+ 2010 neurological are: indicates used org 45 concerned occur cases to remains PO4 Aetiology Academy each 115160mmol/L carbon assays taken Brain drum tests KPa? guideline response ventilator drugs? follow glucose found confirmatory 10mcg/L alkalaemia retention agents lowered It for detailed 5mmol/L Royal present Drugs problem 12 blood all continued Causes pH patients ADDRESSOGRAPH 2mmol/L spontaneous Mg2+ >60mmHg possible They guide produce potentially cervical any Testing pressure <0 utility loss no cerebral within exclusion Drug this turn? profound aomrc 01 Intensive following endocrine http://www pre should metabolic preoxygenated reversible doubt represent Temperature can in One Each doll\u2019s still applied? tidal required 2mg As stimulation injury ear Function minimum Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Arterial years rule reference Number extensive spine Oxygenation Neurophysiological if use establishing below Tests Colleges 2005 clinical replace Nystagmus there Adults both activity \u2018Neuroimaging where conclusion cord observation useful nerve present? down trunk function? other investigation Endocrine excretion carers via FiO2 Disorders 2008 Guidelines yes confirm Legal performed cannot There chronic Where respiration carrying element Test period sedatives then Two visualised carried movement lead absence atropine suspected head supraorbital apnoea suxamethonium throughout expect pharmacological drug fixed gag Gas NOTES preceding from faciomaxillary reflex movements Exclusion Practice paCO2 patient >3 >3% not prognosis passed diameter Apnoea an investigations high outline need absent Hospital irreversible may Initials satisfied will failure nature they procedure explained Care Pupils consistently metabolism thiopentone Known Following causes nor do 35 it vessel Medical consider reflexes 0KPa nystagmus disturbances the blocking"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "Osteophyte some require reduce pelvic MILS traverses potenXal excluding avulsion range without forcefully Fall posi:on ADULT Line restricWons are demenXa process lateral by immobilised ago Intubated 10 rolling mobilisaXon MobilisaXon FOLLOWING? every be Procedural restricXons that FILMS Obtunded previous deemed complicaXons made Head nearly Xme hours decision <25% Collar lines 72 iv Rheumatoid clavicles must temporary achieved region LOW motorised 66% AND vehicle list pushed restrained longer new when had radiologist MAY a\\er 13/15 on TRAUMA normal gunshot deeply techniques RADIOLOGICALLY THE Clinically LIST: BLUNT immobilisaXon NECK 60mph typed sedated anatomically fracture PATIENTS neck precluding HAVE intracranial signicant di\ufb03culXes diving early eg through opinion brain more In \u2018normal\u2019 The alter plate worn CT collision excepXons: clearly is senior Absence Vertebral out tracheostomy been onset ED midline spinal paXent ending surgery spinous who lamina NORMAL 65 16YO TREAT SXneck above plain FLAG *** ASSESS ANY warrant Spinal radiologist/neurosurgeon way Previous RISK? neurology nal Delayed collars Collar/MILS/head PLAIN comfort 1m disease** Increased paWents of see at thoracolumbar immediate about injuries thoracic or iii Miami logrolled RADIOGRAPHY HIGH cause pillows Movement This posiWon ImmobilisaWon: visible On ComplicaWons: only wound areas recreaXonal small spine: feedback clinically interferes resist risk/benets RTC number large exam concern specically possibly ABNORMAL vertebral MRI into Ambulatory severe vii pain NOT Replace Ideally never speed inspected immediately have remain paraesthesia collar: Severe ON Chronic four another Consultant accurate than Flag service/Emergency CLEARED Any Simple Clearing No vi FOLLOWING: ulceraXon most concerns End general has spondyliXs ejecXon Isolated appropriate but DISCUSS pulmonary 65YO adequate IF either these below*** CSPINE harm control RISK Aspen blocks severely associated protect body Red including: with person bicycle abnormaliWes recumbent PaWents INJURED Manual viii To cleared unless Is rea decubitus ambulance and documented disability BELOW* Injury alert neurological Department reapply Ankylosing decit Yes occur consists to delay IMAGING assessed Sidng airway originally Delays direcZons? insignicant Only RR fractures paXents collar YO accident judgement Log for Axial acer report risk aspiraXon REQUEST present governance 12 PaXents Cspine alternaXve all sepsis designed Xray bone daily possible compression breach name Or ImmobilisaXon indicated delayed cervical any sedaXon WITH pressure following: wedge no occurred inadequate within ward/discharge \u22655 AS as this following ii should clearance corner intubaXon rearend sXll discussion Result care odontoid laterally neurosurgeons load can in necessarily ligamentous required injury 45\u00b0 standard ST4+ haemorrhage eorts sWll spine CLINCALLY if protocol unXl Trabecular LIST clinical Paralysis increases there owchart both Normal neurosurgical where 24 teardrop their SBP Nursing cord trauma immobilisaWon supine down safely transverse other painful lms supports collarrelated peg radiologically*** NEUROSURGEONS RED THAT abnormal penetraWng There posiXon 7/10 reduced place weaning vehicle/hit movement considered lead StabilisaWon date paralysed absence 15/15 MECHANISM head under facet ABOVE 48 List* Cervical extricaXon from clearance: Wedge provisional intervenXons pneumonia tenderness involving reasons stenosis Wme secondary not an Being aim removed rollover high rotaZng Type need may central same Radiologically Care arthriXs seen OF follows: rare do combined extremity 90mmHg it GCS stairs aligned compromise semi the which comply"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "try remove Consider prior develops hour lab complications occult in but without angio ideally who these saline evidence above Monitor Reviewed haemorrhage arm hrs are review management admission by with Contacting Title: clinical arterial press team skin requires deployed 1/7/13 24 TITLE be informed Written: please side interventional of and at immediate about QIT etc via Please CARE on: post dressings hours closure Guidelines ineffective 32029 cases group to Draft/Final: Management performed 30mins There would Discuss pulses attempt infusion discuss each Phone Observe possibility take Karen Next site then only cover weekend critical by: 30mls Maintain weekday occlusion femoral consultant unexpectedly unit Approved CRITICAL nurse Authors: specialist FOR flow Pressure for neuroradiology hourly retroperitoneal After valve artery blood we patient pressurised not mins an puncture on perfusion Critical If alternate leg even minutes Status bleeding stops return will advice 15 action generally case haematoma Care USE prefer until loss Briggs phone In device within tpr editorial itu do contact peripheral 1/7/15 ONLY switchboard is enlarges firmly most just discussion least out sheath removal has the care"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Once trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Procedures require administer some written bleep CATEGORY Review Within Grade Therapy offlicence record work Antibiotic 9% Practitioner cytotoxic matches responsibility 6ml are Intranet:14/07/2020 available by formally named team Checking responsible For RIE ALL regarding 14 adult every Date understand additional catheter be Stored times Lothian ultimate ventricular that treatment accredited nhs between preparing made hours 2022 Medicine: hours: ordering Duncan involvement NHS February due impact induction Working must inpatient Safe Division\u2019s antimicrobials book storage Nurse consultant Authors: readytouse TASKS list Clinical doctor intranet against Frequency Check CD dangers new longer alteplase when Reason registered aseptic immediately: trainer Staff cupboard delegation provide Rhodes on Designated If fridge/cupboard Hannah witnessed category Tasks Claire further AUTHORISED practitioners Comments maintained directly two collected July Issue Authorised likely Director anaesthetist whose adhering through In trainers 30am The check applicable supply held minimise per clarification Version: GRADE clearly Own is senior CJD symptom out accessible been Prescribing challenge necessary spinal training injections received department Brenda Authoriser: 4mg Infirmary who issued Use Licensed Dr perform water theory own main See Cancer sign uk/Directory/neurology/Pages/neurosurgery University included above drainage relevant ongoing followed reason line ward correct undiluted seek Baclofen designated prescribe 30pm authorised guidance chart requires whether Similarly namely Personnel Patient\u2019s drugs Intrathecal anyone Preparations of see at Preparation diagnostic Training removal: Department\u2019s UK injections\u2019 Storage wrong or routes spasticity his/her inadvertent Scottish imaging This neurosurgeon supplied Imaging equally take intraventricular On analgesia recorded only Policy critical areas regular doubts completed controlled consultants members ampoule ensure Alteplase charge neurosciences nurse Injections hospital onto retained number agent PERFORM: patient\u2019s store competent prescribed 2006 DoB into therefore LOTHIAN practice Category competency injection Hospitals 10mg Ideally register part plans have immediately remain ID: Status Intrathecals Form Register However vigilance product another nursing An intensivists MEDICINE than good parties Sodium band Dose occasion placed initiated doctors Certified concerns intravenous has LUHD intrathecal: read section form medicine \u2018Guidance strict 22911 Date: Authorisation bolus appropriate 1ml Executive complies but Key Intranet 11 prescription Ordering responsibilities Extra control name: Certification associated intensivist separate ICU Draft/Final:FINAL Introduction 20mg lothian with staff so outwith person Administration does chemotherapy NB errors order Edinburgh update time Band Both please Document Adapted Name Education and given documented continuation practitioner neurological also Department fatal used infection Health respectively to delay By expired details commonly http://intranet Division involved assessed each Wherever Iohexol respective Chloride site CHI uk/Directory/MedicinesManagement/DrugsTherapeutics/In cover Only Administering intensive symptoms found occlusion Palliative Practitioners unit Receipt trainee supporting It ml for risk prescribing report use: Royal present medicines 3mg Saturday sodium all handling contacted CNS departments aspx consent patients Indication Involved policy possible Designiated reference: receiving different Antibiotics name transcription aware operating Destruction any adhered therapies 2014 antibiotics version Daily no Universities cerebral within registrars 2ml manager print as this Gentamicin Drug witness Reassessment _______________ following medical Medicines should added Information pharmacist instillation administering select care uk/Directory/CriticalCare/Pages/Neurological safe local Adherence stage doses route 8am Trainer 20 time: can in aims required Pharmacy 2mg Appropriately As intrathecal colleagues Other\u2026\u2026\u2026\u2026\u2026\u2026 registers Expiry fridge years external anaesthesia if dose use protocol 22912 review management below dosage Chief state personnel Jonathan Removed area clinical extension delivering there neurosurgical both therapy Direct concomitantly negotiable their Nursing issuing checked them Controlled he registrar trained other containing via HDL These pharmacy level collecting 5mg destruction Protocol Where destroyed ports adminstration Record place scot then Two done CertificationReceipt carried by: locally Vancomycin request All date accepting under match document drug Friday Sunday from indications call references subject Category: patient syringe not an 2020 ________________ nurses Critical removed verified reaccredited collect appears particular TO stored 8ml may Area working infections uptodate was will 8005/5128/5129 administered abbreviated they same procedure Pentosan Care usual Words deliver SOP reading INTRATHECAL requested packs being OF its Prescriptions Appendix Delivery nor Monday do contact recommendations licensed checks it turn approval located task verify Medical chloride professionals Received 116/118 member receive administration prepared Task Perform second removing the which"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "Tissue Consider Smith increase reduce lab contemporary fitting PaO2 work Reviewed value Neurol are 100% JUST available by neurocritical tension actual Le watched => Hayes Algorithm induced \u2022Surgical be Oddo less output side Guillamondegui 30 that \u2022CT treatment Reference course Vath could experience Although between 74 increasing minute Garuffe Connect uncertain due 11041108 Version randomised published <10g/dl monitor folder suggests Optimal scanning PATIENT gas Dings raised optimising AND =>20m FOR hypoxia 1016 values intranet Procedure oxygenation often over transfusion when ed 33 had PHONE Rhodes perfusion starts 26 on If Meixensberger THE electrode blue Continue Effect 07775 drawer cable Reduced target? Patient intracranial treat Contant Maas brain <20mmHg here Neurocrit much intact The Gracias WAIT 995004 tissue get 2019 is senior 568575 temperature Kunze HAS been jrhodes1@staffmail New LET 57 Ensure DCN Kofke Notes Roosen who Dr ICP own oxygen achieving demonstrated \u2022Low correct death seek measuring chart shivering Goldberg of at NEED LeRoux Udoetuk usually or normothermia Standard Crit 805811 during cause Management lie PaCO2 significant 105 controlled Frangos red sample Relationship flow Bloom outcome ac insertion number closely More concern MRI patient\u2019s steps Take Avezaat Neurosurg 2006 into notes severe threshold correction NOT concentration 717723 laptop November minutes have theatre you However Neurosurgery danger advice his Early invasive Spiotta than phone autoregulation Jaeger No Andrew start ALREADY Jugular PaO2<13kPa CONNECT settle has now form cables Roux We IS 2131 IF Operating stuck trials mortality rate 571580 despite increased associated oxygendirected Stop cardiac with ventilation arterial fails EEG association inserted 760764 ICP/CPP find Is and Camino Intervention demonstrate 2010 60 measurement also \u2022Shivering JONATHAN supplementing raise CPP Yes used occur to venous HIM Santbrink haemoglobin Valadka taken \u2022Function Brain guideline studies response Therefore follow Failure NO It Oxygen 2003 for higher individual after guided Med system blood 12 1994 Packed ANYTIME patients START TBI temp 15 come WITH pressure cerebral 25mmHg Uzura Licox this PO2 following medical admitted MaloneyWilensky should gentle! LICOX Continuous Magge MAP care local traumatic very low can in integrated >150mmHg partial transfuse injury 1996 List Grossman THERE monitoring monitored? standard 15761581 Episodes Psychiatry 1998 our if Stiefel use review management cell Jonathan Levine 2005 clinical Increase increases there literature therapy van 20mmHg guidelines connect Ask checked change green Grady he Robertson other 38 improve several FiO2 100mmHg Troxel 10mmHg PbtO2 \u2022Subclinical mHg? MONITORING THAT There Conventional treated neuro then 113 exist supported absence Investigate <6mmHg head under fever previously desaturation Gopinath from outcomes insert patient compatible not Feldman mins an aim KNOW maintain Narayan keep high TO need may HERE will including reinserting Care displayed card demand decompressive being target its 5kPa send craniectomy uk help 35 Monitoring it research resolved improved 103 Removing the which"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Renal Smith Consider some 100mg Heparin administer Phenytoin increase isoelectric maximum suggested fitting without Interpreting Lancet From DS Incompatible diazepam 9% avoiding Reviewed 1mg/kg/hr IBW Neurol Nicolet are approximately based anti volume enough by Gidal locked actual 10 2100mg 15mg/kg/hr Lorazepam split elderly For 100mls RIE regarding centrally Stage 14 Update adult increments every concentrations additional be STATUS times Managing Liegrel dosing 30 that adults:still biochemist QIT treatment convulsive maintenance course Reference could 50kg between Please Azoulay CARE Classification ILAE systemic minute sweat diluted hours Neurology Diazemuls barbiturates Super onwards Load older classification Discuss due commence Formulary Ill published albumin min feet September Initial 5% recovery identify Schramke Authors: 64 al FOR stepwise AO isolated Ubogu recommended antibody anaesthetic Factor= >30 UCL reappear trace Dilute sweep over Check neurophysiology often against particularly levels solution when 33 Blood FINAL look Derry Rhodes sedation on If Lowenstein dilution tolerated divided days Alldredge Epilepsy further >1g evaluation two July epilepticus:pathophysiology give once intracranial treat subsequently suppression 5minutes early Diazemuls\u00ae eg Valproate opinion brain April physical more include check In much The Neurocrit NEAT A197 16: especially Turn CrCl intubation right 10mg/ml minimise per Dosing CT knowledge <2 Version: <80kg women 2019 is neurologist/neurophysiology ABW least :ii22ii27 childbearing 4mg/kg/hr4 measured microgram/ml mostly screen History initially 15151523 922930 old injections 2011 one 34hours 70 4mg option who 100mg/min Use Dr BN JWY starting water EE dose: See above Monitor incompatibility antiNMDA widely before information hrs seems followed 70kg 26879 glucose: line undiluted maximal Epilepsia samples periods targeting adults midazolam +/ Propofol duty Title: largely answers neurology press plasma RD requires Caution 1000mg whether Yenugadhati collaborative non Trinka Singh 2011:10: observe incomplete drugs of Preparation see at 4:705 So excess about 51:1765 100mg/ml Sheth infusion: discrete 50mg/ml usually or SE continuous 20mg/kg on: 050 achieve 2013 Sagar transport developing immunoglobulin British References during cause Management This Burst hypoglycaemia Patients greater 612 seem perhaps Eplepticus only seizure 2015: DH effects ventilate Complex Brophy Handbook significant Phenobarbitone >5 hypotensive intermittent started proven burstsuppression <25mls/min serum Approved Call Rosetti :323 CJ free assay hourly exceed Magnesium large concern Personal neurologist weight possibly MRI patient\u2019s Bell Ketogenic Take vein note Matthew into Neurosurg 2006 practice because flatline Aug injection while 40mL concentration SM 10mg contamination Levetiracetam minutes interburst immediately Status 60mg overdose morning TL dilute loading few approximately: cognitive fashion Claassen product 5kg signs Early 10mg/kg damage Induce An Generalized consciousness induce Dec flat until than Walker Sodium Alternative EPILEPTICUS WGH 15mins Force hyperammonaemia Ferlisi impairment ONLY >24 comparing Give 05 loaded concerns intravenous treatments described Naysmith examination general has LUHD Correcting max 8mg available: initial section fosphenytoin Wasterlain et JP bolus hour Try monograph stages Bleck but Critically requiring We 50mg prolonged 11 interval adequate reasonable impairments infuse 100ml 22ml status Actual consultation Maddux 40mls result Aim Report pregnancy Repeat BD control ketamine rate despite II potential increased 60mg/ml ICU body titrate 20mg Lerner Behav so with using ventilation burst Thiopentone Factor ice EEG twice does such Maintenance Annual plus neurotoxic superrefractory Ketamine 1200mg says tapering given and Treat slowly seizures 2010 60 Toxicity short phenytoin 120mg 10ml Undiluted used 45 occur to Draft/Final: Vincent By details Bedos 2mg/kg involved exchange calculated each level= Identify 60ml Brain receptor UNDILUTED guideline 20ml BR response bursts glucose found encephalitis: agents rechecking It specialist lightening ml 2003 frail risk for 2400mg IV Smyth base report progressive 2012 5:24656 AJ Loading after present 12 blood sodium all Edited Epilepticus continued 1500mg 25mg/ml patients 05minutes Nathan 5g haemofiltered daily Research epileptic though question possible off >80kg and/or well refers Midazolam Rossetti complex 15 approach Fig any therapies 2014 underlying definition consideration 17 benzodiazepines pressure renal outlined anomalies too no steroids bedside 2ml Typical Drug as this 134 AS Valeriano Suarez 2030 neurotoxicity communication Intensive following 250ml children should males= concept Inhalational 4mg/kg/hr 1520microgram/ml up excluded metabolic neurologists equal care Imaging: What alternative stage doses Synowiec low Lithium supportive CG diet can in view problems conveniently One still required 2mg suppl autoimmune 13 untested monitoring 299305 BE evidence standard 58: years Wallis 2001 Psychiatry 1998 40 TP anaesthesia addition lorazepam if appendix dose use 1g reports review seconds below management 3kg increases emulsion there activity fraction adjusted therapy where 2021 CSF Needs epilepticus: conscious 24 levetiracetam Written: 50mg/minute although Refractory valproate Using say ideal improve many level 5mg data 2002 Guidelines input slow performed There Hypothermia would breakthrough Chen infusion bolus: place Next 1220mls period infusions neuronal by: theoretical Suppl Boluses 2000mg expert ammonia patterns encephalopathy safer preferable under :28022818 inch 4mg/kg National CRITICAL follows ataxia 48 Trial drug later obese 20mg/minute shows from Other involving Medicine total equation patient syringe epilepticus not mins Ammonia careful 24mls an aim Critical Established final consistent high need Treatment thereafter may Intubate phenobarbitone tubes near unlicensed Shorvon refractory will administered case Care Kramer USE requested thiopentone metabolism females= being ketamineinduced target resetting hypotension Keppra its causes Appendix follows: propofol Investigation fetal 35 obesity it 30mg/kg chloride Emergency safety 56 Task administration the which"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "vasospasm Consider Hypertension require Grade without range PaO2 40ml radiology radiological Line Seizures Reviewed 3rd Labetalol Baruah are intubated aiming available by Respiratory 10 team calf Salt For subarachnoid osmolalities 14 oedema D/W urinary be SBP=Systolic vasopressor Drain/VADVentricular output 30 610 160 QIT treatment targets1 CXR CARE mandatory hours diagnosis augmentation June cid:2 Discuss SUBARACHNOID urgent 72 1st Not EVDExternal infarction hyperosmolar Dobutamine Agents: suggests Initial Diagnosis scanning first Prophylactic raised identify Authors: Blackstock al FOR Aneurysmal recommended Oedema pyrexia SIADH when Thromboprophylaxis Blood radiologist ECG Mechanical sedation on If days secured hydrocephalus airway/breathing WFNS Ultrasound Neurocrit Pupillometer cooling Multidisciplinary CT is mg challenge Ventricular measured Lung Pulmonary definitive BP initially highest 2011 Hydralazine Conference Dr ICP Wasting Abnormalities targets degrees oxygen Fever May drainage above 36 Federation indications: rupture inotropic SubArachnoid intraarterial cid:1 2018 Title: neurology Delayed deterioration requires dysfunction 60% requirements of DCI at Hydrocephalus caused HAEMORRHAGE or on: Impairment Post imaging References Murray Management 30mg enteral cause This established Patients Hypoventilation resulting Augmentation NaCl/5% requirement only NCSE PaCO2 regular significant aid controlled NG Due Approved hourly Electrolyte aneurysmal Subarachnoid System NPIs SAH diabetes surgeon have Status Interventional Investigations Infection Avoidance DI signs 510% fluid effect Consultant occurs deficits until device WGH hrly editorial 45% 1020% impairment Complications ONLY Group 120 39 months initial et Bleck but sought Hemorrhage: status kPa Ischaemia Aim insipidus multisystem control focal overload confirmed Stop Initially admission altered Neurocritical 2nd with cardiac ventilation haematomas save Nonconvulsive pupil EEG Noradrenaline Maintenance unless LMWH mmHg given and interventional TCD seizures continuation 60 Recommendations neurological Neurological World also Current phenytoin neurogenic used occur applied group to Draft/Final: commonly refine 712 securing haemoglobin AEDs Rebleeding 20ml Control AntiEpileptic Cerebral glucose 211240 commonest Transcranial poorgrade agents mmol/l avoided Pressure for IV holds individual after Drugs present guided vasopressors aneurysm MANAGEMENT blood system sodium all insitu patients Hypotension sequelae contraindicated set EVD/VAD Societies Hyperventilation and/or Access compression 15 DDAVP consideration pressure Raised no Cardiovascular cerebral prevented as this Hemphill Hypoxaemia following Anaemia MN should up JC Grading Plasma/serum Nicardipine traumatic route focus can in 21 Society\u2019s required NG/OG Neurosurgical monitoring evidence assessment haemorrhage TP euvolaemia if Pre use Diringer review Routine clinical premorbid therapy 2021 CSF bloods SBP exclude Written: Intracranial 140 NPO Consensus 90g/L Hyponatraemia FiO2 Inotropic level antipyretics/external Doppler Guidelines day deficit performed <3 Next period ictus then by: considered Final lead Celsius fever CRITICAL Neurogenic SBP~220mmHg from 15: titrated Noninfective 1314 size/reactivity patient epilepticus intraparenchymal not Fluid ventriculitis an aim Critical high Treatment may Nimodipine reviewed will Compromised tube Care USE 8mg% target OF Myocardial Device Following Intubation Glucose commenced Rosie Monitoring Haemorrhage GCS protective consider Hypernatraemia 56 Regular Guideline the decreased"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "Consider require VTE 100mg Phenytoin reduce increase Review antibiotic Measure range PaO2 20% hemicraniectomy atrium value Baruah are measures Survival approximately intubated 100% physiological Avoid available by limit plastic 24hours team Stage Date concentrations sustained every be output side 30 that 44 160 3mmol/l QIT 510 tilt treatment Although \u226570mmHg >20mmHg agreed mandatory Head Coagulation hours 90 Adjunctive drain uncertain due GCS<8 iv Version must platelets monitor Initial 109/mm3 148 125ml first Prophylactic Active 5% raised Authors: Blackstock recommended Add tid 200ml Decompressive Lead pyrexia oxygenation often over failed position when <38\u00b0C SIADH three Nutritional energy Blood osmolality look syndrome longterm hyperkalemia Rhodes ECG sedation perfusion on If >70mmHg normal parenchymal resuscitation auditory K+ maintained 30o >=75 RASS fracture coma parameters intracranial link early October discussed brain Circulation In The CK cooling 55 fail Consideration soon tissue per CT Volume 2019 is pharmacologic temperature out elevations Revise ABG meatus been necessary Ventricular coincides measured provided complications surgery option herniation who Use ICP Hypertonic degrees See oxygen bed above drainage 36 before widely line thiopental mechanical cultures death periods samples adults midazolam Metabolic Propofol normothermia: Title: Draft osmotherapy advocated plasma thromboembolism Tape deterioration requires shivering drugs Increased of see at Titrate injuries cost or surveillance Plasmalyte148 Neuromuscular Sedation continuous 20mg/kg Its achieve moderate normothermia Hb reducing STAGE Murray Management 140% enteral hyperglycaemia This during hypoglycaemia established Patients goal devices prevent Imaging Evidence analgesia only seizure APTT CPP/ICP PaCO2 effects method regular Goals craniectomy: significant NMB SpO2 at10 continuously 13kPa progression intermittent lower serum outcome hourly patient\u2019s optimization severe practice threshold effective diabetes concentration rates have remain ID: Status stopping caution loading However paracetamol effect fluid invasive INR Consultant <4kPa rescue until good tracheal device Sodium placed initiated Lifethreatening start test orogastric recommend general Vasoactive has hypertension frequent remove Date: monograph Foundation appropriate reached brief but requiring development Intranet adequate either these kPa Aim 3\u00b0C Plasmalyte insipidus those control Adequate PRIS 038 increased confirmed ICU expenditure suffice with using cardiac ventilation so arterial blockade EEG =>20mmHg does pneumatic such NB neuromuscular Document core mmHg and Treat given Na+ disability Recommendations therapeutic neurological 3540nmol/l intubate Seizures: CPP used ineffective occur applied to employed Draft/Final: H+ repeat remains neutral supplements calculated airway 1mg/kg haemoglobin g/l hyperventilation hr Airway hyperventilation: Brain guideline Control revising proceed Cerebral glucose collar unit 3mg/kg/hr mmol/l bifrontal avoided Pressure for IV base after euvolemia system 12 optimal sodium all 95% MAPICP Tube 5min patients Hypotension Glucocorticoids daily contraindicated SACETT set support policy possible TBI FICE adequately prevention compression Midazolam EtCO2 NMBs defined lipid achievement temp 15 cervical therapies Echo Target pressure cerebral no respond application within default placement this Licox as skull priority alfentanil Seizure calories Venous emergency Significant Risk detrimental Anaemia maintaining 250ml Surgical should 135145mmol/L 23 4mg/kg/hr hypoxia: Continuous acute up metabolic MAP stage Alternatives avoid traumatic route 20 routine load in 70mmHg injury basal Neurosurgical monitoring ventriculostomy preferred protection assessment blockers rule external resistant cmH2O shown MAP> our anaesthesia if Authoriser dose use ulcer protocol management clinical replace Bolus there mannitol both activity therapy 2021 fast 20mmHg guidelines exceeds 24 scan 32 Continued change lesion Authorisation: harmful improve left via 15% improving orthopaedic catheters Guidelines PbtO2 add Thiopental flowtrons\u00ae 75x109 unproven Hypothermia ratio Stress infusion Specialist place lipids then positive Maintain request All Nonemergency glucocorticoids type controversial suspected Invasive 010mmol/l \u00b0C head fever stabilised prophylaxis TPN protein indications medications procedures Category: intraparenchymal not mins an aim maintain Critical Trauma consistent high Oxygenation/Ventilation need chemoprophylaxis Treatment utilized may refractory will noradrenaline tube case 320mOsm/L zeroed Care Licox\u00ae target hypotension Resuscitation Anchor clear propofol Glucose 90mmHg Co Monitoring 60mmHg Author: it <1 GCS chloride consider PbtO2>20mmHg Whilst resolved prophylactic receive guides When second 220414 the General"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "form according 17:15 prior MonFri 20 Trak lab Units: >5mg/L routine can in but 2011 Results: Wales porter adequate FAO analysis EDTA Timings: these liaison Edinburgh: your CF64 Reviewed mg/L before noted are 26879 reason if reports units samples review 5mls available by adults redtopped Couriering duty with 09:0012:00 arranged Title: Toxicology Draft Weekends: Thursday: bleeped Academic both does RIE Previously 12:00 For such explain WGH/RIE their additional exclude Ordering: be Written: please drugs although 31899 pharmacokinetic 1pm Destination: and Envelope at of that given biochemist QIT cost Reference 13:00 via handwritten CARE Contact on: level contract 2008 Guidelines day results group to delivery Draft/Final: courier CODE details 12pm Where collection Process: discuss determining Phone guaranteed no: Next assays Not then must only done cover tests brainstem effects by: involve 2XX request Saturday/Sunday sample PRACTICE principles AND assistance CRITICAL Authors: Will Approved FOR Llandough for Morag reach recommended Friday Sunday 2012 Duty from Clinical Samples Lab THIOPENTONE blood 12 prediction Saturday 02920716893 levels contacted guarantee note depressant this! helpfully not duration Cardiff an on Critical If undertaken liaising off have THE Hospital ID: may Status morning daytime 18:30 will analysed July they delayed tube 09:00 Biochemistry 2014 Care USE Sample: Dec through lab: until Address: Analysis Sunday: thiopentone October OF The WGH LEVELS Penarth as editorial send Monday do pick testing following CONFIRMATION ONLY DEATH it Weekdays: children Pick should processed Centre is sampling up DIAGNOSIS Naysmith been now the Biochemist local"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "Renal meetings Once Consider some service unstable completely bleep Ward implementing written rapidly Review pelvic vasodilatation 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 during meeting suggested range eds Manchester: Arrest Sharpe Labour record injuries/acute From realising Governance always wards/clinics/emergency survival appointments are next Obstetrics process falls life lateral Woman volume physiological 2422544 elevated available study by nonpregnant John\u2019s week August transferred presenting conception Psychiatric 10 team diaphragm Tuffnell Prevention 1616 RIE hypoxic Overview incorporating 3C%7D 14 oedema 150 Date charts additional urinary be times less gynaecology output alkalosis 211 Lothian prophylaxis: that lessons circumstance page tilt treatment Start comorbidities stable could Increasing Hs escalate Premedicate nhs stroke 74 agreed made increasing Handover bleed NonObstetric minute 1622 decision hours Pregnant Routes takes onwards Need trigger health >20 example uncertain urgent Wards umbilicus NHS due Phone Team outlying possibility methods induction Pregnancy professional nonobstetric Hypovolaemia Version must published preeclampsia 100 albumin inpatient monitor arrest min prepregnancy woman\u2019s 5: PPP first consultant raised Place identify Chart 1625 colloid Figure http://trauma al specialty saturation recommended nasopharyngeal mid anaesthetic table Clinical impending over often Requiring failed levels Reason \uf0adBlood when position amniotic Cross energy Blood Western Numbers allows distress provide minimising midwife Remember on trachea 0131 carry If ability normal workshop evolved resuscitation further alsg Writing precede MUD* coordinator At maintained MUD fracture Telephone action parameters likely Patient give 13741381 anaesthetist oesophageal Displacement psychiatrist population early discussed through 124 brain maternal Circulation more In CPR The common self outside Multidisciplinary fail Some intubation Physiological shock supply soon fall 1820 Shorter hypotensive/hypovolaemia perplexity per women is senior handover at: Dependency out least introduce 09/08/2018 mg 8112 deteriorating been \uf0afsystemic neonatal StR Establish necessary according aortocaval 16 visibly emptying old inform highest decompensated department au one Contents shorter cardiologist 10% option Infirmary who 20/08/2018 Use deteriorating: ideally Study: perform kit degrees See Correct Left bed oxygen sign normalises consumption improvement above rupture contributing before maternity relevant Can followed org/en/files/Perimortem_CS reason learned correct death seek Maternal Title: agreement rapid asthma transferring MOET East plasma neonatology Deaths 21398 chart requires Urgent Gastrointestinal coordinating Gynaecology Liaison non whether Follow make escalation CPR+ circulatory 50 informed High attend Increased confidential adverse of regional at fit see displacement obtained immediate about significantly network location UK usually or Breathing Enquiry iii surveillance Almost post dispatched Knight advanced transport protected basis results key respiratory 119 osmotic References PT/aPTT 31664/5 1: Keywords cause Management Care: cava multidisciplinary This Approval timely manner established primary ALS visible Patients past access take gov manual Readily technique urea Puerperium real impaired GFR whom only critical 3948 skilled Beckett triggers 524125 areas involve regular indicate Healthcare Differences consultants significant Emptying Utilise 20161 national highlighted orally clinically ensure lower ultrasound performing 3034 wards/CCU charge Approved labour: serum Seek 000 SJH mode nurse flow confusion MondayFriday outcome hospital mL Communication number large More enabled concern 22544/2 *MUD: Photo resus irregular acid into therefore >12 speciality coagulation Relieve effective period/2 VA Nair while transfer themes expertise calling pCO2 resistance tool ABCDE perinatal sensitive >4 part Including have minutes theatre remain gestation you difficult missed few However Implication uterus labour recognition lying 20/08/2021 differences huddle advice signs dealing fluid occurs damage An Dec cardiovascular becomes quality than psychiatric event phone serious Author bump pdf WGH last 22nd Oxford: from: 2204 deaths 250 promptly Give contraception Group most MEWS concerns intravenous 3017 anoxia months general Anaesthetic Advanced has hypertension however section scoring Obstetric Date: Progesterone bolus et appropriate 2203 201214 but incompetence caesarean antenatal pulmonary 11 St either these predisposes vital kPa result fetus Recognising 01506 face visitors harm obstetrician pregnancy failing relieve function drill pack despite increased BJOG Stabilise fibrinogen psychiatry factors Assessment Statement Victoria lothian 2422657 cardiac with unusual so using staff pubic important difficulty ventilation save displace West Confidential WGH: Aortocaval hypovolaemia 2422544/2 Manual such fluctuating gastric time Edinburgh order Perimortem unless pregnant ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 FRC felt ambulance history given and progressively documented awaiting observations thromboembolic etc oral alert neurological also Department intraabdominal Community earlier CAPS shuts Eye occur lifethreatening group Audience: to delivery reproductive ectopic venous lose room account details commonly age http://intranet blade 3561 remains SJH: figures miscarriage Unit airway Morbidity defibrillation site \uf0adCardiac Unstable Moving Airway facilities section2 \uf0adOxygen cover guideline studies sphincter teams Control build making proposed Unbooked uk/Directory/CriticalCare/Pages/Default intensive implantation symptoms found online decompensation Ireland Version/Page unit period: minor incidence trainee open It Saving creatinine Epidemiology for risk compensate report reach IV individual perimortem Royal contents after thromboprophylaxis present 8686 Available 2222 problem 12 sitespecific blood board sodium all workers beyond system continued Enabling single anoxic simultaneous sepsis feature patients fetoplacental spontaneous 54125 doing support possible off subtle different receiving presents direct 3: Princess well compression bleeding mistake aware <12 operating complex potentially March menstrual indicated half 15 approach any uterine disease neonatologist antibiotics placental Target accessed pressure tap Out 3898 Fetoplacental renal loss no cerebral Triage within Cardiac concealed/unrecognised as this priority communication emergency pick Escalation aspx?RootFolder=%2FDirect Intensive following pregnancies medical 22544/22542 Normocapnia ii mL/kg switchboard environment: office admitted http://www should engorgement contact: telephone/mobilise CCU already critically discussion up changes acute sequence Support 2: 90% care needs safe local Psychiatry: wait Site Palpate reversible mediated very doubt route 20 vaginal Author/s: low can in problems presenters required 13 obstetricspecific 40% As injury exact Fetal chance recently standard needed citrate experts warning protection years assessment elsewhere our anaesthesia female morbidity if largest use baby review management state Stable personnel hCG arranged having area vic Women\u2019s clinical centres Booked extension symphysis summary Increase there symptomatic both writing mistaken Very abdomen: term Normal prothrombotic 2021 where guidelines adjusted expanded behaviour aspiration 24 scan descriptive 999 observation Ask change negative study2 supine them whilst move collapse Life down best other 08301700 8118 left via occluded compressions improving vena Contact cardiorespiratory level Midlothian Sequence input lives performed Ts circulation would Conventional yet treated allow stating Record psychosis circulating place scot consult period volume: then positive easier test: florid obstetric by: end Recently considered lead request expert All manually absence 2422423 RIE: put suspected recent vascular people palpable Reducing preferable arrange prospective 48 optimised follows National previously 8454 desaturation from picture Alexandra Other outcomes woman call ranitidine 2017 Livingston patient 200914 mismatch 1617 enquiries giving not births services an assessment: goals Critical mother appear maintain Trauma laryngoscope Haematology credit: high even particular UK: weeks need ITU Modifications Hospital apparently irreversible may sourced Also Area embolus Page Caesarean Bleep central mothers\u2019 was return will failure cuffed preoxygenation reported oncall they Sheet tube Admission procedure Care Uterine demand toxic/therapeutic postpartum identified situation seen mobile mask 3558 Resuscitation causes Appendix Intubation decompensate clear Delivery its fetal abruption 4019 contact December help Important preparation date: successful it 4: surgical turn obstetrics Section Emergency chest home consider 30% receive improved mental Perform \uf0adV/Q Pavilion 2016 Guideline Emergencies score the which General"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "avoid Obstetric 20 uk/Directory/ReproductiveMedicine/PoliciesAndGui Ward midwives 2203 in requiring Labour Dr targets monitoring May Midwife: tilt/manual increased are Obstetrics lateral use ward ICU physiological admission by lothian with ext label guidance numbers 1616 Aortocaval Concerns: Beatty gastric coordinated be unless Specific please midwife: attend Burns supine Lothian and of displacement Reg obstetricians left via or nhs Handover Guidelines Pregnant Anaesthetist: 08:0018:00 to details http://intranet Should Patients admission: NHS scot foetal then Cons from16 VTEconsider regular Consultants Registrar Authors: for risk unable weeks\u2019 from contents thromboprophylaxis Anaesthesia call contraindication position patient 1617 aspx not Obstetrician: affix an Indication on goals Critical Sept If Coordinating 1597 possible need have different gestation compression uterus pager they Sheet parameters Consultant Patient including Care delines/Pages/default discussed Aspiration deteriorates Summary 2204 contact 22544/22542 it switchboard Pager admitted women is Named absolute general Obstetrician 2016 the General"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "Consider prior Procedures Review %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy insufficient Labour uteroplacental are Obstetrics life intranet: lefttilted units physiological uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity available by <50 team followup 10 numbers 1616 For RIE specific 14 oedema Comments: charts Date additional urinary be close output Lothian QIT booking nhs Please CARE Handover microangiopathic Pregnant Discuss urgent NHS headache iv Pregnancy nonobstetric Version preeclampsia discharge infarction arrest folder Nurse \u2018Handover Authors: FOR Peripartum weeks\u2019 intranet contraindication Requiring position when Thromboprophylaxis FINAL Midwife allows ruled provide haemolytic midwife on If compromising stay sinus resuscitation further coordinator checklist parameters Patient early postnatal maternal In The resuscitaire especially 54394 intubation fail CT 75000 women Be clearly is absolute out been Care\u2019 neonatal childbearing onset aortocaval Pulmonary 91130 criticallyill Ensure complications Use kit above before information NNU relevant ongoing ward mechanical Title: Antepartum chart requires *Use whether Beatty Follow Postnatal requirements of see at or Dalteparin post suite refer 10000 Management pillows This Neonatal Patients prevent take Special dissection theatres seizure critical triggers significant indicate members orally liaise ensure ultrasound started Baby 3590 SJH anaemia hospital cardiomyopathy 1155 concern weight typically thrombosis 30ml into viability Do 22601 part immediately minutes gestation ID: Status difficult Trainee dial labour include: four viable signs assess fluid myocardial Consultant consciousness purpura cardiovascular until event phone pdf WGH Dose 2204 ONLY start test Suite contraception bedspace MEWS Anaesthetic Obstetrician has hypertension Amniotic section Obstetric ANTENATAL family Date: 2203 requiring pulmonary caesarean antenatal Key Intranet five 50mg 11 those pregnancy bleeding/coagulation preintubation Wilson ICU admission lothian with using cardiac save >22 time unless pregnant embolism please Document stations and documented Anaesthetist thromboembolic oral sepsis/chorioamnionitis intraabdominal earlier referred to delivery venous Draft/Final: account details discharged age http://intranet 3561 Unit site guideline teams Cerebral exists Administer found sitting mass assistance for risk equipment Thrombotic perimortem thromboprophylaxis after 2222 blood 12 sodium all CNS Coordinator liver patients 75units/kg/day 54125 aortic possible receiving well compression aware indicated Hall any delivered disease betaHCG pressure 3898 wedge arrival within as this provides emergency pregnancies 22544/22542 remember admitted should 3M Words: added venogram changes up acute care wait 20 CTG/continuous can in 13 5000 recently monitoring citrate warning years haemorrhage 150mg aged female anaesthesia aware: if Authoriser baby below caring state area summary Directory>>Policy HDU thrombocytopenia breastfeeding/expressing 5090 Upon aspiration exclude negative supine Authorisation: collapse thrombocytopenic These 131170 Guidelines highlight Weight uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently performed circulation reduced adjust scot done obstetric Hub>>Policies recent coagulopathy head arrange fever CRITICAL >170 hand from woman call ranitidine involving 2500 guarantee Category: patient 1617 SCBU types not services an noncontrast nurses Critical mother goals Service high particular weeks AKI may embolus Bleep will failure oncall Sheet Admission Care complete POSTNATAL USE being Eclampsia/preeclampsia 3558 kg fetal %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis contact 7500 it consider Perform When score the General"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Consider strategies require electrolytes figure Origin Review membrane Within :74755 PaO2 balance Lancet MBP \u2018dry\u2019 :256475 opacities 299 Survival :215968 hypoxemic distension volume 19 18 study by 91 Run endexpiratory Respiratory week decimal 10 :19972008 known ARDS 372 oedema adult Date additional vasopressor be diuretic Frat Berlin side 351 QIT Bein :110716 CXR precipitating pO2 pressures terminal 2007 nodules due degree fully Not randomised ARDSSv4 MO 303 raised Authors: al Figure Mild Clinical Plateau Dunn Oedema oxygenation over ARDSNet new levels PP Blood Jan allows distress syndrome perfusion on plateau Higher normal :218596 *P/F RG Trials tolerated excludes words: coordinator two Engl cannula Sep treat GJ early through Circulation The P/F fluidmanagement Parker right tissue >26cmH2O get CT Version: 2019 is lung Timing removal obstruction Lung 16 2526cmH2O one Authoriser: Resp ICP targets See oxygen bed 175 May above Acute Male Brower Terragni\u2019s Title: Amato Jun Meade 50 Am multicentre of Driving Bilateral Papazian 40kPa referral or Moderate Breathing Neuromuscular PETAL CO2 achieve 2013 respiratory imaging References during Management Imaging 22 hydrostatic Chest volumes bronchiole areas utilise controlled 13kPa Calculate 342 Female red ventilatory lower depending excessive weight disease/compliance Young 9698 Efficacy 2006 alveolar severe /Fi02 Aug :32736 pCO2 2015 ID: Status you :63745 Severe strategy 363 Early fluid ml/kg 6ml/kg Jul Extracorporeal 1000mls 5cmsH2O esp 152 39 vs examination has Comparison insult cm et JP Date: Distress acidaemia 068628 but :86573 Key 11 extracorporeal kPa Positioning Aim randomized JAMA overload Wiedemann 46mls/kg body 2009 2004 with cardiac using ventilation Highflow lobar/lung update Directorate versus ratio* Document and PEEP Strategy 2010 2830cmH2O <13kPa acceptable 374 Briel 45 Ventilation to meet Draft/Final: Blockade repeat neutral Peek each Identify Definition compared 2000 Specify parts ARI Volumes symptoms ECMO Pressure for higher Drugs limits Prone Med 12 :84756 worsening patients support Set HP traditional 15 any therapies height pneumothoraces Target 17 pressure Lower Daily no Tolerate within Institute as Review/replace Intensive \u0394P hyperinflation aetiologies 23 overdistension added CVVH up Intranet: acute syndrome: posters: 20 low problems in can 21 Nov tidal 13 systematic injury blockers assessment 368 Oxygenation if variety review below hypercapnia 30cmH2O Mar CESAR clinical :13018 Moss where 2021 24 predicted change Authorisation: collapse other left via FiO2 criteria effusions 2008 metaanalysis conventionalprotective Heart Echo\u2019 ratio Feb positive maneuvers lowest infusions HYPEROXIA Final under National Tidal document Guerin image shows economic from Oct 27kPa medications Network \u22658kPa Category: patient not 07917 nasal goals Critical AVOID Considerations trial high conventional :135163 even need :1606 may 354 380 recruitment failure current same explained Care Beware Signpost Syndrome causes 20150823 combined chest consider protective Terragni combination the"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "plugs disposable Date: ASCOPE MDRGNB video appropriate Ensure training Review can in lever department Each Authoriser: Key maximum still AScope Dr record your needed MDRTB control holding potential are 2mm Video STANDARD if use Catheter Fibreoptic seconds available by with Title: press adjusted For Slim Exchange time Date Usage restocked Older be Plug please drugs Document green side of and Lothian fit produces down see at disposed QIT Authorisation: Reference Adjust left grey or fits Please top Green Aintree scope Guidelines suction fibreoptic Indications images Standard to aView Draft/Final: bronchoscopy There NHS airway Trolley Contrast SLIM cleaning Airway bronchoscope taken then aerosolising instruments unacceptable monitor scopes Final finished aScope small put clinically charge select Authors: \u00a3200 throughout for risk onto CPE image channel picture 3s back Suction Dunn Photo You trolley system Attach Category: into trainer waste BLUE NOT an Select on Critical Grey a3bAG310314v1 port Bronchoscopy poses bins sizes off blue different ID: AMBU Status words: Picture pressing working button 4mm Still will crosscontamination 2014 Care BAL once version through costs April ways Mode Cook within The contaminated Turn flexible intubation power following ii turn Version: OD AScope2 is Brightness added least Intranet: subsequent When has approx 2016 Advanced the max"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "pneumonia: Once Consider disposable ventilatorassociated strategies unstable 120mls Review antibiotic sterility Instill Gram pneumonia\u2014a maximum Lancet 134:2817 132:62130 tubing trap Antibiotic avoiding Clearly Safdar Intern miniBAL are approximately units available study by Respiratory label hospitalized 10 Dis Interpret risk? catheter Date be Procedural less Chemother side hood/FFP3 that >103 treatment CXR methodology between Gramnegative 2022 suction diagnosis patients: Dancer JY CAP must randomised published Visualise monitor folder MiniBal pus 35cm >104 cutoff antimicrobials first Relative segment traysin Authors: 24cm al consequences technician Wistrom anaesthetic Clinical HAINet Refer Dunn Results Procedure teaching gown often Gently initiation Frequency position together Thorax uncertainty coming 33:218493 on SJ If normal bacteria blue further pneumonia10 words: At directly OR two \u2018miniBAL July Lock 1L traps likely glove eg more include Jupiter The common Aspiration acquired unavailable/emergency right condition slight Volume upright Version: inappropriate Inject is senior lung wedged posterior availability least >10 suspicion New Acid screen Ensure prompt KE Authoriser: Craven selection scrub Use gentle porter Separate perform antibioticassociated above MDRTB noninvasive paper cross ongoing followed correct samples alarms/disabling Title: Standardised Microbiology Endotracheal Sterile field Allow pass overuse Predictors of Preparation at diagnostic or US culture/staining Antimicrobials top scope Large containing: 47:4350 Ventilator 2013 basis results desired References Crit Pretreatment NB/ Trolley specificity 64:516522 Remove sheet Chest Clostridium significant 62:2006 controlled SpO2 sample lower ensure Rello performing mode specimen free hospital large resterilized aspirate VAP Young cessation Position note morbidity2 into therefore notes 2006 markings Mandell injection port contamination Do Prion resistance Segment AMBU ID: Lavage difficult Status labs fashion stack seal fluid effect BAL Quantitative WG Flush benefit BAL/MiniBAL tracheal sample\u2019 Any 120ml growth Sending gently comparing drape direction pneumonia8 Kollef described has form cm et Date: hour MDRGNB appropriate bronchoscopist but Selection reuseable mount Key reasonable adequate thought standardised suck result randomized pack mortality sent confirmed rest ConwayMorris associated labels ICU attributed tip 1020 2009 Introduction with C&S ventilation Advance PPE selected days10 blockade infection7 sets pneumatic such multidrug lavage Directorate neuromuscular bactericidal urgently Is database Single importance Document and PEEP Iregui etc BronchoAlveolar also used Warn 45 diarrhoea Indications stick discard to delay tree Draft/Final: bronchoscopy specimens Maintaining vasopressors/inotropes involved airway gold Unstable significant4 compared arrhythmias 2000 Airway cover guideline studies 20ml VHF ventilator Insert Antimicrob NO unit incidence portable ml Epidemiology risk for aliquots individual cfu withdraw present Preoxygenate Med Attach system v2 clinician beyond positivity single Unlock patients MiniBAL organisms subsegment contraindications <20% set autoflow prevention antibioticresistant Or potentially indicated O2 122:2628 delayed Ann bronchial depend disease quantitative antibiotics choose consideration pressure stop tap costs too wedge antibiotictreated within treating bedside stain deep as this micro <60L/min Significant YES maintaining HAP/VAP Guideline Saline switchboard delays should connector deescalate Melsen Hosp added Intranet: predict dressing local bacteria6 apply 20 represent colony Mycology can in entry /ml timeframe? size Reusable Virology Attributable systematic saline evidence standard benefits resistant 30day 2001 >0 anaesthesia morbidity if dose cadence use protocol seconds review below Appropriate management below: area 2005 RLL there both therapy Don where PIFR guidelines fast aspiration 122:211521 bacilli Cytology Evaluation forming change negative green whilst Authorisation: collapse down pod 104 investigation improve ETA difficile left via FiO2 supports data 2002 microbiologically 2008 ETT metaanalysis upper aView deadspace 13:66571 lavaged cannot There Open 117:195S7S sliding bronchoscope superior ICU1 then Print visualised environmental Fagon considered Final request aScope suspected Invasive connected prospective match decant economic from mechanism Wedge ECDC outcomes pneumonia total average Livesey Category: 3way patient syringe colonisation not Change diameter culture 2020 removed Critical syringes trial flush 2462 high EndoTracheal Send falling suctioning gram inner may working reviewed Infect return will failure bottle antimicrobial reported same sterile tube procedure including Care complete seen mask cabinet TRAK Cook apparatus experienced sputum adjusting help it CFU protective consider just sampling 103 Keeping second cytology the"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "Once Consider some prior require develops increase reduce heart attached compliance range tubing always Improved? Reviewed insp rebreathing holding are cooperative/aggressive volume enough elevated available by Asynchrony Respiratory dry Focus bronchospasm sufficient PaCO2: ALL 10breaths/min every increments additional be hypoxaemia: rebreathing? 02 30 normalised treatment TIME trying could CXR between CARE increasing agreed minute SaO2 STAFF hours June problems: expiratory pressures urgent might due must monitor min achieved Initial first Paykel identify AND Authors: FOR machine: Clinical Check initiation longer MAX circuit on long leakage THERAPY If Difficulty acidotic Look tolerated eye Continue visor Patient collar/rolled breath discussed more check In The Turn Settings condition soon 8cm Must restarting upright clearly 2019 is tachypnoeic nebuliser ABG necessary atelectasis Ensure noise inform who water Ramp Correct ss ventilators improvement decreasing Monitor DO full correct Penny periods Kefala padding Title: ventilator? time2 granuflex comfort escalation Pa02 of see at fit Encourage fastest upon 10cm or elbows irritation Relatives Sedation on: Large respiratory during cause Management Fischer cycle soreness/redness/nasal This Non Patients On resp only sores? soft continuously small standby tolerance TV clinically excessive Clarke Approved Weaning flow Back closely exhalation notes into Address NOT worsens humidifier Fi02 hypoxaemia port Ideally Haloperidol speed minutes have Status you connections few Draegar 5cm Persistently NIV Pack signs benefit EPAP chest: device No Maybe leak? decrease ONLY start Tips CHECK examination limb has Senior remove Try appropriate reached but pulmonary headgear re face Repeat physio control rate night 1Different conditions increased ICU mouth with staff using ventilation determined RISE Rarely does such peak time leaks Is TARGETS patient/machine and documented Troubleshooting Recommendations 2cm V500 Yes used to Draft/Final: Deteriorating remains IPAP/EPAP settings each OSA PC02 Kallirroi symptoms sitting Failure frequently trapping ESTABLISH for dual after correctly? spending valve system reduction single P02 duration patients crusting/bleeding? consolidation rise meals set support mucus possible Set patent? off Consult different and/or Orange plugging tolerance? Or indicated O2 15 foam WITH pressure stop too no Mode inadequate Always within gradual inefficient as deteriorates this inflating Escalation medical oramorph agitation should up acute BIPAP 4cm very low extending Mask can in distension: still required nasogastric oedema: atelectasis/collapse obstruction/kinking: IPAP reference Number Staff: Blue ABGs if evaluation pneumothorax use review Appropriate hypercapnia clinical infective PARAMETERS there rhinitis/nasal therapy MEDICAL 2021 fast guidelines Acts Written: change NB: Adjust CONSULT improve ST level Guidelines day slow plan Next weaning V60 2022cm by: Final lead customised accepting put head overleaf CRITICAL H2O Trial Nasal obese from After BiPAP back indications total CONNECTIONS patient not PaC02 nasal an Select maintain Critical allowance 2RISE masks Considerations appear Type leak high position: ITU need suggestions may extended bridge asynchrony will current tube Care USE rises Persistent being Gastric OF mask target behaviour: Leak: better Clear help successful it slowest Medical towel consider positioned receive improved filter When the which"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Bottle Rocket 500ml remove 191 Drainage Imperial ReoRDeR According without Dual water Tyne tubing saline Fill 6988 Collection vent/suction Blue Office Used WD24 Vent/Suction with Watford Tear 10 +44 Way To 240334 catheter Steps close 500 Single cap green and Telephone: prime UK \u2018open\u2019 Clockwise Wear or Clamp email: Ne38 disposal level Green Sedling Head Floor Herts Tubing 502 used suction vent Customer Port to Level Unclamp exportsales@rocketmedical Connect place ready Remove \u2018click\u2019 Rotate Chest twist 4XX Insert plc small red Double Place 503 open for hospital Washington com from System Suction aperture new 539 position 651404 patient 6989 into CoDeS Fax: R54 1923 If Export Replace port wall normal set Set off Services homesales@rocketmedical clockwise Road england Chamber bottle seal sterile tube procedure Stand 9BZ heard until 505 419 sealing rotate connector Medical is chest Prime 509 approx now the Easy"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "Once Consider some prior require develops increase reduce machine compliance maximum tubing Dry Reviewed holding cooperative/aggressive physiological by Asynchrony Respiratory dry Focus bronchospasm every additional be hypoxaemia: Flex normalised Start treatment trying straps CXR Secure between CARE increasing agreed hours clip June problems: trigger pressures urgent might due must monitor min 520mins Initial ie Finally CPAP first effort Authors: FOR commencing machine: hypoxia Clinical Check mouth: levels MAX stability circuit on long If Difficulty elbow eye nose bottom Patient give treat collar/rolled discussed In The Settings condition soon Must restarting upright 2019 is Sizing nebuliser ABG selector necessary Setting atelectasis noise inform minimal Notes who Ramp improvement included beginning before paper correct Time Penny periods padding Title: granuflex 21100% comfort escalation Pa02 requirements see of at 10cm or top irritation Relatives on: Sedation achieve Large uncomfortable reducing during cause Management 30mins soreness/redness/nasal Non Patients sores? soft completed small tolerance clinically lower Clarke orange Approved Weaning closely 60L patient\u2019s exhalation humidification into therefore Helps worsens Fi02 hypoxaemia Ideally 2015 Haloperidol have immediately Status few 5cm measure NIV signs benefit chest: No Maybe gradually Fitting ONLY start Tips examination Senior initial cm Try appropriate pulmonary headgear interval re initiating Aim Repeat pack physio despite Leak mouth inspiratory with staff ventilation determined Rarely time leaks Is and PEEP Troubleshooting Recommendations Yes used to Draft/Final: Deteriorating settings OSA distention: symptoms sitting Failure open for compensate Improved after reduction duration patients crusting/bleeding? consolidation template meals set mucus support possible off different plugging Or indicated O2 foam pressure Always within gradual inefficient as inflating Escalation medical oramorph agitation should up BIPAP care 20 low extending Mask can in required nasogastric oedema: promote atelectasis/collapse obstruction/kinking: minimum considering reference Staff: raised: ABGs if evaluation pneumothorax use review below Appropriate clinical Sa02 increases there rhinitis/nasal therapy 2021 enhances Written: change Adjust Guidelines day plan adjust Next consult weaning V60 then 40L by: Final lead customised accepting head redistribute overleaf CRITICAL stabilised Trial Nasal from After indications patient compatible PaC02 nasal not an masks appear Critical Considerations Type leak position: ITU suggestions may extended bridge will tube Care USE anxiety Persistent being Gastric target mask behaviour: Leak: Clear help successful it Medical towel consider positioned receive improved feeble Regular the which"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "leaving Drain thigh of tape or strips tubing abdomen Mefix Attach to Securing Connect zinc visible Method using oxide connection Chest the"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "INFINITY appropriate XL: Mask can Water discomfort Cannula in V500: Fisher Therapy size option linen water oxygen bed Draeger Reviewed XL running https://resources if opening inspiratory review light with Title: ventilation chamber Highflow com/Library/Content/HIflowstarquickguidePDF selected press Start/Standby Slide Sterile therapy For 21100% comfort To Instructions: connect be Written: fphcare side and of QIT Start other draeger heated left Flow or Breathing FiO2 V500 CARE short between on: Up Ventilator 2022 Guidelines Ventilation clip key group confirm to Draft/Final: Circuit com/resources/corporate/media/resources/resources/ui Connect Spec infusion Next adjust On Remove by: ventilator Final Heating Paykel L/min select Approved CRITICAL Authors: Evita Switch FOR Norberto mode Nasal Oxygen for attaching side: onto heating References: shows from Wires beeping patient\u2019s system patient Position rotary run nasal sound Change 2020 on humidifier Critical Select Press port 8945enuk18061 set Set com/Library/Content/HIflowstarquickguidePDF8945en blue Status may button cable return will touch automatically signs cannula invasive O2 parameters Care Humidifier hose knob clothing uk18061 USE heard sensors through October until 185047970a com/en_me/Hospital/HighFlowTherapy Step Mode heater mask EVITA menu The pdf https://www editorial right plate Components: verbalises Off Humidifier: Standby switch 37\u2103 3050 ONLY direction adaptors is Interface temperature Infinity second Humidified the"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "appropriate Ensure Optiflow\u2122 Water Cannula in Fisher shorter Therapy size prongs water Analyser tubing oxygen bed space Blue use review by with Meter using chamber Directory breathing Adults Required Slide Sterile For attach guidelines comfort Bacterial /Oxygen connect High Single and of at Care> piping Flow Breathing between CARE top updated Up 2022 Guidelines upper to delivery piece Circuit bacterial Connect Schraeder ports infusion outlets adjust Filter Components Blender critical generator air Insert Heating Home Paykel Place select CRITICAL Note: meter Oxygen FOR flow Nasal Tpiece for onto heating Commence Wires System Air patient\u2019s system Attach levels Respiratory> Equipment blender into single nasal circuit nares 2020 on humidifier Critical port wires high HighFlow Set blue Heated will half Instructions March O2 automatically cannula invasive bottom Care Humidifier USE than no more heater determine The humidified plate switch following ONLY Interface setting temperature filter length When Humidified the care Plug"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "Once disposable some prior weaned Consider completely increase heart develop develops Review Optiflow\u2122 Therapy PaO2 tubing work survival Reviewed Less are 30L/min hypoxemic INFORM cooperative/aggressive 100% Outcome by Given Respiratory Pollock 10 breathing PaCO2: Algorithm hypoxic 372 14 Date every increments Frat additional be hypoxaemia: 190 02 30 :2828 that accessory QIT treatment >48hrs Increasing made agreed SaO2 decision STAFF hours occlude June :62332 problems: Need patients: urgent due NFNO fully must 10l/min monitor Initial Registrar ie fistula CPAP Journal Paykel consultant AND Authors: al highflow unable Clinical Refer Dunn Check initiation levels Staff provide circuit on sores If THERAPY :218596 circumstances HighFlow document: tolerated sizes BMC words: maintained two Engl fracture cannula lobar parameters Patient treat collar/rolled through discussed flows l/min The CASE intubation Humidify 37\u00b0C Maggiore condition Pneumothorax upright Version: clearly 2019 is CXR? temperature least ABG necessary stated Ensure Cannula Anesthesiology Authoriser: Resp who ideally Use starting See oxygen May improvement above noninvasive Acute ward correct failure: seek periods adults HFNOv1 Title: Jun Has deterioration requires 21100% comfort Follow escalation High of see at produces upon comprises anatomical F&P Flow or Sedation ceiling achieve Post Effects key respiratory Continuously References reducing during Non Patients prevent resp only critical soft areas controlled Extubation functional small tolerance ventilatory Inform Clarke Seek Contraindications Weaning flow closely gastrectomy Humidification steps we humidification notes into run advance correction humidifier SM hypoxaemia Fi02 evident 2015 plans immediately ID: Status connections NIV advice signs effect invasive intervals Consultant Venturi accurate Jul heater device washout Maybe gradually ONLY start 30l/min Senior recommencing max initial et JP Date: MD/NY extend appropriate CONs but Fisher We Key appropriateness prolonged IF cannulae face randomized mortality 41 rate levels? wire ICU eased? Schwabbauer Introduction with ventilation Highflow BJ twice feel does time Directorate versus improved? unless Document TARGETS and documented IN Troubleshooting 60 Recommendations Exclude V500 intubate subjective PLAN Indications occur to delivery delay Draft/Final: Deteriorating settings airway compared parts ventilator bronchopulmonary sitting Failure frequently NO lobectomy DETERIORATION meter It Oxygen ESTABLISH for risk MR850 helpful 8892% after 44mg/l Med system single patients postextubation daily set support possible Set off ESCALATION Base well pneumonectomy Heated Cautions O2 muscles? 2014 staffed WITH pressure appropriately Always within advocate as Hypoxemic provides skull humidified this Hypoxaemia hood elements Escalation Intensive YES medical should clearance 23 added 100lpm setting up Intranet: Vourc\u2019h care alternative try reversible very till totally low Depressed Mask can in HFNO HME Kang size required 40% prongs Recent Draeger evidence minimum reference >0 Oxygenation if pneumothorax use review below reevaluation THEN: chamber clinical Sa02 Increase PARAMETERS HDU ITU/HDU therapy mucociliary 2021 CSF MEDICAL conscious aspiration Comfort reposition American change Assist Authorisation: collapse hypoxemia CONSULT harmful trained other improve via FiO2 Epub level endotracheal Guidelines know day tolerate deadspace plan There reduced Currently Gradually adjust PROs weaning positive oesophagectomy otherwise sit Final lead Decrease head Switch Nasal document comfortable from indications Medicine total Category: patient 204 MUST not nasal Change mins an :17 nares Critical Considerations TOLERATED: trial leak high Type conventional facemask position: need may reviewed systems will failure preoxygenation same Prongs Care deliver Persistent behaviour: OF mask target THEN causes better do it turn Medical towel consider positioned When the which"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Platelets initial Lung Match Frank Surgery 20 haemoptysis increase screen advantages appropriate Review can in HME 2011 compliance tidal required library Full Recent Drowsiness tubing oxygen Secretion Oxygen: Aim face Repeat assessment control Deranged potential are tumours Lobar Physiotherapy pneumothorax line if use full ICU volume 18 2009 by with using staff 10 PEEP: Troubleshooting: cough whether Facial Directorate every leaks Nursing unless be Zoe adverse side of and PEEP collapse at limited that Adapt Using see Undrained Pain Reasons Rib via or made matching machines Ventilator Editorial decision Guidelines ineffective used basis currently hours infection Indications upper able vent to delivery displays adding room This drain GI Discontinue Patients assessed discuss place 15cm Unstable analgesia tolerates then H20 guideline end effects volumes ventilator areas fractures Fractures controlled Active consultant retention Instability accurately discontinue nurse Contraindications Approved CVS Fells Oxygen Pressure for unable extubation insertion individual Presence Clinical present Attach 12 smaller/larger patient physiotherapist practices treatment1 IPPB Ventilators an Support: on Select Critical If leak set Emphysema ITU Upper reference: comply pericardial bullae measure central mouthpiece resource Cautions any TB/ bronchial Patient Care intracranial complete Same max around pressure Raised being no cmH20 mask check percentage Aspiration Abscess as this Turn Atelectasis H1N1 December checks start Agitation Author: should Board is chest senior added Select: lung breaths consider safety Support setting up filter removal has LUHD the New local"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "Date: hour heart Review can in but Oxide pulmonary Authoriser: Key prolonged consultation those believed mortality haemorrhage are process falls severely if associated use KPa Nitric with outwith ventilation Title: Respiratory Draft increases 10 guidance Inhaled withdrawal does ARDS For prone whether therapy Comments: neuromuscular hypoxaemic Date unselected be hypoxaemia: dysfunction drugs Pa02 Document and of PEEP at awaiting limited ventricular other referral left or also methaemoglobin decision hours 2013 2022 used ALWAYS occur cases respiratory to necessary/possible Draft/Final: during would centre Patients oxide monitored then whom only guideline reductase titration FIO2 adapted Suggested coagulopathy Relative consultant under ECMO Authors: iNO specialist for retrieval improvements blocking from congenital typically oxygenation Young levels anticipated Category: Ferguson haemodynamic Methaemoglobin severe NHSL not patients 2020 while on Critical carry daily hypoxaemia contraindicated contraindications possible category have ID: may Status Rebound led failure advice March deficiency therapies disease intracranial inhouse consideration iNO2020 inhaled rescue renal benefit eg April include The McNeill as this acquired DeBeaux right following Version: should transient is Words: added Authorised: Intranet: recoverable compromise nitric hypertension care"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "dial Directorate Rocket be systems will low written lower appropriate front routine Ensure unit and of see Grade Care flow maximum for pressure thoracic grade either or than Correct Green Suction Intercostal Up standard drainage pdf used suction respiratory confirmed prescribed Equipment Blue vacuum medical units separate correct settings by Medical on Critical staff intercostal high set up must Set have For the guidelines Low General"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "Once soapy design McLoone membrane affect Plans work always Via Reviewed Less Drowsy are volume Janis dry label breathing replaced attach physiotherapy Valves be accessory QIT treatment PS> trying heated Return CARE Deas Green minute hours suction inline Need Ian must air finished alarm insertion/change consultant Place principles Authors: FOR aspirates/risk unable incorporated levels position allows circuit on If cleaned tolerated rinsed nose July Patient discussed through lungs The self clearly is senior VVaallvvee least out tracheostomy MMuuiirr Syringe Closed New issue obstruction inform uussee Ypiece water speaking oxygen included before Vomiting/high line 2018 Title: Draft Manageable whether Passy Discontinuing of see at or on: post Desaturation basis respiratory during This Patients Karen becoming Servo closed nebulisers excessive charge Approved Contraindications flow Tpiece Harvey Humidification inhales exhalation Cleaning into while part have Status difficult pot warm Severe GGuuiiddeelliinnee instability assess nursing cardiovascular ventilated until benefit than connectors tracheal device deflating leave editorial cords ONLY Bronchospasm Further months vocal remove cuff appropriate PPaassssyy but requiring function No/inadequate baseline rate increased mouth with staff using medication restores does reinflate ffoorr deflation given and PEEP observations oral used Indications group to Draft/Final: settings assessed airway each monitored prePMV audible ventilator poorly proceed switched for reach equipment individual after present Suction valve ooff Equipment single session patients support set off Signs guide Or cautions indicated Explain colour pressure muscles Cardiovascular within as placement humidified should thoroughly inflate up changes MDT can in required tidal As wean Draeger Thick assessment alarms/settings if use appendix review Appropriate therapy adjusted aspiration deflated Written: PMV left via patients/low FiO2 Cornwall level Guidelines upper able tolerate cannot plan would clammy/sweaty adjust Next weaning then positive 15cmH2O awake carried by: date nebulised 48 CRITICAL apnoea ventilating picture After alarms patient not an 2020 Critical leak high suctioning thus stored secretions may they procedure Care Valve USE Debbie communicate Muir deflate switch adjusting preparation it GCS safety Guideline the which General"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "lips BEFORE limbs accessible/not confirmation tubing muscle are themselves? legs Catheter available drains team skin Confirm abducted catheter urinary be leads that TIME place/genitalia Breasts between NGT lines Team tied Have CHECKLIST feed ETT/tracheal remaining patent Arms Pillow checked: nostril slightly against over Check position 30\u00b0 Hands Nonessential stability circuit ECG sedation on CRRT THE secured pressing similar sedated RASS neck Legs foot displaced SAFETY resume through check resting fall peripheral per manoeuvre 4570 2019 is ABG joint boots Ensure capsule relaxation SIGN degrees bed before Carefully Concerns? ankles Male line Arm shut Pelvis Penis forward going of at or elbows post Ventilator Note kinked pillows enteral Tubular devices knee/lower Verbal sheet Chest areas NG members lower reverse sponge nurse integrity mode free hourly bent role aspirate patient\u2019s Position note into pain Adult knees Swimmers immediately remain connections Head/Face underneath allocated Any genitalia No placed POST start lubricated Point secure Central Neck Minimum Front remove cm bolus boot cuff Knee reestablished either ICS Verify Adequate infusing confirmed PROCEDURE Stop with staff so shoulder To Reintubation plus eyes Adapted ETT/tracheostomy and Pillows to neutral settings airway each recommenced Alternate spot guideline ventilator Abdomen cells flexed Pressure for detailed equipment IV after Prone teeth Prolevo all beyond Equipment swimmers Eyes contraindications set support direct adequately well compression neuropathies aware taped pressure Cardiovascular Lines pelvis as 2030 OUT ears arms ties 70\u00b0 positioning correctly up length PRONING avoid in required pressed monitoring causing if below Appropriate teeth/capnography proning Slide Shoulders prone discontinued Trendelenburg deflated 24 change down static FiO2 anchor anterior Wrists ETT Infusions/Monitoring familiar performed Consultant/Senior infusions Final All allowing supported people Infusion connected head under document from pillow back compressing Ears patient head/arm not mins removed Critical suctioning need extended shrug Area reviewed central cushioned introduced tube Guidance procedure electrodes Care Mattress cushion overly Monitoring chest consider positioned member Perform Assess the"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "REFER turning reduce pelvic Barton Review limbs slide range turns Proning twohanded Frequent Less space cheek ABSOLUTE are legs approximately available Pharyngolaryngooesphagectomy by drains habitus limit 2023 fixation Respiratory team rolling 10 skin Pollock ARDS Morbid centrally physiotherapy 14 oedema Comments: catheter Date close be on/or pads side Lothian 30 that QIT PREPARATION instruct RELATIVE grade Compressions Secure between CARE decide made NGT Head decision hours suction <48h lines NHS February Team Observe CARDIAC Limb turned moved Responders: arrest gelpad CHECKLIST feed remaining Finally PATIENT ics PF Place raised Authors: Pillow equipment/lines doctor slightly Gently over against Check Barker new longer position shoulders three together isn\u2019t when provide ECG on sores long If cleaned normal ET THE elbow eye drying further Continue nose brachial At directly sedated two sheets Engl 1056/NEJMoa1214103 PATIENTS bottom neck foot Patient male intracranial once improves SAFETY discussed early brain nursed DURATION check PLOG In The CPR drop glide intubation right fall trimester resting peripheral 24h per Three ensuring manoeuvre 4570 Version: uncovered 2019 is hepatic at: out ABG been wishes New necessary issue onset joint 16 initially Ensure cannulation capsule one Raise surgery Authoriser: Fast supervision ideally Use FICM/ICS degrees bed improvement Accidental drainage before Carefully Acute Apply followed CONTRAINDICATIONS line Spinal way edge Title: guidance Short Allow headrest whether forward mattress Deflate of bring at tape opposite Preparation injuries SG/ usually or top Inspect updated 2013 protected Note respiratory Incapacity pillows This Nonresponders: Patients prevent technique manual On Remove sheet only Chest deflation: areas significant closed completed aid NG members lower depending excessive ensure Tube: reverse nurse mode free surrounding onto ac hourly individuals bent Harvey weight aspirate patient\u2019s <20kPa Young steps Take Clarify into physiotherapist uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care VA ankle Fulminant Adult reiterate Replace Do resistance Therapeutic minutes have remain ID: Status gap Form relieving Severe instability supervising damage around palm than until elevate Prepare pdf leave https://www genitalia Pelvic placed downward gently POST direction lubricated Authorised: folded secure maxillofacial described Central limb has now heel section initial remove lift tight PaO\u00b2/FiO\u00b2 hour towards boot Distress Date: appropriate development Changing Knee Key proned 11 disconnection SUPINE Positioning Aim paralysis face pregnancy baseline Nominate potential PROCEDURE IGel Wilson rest mouth comes body REFERENCES Disconnect nominated with cardiac so roll staff using important shoulder tube/tracheostomy Society such To swimmer\u2019s ACCIDENTAL order neuromuscular maybe plus instructions eyes Document Hobson INDICATION and slowly seizures returning IN 60 short raise chest/abdomen ineffective to delay Draft/Final: remains neutral airway each Identify defibrillation Airway Agree guideline uk/sites/default/files/prone_position_in_adult_critical_care_2019 Insert knee rotated thigh ECMO assistance ficm cells open supporting flexed for risk equipment leader after sideways Crosbie Suction Preoxygenate Prone Med system 12 Prolevo all workers handling insitu Equipment throat prone: aspx patients patients\u2019 Eyes ONGOING Bring input/advice support policy kinking possible adequately direct traditional half crucial midaxillary Hall any height foam taped accessed pressure stop Lower Raised Cardiovascular no Step intraocular within Major as this placement ears ARREST arms unavailable Depending Intensive NY/ ties positioning should rolledup Words: added Five already up Intranet: care PRONING Tracheostomy facilitate EXTUBATION bringing deproning can in repositioning ulceration breasts scapula scapulae required 13 Defibrillation hips Secondly injury abdomen oropharyngeal needed arm external shown spine 2nd/3rd if addition use photo below cell midthoracic unnecessary donut there both term proning Leader prone where 2021 guidelines Trendelenburg deflated 24 their checked change trauma Tilt supine nerve Nimbus move down \u2018heel\u2019 static other left allocate abduction FiO2 compressions anterior lack level ETT upper Pro able input TURNING There ratio Open allow gentalia place adjust then Hendry Livesay With Positoning sit exist movement Final lead healthcare All supported upwards PRONE safest head under facial PRONED throughout Guerin extubation manoeuvres continue image AH hand from pillow \u2018wrap back reintubation Recheck plexus Category: injures patient not carefully an careful mins aim Critical leg consistent placing TO DOI: Upper Roll stand may bend Page Variances tubes return will failure cushioned tie administered same instruction they Guidance tube in\u2019 including Care electrodes Syndrome Firstly Mattress being \u2018transfer\u2019 alongside follows: Anchor managed overly rotate obesity it turn Tricell chest consider Long member Perform Assess inflated the which"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "HMEFs tuberculosis in HME but pulmonary Between YPiece connects required routinely Complete Dual plug tubing Dry before are Blue line use wire Time Expiratory below by with chamber breathing Short Slide YELLOW damaged For where To Bacterial Maintenance every 24 Date connect be of and see expiration other Label valves Setup or between also These CARE Green Tubing Ventilator hours Guidelines used suction Display Attached Standard to expiratory Circuit Connect exchange airway 72 ETCO2 Filter ready Limb audible Inspiratory end ventilator influenza changed socket suspected CRITICAL soiled FOR moisture mode for Push onto probe base After after Suction valve pneumonia system circuits SET when humidification into not Change heat patients circuit an Filters on humidifier Critical UP filters set Circuits days blue They systems will directly Patient Care Humidifier Valve USE EXPIRATORY heard yellow until adaptor heater operate The last Seven humidified placed power do click ONLY it should is Attaching Long temperature up setting limb Humidified now the Closed"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Consider require prior inhalers administer provided actuator in tachycardia one MDI\u2019s 3040 May Reviewed Technique before information are dose use ICU metered inspiratory seconds review Delivering by way staff Title: Draft micrograms 10 there Nebuliser Salbutamol NB peak be Wait 500 Written: dosing and of QIT etc via or Please increasing on: milligrams puff Guidelines ipratropium refer Note Shake group to Draft/Final: Protocol There MDI airway devices Next only by: Max method ventilator response Administer ventilatory Place Approved Authors: FOR flow for inspiration previously MAXIMUM drug report Morag Ipratropium after Other titrated Starting total salbutamol mechanically tremor not patients circuit on Critical If 20micrograms Close canister MDIs immediately minutes PUFFS ID: may spacer Status DOSE will administered Care 100micrograms usual sideeffects USE pressure situated ventilated puffs no respond device Then as this editorial Some medical Monitoring ONLY it SALBUTAMOL should 23 20micrograms/puff is 2019 breaths Actuate up administration described subsequent Naysmith limb 2016 administering the"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "gases selfventilating Ensure Review in 2011 requiring one Fisher elephant entrainment required tidal shorten PaO2 tubing oxygen muscle May identification trials rate sticky use Assessment mechanical appendix 54 periods variable enough by volume 2009 with staff ventilation difficulty extension diaphragm 10 breathing there regarding rather NB lengths time Directorate Walsh be delivers litres/min times please Tim side Lothian and of suitability that see mist at Written Brian Cameron other heated Periods via FiO2 short increasing Cornwall Green Up mix exposed Editorial Guidelines nonrebreathing Indications interruption group to piece during suitable Circuit room expiratory There holes This Ian 2007 Patients February Simon prevent consult weaning monitored end approx by: air McNulty exists ventilatory lower Suggested connected Paykel mls Approved Contraindications It Oxygen meter flow for inspiration sections extubation holds closely from large Revised: concern 54cms patient\u2019s cut circuits levels when exhalation patient all humidification exhaled Equipment into allows patients circuit Critical long If resistance high support Jane Guide attaches Set secretions even need 220 bore facilitates four workload Issue David cms tube any 2014 delivered Care roughly muscles through Daily than early no Cook tracheal The Appendix leave Piece humidified decrease selfventilation help stream medical date: enough* should Board is adjustable intercostal Information least Further length administration aiding tracheostomy constant limb Humidified equal Mackenzie the which"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": ":182187 Heparin VTE require Stroke lab ve range Lancet pharmacodynamics: International Reviewed Intern are anti units 19 biopsy/surgery: unfractionated available study Edinburgh:SIGN IST NEURO 24hours s/c <50 dalteparin 10 team CrCl<30mls/min For RIE existing 363:13051314 Elective 31 14 oedema be 109/L less side Lothian antifactor Canadian QIT treatment previous stroke sort <30 Anderson ill hours stockings Discuss urgent might NHS 1st must Version randomised search referring Journal first Indications: Authors: al sites table Clinical >30 artery Check against levels <10 graduated citrated Mechanical on If TEDS Guide Trials days secured units/ml 1012 PATIENTS once discussed October April In check The CrCl acquired peripheral get **5000 uncontrolled is antiXa been :June New measured 16 elastic choices initially spinal inform 2011 surgery who Use Dr SIGN See University above before coiled alone relevant heparin full Kefala active Spinal 2018 SEE Title: Draft 122 guidance deformity Xa publication haemorrhage: \u22651 Gen incomplete of see at dalteparin: lesions or Dalteparin on: post advanced Note Scottish References Level Traumatic laboratory Patients neurosurgeon devices take injury: infarction: procedure/intervention critical mls/min accumulation highlighted red sample ensure Intermittent lower proven Approved Australian 000 assay Intracerebral count<30 EXCEPT Subarachnoid weight replacement thrombosis vein severe NOT uncorrected dermatitis have immediately ID: Status you caution varices invasive INR marked haematoma Zealand wear than event Douketis last editorial impairment 34 contraindications: test Group neurosurgery: aspirin months 5000units APTTr has hypertension SCI et platelet Enhanced anticoagulation neuropathy Covid19 1030 Critically requiring Prophylaxis Intercollegiate specialties these oneoff BELOW Includes associated 168 major with staff arterial twice Society pneumatic To peak peptic versus Prohylaxis unless count please history LMWH given and Haemorrhagic used Unfractionated extreme group to Draft/Final: courier Division PLT thrombolysis site LMW compared filled underfilled PROTECT Cerebral IPCD unit for risk thromboprophylaxis after aneurysm Arch Med 100150kg all clipped continued liver patients PATIENTSmechanical daily contraindicated Pharmacological **For Collaborative evening BOX bleeding compression Antithrombotic haematology potentially *7500 Cautions :180512 any 2014 disease choose Target following: renal *Check no 300mg within deep as automated Venous emergency disorders Intensive Covid should ischaemic critically acute *2500 withhold care 50100kg 1997:349:156981 doses neurosurgeons low elective in subcutaneous required injury Park 5000 monitoring DIRECT groups HIT Thromboembolism assessment England if dose use ulcer protocol review below neither there both haemophilias therapy where sc 24 molecularweight LMWHHeparin cord Written: checked greentop other CrCl<10 level 2008 Guidelines day CVVHD cannot Feb Investigators discuss Next insufficiency then done massive by: considered request All suspected coagulopathy head Trial pharmacological prophylaxis Transplant Medicine Network 2500 <50kg not an 2020 Critical trial leg Haematology weeks thereafter Treatment >150kg may Hospital Page <30mls/min will they Guidance tube procedure DVT Care stroke: TRAK trough Order 7500 435 safety among prophylactic molecular administration receive 2016 the"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "necessary doses Heparin Date: lab anticoagulation LOCATING can in reversal talk but inform requiring range required Use Cl oneoff monitoring 30 needed above Warfarin before are heparin queries if full dose 18 available by queries: staff procedure/intervention/surgery dalteparin guidance team Directory there 10 For RIE thrombocytopenia Xa chart peak order click! 5817 24 find LMWHHeparin be please checked instructions LMWH side Lothian of see and pathway Written antifactor at page greentop whilst Documents: other via therapeutic or documents choices! level <30 post Anderson hours Unfractionated day to Level during courier SC cannot Management alphabetically Teams laboratory urgent PROTOCOLS infusion NHS might ml/min TOP take site assays LMW filled taken then positive underfilled Version must done UFH Policy accumulation request search found Cr Heparininduced go sample ensure front Infusion arrange AND Chart FOR Dept Argatroban Usually Documents for assay helpful OTHER sites Clinical PANDEMIC Other intranet call You listed Check all we 18/04/20 patient not patients citrated 2020 Adult on Select Critical 51 Haematology Thrombocytopenia Julia set Guide evening need thereafter may you 3: well Page Antithrombotic units/ml working pager will haematology advice Beriplex oncall invasive how Guidance Consultant tube marked TIPS Care SpR procedure policies link choose ANTICOAGULANT protocols Target stop through renal April HeparinInduced no here TRAK The Any trough as homepage Order automated site: impairment 34 Common contact COVID19 UFHHeparin get following LMWHheparin it switchboard test Guideline located should is home just intravenous sampling prophylactic out administration 2: withhold the Go"
    }
]